archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,1.1237e-07,1.6202,1.4836,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.3218e-05,1.537,1.3321,1,1
1,GO MEMBRANE RAFT ASSEMBLY,9.4334e-07,1.4257,1.6075,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.2317,1.0334,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,7.8282e-05,1.2056,1.0142,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.071e-07,1.1934,1.1733,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.6603e-06,1.1702,1.1577,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,6.5896e-07,1.1589,1.0076,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.8084e-07,1.134,1.0144,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0207e-07,1.0912,0.96928,1,1
1,GO RESPONSE TO INTERFERON ALPHA,4.5813e-07,1.076,1.1429,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,3.9926e-07,1.0692,1.0034,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.6228e-06,1.0476,1.0026,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.8251e-06,1.0451,0.9169,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00017796,1.0416,0.74827,1,1
1,GO NEUTROPHIL HOMEOSTASIS,3.9926e-07,1.0348,0.98055,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.8084e-07,1.0286,1.0431,1,1
1,GO HYALURONAN CATABOLIC PROCESS,3.6563e-08,1.0272,1.1005,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,8.1192e-05,1.0145,0.8732,1,1
1,GO RESPONSE TO INTERFERON BETA,1.4044e-06,1.0058,1.0056,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.8958e-07,0.99939,1.0022,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,8.4155e-08,0.99651,0.92658,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,7.9801e-06,0.97653,0.82404,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.4878e-05,0.96933,0.81612,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.4772e-07,0.93268,0.98915,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,7.9801e-06,0.92892,0.80681,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.0033e-05,0.92141,0.81434,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,5.4272e-08,0.92007,0.9478,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,9.8628e-07,0.91994,0.86583,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,1.5201e-05,0.9193,0.8749,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,1.5816e-05,0.91599,0.78809,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00016595,0.91524,0.68482,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.2424e-08,0.91414,0.94863,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.4728e-06,0.90936,0.87337,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.5896e-07,0.90321,0.82466,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.6228e-06,0.89257,1.0796,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.6455e-05,0.88469,1.1712,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,3.0264e-07,0.87942,0.82221,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,4.9191e-08,0.87035,0.93596,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,8.628e-07,0.86993,0.81337,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00016023,0.8676,0.79602,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.4044e-06,0.86521,0.72344,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,8.0176e-08,0.86182,0.87975,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.0683e-06,0.85999,0.77134,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,6.2859e-08,0.85508,0.85239,1,1
1,GO MEMBRANE RAFT ORGANIZATION,1.3441e-06,0.85217,0.95192,1,1
1,GO BONE TRABECULA FORMATION,0.00011241,0.84028,0.79195,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.5122e-07,0.83422,0.79977,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.4994e-06,0.83326,0.67467,1,1
1,GO CD40 SIGNALING PATHWAY,9.2696e-08,0.82693,0.78863,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.5691e-07,0.82175,0.78534,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.8084e-07,0.81999,0.76049,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.0311e-06,0.81759,0.93372,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.4334e-07,0.81364,0.87121,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,5.2837e-06,0.80982,0.86645,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.9904e-06,0.80446,0.63411,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.9301e-06,0.80137,0.65367,1,1
1,GO ZYMOGEN INHIBITION,5.753e-07,0.79652,0.80434,1,1
1,GO PLASMINOGEN ACTIVATION,0.00010092,0.79105,0.62348,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.3763e-07,0.79033,0.73223,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.4728e-06,0.78315,0.65368,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.0829e-07,0.78271,0.78567,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,1.8521e-05,0.7774,0.63198,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,9.8628e-07,0.77482,0.67983,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.77167,0.65046,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0033e-05,0.76869,0.61658,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.4044e-06,0.76756,0.72141,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.5122e-07,0.76737,0.74242,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00081984,0.76704,0.61104,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,4.4572e-08,0.76567,0.81147,1,1
1,GO ENDODERM FORMATION,6.6003e-08,0.76452,0.82532,1,1
1,GO HIPPO SIGNALING,2.0784e-06,0.75833,0.62243,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,5.8301e-05,0.75597,0.61384,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,8.2505e-07,0.75166,0.72035,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00012512,0.75149,0.63767,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.8077e-06,0.74902,0.80662,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.1776e-06,0.74323,0.65467,1,1
1,GO CYSTEINE METABOLIC PROCESS,7.547e-05,0.74235,0.59077,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.2308e-06,0.74179,0.68499,1,1
1,GO EPIBOLY,9.2696e-08,0.73565,0.79916,1,1
1,GO LATERAL MESODERM DEVELOPMENT,9.3916e-06,0.73191,0.60779,1,1
1,GO GAP JUNCTION ASSEMBLY,8.628e-07,0.73129,0.67873,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2366e-07,0.72952,0.67823,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,5.6999e-08,0.72741,0.72055,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.6455e-05,0.72536,0.70767,1,1
1,GO CELLULAR RESPONSE TO X RAY,3.1888e-05,0.72155,0.55245,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.5774e-06,0.72044,0.66677,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.2424e-08,0.71993,0.71921,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,4.3763e-07,0.71959,0.66344,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.4674e-06,0.71211,0.66611,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.3441e-06,0.70893,0.67334,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.70463,0.61357,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.4712e-06,0.70343,0.72451,1,1
1,GO LEUKOCYTE AGGREGATION,0.00023468,0.69722,0.5829,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.2879e-07,0.69195,0.66353,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,3.4772e-07,0.68664,0.84811,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.2837e-06,0.68636,0.60558,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00044439,0.68562,0.62353,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,9.3916e-06,0.68372,0.6945,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,4.0073e-05,0.68327,0.5481,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.8131e-07,0.68278,0.6349,1,1
1,GO VASCULOGENESIS,3.6563e-08,0.68204,0.6538,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,7.889e-07,0.67903,0.81183,1,1
1,GO FIBRINOLYSIS,6.5896e-07,0.67892,0.82778,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.5331e-06,0.67604,0.59747,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.906e-06,0.66631,0.71738,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.0073e-05,0.66583,0.57596,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,4.3763e-07,0.66483,0.71001,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.5816e-05,0.66109,0.47875,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.5759e-05,0.66063,0.59806,1,1
1,GO T CELL EXTRAVASATION,7.6603e-06,0.66048,0.67073,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.1964e-05,0.66029,0.73701,1,1
1,GO REGULATION OF PINOCYTOSIS,3.9418e-06,0.65699,0.66586,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,6.0504e-05,0.65196,0.59068,1,1
1,GO SKIN MORPHOGENESIS,1.7118e-05,0.65191,0.78369,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,8.3127e-06,0.64875,0.61738,1,1
1,GO SALIVARY GLAND DEVELOPMENT,2.4692e-06,0.64757,0.62551,1,1
1,GO APOPTOTIC CELL CLEARANCE,1.3605e-07,0.64512,0.72745,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,2.3654e-06,0.64366,0.64371,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.4121e-05,0.6423,0.51051,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00011241,0.64199,0.61132,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0001165,0.64162,0.53407,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.7578e-07,0.64148,0.62761,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.2111e-07,0.64007,0.6592,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6729e-06,0.6392,0.59043,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.0226e-05,0.63898,0.52941,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,6.4994e-06,0.63626,0.71843,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.9841e-06,0.63346,0.67457,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,7.2754e-05,0.63336,0.53998,1,1
1,GO PIGMENT GRANULE MATURATION,5.0226e-05,0.63062,0.46882,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,2.7104e-08,0.62907,0.63903,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.6603e-06,0.62864,0.53364,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.9301e-06,0.62737,0.71842,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,1.104e-05,0.62689,0.52799,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.1617e-05,0.62645,0.52547,1,1
1,GO NOTOCHORD DEVELOPMENT,6.2985e-07,0.62633,0.70423,1,1
1,GO ENDODERM DEVELOPMENT,1.6452e-07,0.62469,0.66681,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.6452e-07,0.62358,0.678,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,2.4346e-05,0.62346,0.50282,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,3.0689e-05,0.62256,0.57686,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,9.7801e-06,0.62202,0.65902,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.61556,0.56702,1,1
1,GO DNA DEAMINATION,1.5816e-05,0.61555,0.60349,1,1
1,GO AMYLOID BETA CLEARANCE,8.4155e-08,0.61524,0.54825,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,9.389e-05,0.61339,0.55027,1,1
1,GO VAGINA DEVELOPMENT,3.3202e-07,0.61256,0.65971,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,2.1663e-05,0.61217,0.53119,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.4044e-06,0.61151,0.55407,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,3.0576e-06,0.61138,0.49239,1,1
1,GO SNRNA PROCESSING,0.00055855,0.60934,0.62006,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0081404,0.60817,0.41231,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00016595,0.60764,0.55067,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,7.9801e-06,0.60628,0.69415,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,5.0683e-06,0.60619,0.49758,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2658e-06,0.60537,0.57039,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,1.4609e-05,0.60305,0.62135,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.8251e-06,0.60224,0.65497,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.0221e-07,0.60223,0.61496,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.17e-07,0.60211,0.64619,1,1
1,GO COLLAGEN METABOLIC PROCESS,7.889e-07,0.60033,0.59808,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.2366e-07,0.59871,0.52701,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,5.2837e-06,0.59842,0.57506,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.8251e-06,0.5982,0.58861,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.2985e-07,0.59693,0.70293,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,5.508e-06,0.59621,0.47806,1,1
1,GO LIVER REGENERATION,5.6999e-08,0.59611,0.6007,1,1
1,GO BIOLOGICAL PHASE,0.00030804,0.59458,0.58572,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.8251e-06,0.59451,0.52684,1,1
1,GO HEME METABOLIC PROCESS,1.2308e-06,0.59409,0.53114,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.001872,0.59369,0.71041,1,1
1,GO REGULATION OF FIBRINOLYSIS,3.5759e-05,0.59308,0.60062,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,2.7343e-05,0.59277,0.51514,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.8958e-07,0.59276,0.61529,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.2308e-06,0.59159,0.654,1,1
1,GO CELLULAR RESPONSE TO IRON ION,1.2962e-05,0.59125,0.54788,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.2962e-05,0.58993,0.51416,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.349e-05,0.58951,0.57788,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.0689e-05,0.58926,0.65964,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,1.7118e-05,0.5891,0.56174,1,1
1,GO MUCUS SECRETION,0.0028957,0.58748,0.46948,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.6228e-06,0.58588,0.6777,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,4.8612e-06,0.58529,0.60886,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,5.0226e-05,0.58365,0.46739,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,8.6584e-06,0.58286,0.49544,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.0829e-07,0.58243,0.58483,1,1
1,GO MACROPHAGE PROLIFERATION,4.0073e-05,0.57999,0.56675,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00016595,0.57954,0.70907,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.0022332,0.57928,0.47339,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,8.8325e-08,0.57919,0.6336,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.3605e-07,0.57918,0.63182,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,6.2367e-06,0.57865,0.60154,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00013433,0.57848,0.48403,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.9904e-06,0.57823,0.50676,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.2837e-06,0.57606,0.63028,1,1
1,GO AORTIC VALVE DEVELOPMENT,9.3916e-06,0.57598,0.53352,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,4.1112e-06,0.57423,0.62196,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.0184e-05,0.57321,0.5496,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00026903,0.57251,0.61432,1,1
1,GO ENTRY INTO HOST,3.17e-07,0.57198,0.59247,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4674e-06,0.57079,0.49872,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.104e-05,0.56938,0.502,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,2.9532e-05,0.56806,0.73866,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.6455e-05,0.56519,0.46243,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.0194e-07,0.5628,0.61117,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0022992,0.56159,0.39377,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.6307e-05,0.55988,0.46954,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.55959,0.50843,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4712e-06,0.55853,0.53271,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.2862e-06,0.55774,0.48513,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.725e-07,0.557,0.57794,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.042857,0.55357,0.34697,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,9.7346e-05,0.55336,0.48007,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00024286,0.5528,0.58782,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.0207e-07,0.55218,0.53285,1,1
1,GO TYPE 2 IMMUNE RESPONSE,7.9801e-06,0.5506,0.54977,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,2.0784e-06,0.5505,0.52172,1,1
1,GO CYTOLYSIS,1.2862e-06,0.54962,0.4966,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.4977e-07,0.5495,0.64045,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.17e-07,0.54697,0.52031,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.0576e-06,0.54645,0.5054,1,1
1,GO RESPONSE TO X RAY,5.4977e-07,0.54565,0.5777,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00042998,0.54443,0.45712,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00026903,0.54429,0.45909,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0007696,0.54281,0.3958,1,1
1,GO INTERLEUKIN 1 PRODUCTION,5.2837e-06,0.53987,0.48705,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,7.9801e-06,0.53874,0.50146,1,1
1,GO COLLAGEN CATABOLIC PROCESS,1.8251e-06,0.53677,0.57596,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.5331e-06,0.53434,0.46425,1,1
1,GO ZYMOGEN ACTIVATION,1.9263e-05,0.53383,0.52862,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.7955e-07,0.5333,0.57902,1,1
1,GO TOLERANCE INDUCTION,0.00020448,0.53304,0.48451,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.8084e-07,0.53268,0.54957,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.5816e-05,0.53094,0.54671,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,8.1192e-05,0.53002,0.51754,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,3.8131e-07,0.5296,0.53414,1,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.033166,0.52838,0.29197,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,1.4674e-06,0.52806,0.50398,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,5.2837e-06,0.52665,0.47363,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,7.2754e-05,0.52653,0.442,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.2971e-07,0.52641,0.6023,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0012662,0.52614,0.54319,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.025414,0.52405,0.29166,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,1.2971e-07,0.52372,0.52548,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.4692e-06,0.52328,0.47487,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.8077e-06,0.52287,0.43441,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.2533e-07,0.52137,0.50961,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0001165,0.52076,0.45073,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0311e-06,0.51992,0.47903,1,1
1,GO VIRAL GENOME REPLICATION,1.5331e-06,0.51779,0.45913,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,0.51762,0.50648,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.5896e-07,0.51749,0.45881,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00023468,0.51714,0.43271,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.9301e-06,0.51547,0.55253,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00034072,0.51399,0.49181,1,1
1,GO RESPONSE TO INTERFERON GAMMA,3.1904e-06,0.51373,0.51566,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.3287e-06,0.51344,0.4293,1,1
1,GO RESPONSE TO TYPE I INTERFERON,7.2754e-05,0.51342,0.60157,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0007696,0.51309,0.42695,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.001986,0.51179,0.468,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.5427e-07,0.51143,0.51989,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.51114,0.43642,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,4.8379e-05,0.51054,0.50322,1,1
1,GO PULMONARY VALVE DEVELOPMENT,2.9532e-05,0.51006,0.52798,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.1802e-07,0.50975,0.75103,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,3.9418e-06,0.50831,0.45685,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,7.0571e-06,0.5083,0.51712,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.986e-08,0.50793,0.51951,1,1
1,GO T CELL MEDIATED IMMUNITY,5.7413e-06,0.50749,0.46847,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.8131e-07,0.50644,0.445,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,8.4205e-05,0.50559,0.48982,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,2.8418e-05,0.50512,0.6686,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,2.1702e-06,0.50384,0.64394,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,1.5201e-05,0.50369,0.49493,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.5759e-05,0.50344,0.39801,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,2.7578e-07,0.50231,0.50057,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.9904e-06,0.50181,0.43838,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.4044e-06,0.50099,0.59299,1,1
1,GO NCRNA 3 END PROCESSING,0.0023671,0.50049,0.41998,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,3.1904e-06,0.49913,0.51372,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00055855,0.49904,0.43655,1,1
1,GO PEPTIDE CROSS LINKING,9.0551e-05,0.49844,0.51113,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,3.4772e-07,0.49818,0.48082,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.1267e-06,0.49778,0.5467,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.2862e-06,0.49739,0.54362,1,1
1,GO SNRNA METABOLIC PROCESS,0.00014935,0.49715,0.50159,1,1
1,GO LYMPHANGIOGENESIS,6.8936e-07,0.49659,0.49766,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00021909,0.49644,0.44276,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.013e-05,0.49636,0.51062,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0024367,0.49603,0.40703,1,1
1,GO RESPONSE TO HYPEROXIA,3.1888e-05,0.49576,0.50399,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,2.3418e-05,0.4957,0.60339,1,1
1,GO STORE OPERATED CALCIUM ENTRY,9.7801e-06,0.49539,0.40482,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00042998,0.49536,0.45955,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0006154,0.49409,0.42515,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0006154,0.49387,0.4633,1,1
1,GO PHAGOCYTOSIS RECOGNITION,4.6597e-05,0.49342,0.56282,1,1
1,GO DETECTION OF BIOTIC STIMULUS,5.9841e-06,0.49201,0.48496,1,1
1,GO GERMINAL CENTER FORMATION,0.00014935,0.49189,0.45072,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.3654e-06,0.48985,0.42737,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,8.3127e-06,0.48682,0.50153,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.0194e-07,0.4858,0.48739,1,1
1,GO PINOCYTOSIS,6.0198e-07,0.48579,0.6063,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.2859e-08,0.48568,0.49808,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.9904e-06,0.48502,0.45136,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00014418,0.48496,0.38321,1,1
1,GO PROTEIN OXIDATION,0.00028792,0.48447,0.48241,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.3287e-06,0.48156,0.47304,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.7801e-06,0.48118,0.48285,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.8583e-05,0.48084,0.41102,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040247,0.48059,0.3766,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00013433,0.48017,0.48185,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,4.2876e-06,0.47981,0.5046,1,1
1,GO RESPONSE TO ANGIOTENSIN,6.0198e-07,0.47974,0.47927,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00037661,0.4782,0.39544,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.47789,0.43376,1,1
1,GO VIRAL RNA GENOME REPLICATION,8.8325e-08,0.47778,0.45863,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014418,0.47666,0.37759,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,9.2696e-08,0.4766,0.42306,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00025131,0.47632,0.37753,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.00069957,0.47561,0.34712,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,9.8628e-07,0.47554,0.39637,1,1
1,GO NIK NF KAPPAB SIGNALING,4.7955e-07,0.4751,0.42039,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.2862e-06,0.47487,0.50251,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.5331e-06,0.47403,0.41655,1,1
1,GO BLOOD VESSEL REMODELING,2.0833e-05,0.47379,0.43883,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00021909,0.47378,0.45168,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00011241,0.47378,0.46108,1,1
1,GO REGULATION OF TRANSPOSITION,0.00014418,0.47325,0.46463,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.47301,0.53275,1,1
1,GO HYALURONAN METABOLIC PROCESS,1.1237e-07,0.47297,0.52167,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0047853,0.4729,0.35353,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,5.753e-07,0.47243,0.4334,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.7955e-07,0.47221,0.49545,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.5308e-05,0.47181,0.44513,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.2962e-05,0.47136,0.48344,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9904e-06,0.47106,0.45275,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0087944,0.47047,0.40213,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0010528,0.46949,0.46298,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0014738,0.46929,0.37036,1,1
1,GO ENAMEL MINERALIZATION,0.00072223,0.4692,0.423,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,1.7806e-05,0.46886,0.43651,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.5308e-05,0.46844,0.45581,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.46829,0.42022,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,4.3763e-07,0.46814,0.50586,1,1
1,GO DEFENSE RESPONSE TO VIRUS,9.3916e-06,0.46678,0.41691,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.43498,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.4977e-07,0.46666,0.50854,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9418e-06,0.4665,0.41569,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.6455e-05,0.46553,0.46816,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.001662,0.46536,0.31918,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,3.1904e-06,0.46434,0.45831,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.5308e-05,0.46346,0.50702,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0012662,0.46336,0.39519,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,6.7728e-06,0.46328,0.52107,1,1
1,GO RESPONSE TO INTERLEUKIN 12,2.7578e-07,0.4632,0.44563,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0024367,0.4632,0.38962,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.9904e-06,0.46315,0.41691,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00045924,0.46295,0.33024,1,1
1,GO REGULATION OF MRNA BINDING,3.3287e-06,0.4627,0.41994,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.00022676,0.46245,0.40815,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.4421e-05,0.46232,0.46111,1,1
1,GO BONE GROWTH,7.0571e-06,0.4616,0.52384,1,1
1,GO PROTEIN ACTIVATION CASCADE,5.0683e-06,0.46127,0.40035,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.1964e-05,0.46093,0.43354,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00010845,0.4598,0.52745,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.020205,0.4594,0.23727,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,6.2985e-07,0.45774,0.50017,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00022676,0.45763,0.41872,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.033166,0.45761,0.29427,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,5.2837e-06,0.45696,0.45234,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.5427e-07,0.45695,0.43908,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.8521e-05,0.45626,0.40839,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,6.2367e-06,0.45585,0.4609,1,1
1,GO RESPONSE TO PROGESTERONE,0.0017641,0.45583,0.32059,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.2658e-06,0.4558,0.46274,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.45573,0.4068,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00016023,0.45571,0.4926,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00081984,0.4554,0.34936,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.2876e-06,0.45535,0.36981,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,3.4421e-05,0.45525,0.39758,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,8.3127e-06,0.45515,0.49197,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.5774e-06,0.45481,0.39375,1,1
1,GO ANIMAL ORGAN REGENERATION,2.3975e-07,0.45455,0.50144,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6322e-07,0.45439,0.3975,1,1
1,GO PROTEASOME ASSEMBLY,4.1617e-05,0.45437,0.3364,1,1
1,GO REGULATION OF MYOBLAST FUSION,0.00023468,0.45363,0.50937,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.4268e-07,0.45311,0.41291,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,1.2962e-05,0.45257,0.48879,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,2.2879e-07,0.4525,0.50145,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.628e-07,0.45234,0.47687,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.2505e-07,0.45233,0.44963,1,1
1,GO MRNA TRANSCRIPTION,1.4039e-05,0.45148,0.38383,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.3654e-06,0.45052,0.39493,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.5331e-06,0.45007,0.39722,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.889e-07,0.44967,0.50353,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00017796,0.44966,0.36998,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.00027832,0.44965,0.41466,1,1
1,GO REPLICATIVE SENESCENCE,0.00353,0.44847,0.39897,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,5.4121e-05,0.44817,0.48627,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00010845,0.44817,0.37787,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,9.4334e-07,0.44781,0.41043,1,1
1,GO VIRAL TRANSLATION,1.3441e-06,0.44742,0.46639,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00010845,0.44599,0.40653,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9904e-06,0.44516,0.41648,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,2.2658e-06,0.44452,0.37293,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,7.8282e-05,0.44444,0.4301,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.6902e-06,0.44436,0.45121,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.5308e-05,0.44397,0.53678,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00014935,0.4436,0.4002,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,4.4712e-06,0.44329,0.41603,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00031859,0.44306,0.32562,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.8521e-05,0.44305,0.39401,1,1
1,GO RETINAL METABOLIC PROCESS,0.0060989,0.44287,0.33196,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.725e-07,0.4425,0.43634,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.3287e-06,0.44232,0.48818,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,7.547e-05,0.44199,0.42664,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0012662,0.44186,0.37157,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,4.5813e-07,0.44172,0.37855,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.1663e-05,0.44164,0.43129,1,1
1,GO EMBRYO IMPLANTATION,2.6322e-07,0.44132,0.5358,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.8612e-06,0.44108,0.53545,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.1904e-06,0.44026,0.40879,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00050664,0.43989,0.47689,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6015e-06,0.43934,0.44559,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,6.4994e-06,0.43912,0.42886,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.011047,0.43852,0.43959,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0014299,0.43804,0.52162,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00063551,0.4374,0.51307,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00063551,0.4374,0.63563,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,5.0194e-07,0.43604,0.48761,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,6.2786e-05,0.43596,0.39399,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.753e-07,0.43407,0.45456,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,5.2533e-07,0.43302,0.41205,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,3.3132e-05,0.43244,0.39143,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00029782,0.43191,0.44502,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.7343e-05,0.43171,0.38489,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.4121e-05,0.43024,0.3901,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00069957,0.43016,0.44846,1,1
1,GO RECEPTOR CATABOLIC PROCESS,2.5774e-06,0.42956,0.43152,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00040247,0.4288,0.41113,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.6015e-06,0.42879,0.42076,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.906e-06,0.42869,0.58892,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,1.104e-05,0.42862,0.4467,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,6.0504e-05,0.42837,0.37197,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00016595,0.42826,0.4472,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.42797,0.32597,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00045924,0.42784,0.37855,1,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.027188,0.42765,0.24147,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0045306,0.42732,0.38713,1,1
1,GO RIBOSOME ASSEMBLY,0.00021909,0.42689,0.37441,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0010859,0.42653,0.33772,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.5759e-05,0.42639,0.37995,1,1
1,GO FIBROBLAST MIGRATION,1.5331e-06,0.42632,0.42232,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.0033e-05,0.4263,0.43865,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.2366e-07,0.42609,0.46131,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00041602,0.42578,0.43941,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0031536,0.42541,0.3265,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2366e-07,0.42501,0.39274,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.42457,0.54563,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,1.8521e-05,0.42362,0.38165,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,7.0571e-06,0.42352,0.41672,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,4.1112e-06,0.42312,0.44122,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00025131,0.42276,0.3656,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.045624,0.42165,0.24348,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.8301e-05,0.42162,0.37248,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0010859,0.42149,0.38134,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00045924,0.42118,0.48267,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0001547,0.42069,0.34638,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,3.1888e-05,0.42058,0.38257,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.1663e-05,0.42048,0.38773,1,1
1,GO CERAMIDE CATABOLIC PROCESS,6.0504e-05,0.4201,0.38148,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1776e-06,0.42008,0.42852,1,1
1,GO VIRAL LIFE CYCLE,3.0264e-07,0.41928,0.42543,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0001547,0.41923,0.36848,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0038387,0.41914,0.53671,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.2454e-05,0.41881,0.36178,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,8.6584e-06,0.4188,0.38209,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.0689e-05,0.41844,0.39791,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,7.6603e-06,0.41807,0.49516,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00020448,0.41777,0.40296,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00014935,0.41754,0.59989,1,1
1,GO MULTI ORGANISM LOCALIZATION,4.9191e-08,0.41721,0.4244,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00010845,0.41699,0.36499,1,1
1,GO REGULATION OF GASTRULATION,2.3975e-07,0.41601,0.41245,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00032948,0.41595,0.33092,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.2524e-05,0.4159,0.39301,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00030804,0.41575,0.33338,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,4.6623e-06,0.41524,0.44584,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.4143,0.36184,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.4772e-07,0.4132,0.40957,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,9.3916e-06,0.4132,0.36957,1,1
1,GO IMMATURE T CELL PROLIFERATION,3.8583e-05,0.41288,0.45111,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.349e-05,0.41274,0.38678,1,1
1,GO REGULATION OF STEROL TRANSPORT,6.2985e-07,0.41259,0.38198,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0015653,0.41227,0.31667,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,9.8628e-07,0.41222,0.40637,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,2.5308e-05,0.41174,0.33445,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00069957,0.41129,0.29911,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41099,0.39983,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00019079,0.41069,0.37711,1,1
1,GO I KAPPAB PHOSPHORYLATION,3.3132e-05,0.41068,0.3092,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,9.0221e-07,0.41033,0.42967,1,1
1,GO RESPONSE TO SALT STRESS,2.6902e-06,0.41028,0.3857,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0028141,0.41024,0.33095,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00019753,0.40996,0.35024,1,1
1,GO MATURATION OF SSU RRNA,9.0551e-05,0.40983,0.37767,1,1
1,GO COPPER ION HOMEOSTASIS,2.0784e-06,0.40959,0.50766,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.5331e-06,0.40922,0.37514,1,1
1,GO PLATELET AGGREGATION,5.0683e-06,0.40867,0.36513,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.40854,0.45453,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00029782,0.40834,0.342,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,2.2658e-06,0.40805,0.45816,1,1
1,GO INTERLEUKIN 17 PRODUCTION,8.2505e-07,0.40798,0.48558,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,4.1112e-06,0.40748,0.44665,1,1
1,GO INTERACTION WITH SYMBIONT,5.508e-06,0.40735,0.35444,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,2.0033e-05,0.40725,0.58454,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.1617e-05,0.40626,0.43064,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,5.7413e-06,0.40615,0.41037,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.0604e-05,0.40562,0.39872,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.9801e-06,0.4053,0.47221,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,7.013e-05,0.40486,0.43489,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,2.2524e-05,0.40417,0.49295,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00023468,0.40416,0.33159,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0036303,0.40393,0.40015,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,5.7413e-06,0.40352,0.48342,1,1
1,GO INTERLEUKIN 8 PRODUCTION,1.4609e-05,0.40344,0.37777,1,1
1,GO TRANSLATIONAL INITIATION,5.2139e-05,0.403,0.3605,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.1663e-05,0.40265,0.44973,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.3441e-06,0.40259,0.38901,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00037661,0.40258,0.356,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.1617e-05,0.40231,0.4844,1,1
1,GO CELL SUBSTRATE ADHESION,1.4044e-06,0.40222,0.41372,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.628e-07,0.40216,0.40876,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,6.7728e-06,0.40163,0.34615,1,1
1,GO FOREGUT MORPHOGENESIS,1.349e-05,0.40157,0.45945,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.4121e-05,0.40103,0.33543,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.8282e-05,0.39932,0.38795,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00065623,0.39931,0.39145,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.6902e-06,0.39927,0.36682,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00017186,0.39849,0.49779,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.5813e-07,0.39777,0.43334,1,1
1,GO INTERFERON BETA PRODUCTION,0.0001165,0.39715,0.2995,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00014935,0.39707,0.28036,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.7728e-06,0.39685,0.33904,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.023741,0.39657,0.31789,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,5.2139e-05,0.39652,0.36547,1,1
1,GO PRIMARY MIRNA PROCESSING,8.7323e-05,0.39624,0.38327,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.3441e-06,0.39594,0.33394,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.2308e-06,0.39547,0.50288,1,1
1,GO SPROUTING ANGIOGENESIS,1.2962e-05,0.3953,0.35812,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.1702e-06,0.39518,0.33824,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2454e-05,0.39516,0.43612,1,1
1,GO HAIR FOLLICLE MATURATION,0.0015653,0.39467,0.32374,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00030804,0.39438,0.35727,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00090094,0.39437,0.32512,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.001191,0.39434,0.51396,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0019282,0.39327,0.3967,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.023741,0.39315,0.30851,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.9532e-05,0.39301,0.46268,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0030654,0.39272,0.38591,1,1
1,GO B CELL MEDIATED IMMUNITY,2.5774e-06,0.39219,0.35276,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00016595,0.39211,0.31308,1,1
1,GO PLATELET DEGRANULATION,2.6902e-06,0.39201,0.45925,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,3.3287e-06,0.39165,0.3422,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.104e-05,0.39129,0.34261,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.9841e-06,0.39084,0.41501,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.9418e-06,0.39052,0.43315,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00021909,0.38987,0.34272,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0079323,0.38965,0.30906,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,8.0176e-08,0.38928,0.37665,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.4712e-06,0.38909,0.35891,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00013433,0.38888,0.32394,1,1
1,GO INTERACTION WITH HOST,6.2985e-07,0.38851,0.43434,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.9301e-06,0.38821,0.40493,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.00017186,0.38817,0.39047,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.38815,0.35503,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00059588,0.38813,0.34016,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,9.7801e-06,0.38778,0.35051,1,1
1,GO T CELL APOPTOTIC PROCESS,1.6729e-06,0.38743,0.36383,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.6455e-05,0.38722,0.39392,1,1
1,GO REGULATION OF PROTEIN IMPORT,8.3127e-06,0.38711,0.37908,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4039e-05,0.38665,0.37537,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00098941,0.38633,0.40189,1,1
1,GO MUSCLE FILAMENT SLIDING,9.4334e-07,0.38628,0.41839,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,2.3975e-07,0.38616,0.38284,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00092958,0.3861,0.30747,1,1
1,GO RESPONSE TO ESTROGEN,1.9904e-06,0.38605,0.3778,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.001662,0.38604,0.4903,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,6.0504e-05,0.38559,0.56029,1,1
1,GO MATURATION OF 5 8S RRNA,0.00012512,0.38425,0.32521,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.00012074,0.38399,0.3414,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00028792,0.38394,0.35911,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.0001547,0.38381,0.29597,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00028792,0.38332,0.32387,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0022992,0.38332,0.331,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.018836,0.3829,0.29875,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,4.9191e-08,0.38225,0.38719,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00054072,0.3818,0.35158,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0067808,0.38149,0.37362,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0010528,0.3813,0.38381,1,1
1,GO ARGININE METABOLIC PROCESS,0.00021909,0.38098,0.39643,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.0184e-05,0.38043,0.33361,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00028792,0.37978,0.38542,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0047853,0.37968,0.27982,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,1.104e-05,0.37912,0.34024,1,1
1,GO MEMBRANE INVAGINATION,1.0207e-07,0.37863,0.40224,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,4.6623e-06,0.37795,0.33384,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0015189,0.37771,0.42536,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,1.1964e-05,0.3776,0.31284,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.8251e-06,0.37732,0.36546,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.4609e-05,0.37726,0.32799,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00020448,0.37719,0.3185,1,1
1,GO REGULATION OF PHAGOCYTOSIS,3.17e-07,0.37716,0.40851,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0038387,0.37671,0.42188,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0022332,0.37628,0.2832,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.1964e-05,0.37625,0.32639,1,1
1,GO GLAND MORPHOGENESIS,4.3218e-05,0.37522,0.41221,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,2.8418e-05,0.37495,0.38061,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00026003,0.37486,0.31498,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00010845,0.37483,0.30565,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,3.7145e-05,0.37481,0.35205,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,4.3218e-05,0.37455,0.41245,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00040247,0.37435,0.34468,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00016023,0.37418,0.3585,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.7145e-05,0.37396,0.46547,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.8282e-05,0.37373,0.33779,1,1
1,GO VIRAL GENE EXPRESSION,1.7118e-05,0.37334,0.37695,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,1.9263e-05,0.37273,0.34379,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00029782,0.37209,0.29398,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,3.7791e-06,0.37192,0.39776,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.001872,0.3718,0.32209,1,1
1,GO FIBROBLAST PROLIFERATION,3.7145e-05,0.37164,0.3409,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,7.3528e-06,0.37147,0.36544,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.5201e-05,0.37096,0.33116,1,1
1,GO TRABECULA FORMATION,0.00052342,0.37094,0.45107,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.036948,0.37062,0.21831,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,3.0689e-05,0.36943,0.34969,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00065623,0.36932,0.33428,1,1
1,GO MEMBRANE DISASSEMBLY,0.00027832,0.36932,0.29925,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.5427e-07,0.36891,0.36789,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,4.0073e-05,0.3687,0.3934,1,1
1,GO RIG I SIGNALING PATHWAY,3.4421e-05,0.36825,0.37021,1,1
1,GO REGULATION OF LIPASE ACTIVITY,1.4609e-05,0.36824,0.2794,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00081984,0.36805,0.36957,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0041716,0.3679,0.29498,1,1
1,GO GLIAL CELL ACTIVATION,3.3132e-05,0.36788,0.36745,1,1
1,GO CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.36766,0.33175,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0006154,0.36671,0.35586,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0015189,0.36667,0.43241,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.36639,0.27119,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.013e-05,0.366,0.32724,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.3127e-06,0.36579,0.42378,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0054795,0.36563,0.38914,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0034322,0.36536,0.29737,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00034072,0.36523,0.39902,1,1
1,GO ERAD PATHWAY,1.2308e-06,0.36505,0.30767,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00069957,0.36504,0.34157,1,1
1,GO REGULATION OF COAGULATION,2.7343e-05,0.3648,0.4143,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,2.9532e-05,0.36479,0.3134,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0015653,0.36442,0.38977,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,5.2837e-06,0.36359,0.35386,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.8521e-05,0.36351,0.39524,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.9418e-06,0.36329,0.49364,1,1
1,GO FOCAL ADHESION ASSEMBLY,7.3528e-06,0.36329,0.40534,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4712e-06,0.36285,0.40413,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00016595,0.36279,0.272,1,1
1,GO MESODERM MORPHOGENESIS,2.8891e-07,0.36274,0.38224,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.4609e-05,0.36256,0.31787,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00095906,0.36245,0.35396,1,1
1,GO GENITALIA MORPHOGENESIS,0.0017641,0.36221,0.33722,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.349e-05,0.3622,0.37599,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00038934,0.36215,0.45525,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00079435,0.36213,0.36151,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.001228,0.36203,0.28489,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010092,0.36198,0.29342,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.4346e-05,0.36163,0.35248,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00079435,0.36051,0.35195,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.05161,0.3604,0.16368,1,1
1,GO VASCULATURE DEVELOPMENT,4.1112e-06,0.36033,0.31669,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.045624,0.36024,0.21688,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0015189,0.36023,0.33471,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00049035,0.36016,0.43747,1,1
1,GO GASTRULATION,2.1831e-07,0.35998,0.38701,1,1
1,GO RESPONSE TO VIRUS,4.2876e-06,0.3591,0.36356,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,7.2754e-05,0.35868,0.29828,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0604e-05,0.35848,0.4102,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.5308e-05,0.35847,0.29108,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.027188,0.35829,0.19678,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.7346e-05,0.35799,0.29216,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00021909,0.35799,0.26595,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,9.7801e-06,0.35757,0.39709,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0010206,0.35754,0.31076,1,1
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.027188,0.35714,0.23848,1,1
1,GO HYPOTONIC RESPONSE,0.00016595,0.35712,0.32895,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,6.2786e-05,0.35696,0.29233,1,1
1,GO WOUND HEALING,8.6584e-06,0.35685,0.33441,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.0833e-05,0.35633,0.32695,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0036303,0.3562,0.31111,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0024367,0.35608,0.43759,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,5.2837e-06,0.35555,0.37305,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.3441e-06,0.35527,0.37314,1,1
1,GO REGULATION OF PROTEIN MATURATION,2.6902e-06,0.35515,0.36714,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00034072,0.35492,0.39162,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0062634,0.35477,0.27362,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.7118e-05,0.35458,0.31043,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0021689,0.3545,0.29184,1,1
1,GO ENDOTHELIAL CELL MIGRATION,1.5201e-05,0.35421,0.3406,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.5308e-05,0.35415,0.33292,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.0023671,0.35364,0.31022,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,8.3127e-06,0.35336,0.36198,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6174e-05,0.35295,0.32769,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,5.2139e-05,0.35283,0.38232,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,7.9801e-06,0.35225,0.31169,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0015189,0.3522,0.35896,1,1
1,GO RESPONSE TO MANGANESE ION,7.6603e-06,0.3521,0.34046,1,1
1,GO PIGMENT ACCUMULATION,0.0001547,0.35138,0.32351,1,1
1,GO NUCLEOSIDE SALVAGE,0.00095906,0.35108,0.43139,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00044439,0.35092,0.31778,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.9263e-05,0.35072,0.3416,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,0.3507,0.28609,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.3654e-06,0.35015,0.34466,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.1888e-05,0.34969,0.26324,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.4421e-05,0.34844,0.38486,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00038934,0.34802,0.30143,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.0571e-06,0.3479,0.32981,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.7323e-05,0.34714,0.43855,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00031859,0.34688,0.34565,1,1
1,GO L GLUTAMATE IMPORT,0.00038934,0.34672,0.35787,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.6902e-06,0.34652,0.36698,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.001872,0.34601,0.37409,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00045924,0.34569,0.39439,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00011241,0.34546,0.31263,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.0375e-08,0.34525,0.34067,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00042998,0.34519,0.37271,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0007696,0.34498,0.27082,1,1
1,GO NCRNA PROCESSING,2.5308e-05,0.34461,0.30403,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.3418e-05,0.34451,0.37511,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.9904e-06,0.34431,0.34938,1,1
1,GO TISSUE MIGRATION,3.8583e-05,0.34364,0.30732,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,2.0033e-05,0.34364,0.3351,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.012508,0.34348,0.37386,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00022676,0.34331,0.37889,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0075304,0.3431,0.2846,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.5774e-06,0.34289,0.32212,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6729e-06,0.34281,0.39055,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00021909,0.34226,0.37044,1,1
1,GO PEPTIDE CATABOLIC PROCESS,1.104e-05,0.34213,0.29851,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0016129,0.34158,0.34907,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0090226,0.34122,0.24725,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,6.7596e-05,0.34108,0.34712,1,1
1,GO PROTEIN HYDROXYLATION,0.0046564,0.34105,0.3742,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.010245,0.34058,0.29353,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.0779e-06,0.34036,0.42456,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00059588,0.33985,0.30223,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.33959,0.27452,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00054072,0.33946,0.30081,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,4.4878e-05,0.33939,0.34297,1,1
1,GO T CELL MIGRATION,4.8379e-05,0.33927,0.30731,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00054072,0.33911,0.36866,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.33876,0.30838,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0023671,0.33853,0.39066,1,1
1,GO NADPH REGENERATION,0.00022676,0.33842,0.31369,1,1
1,GO NATURAL KILLER CELL ACTIVATION,4.4712e-06,0.33817,0.33046,1,1
1,GO CARTILAGE DEVELOPMENT,2.1663e-05,0.33751,0.29274,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.5201e-05,0.33746,0.27946,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.349e-05,0.33712,0.45658,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0604e-05,0.33709,0.33633,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.5813e-07,0.33696,0.32253,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00013433,0.33692,0.27269,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.5813e-07,0.33631,0.34936,1,1
1,GO PROSTATIC BUD FORMATION,0.00087311,0.33585,0.45168,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.33546,0.31306,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021062,0.3352,0.31817,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,9.3916e-06,0.3351,0.30708,1,1
1,GO FIBROBLAST ACTIVATION,0.0010859,0.3347,0.35971,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,3.3287e-06,0.33466,0.40503,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,9.7346e-05,0.33419,0.30144,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,5.4121e-05,0.3341,0.2725,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.7806e-05,0.3341,0.39181,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00081984,0.33395,0.21264,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00021167,0.33394,0.27285,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,4.4712e-06,0.33393,0.3397,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.3418e-05,0.33349,0.40185,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.5813e-07,0.33348,0.40688,1,1
1,GO IRON ION HOMEOSTASIS,1.9904e-06,0.33337,0.29119,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.00012964,0.33307,0.2633,1,1
1,GO DECIDUALIZATION,0.0028141,0.33303,0.3997,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00012964,0.33299,0.35197,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.010245,0.3324,0.25072,1,1
1,GO MYOBLAST DIFFERENTIATION,7.9801e-06,0.33197,0.34007,1,1
1,GO AMYLOID FIBRIL FORMATION,0.0037331,0.33182,0.31092,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00044439,0.33181,0.33212,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00057693,0.3317,0.37076,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,7.547e-05,0.33161,0.29919,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00081984,0.33142,0.23567,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,6.4994e-06,0.33124,0.3086,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0041716,0.33107,0.28048,1,1
1,GO PROTEIN TARGETING TO VACUOLE,9.7801e-06,0.331,0.28905,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,5.2837e-06,0.33076,0.32005,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.33076,0.24713,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.7145e-05,0.33059,0.28758,1,1
1,GO RESPONSE TO WOUNDING,9.7801e-06,0.33042,0.28797,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,4.3218e-05,0.33019,0.26161,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00016023,0.33008,0.29939,1,1
1,GO TISSUE REGENERATION,5.6174e-05,0.32996,0.316,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,5.0226e-05,0.32992,0.32222,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00035231,0.32987,0.34705,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.7413e-06,0.32971,0.2984,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00049035,0.32957,0.31638,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,3.7791e-06,0.32946,0.39779,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,8.1192e-05,0.32881,0.26985,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.8612e-06,0.3284,0.31024,1,1
1,GO PIGMENT METABOLIC PROCESS,6.2367e-06,0.32794,0.31283,1,1
1,GO REGENERATION,5.753e-07,0.32782,0.31146,1,1
1,GO TOOTH MINERALIZATION,0.0038387,0.32768,0.28371,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00081984,0.32768,0.29554,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0015653,0.32766,0.35193,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.327,0.31905,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0022992,0.32691,0.34381,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.32652,0.35008,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00041602,0.3263,0.36731,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.0007696,0.32583,0.25501,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0032441,0.32576,0.32374,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00044439,0.32549,0.35337,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00049035,0.3253,0.38365,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,2.0033e-05,0.32525,0.30646,1,1
1,GO MUSCLE CELL PROLIFERATION,5.9841e-06,0.32517,0.32699,1,1
1,GO COMPLEMENT ACTIVATION,2.6902e-06,0.32499,0.32038,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.2454e-05,0.32487,0.28297,1,1
1,GO ASYMMETRIC CELL DIVISION,0.00036427,0.32482,0.28376,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0025083,0.32481,0.30746,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00045924,0.32476,0.26561,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0021062,0.32454,0.25603,1,1
1,GO CELL REDOX HOMEOSTASIS,1.4609e-05,0.32449,0.29923,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.4205e-05,0.32447,0.35753,1,1
1,GO REGULATION OF HEART GROWTH,2.6307e-05,0.32407,0.27893,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.3441e-06,0.32407,0.28376,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00026903,0.32306,0.33732,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00030804,0.32259,0.28955,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.02843,0.32249,0.18206,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0021689,0.32248,0.33873,1,1
1,GO RESPONSE TO INTERLEUKIN 1,3.0576e-06,0.32236,0.35341,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00037661,0.32232,0.33249,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.049546,0.32232,0.29605,1,1
1,GO REGULATION OF RNA BINDING,1.8251e-06,0.32229,0.32726,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.015953,0.32214,0.31562,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.3287e-06,0.32205,0.35429,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.322,0.34007,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.023205,0.32195,0.22463,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.001191,0.32189,0.28596,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2876e-06,0.32185,0.31692,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0011549,0.32181,0.23169,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0042883,0.32181,0.25404,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0010206,0.32125,0.31164,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00021909,0.3212,0.30991,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00036427,0.32043,0.21272,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00042998,0.32013,0.28712,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00021167,0.319,0.3633,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.9301e-06,0.31874,0.33197,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0027346,0.31856,0.29315,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0064317,0.31838,0.19883,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,2.5308e-05,0.31838,0.3141,1,1
1,GO HISTONE PHOSPHORYLATION,1.3441e-06,0.31819,0.30491,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,9.389e-05,0.31814,0.35779,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00030804,0.31799,0.33109,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.4728e-06,0.31778,0.32173,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,9.0179e-06,0.31755,0.40472,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0033369,0.31751,0.41124,1,1
1,GO NECROTIC CELL DEATH,7.8282e-05,0.31738,0.39379,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.349e-05,0.31729,0.3179,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,5.9841e-06,0.31723,0.40967,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0025083,0.31703,0.29035,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0097392,0.31662,0.27932,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.4044e-06,0.31659,0.35182,1,1
1,GO ASTROCYTE ACTIVATION,0.0010206,0.31652,0.31038,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00032948,0.31639,0.26239,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00047456,0.31617,0.30627,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0085714,0.31575,0.30611,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0067808,0.3156,0.43487,1,1
1,GO CYTOKINETIC PROCESS,3.0689e-05,0.31522,0.29585,1,1
1,GO SYNCYTIUM FORMATION,5.4121e-05,0.31517,0.32681,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00014418,0.31509,0.32332,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0021062,0.31497,0.36082,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.0033e-05,0.31461,0.32994,1,1
1,GO INNATE IMMUNE RESPONSE,1.4039e-05,0.31441,0.27788,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,5.6174e-05,0.31417,0.33699,1,1
1,GO PLASMA MEMBRANE TUBULATION,1.1776e-06,0.31413,0.37146,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.1112e-06,0.31412,0.29353,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00016595,0.31346,0.23128,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.5816e-05,0.31333,0.3292,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.03939,0.31279,0.1933,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00036427,0.3127,0.29517,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00018427,0.31232,0.31437,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.00013917,0.31231,0.39721,1,1
1,GO RNA 5 END PROCESSING,0.00026903,0.31199,0.28801,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,5.9841e-06,0.31172,0.30218,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010462,0.31172,0.29202,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00013433,0.31169,0.28328,1,1
1,GO KERATINOCYTE MIGRATION,8.7323e-05,0.31165,0.3432,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.2524e-05,0.31153,0.37744,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.3441e-06,0.31129,0.28248,1,1
1,GO VESICLE CARGO LOADING,0.00010845,0.31075,0.29275,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00038934,0.31035,0.26265,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,8.1192e-05,0.30967,0.27815,1,1
1,GO RRNA METABOLIC PROCESS,0.00012964,0.30964,0.30083,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00063551,0.30959,0.29875,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,9.0551e-05,0.30957,0.37805,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.30918,0.29374,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,1.7118e-05,0.30894,0.43469,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,6.5149e-05,0.30894,0.29085,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.30883,0.30611,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.001872,0.30877,0.28226,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.2658e-06,0.30865,0.35243,1,1
1,GO GONADOTROPIN SECRETION,0.0071468,0.30838,0.26456,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.017137,0.30809,0.26241,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,2.3418e-05,0.30748,0.25106,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.0025817,0.30672,0.30695,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00031859,0.3067,0.34436,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,7.3528e-06,0.30614,0.29803,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,4.4712e-06,0.30588,0.28108,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,6.0504e-05,0.30587,0.29954,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00049035,0.30567,0.27372,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.1192e-05,0.30565,0.33582,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00012074,0.30545,0.25859,1,1
1,GO TRNA 5 LEADER REMOVAL,0.0001547,0.30539,0.31858,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.007729,0.30531,0.20372,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,4.0073e-05,0.30525,0.25966,1,1
1,GO RESPONSE TO DSRNA,9.8628e-07,0.30518,0.37605,1,1
1,GO MACROPHAGE MIGRATION,3.9418e-06,0.30506,0.36068,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.3218e-05,0.30485,0.3339,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.001872,0.30485,0.26523,1,1
1,GO NCRNA METABOLIC PROCESS,5.2139e-05,0.30479,0.26796,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.9418e-06,0.30478,0.307,1,1
1,GO CELL MATRIX ADHESION,1.7118e-05,0.30469,0.34271,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,1.2454e-05,0.30468,0.26794,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.6902e-06,0.30461,0.29689,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.046579,0.30444,0.39175,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,8.1192e-05,0.30437,0.34894,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2962e-05,0.304,0.40382,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00029782,0.30389,0.29192,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00019753,0.30383,0.29042,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.889e-07,0.30344,0.24135,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.2524e-05,0.30341,0.28314,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0010859,0.30333,0.28202,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00044439,0.30304,0.3445,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.906e-06,0.30251,0.44456,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0014738,0.30227,0.30753,1,1
1,GO TRANSLATIONAL TERMINATION,0.00057693,0.30227,0.24308,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0081404,0.30201,0.24022,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00012074,0.30194,0.32051,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,4.1617e-05,0.30191,0.34806,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.1702e-06,0.30181,0.35084,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.3441e-06,0.30171,0.3822,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00055855,0.30164,0.26104,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.001191,0.30159,0.27792,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00014418,0.30158,0.24673,1,1
1,GO SELECTIVE AUTOPHAGY,3.17e-07,0.30121,0.32186,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,2.2524e-05,0.30117,0.30233,1,1
1,GO MUSCLE CELL MIGRATION,0.023205,0.30077,0.22351,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.7145e-05,0.30073,0.26853,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.0604e-05,0.30055,0.31976,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00067758,0.30023,0.27416,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0037331,0.30007,0.31925,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.4994e-06,0.30003,0.29449,1,1
1,GO T CELL CYTOKINE PRODUCTION,9.3916e-06,0.29996,0.40732,1,1
1,GO URETER DEVELOPMENT,0.011904,0.29983,0.23486,1,1
1,GO LIPID IMPORT INTO CELL,0.0032441,0.29972,0.25292,1,1
1,GO STEROL TRANSPORT,2.5308e-05,0.29969,0.26096,1,1
1,GO SPERM EGG RECOGNITION,1.3441e-06,0.29954,0.27761,1,1
1,GO ETHANOL OXIDATION,0.031059,0.2994,0.30429,1,1
1,GO RRNA MODIFICATION,0.0021689,0.2993,0.22642,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.02843,0.29922,0.36721,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.1112e-06,0.29899,0.25283,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,8.6584e-06,0.29871,0.3205,1,1
1,GO FOAM CELL DIFFERENTIATION,0.00034072,0.29858,0.28637,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0056288,0.29853,0.36097,1,1
1,GO LYMPHOCYTE MIGRATION,5.6174e-05,0.29851,0.24202,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.29845,0.36124,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00084609,0.29836,0.27165,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0041716,0.29829,0.22142,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.29795,0.27465,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,7.9801e-06,0.29783,0.28569,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.001872,0.29761,0.31318,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00026003,0.29748,0.25978,1,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.020205,0.29705,0.24385,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.6455e-05,0.2969,0.34688,1,1
1,GO RIBOSOME BIOGENESIS,0.00010092,0.29663,0.31796,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00098941,0.29649,0.28806,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00010845,0.29605,0.31195,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.2879e-07,0.296,0.29876,1,1
1,GO RNA CATABOLIC PROCESS,4.5813e-07,0.29577,0.27874,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,5.7413e-06,0.29555,0.2837,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.4421e-05,0.29543,0.27075,1,1
1,GO CHOLESTEROL EFFLUX,4.2876e-06,0.29542,0.32058,1,1
1,GO RESPONSE TO CYTOKINE,7.6603e-06,0.29539,0.30307,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00067758,0.2953,0.26988,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.2524e-05,0.29524,0.31439,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00032948,0.29502,0.23839,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,2.6902e-06,0.29489,0.25646,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013457,0.29486,0.2767,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,3.9418e-06,0.2947,0.3112,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021909,0.29444,0.35579,1,1
1,GO CYTOKINE PRODUCTION,1.2454e-05,0.2941,0.26883,1,1
1,GO REGULATION OF CELL AGING,1.4268e-07,0.29407,0.33608,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.014486,0.29383,0.26868,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.0779e-06,0.29365,0.25265,1,1
1,GO T CELL CHEMOTAXIS,4.6597e-05,0.29304,0.27183,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00012512,0.29295,0.34201,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,8.7323e-05,0.2926,0.26392,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,9.0179e-06,0.29254,0.2905,1,1
1,GO COAGULATION,1.0604e-05,0.29223,0.29182,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00038934,0.29203,0.23173,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,6.0504e-05,0.29202,0.33534,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0031536,0.29199,0.23119,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0036303,0.29141,0.2024,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00012512,0.29119,0.28939,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.628e-07,0.29105,0.33379,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00055855,0.29089,0.32118,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.4039e-05,0.29078,0.25405,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0053338,0.29072,0.23229,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0007696,0.29044,0.34819,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,8.3127e-06,0.29034,0.31033,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00065623,0.29023,0.18154,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.02166,0.2901,0.25645,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.29,0.24499,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0001165,0.28977,0.30431,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00013917,0.28974,0.29384,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00018427,0.28965,0.41056,1,1
1,GO TRACHEA MORPHOGENESIS,0.0020453,0.28909,0.25979,1,1
1,GO TRNA 5 END PROCESSING,0.00010845,0.28894,0.3013,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.2139e-05,0.2886,0.28375,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0031536,0.28801,0.2376,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00012964,0.28779,0.30882,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.6597e-05,0.28766,0.26542,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0028141,0.28759,0.26741,1,1
1,GO COPPER ION TRANSPORT,6.2786e-05,0.28722,0.31354,1,1
1,GO RESPONSE TO BACTERIUM,1.7806e-05,0.2872,0.26679,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.2962e-05,0.28709,0.25178,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,5.508e-06,0.28707,0.2629,1,1
1,GO SYMBIOTIC PROCESS,1.6452e-07,0.28705,0.28642,1,1
1,GO REGULATION OF WOUND HEALING,0.00034072,0.28669,0.29517,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00035231,0.2865,0.27454,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.044685,0.28646,0.31554,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,9.0551e-05,0.28628,0.34389,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013917,0.28627,0.28142,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.7806e-05,0.28589,0.29213,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0069616,0.28584,0.47379,1,1
1,GO CELL CELL RECOGNITION,5.4977e-07,0.28569,0.30051,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.012508,0.28563,0.34061,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0025083,0.2856,0.19463,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.00040247,0.28499,0.26649,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.05161,0.28464,0.19095,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.28445,0.31518,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00021167,0.28443,0.42295,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00016023,0.28441,0.32742,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,5.0226e-05,0.28405,0.28948,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00090094,0.28405,0.20127,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,8.3127e-06,0.28401,0.25233,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28401,0.33848,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.2454e-05,0.2838,0.26806,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.28378,0.24471,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,7.2754e-05,0.28367,0.31239,1,1
1,GO CHEMOKINE PRODUCTION,0.0019282,0.2836,0.25622,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00090094,0.28352,0.27363,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.0264e-07,0.28314,0.2503,1,1
1,GO MYOBLAST FUSION,0.00042998,0.28309,0.32007,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,2.3418e-05,0.28291,0.2761,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00019079,0.28284,0.26959,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,7.8282e-05,0.28274,0.27209,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.007729,0.28268,0.23585,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00019753,0.28267,0.31259,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.022165,0.28263,0.22768,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.9418e-06,0.28244,0.25902,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00016595,0.28222,0.21555,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.349e-05,0.2822,0.27405,1,1
1,GO RESPONSE TO PROTOZOAN,0.0013457,0.28213,0.28525,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.013465,0.28171,0.1997,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.28144,0.31943,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.011904,0.28094,0.20273,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,4.4878e-05,0.28075,0.29044,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.28061,0.36608,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00029782,0.28031,0.19958,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00010845,0.2803,0.29885,1,1
1,GO REGULATION OF GENE SILENCING,3.6228e-06,0.28012,0.24958,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0060989,0.27924,0.2909,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0019282,0.27913,0.23043,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0021062,0.2791,0.2719,1,1
1,GO TISSUE REMODELING,0.00024286,0.27882,0.26365,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0054795,0.27822,0.21743,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00054072,0.27804,0.22018,1,1
1,GO REGULATION OF ORGAN GROWTH,3.8131e-07,0.27763,0.32653,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00087311,0.2776,0.2834,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00019079,0.27752,0.34228,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.021165,0.27745,0.32363,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00045924,0.27725,0.29284,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.2837e-06,0.27713,0.28953,1,1
1,GO PROTEIN FOLDING,3.3287e-06,0.27687,0.26021,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.00024286,0.27682,0.25774,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00092958,0.2768,0.20452,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,8.3127e-06,0.27674,0.26394,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00040247,0.27599,0.30532,1,1
1,GO ERK1 AND ERK2 CASCADE,1.4039e-05,0.27594,0.24463,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00059588,0.27529,0.19027,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00021167,0.27523,0.30172,1,1
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.046579,0.27522,0.23118,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00022676,0.27517,0.25052,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00045924,0.27502,0.29665,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,9.7346e-05,0.27492,0.28283,1,1
1,GO CELLULAR RESPONSE TO LIPID,8.4205e-05,0.27488,0.2049,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00017186,0.27479,0.28495,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.2754e-05,0.27396,0.34051,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.7118e-05,0.27379,0.41789,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,1.5201e-05,0.27378,0.22928,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.9418e-06,0.27378,0.27594,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.00034072,0.2735,0.28797,1,1
1,GO TRANSPOSITION,0.017137,0.27334,0.22313,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.3654e-06,0.2732,0.2455,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,4.4712e-06,0.27312,0.30196,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,2.8418e-05,0.27309,0.34204,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.1192e-05,0.273,0.27723,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00069957,0.27278,0.3624,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.034637,0.27253,0.27901,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.00079435,0.27238,0.26115,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.015953,0.27228,0.21594,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.7346e-05,0.27212,0.23555,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00031859,0.27188,0.20007,1,1
1,GO MESODERM DEVELOPMENT,7.3528e-06,0.27184,0.23371,1,1
1,GO DNA LIGATION,0.00010462,0.27181,0.3051,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,7.547e-05,0.27171,0.22488,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00036427,0.27157,0.29141,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00011241,0.27149,0.22639,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.031748,0.27144,0.3077,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00057693,0.27143,0.31548,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.6414e-07,0.27113,0.28569,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,8.4205e-05,0.27105,0.21603,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.3441e-06,0.27062,0.34139,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.0571e-06,0.27041,0.31506,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,4.8612e-06,0.27039,0.24794,1,1
1,GO BONE MORPHOGENESIS,0.00020448,0.27018,0.27187,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00034072,0.26968,0.28374,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0028957,0.2695,0.22305,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.001228,0.26909,0.30736,1,1
1,GO ACUTE PHASE RESPONSE,0.0085714,0.26901,0.26263,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.020205,0.26879,0.20972,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0037331,0.26864,0.25061,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00045924,0.26843,0.22655,1,1
1,GO PHAGOCYTOSIS,1.0311e-06,0.26827,0.3337,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0013054,0.26819,0.2135,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.26815,0.27566,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,5.8301e-05,0.268,0.2303,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,9.0551e-05,0.26768,0.43824,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00010092,0.26759,0.25239,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00052342,0.26751,0.28039,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.2837e-06,0.2675,0.29041,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.5816e-05,0.26748,0.2561,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0014299,0.26717,0.31539,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.0779e-06,0.26716,0.2717,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00013433,0.26705,0.2505,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0036303,0.26677,0.28222,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.2754e-05,0.26676,0.24832,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00030804,0.26664,0.28785,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0016129,0.26639,0.21985,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,1.7118e-05,0.2662,0.28269,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0041716,0.26596,0.26727,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,7.013e-05,0.2657,0.37263,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001228,0.26549,0.23186,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00014418,0.2653,0.34472,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0024367,0.26525,0.26204,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0071468,0.26523,0.279,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,4.3763e-07,0.26522,0.2728,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0045306,0.2651,0.28188,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0049174,0.26495,0.24024,1,1
1,GO GTP METABOLIC PROCESS,0.00011241,0.26495,0.32762,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00050664,0.26473,0.2916,1,1
1,GO REGULATION OF PROTEOLYSIS,1.349e-05,0.26473,0.21005,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00055855,0.2647,0.19294,1,1
1,GO SEQUESTERING OF METAL ION,0.0039469,0.26461,0.23234,1,1
1,GO CELL AGING,2.8077e-06,0.26455,0.22643,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0013457,0.26451,0.43266,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.26443,0.23141,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0079323,0.26441,0.24154,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0040578,0.2644,0.22187,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00010845,0.26425,0.24193,1,1
1,GO TOXIN TRANSPORT,0.0022332,0.26416,0.18484,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0025817,0.26397,0.21574,1,1
1,GO DETECTION OF OTHER ORGANISM,0.0064317,0.26393,0.28754,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.7474e-06,0.26387,0.29351,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00029782,0.26345,0.24997,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00095906,0.26343,0.22679,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.027803,0.26329,0.16236,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00016595,0.26312,0.25072,1,1
1,GO LUNG MORPHOGENESIS,0.0024367,0.26306,0.25877,1,1
1,GO PROTEIN KINASE B SIGNALING,2.2524e-05,0.26305,0.21807,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00017796,0.26292,0.20864,1,1
1,GO VIRION ASSEMBLY,0.00050664,0.26279,0.18733,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0011199,0.26272,0.28011,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.3418e-05,0.26219,0.24309,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.5774e-06,0.26207,0.25923,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00021909,0.26194,0.24287,1,1
1,GO XENOBIOTIC TRANSPORT,0.00055855,0.26183,0.258,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00019079,0.2616,0.24078,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00016595,0.26157,0.27308,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00010092,0.26154,0.23798,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0094949,0.2611,0.3145,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,4.4878e-05,0.261,0.21933,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,6.7596e-05,0.261,0.19902,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.018836,0.26097,0.1915,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.016734,0.26096,0.15377,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010506,0.26089,0.18674,1,1
1,GO AUTOPHAGOSOME MATURATION,3.8583e-05,0.26078,0.26899,1,1
1,GO FATTY ACID BETA OXIDATION,0.00026903,0.26068,0.2486,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,4.1802e-07,0.26052,0.23059,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0083534,0.26052,0.20388,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0047853,0.2604,0.21311,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00035231,0.26035,0.25813,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0045306,0.26021,0.19797,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011326,0.26015,0.29195,1,1
1,GO RNA 3 END PROCESSING,0.00016023,0.26012,0.20803,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.012203,0.25969,0.26277,1,1
1,GO RNA DESTABILIZATION,2.8418e-05,0.25959,0.25233,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00030804,0.2593,0.27285,1,1
1,GO CHYLOMICRON ASSEMBLY,0.010245,0.25909,0.23147,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00022676,0.2588,0.20508,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0094949,0.25865,0.33269,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00050664,0.25858,0.23649,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.044685,0.25853,0.35487,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.2837e-06,0.25824,0.25679,1,1
1,GO IMMUNE EFFECTOR PROCESS,9.3916e-06,0.25819,0.28073,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.6228e-06,0.25786,0.23765,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.0683e-06,0.25781,0.26207,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00012074,0.25738,0.23465,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.4878e-05,0.25729,0.21329,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00035231,0.25727,0.27444,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00012964,0.25725,0.24706,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.1267e-06,0.25672,0.28241,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0013054,0.25651,0.23903,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0046564,0.25635,0.39489,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00010462,0.25612,0.29357,1,1
1,GO DE NOVO PROTEIN FOLDING,0.00042998,0.25611,0.20853,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.6729e-06,0.25568,0.23244,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00040247,0.25562,0.21628,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,2.4692e-06,0.25531,0.24124,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00021167,0.25529,0.26062,1,1
1,GO MACROPHAGE CHEMOTAXIS,2.7343e-05,0.25482,0.3462,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.015203,0.25475,0.24057,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.6455e-05,0.2547,0.29413,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00047456,0.25446,0.27334,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.3132e-05,0.2544,0.23957,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.029068,0.25432,0.19462,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00050664,0.25428,0.21171,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0017641,0.25408,0.25202,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.5774e-06,0.2537,0.31297,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00057693,0.25364,0.31053,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00026003,0.25364,0.24404,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0097392,0.25352,0.24873,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0026572,0.25345,0.28558,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,9.7801e-06,0.25303,0.25075,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.9926e-07,0.25298,0.25389,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,2.9532e-05,0.25276,0.29501,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.0571e-06,0.25242,0.22575,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00034072,0.25227,0.2501,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5308e-05,0.25221,0.22122,1,1
1,GO INFLAMMATORY RESPONSE,6.0504e-05,0.25125,0.25003,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00023468,0.25104,0.24269,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.00012074,0.25096,0.25952,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00013433,0.25094,0.23384,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.027188,0.25089,0.21473,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0024367,0.25077,0.21169,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.508e-06,0.25066,0.24796,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00012512,0.2499,0.28194,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0033369,0.24977,0.19764,1,1
1,GO RRNA METHYLATION,0.0038387,0.24974,0.20013,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.044685,0.24946,0.22732,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.24934,0.25232,1,1
1,GO CERAMIDE TRANSPORT,0.0051916,0.24917,0.23399,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00081984,0.2481,0.20718,1,1
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00027832,0.24798,0.26553,1,1
1,GO OSTEOCLAST DIFFERENTIATION,3.8583e-05,0.24794,0.2167,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0029794,0.24757,0.22647,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.045624,0.24744,0.26618,1,1
1,GO FACE DEVELOPMENT,0.00019753,0.24712,0.26851,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00038934,0.24708,0.21103,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.014486,0.24699,0.2645,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.3418e-05,0.24693,0.25389,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0012662,0.24666,0.20636,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.017969,0.24652,0.32456,1,1
1,GO PODOSOME ASSEMBLY,0.00014935,0.24635,0.35735,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00017796,0.24615,0.23006,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.023741,0.24609,0.16462,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00012512,0.24601,0.25949,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8379e-05,0.24585,0.23346,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00027832,0.24564,0.2019,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00069957,0.24532,0.19117,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0015653,0.24528,0.22923,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.020205,0.24469,0.17548,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019753,0.24461,0.21987,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.4039e-05,0.24432,0.24738,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0010206,0.24424,0.24016,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00049035,0.24414,0.24841,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.00027832,0.24414,0.23153,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0006154,0.24362,0.41866,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00012512,0.24347,0.23648,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010206,0.24322,0.27225,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.00353,0.24287,0.25971,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00032948,0.24275,0.19098,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0036303,0.24221,0.23287,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0033369,0.2422,0.2106,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0012662,0.24212,0.24947,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.1964e-05,0.24185,0.28568,1,1
1,GO REGULATION OF MITOPHAGY,0.015574,0.24166,0.19585,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00042998,0.24163,0.22332,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.24144,0.16769,1,1
1,GO DNA DEALKYLATION,0.00090094,0.24115,0.22595,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,2.7343e-05,0.24098,0.21455,1,1
1,GO METANEPHROS DEVELOPMENT,0.00067758,0.24092,0.22046,1,1
1,GO NEURAL TUBE PATTERNING,0.0017123,0.2407,0.23859,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.0033e-05,0.24064,0.21516,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00041602,0.24056,0.24421,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.029719,0.24051,0.16689,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001191,0.24048,0.22184,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.22474,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.4421e-05,0.24009,0.25435,1,1
1,GO HEART VALVE DEVELOPMENT,0.00040247,0.23972,0.29763,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,5.8301e-05,0.23944,0.23673,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.3654e-06,0.23932,0.25068,1,1
1,GO DEFENSE RESPONSE,4.0073e-05,0.2391,0.22623,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,9.389e-05,0.23904,0.21096,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0021689,0.23881,0.22263,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014935,0.2387,0.35059,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00036427,0.23868,0.24054,1,1
1,GO MEMBRANE BIOGENESIS,0.0049174,0.23859,0.23502,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.23845,0.30052,1,1
1,GO TUBE MORPHOGENESIS,6.7596e-05,0.23845,0.22029,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,5.2139e-05,0.23811,0.21855,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00069957,0.23806,0.18497,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0032441,0.23782,0.2735,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00031859,0.23766,0.25083,1,1
1,GO TONGUE DEVELOPMENT,0.011326,0.23753,0.26438,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.23751,0.2494,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0010206,0.23747,0.32472,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.6597e-05,0.23722,0.32263,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019283,0.2372,0.18478,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.23709,0.22861,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.6455e-05,0.23703,0.27242,1,1
1,GO PLATELET ACTIVATION,0.00057693,0.23675,0.22268,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,6.7596e-05,0.23633,0.20332,1,1
1,GO STRESS FIBER ASSEMBLY,0.00090094,0.23576,0.22714,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.029719,0.23566,0.16109,1,1
1,GO RESPONSE TO RETINOIC ACID,7.013e-05,0.2356,0.25855,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00019753,0.23541,0.23322,1,1
1,GO REGULATION OF ANOIKIS,0.047551,0.23482,0.21286,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0047853,0.23473,0.19888,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0067808,0.23455,0.20173,1,1
1,GO TRNA PROCESSING,0.00049035,0.23411,0.18611,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.024288,0.23397,0.35347,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00018427,0.23384,0.18895,1,1
1,GO LIPID STORAGE,0.00059588,0.23358,0.23299,1,1
1,GO PROTEIN TARGETING,3.0689e-05,0.23319,0.20101,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.9301e-06,0.23313,0.25943,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0038387,0.23311,0.17584,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.4728e-06,0.2331,0.26174,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00013917,0.23293,0.2282,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,8.7323e-05,0.23279,0.26466,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.0014738,0.23279,0.21045,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.1493e-05,0.23268,0.35401,1,1
1,GO P38MAPK CASCADE,9.7346e-05,0.23257,0.31846,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.6597e-05,0.23253,0.2062,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00011241,0.23229,0.24078,1,1
1,GO MYELOID CELL HOMEOSTASIS,1.349e-05,0.23169,0.22021,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,3.0689e-05,0.23146,0.36514,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.023741,0.23124,0.1539,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0067808,0.23099,0.23929,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00036427,0.23093,0.2591,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.009256,0.23089,0.19531,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,8.628e-07,0.23084,0.22357,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00041602,0.2308,0.20351,1,1
1,GO POSITIVE CHEMOTAXIS,0.0041716,0.23075,0.22772,1,1
1,GO CRISTAE FORMATION,0.025414,0.23065,0.18741,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.0027346,0.23029,0.23109,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.010773,0.23012,0.35613,1,1
1,GO MITOPHAGY,0.00019079,0.2301,0.23929,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,3.6228e-06,0.22991,0.22802,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.2658e-06,0.22984,0.24722,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00014935,0.2298,0.21116,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.9263e-05,0.22979,0.2163,1,1
1,GO PLACENTA DEVELOPMENT,0.0010528,0.22933,0.20752,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.22927,0.33993,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0007696,0.22915,0.17588,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00090094,0.22889,0.25738,1,1
1,GO NUCLEAR EXPORT,5.7413e-06,0.22858,0.21112,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.019283,0.22833,0.33345,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.7596e-05,0.22768,0.29144,1,1
1,GO TRABECULA MORPHOGENESIS,0.00081984,0.22732,0.27815,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,5.8301e-05,0.22731,0.20156,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00014418,0.22728,0.24797,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0024367,0.22693,0.19282,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,8.1192e-05,0.22691,0.21576,1,1
1,GO REGULATION OF HEMOPOIESIS,5.6174e-05,0.22687,0.19816,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00087311,0.22681,0.22472,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.050569,0.22679,0.20549,1,1
1,GO AGING,1.5816e-05,0.22677,0.20055,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0041716,0.22631,0.22911,1,1
1,GO STEROL IMPORT,0.00054072,0.22611,0.41555,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0023671,0.22601,0.27071,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00010845,0.22582,0.21368,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0033369,0.22574,0.20098,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,9.0551e-05,0.2257,0.26549,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.019739,0.2255,0.18337,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00065623,0.22529,0.17424,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00050664,0.22526,0.20777,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.8628e-07,0.2252,0.19916,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.00021167,0.22515,0.19671,1,1
1,GO CELL PROLIFERATION IN HINDBRAIN,0.010773,0.22489,0.20424,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0001165,0.22483,0.22212,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.001228,0.22459,0.22025,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.0551e-05,0.22457,0.26763,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00059588,0.22453,0.26205,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,6.0504e-05,0.22409,0.20911,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0083534,0.22404,0.17624,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00017186,0.22367,0.23643,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00021167,0.22364,0.18372,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.01282,0.22344,0.19403,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.00074557,0.22337,0.16108,1,1
1,GO CELL KILLING,0.00353,0.22321,0.15694,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0016129,0.22312,0.17812,1,1
1,GO T CELL PROLIFERATION,0.00049035,0.22309,0.20584,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0011199,0.22304,0.18797,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.010506,0.2228,0.16056,1,1
1,GO PLATELET MORPHOGENESIS,0.00059588,0.22279,0.22458,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0020453,0.22265,0.21424,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00011241,0.22209,0.21219,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.010773,0.22193,0.16857,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.1617e-05,0.22182,0.21175,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0083534,0.2217,0.18214,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00055855,0.22142,0.17329,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00028792,0.22106,0.16628,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0014299,0.22089,0.37989,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0016129,0.22086,0.19128,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,6.0504e-05,0.22078,0.18192,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.0010859,0.22029,0.25296,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.0028141,0.22019,0.19724,1,1
1,GO REGULATION OF VASCULOGENESIS,0.0071468,0.22017,0.30944,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.1617e-05,0.21995,0.2163,1,1
1,GO BODY FLUID SECRETION,0.00024286,0.21983,0.21425,1,1
1,GO NUCLEUS LOCALIZATION,0.031059,0.2198,0.13251,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.004408,0.21975,0.20282,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,5.0194e-07,0.21971,0.20108,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.21957,0.19601,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00050664,0.21924,0.2112,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0021062,0.2191,0.26958,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4609e-05,0.21904,0.23487,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,3.5759e-05,0.21884,0.21656,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0087944,0.21884,0.15379,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.017137,0.2188,0.18169,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00012074,0.21856,0.26116,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.2366e-07,0.21854,0.18213,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0038387,0.21852,0.19732,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.046579,0.21813,0.1638,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.2181,0.20968,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.011326,0.21793,0.21866,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,2.5308e-05,0.2176,0.20256,1,1
1,GO TRNA METABOLIC PROCESS,0.00081984,0.21758,0.17844,1,1
1,GO INTERFERON GAMMA PRODUCTION,4.1617e-05,0.21747,0.26656,1,1
1,GO RNA MODIFICATION,0.00010462,0.21727,0.1981,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.21723,0.31674,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00036427,0.21677,0.2428,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00024286,0.21654,0.19111,1,1
1,GO REGULATION OF URINE VOLUME,0.00027832,0.21647,0.24044,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,8.628e-07,0.21628,0.21255,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00019079,0.216,0.20061,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.024846,0.21586,0.155,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.02268,0.21565,0.14186,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.015953,0.21551,0.26259,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,6.2367e-06,0.21526,0.1974,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0028957,0.21509,0.222,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,9.389e-05,0.21501,0.26076,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0013457,0.21495,0.20475,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0069616,0.21454,0.28703,1,1
1,GO GRANULOCYTE MIGRATION,0.00018427,0.21445,0.27623,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0011549,0.21418,0.18974,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.024288,0.2141,0.19236,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00353,0.2141,0.15204,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0010528,0.214,0.21006,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0067808,0.21346,0.18073,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0016129,0.21295,0.22479,1,1
1,GO T CELL ACTIVATION,0.00011241,0.21262,0.20769,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00012074,0.21229,0.19659,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00055855,0.21222,0.21259,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.012203,0.2118,0.19708,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00072223,0.21173,0.19311,1,1
1,GO CELL ACTIVATION,2.4346e-05,0.21138,0.23077,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.4692e-06,0.21113,0.24364,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,0.027803,0.21105,0.21071,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,2.2524e-05,0.21076,0.19654,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0011199,0.21067,0.21199,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0066042,0.21061,0.18612,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0023671,0.21055,0.23087,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.21022,0.21092,1,1
1,GO HEAD MORPHOGENESIS,0.001228,0.21003,0.25997,1,1
1,GO BLASTOCYST GROWTH,0.0011549,0.20993,0.25414,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.20992,0.17176,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0020453,0.2099,0.17151,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,2.0833e-05,0.20966,0.22543,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,7.2754e-05,0.20944,0.1976,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,7.8282e-05,0.20914,0.21995,1,1
1,GO MESENCHYME DEVELOPMENT,0.00018427,0.20907,0.22643,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0075304,0.20905,0.17936,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0013457,0.20895,0.24051,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00021167,0.20871,0.19465,1,1
1,GO PROTEIN DENEDDYLATION,0.0028957,0.2087,0.18314,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0011549,0.20869,0.18418,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,7.2756e-08,0.20857,0.19434,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.023205,0.20847,0.2341,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.033166,0.20826,0.23744,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.2454e-05,0.20805,0.20492,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.014841,0.20766,0.16415,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0031536,0.20744,0.17695,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.5774e-06,0.20742,0.26238,1,1
1,GO RESPONSE TO KETONE,0.0025817,0.2073,0.16483,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0034322,0.20702,0.16825,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,3.8583e-05,0.20697,0.27622,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,2.0833e-05,0.20677,0.22,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00084609,0.20671,0.22566,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.027803,0.2067,0.17768,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.010506,0.2065,0.20352,1,1
1,GO LEUKOCYTE MIGRATION,0.0018173,0.20628,0.19037,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.011612,0.20613,0.21261,1,1
1,GO STEROID ESTERIFICATION,0.053746,0.20559,0.20482,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,7.013e-05,0.20545,0.19957,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.00065623,0.20544,0.17946,1,1
1,GO RETINOL METABOLIC PROCESS,0.0030654,0.20526,0.20344,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,5.8301e-05,0.20521,0.20799,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.023205,0.20499,0.16649,1,1
1,GO RUFFLE ORGANIZATION,0.0049174,0.20481,0.14416,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00017186,0.2047,0.18396,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00035231,0.20436,0.16841,1,1
1,GO MYELOID CELL DIFFERENTIATION,3.1888e-05,0.20436,0.17745,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.036164,0.20434,0.1784,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.0184e-05,0.2041,0.19524,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.019283,0.20391,0.2282,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015953,0.20391,0.13791,1,1
1,GO NEGATIVE T CELL SELECTION,0.05161,0.20383,0.1673,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00055855,0.20366,0.20191,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.016339,0.2033,0.11167,1,1
1,GO RESPONSE TO CHEMOKINE,0.0046564,0.20321,0.21045,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.0504e-05,0.20319,0.24147,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.0030654,0.20285,0.25006,1,1
1,GO RRNA 3 END PROCESSING,0.0007696,0.20283,0.21338,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,7.9801e-06,0.2026,0.18922,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00011241,0.20259,0.24387,1,1
1,GO REGULATION OF LIPID STORAGE,0.00098941,0.2024,0.23675,1,1
1,GO RESPONSE TO LIPID,0.00050664,0.20226,0.17103,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0014738,0.20221,0.21435,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,9.0221e-07,0.20184,0.21059,1,1
1,GO RESPONSE TO VITAMIN A,0.033166,0.2018,0.17107,1,1
1,GO COENZYME A METABOLIC PROCESS,0.0081404,0.20169,0.16161,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,2.0833e-05,0.20137,0.20105,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,9.8628e-07,0.20085,0.19278,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.20079,0.23505,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00353,0.20072,0.22242,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00059588,0.20058,0.15261,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0037331,0.20055,0.14382,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.017969,0.20052,0.22345,1,1
1,GO OSSIFICATION,0.00035231,0.20032,0.20839,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00090094,0.20027,0.21205,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.042857,0.2002,0.21202,1,1
1,GO RESPONSE TO TUMOR CELL,0.02068,0.19979,0.18965,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00054072,0.19975,0.21189,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00059588,0.19966,0.20134,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00098941,0.19961,0.21676,1,1
1,GO HISTONE H2B UBIQUITINATION,0.03245,0.19959,0.14264,1,1
1,GO REGULATION OF CELL ADHESION,0.0018173,0.19957,0.18596,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,2.8418e-05,0.19935,0.22296,1,1
1,GO MITOTIC CYTOKINESIS,0.00098941,0.19935,0.20065,1,1
1,GO RNA LOCALIZATION,0.00014418,0.19924,0.1994,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.046579,0.19912,0.13684,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0011199,0.19894,0.2288,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0010206,0.19888,0.14647,1,1
1,GO LYMPHOCYTE ACTIVATION,6.0504e-05,0.19873,0.19493,1,1
1,GO MIDBODY ABSCISSION,0.036948,0.19861,0.15932,1,1
1,GO ANIMAL ORGAN FORMATION,0.011612,0.19861,0.17696,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.04854,0.19853,0.15831,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,3.8583e-05,0.19829,0.23625,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0029794,0.19813,0.26308,1,1
1,GO DENDRITIC SPINE MAINTENANCE,0.0097392,0.19811,0.21452,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.0001547,0.19803,0.19568,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013798,0.19799,0.13291,1,1
1,GO RNA METHYLATION,0.00036427,0.19755,0.19289,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.4039e-05,0.19732,0.21747,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.047551,0.19702,0.20995,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.8301e-05,0.19652,0.22774,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0099891,0.19631,0.19245,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0013054,0.19624,0.22164,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,3.4421e-05,0.1959,0.17428,1,1
1,GO VESICLE TARGETING,0.00022676,0.19585,0.20778,1,1
1,GO RESPONSE TO PH,0.0059384,0.1958,0.22017,1,1
1,GO BODY MORPHOGENESIS,0.0034322,0.1955,0.18575,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00087311,0.19549,0.18451,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0011199,0.19541,0.16215,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00017796,0.19523,0.19532,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0017123,0.19516,0.20363,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00059588,0.1951,0.19527,1,1
1,GO PROTEIN PROCESSING,0.00026003,0.195,0.20121,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,1.4609e-05,0.19489,0.17723,1,1
1,GO ORGAN GROWTH,0.00035231,0.19464,0.20728,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.0016129,0.19399,0.29642,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00014935,0.19373,0.17788,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0017123,0.1935,0.16075,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.020205,0.1932,0.20995,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0085714,0.19307,0.14719,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.011047,0.19275,0.1393,1,1
1,GO PROTEIN STABILIZATION,2.5308e-05,0.19262,0.16595,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0067808,0.19166,0.33297,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0022992,0.19149,0.16246,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00021909,0.19129,0.15629,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015203,0.19106,0.13831,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026003,0.19102,0.18544,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.029719,0.19097,0.1667,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00035231,0.1907,0.36498,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0014299,0.1906,0.18118,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.0010859,0.19057,0.25392,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00059588,0.19048,0.18427,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00045924,0.19045,0.17865,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00031859,0.19045,0.23669,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.0011549,0.19036,0.15651,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00011241,0.19027,0.18405,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.19026,0.17321,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.0029794,0.19014,0.244,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00022676,0.19012,0.15191,1,1
1,GO SECRETION BY TISSUE,0.035393,0.18996,0.14018,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00044439,0.18992,0.16934,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00010092,0.18989,0.18737,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00012512,0.18969,0.19343,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.00087311,0.18956,0.20799,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.011612,0.18919,0.17235,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00031859,0.18913,0.2035,1,1
1,GO RESPONSE TO REDOX STATE,0.043763,0.18902,0.19195,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.001986,0.18883,0.19264,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013457,0.18867,0.17886,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00065623,0.18864,0.15251,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.0012662,0.1882,0.19061,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0023671,0.18811,0.16059,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.5816e-05,0.1879,0.19314,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029794,0.18769,0.15195,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,6.5149e-05,0.18746,0.15525,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00013917,0.18744,0.17949,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.8418e-05,0.18716,0.15285,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.0017641,0.18715,0.18699,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00054072,0.18713,0.22555,1,1
1,GO HISTONE DEACETYLATION,0.00084609,0.18712,0.12623,1,1
1,GO LEUKOCYTE HOMEOSTASIS,0.00031859,0.18651,0.18943,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00087311,0.18644,0.18778,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001986,0.18639,0.1638,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.023741,0.18616,0.14857,1,1
1,GO PROTEIN DEMANNOSYLATION,0.014841,0.18607,0.18077,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.00047456,0.18591,0.19967,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0041716,0.18589,0.21394,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0016129,0.18588,0.21972,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0046564,0.1858,0.2674,1,1
1,GO DRUG METABOLIC PROCESS,0.0033369,0.18571,0.15632,1,1
1,GO PROTEIN MATURATION,0.00012074,0.18535,0.15531,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,6.5896e-07,0.18526,0.17336,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.753e-07,0.18517,0.16516,1,1
1,GO RNA PROCESSING,8.4205e-05,0.18508,0.17478,1,1
1,GO ORGANELLE INHERITANCE,0.0018173,0.18502,0.17036,1,1
1,GO SULFUR COMPOUND TRANSPORT,4.0073e-05,0.18493,0.21395,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.019739,0.1848,0.14375,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031859,0.1848,0.20281,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0046564,0.18468,0.27762,1,1
1,GO CELLULAR RESPONSE TO UV,0.00072223,0.18438,0.16825,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.029719,0.1843,0.11571,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0014299,0.18419,0.17225,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0010859,0.18419,0.15436,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00024286,0.18407,0.24352,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0085714,0.18393,0.15841,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0099891,0.18385,0.1559,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.025994,0.18383,0.14087,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029719,0.18369,0.13253,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0036303,0.18367,0.22349,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00055855,0.18354,0.20198,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0024367,0.18333,0.15258,1,1
1,GO BONE DEVELOPMENT,9.0551e-05,0.18328,0.22452,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0038387,0.18328,0.21917,1,1
1,GO STEROL HOMEOSTASIS,0.026586,0.18324,0.1038,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0028141,0.18322,0.19665,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.02166,0.18316,0.16209,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0051916,0.18289,0.16357,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.18279,0.17211,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.906e-06,0.18255,0.19007,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0022992,0.18244,0.26006,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.00011241,0.18229,0.17343,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0040578,0.18224,0.12682,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,6.7596e-05,0.18187,0.21036,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.6455e-05,0.18183,0.19656,1,1
1,GO OVULATION,0.045624,0.18151,0.21515,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0015653,0.18143,0.14491,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0012662,0.18141,0.15887,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.022165,0.18114,0.14393,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0085714,0.18102,0.14807,1,1
1,GO PROTEIN NEDDYLATION,0.0013457,0.18063,0.18757,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.016339,0.18038,0.13803,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,2.0033e-05,0.18001,0.21106,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.7578e-07,0.17974,0.18268,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0028141,0.17962,0.17746,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0030654,0.17955,0.20751,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.0504e-05,0.1795,0.21432,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00092958,0.17948,0.14115,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0090226,0.17942,0.19612,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.17925,0.21327,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0027346,0.17916,0.17754,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.044685,0.17914,0.15418,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0025083,0.17912,0.15965,1,1
1,GO PEROXISOMAL TRANSPORT,0.0017641,0.17852,0.18946,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0013457,0.17778,0.22002,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,1.1493e-05,0.17749,0.17449,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.17733,0.15447,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00021167,0.17714,0.15731,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0017123,0.177,0.1736,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0014738,0.1764,0.13026,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00047456,0.1761,0.19009,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00087311,0.1761,0.21891,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00020448,0.17599,0.16436,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0083534,0.17584,0.13091,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,7.8282e-05,0.17575,0.18998,1,1
1,GO TRNA TRANSPORT,0.0075304,0.17573,0.16343,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00047456,0.17562,0.18106,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.2533e-07,0.17557,0.17718,1,1
1,GO RESPONSE TO HEAT,0.00014418,0.17537,0.18386,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.001662,0.17533,0.15365,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00016023,0.17514,0.19241,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.5774e-06,0.17487,0.17479,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,7.8282e-05,0.17459,0.20051,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00072223,0.17438,0.13207,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0013457,0.17438,0.22613,1,1
1,GO GOLGI VESICLE TRANSPORT,1.1964e-05,0.17426,0.17047,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0025083,0.17392,0.15294,1,1
1,GO RNA POLYADENYLATION,0.0013054,0.17382,0.15341,1,1
1,GO FOLIC ACID METABOLIC PROCESS,0.037747,0.17377,0.15295,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00050664,0.17367,0.17396,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0020453,0.17358,0.16878,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.023205,0.17357,0.12839,1,1
1,GO MITOTIC RECOMBINATION,0.0028957,0.17352,0.1951,1,1
1,GO AXIS ELONGATION,0.030383,0.1735,0.22014,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00031859,0.17309,0.18345,1,1
1,GO REGULATION OF MAPK CASCADE,0.00023468,0.17259,0.15864,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0010528,0.17242,0.1718,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.001191,0.17233,0.18895,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0025817,0.17231,0.16563,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.019283,0.17217,0.13673,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,4.5813e-07,0.17186,0.17112,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0018173,0.17184,0.15918,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00065623,0.17184,0.18891,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.03939,0.17179,0.24763,1,1
1,GO LYSOSOMAL TRANSPORT,0.00010845,0.17172,0.18502,1,1
1,GO PROTEIN IMPORT,7.2754e-05,0.1717,0.16619,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.001872,0.17148,0.16919,1,1
1,GO PEROXISOME ORGANIZATION,0.0010859,0.17129,0.18302,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.015203,0.17095,0.11923,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.5427e-07,0.17084,0.18106,1,1
1,GO REGULATION OF RESPONSE TO STRESS,2.7343e-05,0.17084,0.16487,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.023741,0.17062,0.14843,1,1
1,GO TRANSLESION SYNTHESIS,0.0015653,0.17043,0.15589,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.0226e-05,0.17043,0.18213,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.001191,0.17034,0.13539,1,1
1,GO VACUOLAR TRANSPORT,0.00034072,0.17011,0.15288,1,1
1,GO TUBE DEVELOPMENT,0.00052342,0.17006,0.17617,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0075304,0.1699,0.23762,1,1
1,GO SPINDLE LOCALIZATION,8.1192e-05,0.16972,0.18164,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.017969,0.16959,0.23968,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.0094949,0.16958,0.17495,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00079435,0.16955,0.15913,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0046564,0.1695,0.22304,1,1
1,GO REGULATION OF CATABOLIC PROCESS,5.4977e-07,0.1695,0.16452,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00023468,0.16919,0.13692,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00010092,0.16891,0.20301,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.001986,0.16882,0.15204,1,1
1,GO MRNA METABOLIC PROCESS,2.9532e-05,0.16862,0.16557,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0014738,0.16852,0.17512,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.001191,0.16847,0.18006,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0085714,0.16846,0.12952,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.00054072,0.16827,0.17205,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.0576e-06,0.16817,0.16602,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.055956,0.16814,0.15057,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.00019079,0.16809,0.13753,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,0.011904,0.16808,0.18896,1,1
1,GO NEUTROPHIL MIGRATION,0.0021062,0.16772,0.24021,1,1
1,GO AEROBIC RESPIRATION,0.036164,0.1676,0.098627,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.019283,0.16759,0.18154,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.013798,0.16757,0.13045,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.001228,0.16756,0.19716,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,7.5427e-07,0.16748,0.16734,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00034072,0.16718,0.18579,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00055855,0.1671,0.15103,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00041602,0.16683,0.18232,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0027346,0.1665,0.14795,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.001872,0.16628,0.16832,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0034322,0.16628,0.12961,1,1
1,GO OXALATE TRANSPORT,0.031748,0.16623,0.1071,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.029068,0.16599,0.17541,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022992,0.16567,0.18533,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0001547,0.16563,0.1419,1,1
1,GO PROTEIN REFOLDING,0.042857,0.1656,0.1569,1,1
1,GO NUCLEAR TRANSPORT,3.3132e-05,0.1655,0.15444,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00059588,0.16537,0.22105,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00016595,0.16514,0.21289,1,1
1,GO RNA CAPPING,0.00026003,0.16511,0.16282,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00010092,0.16495,0.28751,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.001662,0.16474,0.1302,1,1
1,GO REGULATION OF MYELINATION,0.0094949,0.16445,0.14529,1,1
1,GO RESPONSE TO GONADOTROPIN,0.0059384,0.16422,0.27755,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.0571e-06,0.16403,0.20062,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0099891,0.16399,0.13145,1,1
1,GO VACUOLE ORGANIZATION,7.8282e-05,0.16375,0.15452,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,5.6174e-05,0.16367,0.15591,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00057693,0.16347,0.21328,1,1
1,GO RECEPTOR RECYCLING,0.0069616,0.16318,0.12983,1,1
1,GO RNA DECAPPING,0.00055855,0.16313,0.18146,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00011241,0.16287,0.16396,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.0057817,0.16279,0.23497,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.9904e-06,0.16278,0.15446,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.053746,0.16273,0.169,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0047853,0.16261,0.15956,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0085714,0.16242,0.1752,1,1
1,GO TELOMERE ORGANIZATION,0.0006154,0.16219,0.13455,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.001191,0.16216,0.14945,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.014486,0.16215,0.15314,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0020453,0.16205,0.17778,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.012508,0.16186,0.13872,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00030804,0.16177,0.22715,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00030804,0.16169,0.15709,1,1
1,GO BONE REMODELING,0.0028141,0.16144,0.18439,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.004408,0.16141,0.1827,1,1
1,GO ERBB SIGNALING PATHWAY,0.00041602,0.16126,0.22356,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.029719,0.16117,0.13968,1,1
1,GO PROTEIN POLYUBIQUITINATION,8.4205e-05,0.161,0.1464,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00047456,0.16094,0.14943,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00038934,0.16085,0.14692,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.019283,0.16063,0.088191,1,1
1,GO MUSCLE ADAPTATION,0.015203,0.1606,0.11148,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.16045,0.16635,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0022992,0.16038,0.16967,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0051916,0.16024,0.27498,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0054795,0.16002,0.18112,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.0020453,0.15997,0.12801,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041093,0.15987,0.13846,1,1
1,GO NEURAL TUBE FORMATION,0.0053338,0.15981,0.17645,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0099891,0.1596,0.17829,1,1
1,GO PROTEOLYSIS,1.104e-05,0.15947,0.14891,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00030804,0.159,0.14214,1,1
1,GO REGULATION OF OSSIFICATION,0.0024367,0.15895,0.19695,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0011199,0.15852,0.17148,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0071468,0.15839,0.17502,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0057817,0.15826,0.13239,1,1
1,GO RESPONSE TO UV,0.00014418,0.15756,0.17273,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0085714,0.15752,0.16111,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00021909,0.15735,0.13334,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0081404,0.15712,0.2453,1,1
1,GO TISSUE MORPHOGENESIS,0.00026903,0.15708,0.17354,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.017969,0.15703,0.128,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00027832,0.15682,0.14603,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025083,0.15681,0.1229,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00059588,0.1568,0.15164,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.052669,0.15674,0.18897,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.00095906,0.15647,0.21339,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.0031536,0.15631,0.16135,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,8.7323e-05,0.15616,0.1751,1,1
1,GO MAINTENANCE OF LOCATION,3.4421e-05,0.156,0.17106,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0015189,0.15598,0.13184,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0030654,0.15593,0.19531,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013465,0.15539,0.16702,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00098941,0.15513,0.13555,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.001872,0.1551,0.15889,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0037331,0.15509,0.14149,1,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.050569,0.15508,0.09393,1,1
1,GO PROTEIN CATABOLIC PROCESS,1.1267e-06,0.15492,0.1538,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.00353,0.15468,0.20365,1,1
1,GO POSTREPLICATION REPAIR,0.00079435,0.15468,0.13962,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.027803,0.15454,0.20689,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0029794,0.15427,0.11791,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.033894,0.15404,0.092987,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.2139e-05,0.154,0.15608,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.014841,0.15383,0.18772,1,1
1,GO LACTATION,0.0049174,0.15374,0.18083,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00072223,0.15358,0.17483,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.001986,0.15344,0.15305,1,1
1,GO RESPONSE TO DRUG,0.01282,0.15335,0.11107,1,1
1,GO MRNA TRANSPORT,0.00034072,0.15332,0.17623,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.2505e-07,0.15325,0.16724,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,3.0689e-05,0.15305,0.1769,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,9.0551e-05,0.15291,0.18315,1,1
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.019283,0.15289,0.10075,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0050528,0.15287,0.25269,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0022332,0.15269,0.16893,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,2.0033e-05,0.15265,0.13936,1,1
1,GO REGULATION OF ERAD PATHWAY,9.0551e-05,0.1523,0.16679,1,1
1,GO REPLACEMENT OSSIFICATION,0.016734,0.15222,0.23853,1,1
1,GO HEART GROWTH,0.0046564,0.15184,0.1689,1,1
1,GO REGULATION OF CELL DEATH,0.00017796,0.15169,0.13612,1,1
1,GO B CELL ACTIVATION,0.001191,0.15151,0.14117,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.00087311,0.15137,0.15736,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00037661,0.15137,0.13301,1,1
1,GO REGULATION OF BINDING,0.00038934,0.15112,0.13773,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00069957,0.15091,0.13695,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.8418e-05,0.15067,0.16131,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.001872,0.15055,0.11492,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.0079323,0.15051,0.12664,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0013054,0.15048,0.15639,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.014138,0.15044,0.10252,1,1
1,GO RESPONSE TO LEPTIN,0.030383,0.15038,0.17542,1,1
1,GO MACROPHAGE ACTIVATION,0.015574,0.14995,0.15745,1,1
1,GO GOLGI VESICLE BUDDING,0.0011199,0.14979,0.17165,1,1
1,GO VACUOLAR ACIDIFICATION,0.0026572,0.14956,0.16886,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0031536,0.14927,0.13185,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.00079435,0.14923,0.14819,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00030804,0.14921,0.14229,1,1
1,GO DNA BIOSYNTHETIC PROCESS,1.0311e-06,0.14876,0.16786,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.021165,0.14857,0.15604,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00018427,0.14825,0.1409,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00036427,0.14769,0.15361,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00059588,0.14727,0.15713,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0060989,0.14723,0.10864,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.00037661,0.14712,0.14854,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.007729,0.14709,0.1382,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0069616,0.147,0.23352,1,1
1,GO NCRNA CATABOLIC PROCESS,0.026586,0.14695,0.15928,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0094949,0.14694,0.11495,1,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.033166,0.14691,0.11648,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.049546,0.1468,0.096097,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0022992,0.14677,0.18254,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.043763,0.14642,0.16522,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.024288,0.14612,0.16179,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00057693,0.14579,0.11465,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0066042,0.14541,0.16472,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.016339,0.14505,0.13921,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00079435,0.14483,0.15391,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0094949,0.14467,0.14752,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0033369,0.14453,0.17456,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00045924,0.1445,0.16244,1,1
1,GO REGULATION OF CHEMOTAXIS,0.001872,0.14433,0.1479,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00021167,0.1443,0.12773,1,1
1,GO CHROMOSOME LOCALIZATION,0.043763,0.14391,0.11104,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00041602,0.14389,0.17786,1,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0064317,0.14388,0.20742,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0031536,0.14365,0.10986,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.026586,0.14317,0.16542,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.0083534,0.14304,0.16937,1,1
1,GO REGULATION OF DNA BINDING,0.054842,0.14296,0.075835,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0010528,0.14264,0.19171,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0064317,0.14253,0.1057,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00059588,0.14245,0.1825,1,1
1,GO COPII COATED VESICLE BUDDING,0.0029794,0.14234,0.16748,1,1
1,GO RESPONSE TO ANTIBIOTIC,0.0049174,0.142,0.17805,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.14185,0.14042,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00044439,0.14181,0.13253,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0019282,0.14163,0.13483,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.020205,0.14161,0.15743,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.03245,0.14156,0.078346,1,1
1,GO RESPONSE TO STEROL,0.054842,0.14152,0.12321,1,1
1,GO GENITALIA DEVELOPMENT,0.0056288,0.14131,0.12734,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0038387,0.14115,0.15157,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013465,0.1411,0.11921,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0062634,0.14109,0.10622,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,6.2985e-07,0.14107,0.13724,1,1
1,GO LIPID CATABOLIC PROCESS,0.0034322,0.14087,0.10094,1,1
1,GO GOLGI ORGANIZATION,0.00069957,0.14082,0.13405,1,1
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.03245,0.14059,0.18866,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0038387,0.14052,0.11408,1,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.033166,0.14051,0.12168,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00026003,0.14043,0.13401,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00030804,0.13999,0.14349,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.024846,0.13973,0.12393,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.0033e-05,0.13946,0.13714,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0022992,0.13909,0.16923,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00020448,0.13874,0.16069,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.033166,0.13863,0.12871,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.007729,0.1384,0.13802,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0039469,0.13829,0.1451,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0050528,0.13812,0.12281,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00095906,0.13811,0.1162,1,1
1,GO NUCLEUS ORGANIZATION,0.0006154,0.13804,0.12879,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028957,0.13779,0.21075,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.00079435,0.1377,0.11917,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.0042883,0.13749,0.26856,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00032948,0.13733,0.18307,1,1
1,GO APOPTOTIC PROCESS,8.4205e-05,0.13719,0.13308,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0050528,0.13715,0.1844,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.0504e-05,0.13711,0.14588,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0019282,0.13704,0.10455,1,1
1,GO MYOTUBE DIFFERENTIATION,0.038561,0.13701,0.12585,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,2.4346e-05,0.13689,0.16824,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.1617e-05,0.1366,0.17834,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00050664,0.13641,0.12096,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.023205,0.13631,0.16326,1,1
1,GO ENDOSOME ORGANIZATION,0.0022992,0.13593,0.14671,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00032948,0.13557,0.18446,1,1
1,GO SULFATE TRANSPORT,0.00069957,0.13554,0.14245,1,1
1,GO CELL CHEMOTAXIS,0.0041716,0.13548,0.18541,1,1
1,GO RNA SURVEILLANCE,0.00069957,0.13536,0.2054,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00036427,0.1353,0.14715,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.019739,0.13522,0.10769,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.00034072,0.1351,0.11821,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00057693,0.13508,0.12335,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00090094,0.13452,0.13898,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.13449,0.13233,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,5.9841e-06,0.13425,0.13309,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.041967,0.1342,0.20415,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.0016129,0.13385,0.1127,1,1
1,GO CENTRIOLE ASSEMBLY,0.05161,0.13348,0.093568,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.00095906,0.13325,0.10309,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0031536,0.13314,0.10457,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.018836,0.13302,0.1737,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00031859,0.13283,0.14611,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0012662,0.13253,0.14007,1,1
1,GO STEM CELL DIFFERENTIATION,0.00021167,0.13218,0.17719,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.034637,0.13208,0.17067,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.033894,0.13204,0.095095,1,1
1,GO VIRAL BUDDING,0.013465,0.13148,0.1175,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0046564,0.1312,0.205,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.0056288,0.13089,0.13595,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.017969,0.13082,0.12895,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00092958,0.1301,0.1192,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00011241,0.13004,0.11411,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0060989,0.1297,0.11017,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.026586,0.12968,0.11388,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00016023,0.12951,0.1844,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.018398,0.12938,0.17737,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00037661,0.12896,0.11847,1,1
1,GO GENE SILENCING,0.00010462,0.12893,0.13271,1,1
1,GO LIPID HOMEOSTASIS,0.011904,0.12884,0.083537,1,1
1,GO ORGANELLE DISASSEMBLY,5.8301e-05,0.12868,0.13596,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00014935,0.1286,0.13625,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.0001547,0.12799,0.13751,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0013872,0.12772,0.12044,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016339,0.12767,0.13858,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00079435,0.12744,0.11966,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0069616,0.12684,0.18514,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0099891,0.12646,0.12961,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.12629,0.13249,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0018173,0.12626,0.13275,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.0062634,0.12624,0.16516,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0014299,0.12615,0.1125,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.045624,0.12612,0.092082,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.012508,0.12584,0.12223,1,1
1,GO RESPONSE TO HORMONE,0.00092958,0.12561,0.12393,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017796,0.12559,0.21496,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010506,0.12549,0.1282,1,1
1,GO MEMBRANE ORGANIZATION,0.00074557,0.12522,0.1104,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.012508,0.12507,0.097319,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00016023,0.12504,0.13887,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.016734,0.12489,0.16986,1,1
1,GO HEART DEVELOPMENT,0.0017641,0.12473,0.14399,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001191,0.12398,0.11453,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,2.4346e-05,0.12394,0.12828,1,1
1,GO CELLULAR SENESCENCE,0.00092958,0.12384,0.13602,1,1
1,GO ENDOCYTOSIS,0.00030804,0.12359,0.14079,1,1
1,GO CELL DIVISION,0.0025083,0.12332,0.10628,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.00081984,0.12304,0.093322,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.021165,0.12303,0.095374,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00057693,0.12281,0.14934,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.014138,0.12254,0.085709,1,1
1,GO REGULATION OF DNA REPAIR,0.0083534,0.12235,0.094956,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0042883,0.12232,0.099417,1,1
1,GO FLUID TRANSPORT,0.0037331,0.12221,0.1533,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.011612,0.12199,0.1263,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.00353,0.12187,0.10535,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.027803,0.1217,0.1232,1,1
1,GO FAT CELL DIFFERENTIATION,0.035393,0.12163,0.090244,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.4121e-05,0.12139,0.13948,1,1
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0071468,0.12099,0.095825,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001662,0.12047,0.10153,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.00021167,0.11983,0.12367,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0028141,0.11973,0.13848,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0028957,0.11934,0.093252,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.11933,0.14714,1,1
1,GO RESPONSE TO PEPTIDE,0.00059588,0.11882,0.11342,1,1
1,GO CYTOKINESIS,0.0085714,0.11861,0.10996,1,1
1,GO LAMELLIPODIUM ORGANIZATION,0.0046564,0.11799,0.18098,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.04854,0.11798,0.13077,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0054795,0.11787,0.11109,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.026586,0.11757,0.15628,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00012964,0.11735,0.15591,1,1
1,GO REGULATION OF DNA REPLICATION,0.0031536,0.11709,0.11091,1,1
1,GO CHROMOSOME SEPARATION,0.011047,0.11668,0.133,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.011904,0.11617,0.087073,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,5.2139e-05,0.11605,0.14524,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0057817,0.11598,0.11393,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.012508,0.11446,0.082696,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0073363,0.11443,0.12396,1,1
1,GO REGULATION OF AUTOPHAGY,6.0504e-05,0.11411,0.13573,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00010845,0.11372,0.122,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00021909,0.11368,0.12092,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.019283,0.1135,0.1069,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0054795,0.11333,0.11892,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0010206,0.11315,0.11398,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0045306,0.11299,0.088532,1,1
1,GO ORGANELLE FISSION,0.0039469,0.11284,0.091543,1,1
1,GO SPINDLE ORGANIZATION,0.0047853,0.11271,0.11735,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.05161,0.11243,0.14607,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0040578,0.11225,0.088591,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.001228,0.11223,0.13113,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.017969,0.11216,0.10068,1,1
1,GO MACROAUTOPHAGY,1.349e-05,0.11204,0.1404,1,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.033894,0.11183,0.13326,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0010859,0.11173,0.16527,1,1
1,GO FEMALE GAMETE GENERATION,0.0032441,0.11153,0.098412,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02268,0.11145,0.10073,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.00052342,0.11135,0.10608,1,1
1,GO MITOTIC CELL CYCLE,0.0018173,0.11133,0.10611,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.013139,0.11055,0.1361,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.02068,0.11039,0.1415,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00081984,0.11018,0.13918,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0022332,0.11003,0.11418,1,1
1,GO METAPHASE PLATE CONGRESSION,0.047551,0.11002,0.10185,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.023741,0.10979,0.074936,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0030654,0.10974,0.10612,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.013139,0.10969,0.13352,1,1
1,GO NEUTROPHIL CHEMOTAXIS,0.050569,0.10966,0.19158,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.017969,0.10963,0.1815,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.030383,0.10947,0.10946,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.001872,0.10946,0.096889,1,1
1,GO CHROMOSOME CONDENSATION,0.0042883,0.10909,0.1303,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0013872,0.10813,0.10278,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.1888e-05,0.10751,0.11115,1,1
1,GO LEUKOCYTE CHEMOTAXIS,0.050569,0.10668,0.14072,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,2.3418e-05,0.10621,0.10747,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.00013917,0.10604,0.087885,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.029068,0.10572,0.088847,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0011549,0.10407,0.10852,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.0014738,0.1039,0.13318,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0011549,0.10375,0.11415,1,1
1,GO MIRNA METABOLIC PROCESS,0.0085714,0.10365,0.13932,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.03245,0.10354,0.097241,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.011047,0.10287,0.10008,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0007696,0.10224,0.088563,1,1
1,GO PROTEIN TETRAMERIZATION,0.0025817,0.10143,0.11286,1,1
1,GO SNRNA TRANSCRIPTION,0.001986,0.10116,0.10652,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.012203,0.10063,0.12057,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.024846,0.10034,0.063311,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.025414,0.10024,0.096378,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0075304,0.10021,0.17427,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.027188,0.10013,0.078171,1,1
1,GO TUBE FORMATION,0.034637,0.099443,0.11719,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.043763,0.09936,0.080727,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0066042,0.098738,0.10349,1,1
1,GO NCRNA TRANSCRIPTION,0.022165,0.098729,0.091303,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0097392,0.098269,0.086968,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0028957,0.097498,0.11183,1,1
1,GO CELL CYCLE PROCESS,0.0022332,0.097231,0.08863,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.01282,0.096579,0.10427,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0012662,0.09651,0.10311,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00021167,0.096419,0.11056,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00028792,0.096304,0.1058,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00084609,0.096052,0.1549,1,1
1,GO IRON ION TRANSPORT,0.004408,0.095384,0.099605,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.049546,0.095163,0.18687,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0053338,0.095001,0.083618,1,1
1,GO MACROMOLECULE DEACYLATION,0.014486,0.094987,0.075986,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.012508,0.094728,0.073052,1,1
1,GO REGULATION OF CELL CYCLE,0.0050528,0.094704,0.075655,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.037747,0.094133,0.079676,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.00065623,0.093972,0.084718,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.030383,0.093569,0.10741,1,1
1,GO HEART MORPHOGENESIS,0.018836,0.093436,0.13754,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.0071468,0.093215,0.090313,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036164,0.092595,0.089066,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.016339,0.090739,0.084969,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0030654,0.090629,0.10176,1,1
1,GO LIPID METABOLIC PROCESS,0.013465,0.090616,0.064994,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.041093,0.090583,0.074688,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00028792,0.090572,0.10451,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.033894,0.090494,0.088325,1,1
1,GO DNA METABOLIC PROCESS,0.00032948,0.090433,0.095284,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.0038387,0.089101,0.10667,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.015953,0.088978,0.088637,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.041093,0.088072,0.14517,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03939,0.088046,0.052093,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00019753,0.087704,0.094827,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.001986,0.087693,0.10511,1,1
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.013465,0.087675,0.12865,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.014841,0.08742,0.1188,1,1
1,GO REGULATION OF CELL SHAPE,0.016734,0.087109,0.1521,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.033166,0.087053,0.095422,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.029719,0.08636,0.088331,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00353,0.086264,0.064463,1,1
1,GO CELL CYCLE,0.0034322,0.085642,0.074152,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00014418,0.085186,0.095811,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.004408,0.084723,0.075421,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00090094,0.084343,0.14786,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0042883,0.084109,0.10169,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.029068,0.083987,0.081845,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.011326,0.083256,0.071316,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0075304,0.082353,0.075734,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.023205,0.081517,0.099039,1,1
1,GO RESPONSE TO RADIATION,0.0047853,0.081251,0.082213,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.012203,0.079508,0.06525,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033166,0.079488,0.082786,1,1
1,GO SPINDLE ASSEMBLY,0.010245,0.078785,0.089603,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.02843,0.078446,0.069587,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0064317,0.078248,0.11349,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00037661,0.077573,0.078478,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.00079435,0.07732,0.13055,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.020205,0.076802,0.11526,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.02843,0.076661,0.085266,1,1
1,GO MITOCHONDRION ORGANIZATION,0.0017123,0.076636,0.082978,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.033166,0.074179,0.081529,1,1
1,GO VITAMIN METABOLIC PROCESS,0.026586,0.073716,0.10658,1,1
1,GO INTRACELLULAR TRANSPORT,0.00049035,0.072534,0.081128,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.03939,0.071957,0.073794,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.010245,0.070289,0.10369,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.018398,0.070249,0.07561,1,1
1,GO DNA GEOMETRIC CHANGE,0.055956,0.069823,0.10365,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0025083,0.069076,0.089662,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.019739,0.068697,0.051409,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.037747,0.067912,0.089757,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.04854,0.064838,0.073677,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.012508,0.063461,0.09116,1,1
1,GO DNA REPAIR,0.0083534,0.062813,0.078005,1,1
1,GO DNA RECOMBINATION,0.02843,0.060878,0.088485,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.012203,0.060807,0.089537,1,1
1,GO CELL CYCLE CHECKPOINT,0.049546,0.059245,0.065995,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.019283,0.05775,0.083183,1,1
1,GO DNA MODIFICATION,0.042857,0.054972,0.070704,1,1
1,GO DNA CATABOLIC PROCESS,0.037747,0.054712,0.060438,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.040234,0.052268,0.055236,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.05161,0.049955,0.065985,1,1
1,GO CHROMOSOME SEGREGATION,0.054842,0.048147,0.078296,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00081984,1.5054,1.0616,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0007696,1.2856,0.86473,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,9.8628e-07,1.2188,0.94324,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.0056288,1.0213,0.84327,1,1
2,GO ETHANOL OXIDATION,7.2111e-07,0.97262,0.88425,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00013917,0.96721,0.7511,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.009256,0.88518,0.54829,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00067758,0.87183,0.65941,1,1
2,GO BIOLOGICAL PHASE,1.2454e-05,0.827,0.71904,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,6.5149e-05,0.82445,0.72374,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,2.9532e-05,0.81815,0.681,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,5.4977e-07,0.8037,0.79231,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.0073e-05,0.799,0.58429,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,0.78649,0.52802,1,1
2,GO RESPONSE TO INTERLEUKIN 18,1.104e-05,0.78371,0.80785,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.7578e-07,0.77703,0.68854,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00074557,0.75365,0.60603,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.0184e-05,0.74882,0.63449,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.011612,0.74167,0.46203,1,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.0081404,0.72282,0.50375,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,5.7413e-06,0.72072,0.66202,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0010206,0.71623,0.53449,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,1.2308e-06,0.70331,0.619,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,8.4205e-05,0.70111,0.6581,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00047456,0.70096,0.48803,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,0.0090226,0.69478,0.44608,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,8.1192e-05,0.69382,0.53793,1,1
2,GO CELLULAR RESPONSE TO ZINC ION,0.015203,0.69096,0.52853,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.6623e-06,0.68144,0.51433,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.67989,0.60528,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,5.508e-06,0.67495,0.6345,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.2837e-06,0.67163,0.65817,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.9926e-07,0.67136,0.52705,1,1
2,GO MUCUS SECRETION,0.00026903,0.66447,0.64927,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,6.4994e-06,0.66368,0.58114,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00012074,0.66273,0.56182,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.6603e-06,0.66265,0.61104,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.00010092,0.66237,0.51745,1,1
2,GO ACTIN FILAMENT SEVERING,0.00024286,0.65998,0.5153,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0011199,0.65048,0.46681,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.2754e-05,0.64618,0.57749,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00052342,0.63924,0.58472,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00010845,0.62532,0.46634,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,9.7346e-05,0.62061,0.50242,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,6.0504e-05,0.6181,0.70213,1,1
2,GO MYOBLAST MIGRATION,0.0069616,0.61589,0.506,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,2.8077e-06,0.61141,0.57587,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.3975e-07,0.6102,0.58745,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00030804,0.60615,0.41645,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00059588,0.59988,0.46816,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0041716,0.59711,0.48998,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.8521e-05,0.59555,0.58604,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0022992,0.59403,0.46948,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.4121e-05,0.59384,0.57368,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00014935,0.58485,0.53377,1,1
2,GO ETHER METABOLIC PROCESS,1.104e-05,0.58474,0.49527,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00012964,0.58454,0.44686,1,1
2,GO HAIR FOLLICLE MATURATION,2.8077e-06,0.58429,0.52615,1,1
2,GO PROSTATE GLAND GROWTH,1.6455e-05,0.58277,0.62272,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.040234,0.58029,0.36474,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00022676,0.57924,0.45547,1,1
2,GO PROSTANOID METABOLIC PROCESS,4.4712e-06,0.57692,0.52271,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.5331e-06,0.5727,0.44674,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00030804,0.56603,0.45909,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0001547,0.5639,0.48257,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00026003,0.56331,0.43826,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.013139,0.56251,0.28267,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0041716,0.5597,0.40562,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0071468,0.54879,0.39377,1,1
2,GO OTIC VESICLE DEVELOPMENT,5.6174e-05,0.54762,0.49438,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00014418,0.54438,0.42808,1,1
2,GO LYSINE METABOLIC PROCESS,0.00021909,0.54427,0.52111,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.00018427,0.54161,0.49314,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.0311e-06,0.54104,0.51568,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,6.5896e-07,0.54029,0.50175,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00037661,0.53478,0.51701,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00021167,0.53459,0.44668,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001662,0.53424,0.36439,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.53143,0.34126,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,4.2876e-06,0.53083,0.49729,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.0779e-06,0.52289,0.49522,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.6455e-05,0.51953,0.5755,1,1
2,GO ZINC ION HOMEOSTASIS,0.0071468,0.51385,0.35525,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00027832,0.51167,0.42703,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.6015e-06,0.50989,0.45418,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00081984,0.5091,0.35871,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.00026903,0.50864,0.47922,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00022676,0.5033,0.42378,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,1.6455e-05,0.50273,0.48734,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,9.389e-05,0.50121,0.5564,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00034072,0.49779,0.36491,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,8.3127e-06,0.49748,0.45719,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0015189,0.48719,0.49569,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00098941,0.48643,0.37082,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,1.9263e-05,0.48444,0.46857,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.48135,0.36888,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00019079,0.48059,0.48747,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.8077e-06,0.47901,0.42664,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0040578,0.47685,0.4666,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0060989,0.47543,0.42012,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00018427,0.47213,0.54063,1,1
2,GO MUSCLE ATROPHY,0.0037331,0.46832,0.37007,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7806e-05,0.46809,0.41503,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,8.4205e-05,0.46792,0.40082,1,1
2,GO NEURAL CREST FORMATION,1.349e-05,0.46776,0.42292,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00026003,0.46656,0.37616,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.043763,0.46427,0.22669,1,1
2,GO TOLERANCE INDUCTION,0.0060989,0.46153,0.34028,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.00012964,0.46114,0.36601,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0019282,0.46104,0.38707,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.7343e-05,0.45356,0.35724,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00037661,0.45266,0.33998,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00018427,0.45158,0.44046,1,1
2,GO MICROVILLUS ASSEMBLY,0.0001547,0.4514,0.42248,1,1
2,GO RESPONSE TO INTERFERON BETA,0.016734,0.4508,0.29331,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00098941,0.45013,0.38732,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00027832,0.44826,0.39212,1,1
2,GO NEPHRON TUBULE FORMATION,0.0028957,0.44818,0.31059,1,1
2,GO RESPONSE TO COPPER ION,0.018398,0.44757,0.32373,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,1.2962e-05,0.44716,0.43722,1,1
2,GO ETHANOL METABOLIC PROCESS,4.2876e-06,0.44613,0.52245,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.05161,0.44602,0.32164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00017796,0.4453,0.42189,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00037661,0.44499,0.42706,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39271,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00024286,0.44394,0.31663,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00017796,0.4423,0.29176,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0006154,0.44006,0.40278,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00037661,0.43886,0.42153,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0022332,0.43843,0.4151,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,4.2876e-06,0.4377,0.43006,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,1.104e-05,0.43697,0.42542,1,1
2,GO DENDRITIC CELL MIGRATION,1.5201e-05,0.43567,0.39949,1,1
2,GO LIPID DROPLET FORMATION,0.014138,0.43462,0.36832,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,8.1192e-05,0.43392,0.49982,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0018173,0.43185,0.41357,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.0001165,0.43141,0.52034,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.2454e-05,0.43137,0.36932,1,1
2,GO CYTIDINE TO URIDINE EDITING,0.024288,0.43033,0.38887,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0079323,0.42715,0.27452,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,1.0604e-05,0.42388,0.36831,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,2.0833e-05,0.42156,0.43825,1,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.017969,0.42068,0.34652,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.001228,0.42048,0.29311,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,2.4692e-06,0.41888,0.40345,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,3.9418e-06,0.4178,0.3897,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0046564,0.4166,0.37787,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0019282,0.41321,0.39375,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.7343e-05,0.41126,0.32383,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,4.0073e-05,0.41095,0.36906,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.2962e-05,0.4109,0.36776,1,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.0053338,0.40971,0.34198,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0020453,0.40915,0.33678,1,1
2,GO RETINAL METABOLIC PROCESS,0.030383,0.40901,0.28392,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0024367,0.40856,0.31171,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00016595,0.40779,0.33981,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00014935,0.40752,0.45601,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00016023,0.40692,0.40904,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0064317,0.40642,0.29103,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.022165,0.40594,0.31691,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.019739,0.40544,0.23868,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00040247,0.40539,0.3318,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.00027832,0.40469,0.26668,1,1
2,GO RESPONSE TO CADMIUM ION,0.00054072,0.40414,0.31455,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0006154,0.40363,0.29582,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00054072,0.40256,0.26992,1,1
2,GO REGULATION OF PROTEIN IMPORT,9.389e-05,0.40199,0.30224,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00010462,0.40029,0.31953,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00025131,0.39978,0.35106,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.1904e-06,0.39783,0.3819,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,4.8379e-05,0.39768,0.35944,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.013798,0.39751,0.30458,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00012512,0.39577,0.30934,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0010528,0.39496,0.34653,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0024367,0.39345,0.3306,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00063551,0.39103,0.35974,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00092958,0.39073,0.3414,1,1
2,GO PORE COMPLEX ASSEMBLY,4.2876e-06,0.39017,0.38489,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,9.0551e-05,0.38945,0.37701,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.1888e-05,0.38885,0.39012,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0069616,0.38851,0.35244,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.024288,0.38821,0.24284,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.031748,0.38807,0.23201,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.4963e-07,0.38804,0.41069,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0029794,0.3878,0.29031,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.024288,0.38674,0.25958,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.2962e-05,0.38659,0.34151,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00059588,0.38625,0.36174,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.012508,0.38383,0.2473,1,1
2,GO HEME METABOLIC PROCESS,0.00025131,0.38291,0.33374,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,4.6597e-05,0.3795,0.46054,1,1
2,GO OXYGEN TRANSPORT,0.052669,0.37796,0.35927,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017123,0.3771,0.2987,1,1
2,GO T CELL MEDIATED IMMUNITY,0.00027832,0.37695,0.30853,1,1
2,GO LIMB BUD FORMATION,0.0041716,0.37637,0.44951,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.35611,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.015574,0.37514,0.24917,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.001986,0.37456,0.25527,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.5759e-05,0.37397,0.32954,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.016339,0.37372,0.24906,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0017123,0.37248,0.32492,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00026003,0.37228,0.29748,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,8.7323e-05,0.37205,0.49353,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0007696,0.37187,0.26008,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,4.1112e-06,0.3715,0.35127,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.0032441,0.37038,0.26839,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.035393,0.37,0.26802,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.5816e-05,0.36991,0.33023,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,4.4712e-06,0.36845,0.34307,1,1
2,GO RESPONSE TO TUMOR CELL,0.0023671,0.36774,0.31462,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0012662,0.36619,0.32638,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,8.3127e-06,0.36538,0.3695,1,1
2,GO PENTOSE METABOLIC PROCESS,0.00010462,0.36507,0.36149,1,1
2,GO CYTOPLASM ORGANIZATION,5.4121e-05,0.36327,0.39834,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00025131,0.36195,0.33315,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00044439,0.36173,0.31755,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00016023,0.36165,0.32376,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.4712e-06,0.36038,0.33692,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.0027346,0.35924,0.29844,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0027346,0.35876,0.33954,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.016339,0.35757,0.31504,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.00057693,0.35743,0.24475,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00013433,0.35729,0.29084,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00016023,0.35727,0.31841,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00012074,0.35702,0.32327,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0064317,0.35689,0.34987,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.1192e-05,0.35675,0.33144,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0017123,0.35603,0.34989,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.00040247,0.35543,0.29418,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0045306,0.3545,0.27943,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00012512,0.35413,0.31449,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.00013917,0.35359,0.30428,1,1
2,GO CARNITINE SHUTTLE,7.6603e-06,0.35351,0.37375,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00010092,0.35346,0.33155,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0087944,0.35338,0.25851,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,1.7118e-05,0.35275,0.36381,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.037747,0.35217,0.2992,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0040578,0.35152,0.27118,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.0059384,0.35118,0.27656,1,1
2,GO MICROVILLUS ORGANIZATION,0.00055855,0.35037,0.39383,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,5.0683e-06,0.3499,0.32162,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00092958,0.3485,0.27632,1,1
2,GO FATTY ACID HOMEOSTASIS,0.012203,0.34829,0.21907,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00045924,0.34785,0.30996,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00027832,0.34747,0.25525,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0029794,0.34625,0.21492,1,1
2,GO URETER DEVELOPMENT,0.0034322,0.34427,0.33211,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0037331,0.34406,0.29859,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0001165,0.3421,0.31532,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0013872,0.34153,0.27522,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00017796,0.34132,0.29219,1,1
2,GO REGULATION OF DNA METHYLATION,2.0833e-05,0.34129,0.28342,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0015189,0.3393,0.31898,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.001986,0.33906,0.25514,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0059384,0.3388,0.24726,1,1
2,GO TONGUE MORPHOGENESIS,0.011047,0.33749,0.303,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.026586,0.33733,0.21069,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,2.5308e-05,0.33665,0.34704,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0028141,0.33597,0.23705,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0026572,0.3355,0.24165,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00029782,0.33545,0.49472,1,1
2,GO DETOXIFICATION,7.2754e-05,0.33512,0.27847,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.33505,0.47953,1,1
2,GO ERBB2 SIGNALING PATHWAY,4.3218e-05,0.33492,0.30443,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,5.4121e-05,0.33484,0.31965,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.04854,0.33405,0.19039,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0011199,0.33393,0.39075,1,1
2,GO RNA DECAPPING,0.00013433,0.33388,0.21463,1,1
2,GO MONONUCLEAR CELL MIGRATION,7.2754e-05,0.33378,0.27952,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,7.8282e-05,0.33295,0.35289,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00019079,0.33228,0.30267,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.02268,0.33166,0.34633,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.33162,0.29239,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00095906,0.33141,0.3427,1,1
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.018836,0.33026,0.25781,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,6.5149e-05,0.3288,0.28829,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00081984,0.32825,0.26775,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.00021909,0.3282,0.32632,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00059588,0.32799,0.2687,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00069957,0.32791,0.25665,1,1
2,GO REGULATION OF CELL KILLING,0.0018173,0.32791,0.24161,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0021062,0.32767,0.53155,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.00012964,0.32632,0.27534,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00026903,0.32536,0.25176,1,1
2,GO RESPIRATORY BURST,0.0011199,0.32518,0.25552,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.0014299,0.32514,0.3733,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0027346,0.32427,0.21658,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0017641,0.32395,0.26655,1,1
2,GO ARACHIDONIC ACID SECRETION,1.5201e-05,0.3226,0.32773,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00084609,0.32251,0.3487,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32232,0.29728,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.016734,0.32212,0.18412,1,1
2,GO RETINOL METABOLIC PROCESS,0.00042998,0.32205,0.28646,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0014299,0.32142,0.41259,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0031536,0.32113,0.24478,1,1
2,GO PRE MIRNA PROCESSING,0.0041716,0.32085,0.20758,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00013917,0.32056,0.27405,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0083534,0.3199,0.30743,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.0050528,0.31889,0.23593,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.011904,0.31851,0.2641,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.0033e-05,0.31787,0.28401,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0057817,0.31773,0.33175,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.1192e-05,0.31732,0.29313,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0081404,0.31708,0.24972,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0022332,0.31689,0.32071,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.0062634,0.31634,0.24643,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.014486,0.31597,0.19437,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0041716,0.31534,0.20408,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0046564,0.31446,0.28646,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.013465,0.31384,0.27947,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.020205,0.31381,0.26071,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.013465,0.31361,0.33393,1,1
2,GO PIGMENT GRANULE MATURATION,0.013465,0.31312,0.24673,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00035231,0.31289,0.30129,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0069616,0.31253,0.24244,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.007729,0.31196,0.36739,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00010462,0.3119,0.27631,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.043763,0.31177,0.23316,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.02068,0.31157,0.24279,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.9263e-05,0.31107,0.25586,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.02268,0.31001,0.18323,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00035231,0.30986,0.23628,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00092958,0.30978,0.24417,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.3218e-05,0.30971,0.29858,1,1
2,GO RENAL VESICLE DEVELOPMENT,0.0010528,0.30936,0.27827,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0032441,0.30912,0.2679,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.025994,0.30869,0.24466,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00034072,0.30825,0.33195,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0017123,0.3082,0.33268,1,1
2,GO RESPONSE TO SALT STRESS,0.0051916,0.3082,0.23213,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0021062,0.30775,0.3256,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010206,0.30773,0.2203,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00026903,0.30761,0.27062,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.021165,0.30733,0.18588,1,1
2,GO AMP METABOLIC PROCESS,0.017969,0.30722,0.22049,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,7.8282e-05,0.30675,0.2752,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0030654,0.30673,0.21157,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00063551,0.30664,0.30688,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.001986,0.30655,0.38834,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.011612,0.30645,0.22615,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00042998,0.30575,0.27796,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0006154,0.30557,0.27656,1,1
2,GO OVULATION,0.00054072,0.30483,0.30405,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0071468,0.30433,0.36471,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00036427,0.30427,0.35045,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0056288,0.30369,0.26188,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00035231,0.30352,0.27679,1,1
2,GO KERATINOCYTE PROLIFERATION,0.014486,0.30281,0.30266,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00087311,0.30237,0.2419,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,3.17e-07,0.30193,0.27736,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0013872,0.30179,0.29363,1,1
2,GO ENTRY INTO HOST,0.0011199,0.30169,0.25336,1,1
2,GO AMINE CATABOLIC PROCESS,0.0024367,0.30063,0.32948,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.027803,0.29992,0.29087,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0011549,0.2998,0.22468,1,1
2,GO REGULATION OF HAIR CYCLE,0.00019079,0.29966,0.3125,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00017796,0.29935,0.31077,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0013054,0.2993,0.33509,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.0020453,0.29848,0.30055,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0040578,0.29827,0.22173,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,2.5308e-05,0.29814,0.31352,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00054072,0.29764,0.24553,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0036303,0.29721,0.32086,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00090094,0.29655,0.2436,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.040234,0.29623,0.2444,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.00022676,0.29587,0.25043,1,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.025994,0.29583,0.40992,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0016129,0.29582,0.1969,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00092958,0.29556,0.22302,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,2.6902e-06,0.29545,0.28057,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0017123,0.29527,0.27013,1,1
2,GO NUCLEAR PORE ORGANIZATION,1.6455e-05,0.29527,0.33608,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0010206,0.29504,0.21297,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0054795,0.29495,0.23478,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00038934,0.29478,0.2612,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,4.8379e-05,0.29462,0.27054,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00028792,0.29355,0.23338,1,1
2,GO RIG I SIGNALING PATHWAY,2.4346e-05,0.29343,0.2764,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001191,0.29317,0.25953,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,0.29291,0.20425,1,1
2,GO PODOSOME ASSEMBLY,0.001662,0.29268,0.26744,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0059384,0.29261,0.19283,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.4205e-05,0.29244,0.23692,1,1
2,GO GASTRIC ACID SECRETION,0.00067758,0.29234,0.25262,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0099891,0.29226,0.15635,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.2754e-05,0.29144,0.27489,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00032948,0.29142,0.27593,1,1
2,GO MATURATION OF LSU RRNA,0.0024367,0.29137,0.26677,1,1
2,GO ZYMOGEN INHIBITION,0.01282,0.29042,0.24983,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00042998,0.28928,0.23931,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013465,0.289,0.22337,1,1
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0090226,0.28848,0.24004,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0054795,0.28817,0.26664,1,1
2,GO REGULATION OF ANOIKIS,0.036164,0.28745,0.20045,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0006154,0.28728,0.23404,1,1
2,GO EPIBOLY,0.052669,0.28686,0.16399,1,1
2,GO T CELL APOPTOTIC PROCESS,0.0001165,0.28681,0.26426,1,1
2,GO FEVER GENERATION,0.0056288,0.28659,0.22255,1,1
2,GO BLASTODERM SEGMENTATION,0.02268,0.28649,0.27786,1,1
2,GO FIBROBLAST ACTIVATION,0.00087311,0.28636,0.31968,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.041967,0.28634,0.16192,1,1
2,GO GAS TRANSPORT,0.031059,0.28628,0.30133,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.023205,0.2862,0.19931,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0054795,0.28588,0.21792,1,1
2,GO RESPONSE TO ZINC ION,0.011612,0.28585,0.24228,1,1
2,GO PEPTIDE CROSS LINKING,0.0099891,0.28569,0.23073,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,2.8418e-05,0.28525,0.28383,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.011326,0.28525,0.42507,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00044439,0.28519,0.27815,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00054072,0.28517,0.23255,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00030804,0.28461,0.28543,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.0833e-05,0.28428,0.30871,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00018427,0.28381,0.25371,1,1
2,GO REGULATION OF NEURON MATURATION,0.0051916,0.28348,0.28528,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00010092,0.28324,0.23119,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0032441,0.28291,0.34393,1,1
2,GO REGULATION OF CELL PROJECTION SIZE,0.052669,0.28251,0.25312,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.018398,0.28248,0.19913,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.2367e-06,0.28243,0.3279,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,3.4421e-05,0.28207,0.29663,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00028792,0.28197,0.24546,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0033369,0.28166,0.19945,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00017186,0.28143,0.23088,1,1
2,GO REGULATION OF LIPASE ACTIVITY,4.6597e-05,0.2814,0.22706,1,1
2,GO RESPONSE TO X RAY,4.1617e-05,0.2813,0.3526,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00013433,0.28127,0.26252,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.040234,0.28097,0.17264,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00036427,0.28074,0.2423,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.0226e-05,0.2807,0.25705,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0007696,0.28062,0.29481,1,1
2,GO INTESTINAL ABSORPTION,0.0022332,0.28038,0.22953,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0018173,0.28019,0.26918,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0067808,0.28016,0.19818,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0019282,0.28014,0.23293,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,8.7323e-05,0.27956,0.23068,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.00067758,0.27951,0.19944,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.00030804,0.27925,0.21737,1,1
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.01282,0.27922,0.18811,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0097392,0.27921,0.2342,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00059588,0.27903,0.2003,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.001872,0.27797,0.30575,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.046579,0.27727,0.19456,1,1
2,GO CHROMATIN DISASSEMBLY,0.0012662,0.2771,0.20787,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0057817,0.27696,0.17199,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0032441,0.27671,0.21179,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.024288,0.27635,0.16237,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00019079,0.27632,0.27004,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.015203,0.27548,0.16518,1,1
2,GO REPLICATIVE SENESCENCE,0.042857,0.27533,0.19251,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0023671,0.27515,0.23931,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0027346,0.27456,0.20815,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0010528,0.2742,0.24246,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,9.7801e-06,0.27419,0.241,1,1
2,GO RESPONSE TO OXYGEN RADICAL,8.4205e-05,0.27336,0.21684,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,6.5149e-05,0.27319,0.24784,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,0.27313,0.21221,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0026572,0.27304,0.21533,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.001986,0.27218,0.19685,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00090094,0.27151,0.29104,1,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0013054,0.27143,0.29048,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.038561,0.27104,0.14301,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.021165,0.27102,0.21674,1,1
2,GO VIRAL TRANSLATION,0.00072223,0.27089,0.27046,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.00030804,0.27085,0.31546,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0045306,0.27052,0.2379,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00026003,0.27047,0.30544,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00027832,0.26954,0.22588,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0094949,0.26922,0.21313,1,1
2,GO MIRNA METABOLIC PROCESS,8.3127e-06,0.26846,0.21676,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001662,0.26824,0.24128,1,1
2,GO NOTOCHORD DEVELOPMENT,0.0010528,0.26823,0.46365,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.0021689,0.26793,0.24776,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,2.0033e-05,0.26787,0.23936,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00021909,0.2673,0.20979,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.029068,0.26705,0.1738,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.2754e-05,0.26701,0.24745,1,1
2,GO MRNA MODIFICATION,0.0028141,0.26692,0.18328,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.017137,0.26689,0.15688,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00037661,0.26664,0.30766,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0054795,0.26658,0.31069,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0001165,0.26647,0.25284,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0021062,0.26638,0.24496,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00038934,0.26616,0.35106,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0010859,0.26538,0.25349,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.3132e-05,0.26504,0.23458,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0010528,0.26478,0.20545,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,7.8282e-05,0.26444,0.26943,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00021909,0.26442,0.21354,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.013798,0.26394,0.18008,1,1
2,GO NUCLEAR MIGRATION,0.00029782,0.26385,0.22599,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0029794,0.26382,0.22882,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.015574,0.26376,0.23034,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00074557,0.26309,0.24617,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.019283,0.263,0.23464,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00029782,0.26238,0.30319,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00036427,0.26237,0.28573,1,1
2,GO LAMELLIPODIUM ORGANIZATION,5.753e-07,0.26228,0.29381,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0046564,0.26208,0.23692,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.00087311,0.26198,0.23341,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.001986,0.26077,0.2725,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0039469,0.26074,0.27836,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00037661,0.26047,0.24384,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0049174,0.2603,0.21149,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.014841,0.25967,0.18575,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,9.389e-05,0.25959,0.23136,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0021689,0.25901,0.19005,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,1.2454e-05,0.25898,0.21785,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.00072223,0.25885,0.21181,1,1
2,GO RNA 5 END PROCESSING,0.00059588,0.25877,0.23397,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0060989,0.25875,0.17096,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0010528,0.25857,0.22588,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.013139,0.25807,0.14864,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0037331,0.25792,0.26815,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00027832,0.25791,0.22054,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.00057693,0.25758,0.22215,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.024288,0.2574,0.21532,1,1
2,GO ALDITOL METABOLIC PROCESS,0.0017641,0.25733,0.26785,1,1
2,GO GLYCINE METABOLIC PROCESS,0.022165,0.25724,0.18658,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00050664,0.25706,0.26133,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.0051916,0.25701,0.22583,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.4039e-05,0.25683,0.25484,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0013872,0.25629,0.19146,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0013457,0.25619,0.19472,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0042883,0.25607,0.20325,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,9.7346e-05,0.25506,0.21078,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0022332,0.25469,0.24254,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00019079,0.25449,0.27585,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.0012662,0.25435,0.25095,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.7145e-05,0.2542,0.26065,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.0025817,0.25401,0.21436,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00098941,0.25358,0.1825,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0013457,0.25355,0.22008,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.010245,0.25313,0.16637,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.00054072,0.25309,0.2573,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0054795,0.25283,0.23433,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.038561,0.25241,0.12915,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.018398,0.2524,0.2296,1,1
2,GO DNA LIGATION,0.011612,0.25197,0.18291,1,1
2,GO HISTONE H3 K9 ACETYLATION,0.00013433,0.25194,0.23236,1,1
2,GO PINOCYTOSIS,0.0019282,0.25187,0.16377,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.025994,0.25168,0.1741,1,1
2,GO RESPONSE TO PROTOZOAN,0.0059384,0.25164,0.18841,1,1
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.017969,0.2515,0.28059,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.055956,0.25127,0.14702,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0050528,0.25126,0.29639,1,1
2,GO PLATELET MORPHOGENESIS,2.0833e-05,0.2509,0.26804,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,2.1663e-05,0.25063,0.22057,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0011549,0.25058,0.26849,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0014299,0.25044,0.26238,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0037331,0.25033,0.17131,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0085714,0.25011,0.23783,1,1
2,GO TRNA METHYLATION,0.00023468,0.25004,0.21423,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00027832,0.24986,0.20468,1,1
2,GO NADP METABOLIC PROCESS,0.001662,0.2495,0.25273,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.8583e-05,0.24932,0.24223,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00042998,0.249,0.22342,1,1
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00054072,0.24878,0.20723,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0060989,0.2486,0.22163,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00021909,0.24817,0.21717,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00092958,0.24791,0.29018,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.036164,0.24772,0.18861,1,1
2,GO INTERFERON BETA PRODUCTION,0.0029794,0.2477,0.1947,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,4.4878e-05,0.24767,0.23244,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00067758,0.24754,0.20423,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.021165,0.24712,0.17479,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00098941,0.24712,0.22408,1,1
2,GO VIRAL GENE EXPRESSION,0.0015189,0.24701,0.21533,1,1
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.03245,0.24699,0.23634,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0007696,0.24684,0.21397,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0037331,0.24683,0.18532,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.041093,0.24593,0.29827,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0032441,0.2458,0.2246,1,1
2,GO RESPONSE TO IRON ION,0.001872,0.24574,0.25941,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00079435,0.24574,0.18075,1,1
2,GO HISTAMINE SECRETION,0.022165,0.24562,0.24493,1,1
2,GO EPITHELIAL CELL MORPHOGENESIS,0.010506,0.24534,0.28793,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0037331,0.24529,0.21195,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0090226,0.24511,0.2439,1,1
2,GO PROTEASOME ASSEMBLY,0.0034322,0.24489,0.19181,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,5.0226e-05,0.24489,0.28407,1,1
2,GO AMINO ACID ACTIVATION,0.00024286,0.2448,0.26448,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.0010528,0.24478,0.22046,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00059588,0.24443,0.20218,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.00011241,0.24431,0.19351,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.031748,0.24419,0.16749,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00020448,0.24407,0.22614,1,1
2,GO NAD BIOSYNTHETIC PROCESS,0.050569,0.24401,0.15927,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00031859,0.24378,0.22801,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1964e-05,0.24378,0.21156,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028957,0.24346,0.21342,1,1
2,GO CORNIFICATION,0.00016595,0.24305,0.34965,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00074557,0.24303,0.20213,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0029794,0.24287,0.23281,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020448,0.24287,0.2347,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.011612,0.24259,0.2638,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.011612,0.2422,0.22648,1,1
2,GO LAMELLIPODIUM ASSEMBLY,1.6729e-06,0.24213,0.26439,1,1
2,GO NUCLEUS LOCALIZATION,0.00011241,0.24193,0.21467,1,1
2,GO NEGATIVE T CELL SELECTION,0.015574,0.24185,0.12618,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.011047,0.24182,0.20943,1,1
2,GO CHEMOKINE PRODUCTION,0.0014299,0.24172,0.23294,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0060989,0.24167,0.27259,1,1
2,GO SECRETION BY TISSUE,0.0011549,0.24153,0.24592,1,1
2,GO NECROTIC CELL DEATH,0.0018173,0.24131,0.21896,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,9.0179e-06,0.24124,0.2168,1,1
2,GO T CELL CHEMOTAXIS,0.00032948,0.24107,0.21522,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.02843,0.24086,0.15424,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00095906,0.24081,0.25904,1,1
2,GO MATURATION OF SSU RRNA,0.001662,0.24052,0.23699,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.4121e-05,0.24025,0.24409,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00092958,0.24012,0.18252,1,1
2,GO HISTONE H4 DEACETYLATION,0.00059588,0.2399,0.29027,1,1
2,GO ERYTHROCYTE MATURATION,0.0050528,0.2397,0.308,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00014418,0.23953,0.20981,1,1
2,GO LIPOXYGENASE PATHWAY,0.016339,0.23946,0.28514,1,1
2,GO LIPID OXIDATION,0.0019282,0.23939,0.17868,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.010773,0.23916,0.19708,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0010206,0.23909,0.22909,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00042998,0.239,0.22493,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00050664,0.23895,0.23704,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00072223,0.2387,0.2128,1,1
2,GO VESICLE CARGO LOADING,9.7346e-05,0.23815,0.25402,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00012964,0.23774,0.24273,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.0094949,0.23703,0.17846,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0006154,0.23682,0.19183,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00036427,0.23639,0.24383,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00098941,0.23604,0.21593,1,1
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0037331,0.23596,0.17216,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0023671,0.23589,0.21873,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00059588,0.23544,0.21152,1,1
2,GO T CELL PROLIFERATION,0.00045924,0.23456,0.19729,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00020448,0.2344,0.19997,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.02268,0.2343,0.20926,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.00069957,0.23381,0.22394,1,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.022165,0.2338,0.12184,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.024846,0.23369,0.19094,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0025083,0.23348,0.19523,1,1
2,GO AEROBIC RESPIRATION,0.00065623,0.23303,0.21846,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001191,0.23278,0.18919,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00047456,0.23221,0.28855,1,1
2,GO RESPONSE TO MANGANESE ION,0.0011199,0.23176,0.25792,1,1
2,GO B CELL HOMEOSTASIS,0.0019282,0.23163,0.17053,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00012074,0.23162,0.20277,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.001662,0.23157,0.21089,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.4121e-05,0.23121,0.2159,1,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0042883,0.23111,0.18213,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0028957,0.23105,0.16285,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.00081984,0.23078,0.25649,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0028957,0.23034,0.23424,1,1
2,GO REGULATION OF CELL MATURATION,0.0013872,0.22995,0.20171,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00014935,0.22989,0.17389,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00018427,0.22981,0.19431,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,1.6455e-05,0.22963,0.19865,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0015189,0.22959,0.24313,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.0025083,0.22954,0.30315,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0014738,0.22949,0.26019,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00040247,0.22941,0.22788,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00065623,0.22911,0.24343,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.020205,0.22907,0.15718,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0013457,0.22905,0.22133,1,1
2,GO LEUKOCYTE PROLIFERATION,0.00019753,0.22891,0.19614,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0037331,0.22863,0.20583,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0071468,0.22855,0.13161,1,1
2,GO RNA STABILIZATION,0.0031536,0.22835,0.14779,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0050528,0.2283,0.17589,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,7.2111e-07,0.22813,0.22725,1,1
2,GO PEPTIDYL PROLINE MODIFICATION,0.0017123,0.22811,0.17502,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0079323,0.22803,0.14413,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00024286,0.22791,0.2726,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.02068,0.22781,0.17606,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.017137,0.22749,0.18202,1,1
2,GO PIGMENT GRANULE ORGANIZATION,6.2786e-05,0.22725,0.23686,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.031059,0.22724,0.16795,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.02068,0.22713,0.20259,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,7.0571e-06,0.2271,0.20948,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00055855,0.22708,0.21194,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.010773,0.22703,0.19146,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.001986,0.22678,0.22454,1,1
2,GO THYMUS DEVELOPMENT,0.00010845,0.22665,0.23047,1,1
2,GO PIGMENT METABOLIC PROCESS,0.0028957,0.22658,0.16121,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,7.013e-05,0.22629,0.20706,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.03245,0.2261,0.14778,1,1
2,GO RIBOSOME BIOGENESIS,0.00027832,0.22553,0.21984,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00016595,0.22491,0.17755,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00027832,0.22488,0.23015,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.010506,0.22487,0.20303,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0046564,0.22477,0.24392,1,1
2,GO MATURATION OF 5 8S RRNA,0.0011199,0.22463,0.24671,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0014738,0.22448,0.22367,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0019282,0.22434,0.19006,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.00074557,0.22431,0.24672,1,1
2,GO DETECTION OF OTHER ORGANISM,0.03939,0.22431,0.20817,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0006154,0.2243,0.16535,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028957,0.22393,0.24439,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.010245,0.22382,0.21489,1,1
2,GO PLACENTA DEVELOPMENT,0.0036303,0.22381,0.16946,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00028792,0.22377,0.2177,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0017641,0.22354,0.23738,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0017123,0.22342,0.19961,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0018173,0.22337,0.26141,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0042883,0.22298,0.1981,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0029794,0.22289,0.19369,1,1
2,GO MAST CELL ACTIVATION,0.014841,0.22042,0.16004,1,1
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019283,0.22038,0.23344,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,2.7343e-05,0.22038,0.26778,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0032441,0.22023,0.21029,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0010206,0.22014,0.21034,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0021689,0.21939,0.23804,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.013139,0.21926,0.16534,1,1
2,GO MAINTENANCE OF CELL NUMBER,2.4346e-05,0.21917,0.2196,1,1
2,GO B CELL PROLIFERATION,0.00040247,0.21914,0.18678,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.013798,0.21912,0.18772,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00079435,0.21894,0.21932,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.00063551,0.21841,0.21004,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00030804,0.21791,0.20269,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00045924,0.2177,0.21014,1,1
2,GO POSITIVE CHEMOTAXIS,0.010506,0.21763,0.1521,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.016734,0.21762,0.23038,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00084609,0.21743,0.21065,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0027346,0.21726,0.15326,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.033894,0.2165,0.1815,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.00034072,0.21648,0.20019,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00074557,0.21629,0.19606,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,3.7145e-05,0.2162,0.20935,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.0060989,0.21601,0.19606,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.001662,0.2155,0.2018,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0014299,0.21502,0.2156,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.044685,0.21489,0.2091,1,1
2,GO RNA INTERFERENCE,0.0017123,0.21481,0.21314,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0037331,0.21452,0.15839,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0040578,0.2144,0.24133,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.7801e-06,0.21428,0.1977,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00012512,0.21418,0.23636,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0049174,0.21407,0.16715,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0071468,0.21405,0.1425,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0097392,0.21398,0.23344,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0054795,0.21338,0.19382,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0019282,0.21293,0.21543,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.022165,0.21288,0.23621,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.00084609,0.21254,0.27225,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00028792,0.21224,0.17853,1,1
2,GO LIVER REGENERATION,0.030383,0.21218,0.15223,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0057817,0.21216,0.23094,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0049174,0.2118,0.19778,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0071468,0.21164,0.15244,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.15541,1,1
2,GO INTERACTION WITH HOST,0.00055855,0.21138,0.20796,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00098941,0.21117,0.32828,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.041967,0.21084,0.14995,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0020453,0.21046,0.1734,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.024846,0.21016,0.15304,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.016339,0.21009,0.16263,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.041093,0.20962,0.18583,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0001547,0.20948,0.22336,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.012203,0.20947,0.22035,1,1
2,GO REGULATION OF WATER LOSS VIA SKIN,0.019739,0.20888,0.27086,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.036948,0.20869,0.17986,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0017641,0.20863,0.1711,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.027803,0.20821,0.1536,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.0039469,0.20814,0.20148,1,1
2,GO PIGMENT ACCUMULATION,0.0045306,0.20811,0.21149,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.014138,0.2081,0.2393,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0059384,0.20774,0.27602,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0001547,0.20735,0.24373,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0046564,0.2073,0.19149,1,1
2,GO RRNA MODIFICATION,0.0034322,0.20725,0.18976,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.00031859,0.20714,0.27185,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00035231,0.2071,0.21002,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0010206,0.207,0.15996,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.0013872,0.20672,0.17267,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.014138,0.20661,0.19401,1,1
2,GO PERICARDIUM DEVELOPMENT,0.022165,0.20653,0.19549,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0075304,0.20642,0.15073,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0010859,0.20632,0.20475,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0025083,0.20625,0.21288,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.017137,0.20598,0.17327,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0015189,0.20592,0.20876,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.026586,0.20571,0.12543,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0038387,0.20555,0.20768,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.023741,0.20547,0.12743,1,1
2,GO SKIN DEVELOPMENT,0.001986,0.20541,0.22053,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.0013054,0.20516,0.14625,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.045624,0.20513,0.17134,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00023468,0.20513,0.1746,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00081984,0.20511,0.21547,1,1
2,GO VIRAL GENOME REPLICATION,0.0099891,0.2051,0.18221,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0053338,0.20464,0.22031,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.001986,0.20434,0.25067,1,1
2,GO BLASTOCYST FORMATION,0.00025131,0.20426,0.20032,1,1
2,GO NCRNA PROCESSING,0.00035231,0.20423,0.1893,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.00045924,0.20416,0.18162,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,1.7806e-05,0.20398,0.23825,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.02268,0.20373,0.16666,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.17875,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.001662,0.20357,0.22121,1,1
2,GO L SERINE METABOLIC PROCESS,0.055956,0.20349,0.21095,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0019282,0.20329,0.23509,1,1
2,GO NAD METABOLIC PROCESS,0.031059,0.20321,0.1746,1,1
2,GO COPPER ION TRANSPORT,0.0046564,0.2032,0.22689,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.007729,0.20314,0.20924,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0049174,0.20306,0.23644,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.0020453,0.20281,0.18023,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.001872,0.20275,0.16731,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0025083,0.20259,0.14419,1,1
2,GO ANOIKIS,0.038561,0.20251,0.14436,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00065623,0.20244,0.18112,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0060989,0.2022,0.18738,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.013798,0.20216,0.19854,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.019739,0.20196,0.13861,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,2.1663e-05,0.20166,0.2097,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0051916,0.20159,0.16163,1,1
2,GO TRNA 5 LEADER REMOVAL,0.00067758,0.20129,0.24237,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.011047,0.20114,0.14344,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00030804,0.20085,0.21447,1,1
2,GO RESPONSE TO ESTROGEN,0.0073363,0.20081,0.16582,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,5.508e-06,0.20069,0.19438,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0069616,0.20066,0.2302,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0067808,0.20049,0.12568,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016595,0.19988,0.18865,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00031859,0.19984,0.19042,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0010528,0.19979,0.156,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0014738,0.19943,0.13455,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0059384,0.19935,0.13661,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.040234,0.19931,0.12318,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.009256,0.19912,0.15568,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0025817,0.19911,0.19752,1,1
2,GO RIBOSOME ASSEMBLY,0.0067808,0.199,0.19992,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.02843,0.19854,0.1354,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00049035,0.19835,0.17979,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0037331,0.1983,0.16934,1,1
2,GO FOREGUT MORPHOGENESIS,0.009256,0.19825,0.3116,1,1
2,GO LENS FIBER CELL DEVELOPMENT,0.038561,0.19816,0.18863,1,1
2,GO RNA METHYLATION,0.0015653,0.19798,0.14932,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00057693,0.19779,0.19057,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.016339,0.19763,0.13289,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00020448,0.1976,0.20678,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.036164,0.19752,0.16611,1,1
2,GO T CELL DIFFERENTIATION,0.00032948,0.19752,0.16702,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0014299,0.19743,0.17276,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.027803,0.19717,0.13809,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.011326,0.19686,0.19925,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.1966,0.16787,1,1
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.021165,0.19626,0.14354,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.038561,0.19613,0.12612,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0073363,0.19613,0.15399,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.019739,0.19535,0.15663,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.019739,0.19525,0.12771,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.00353,0.19519,0.20761,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.013139,0.19516,0.28637,1,1
2,GO FATTY ACID BETA OXIDATION,0.011047,0.19511,0.14123,1,1
2,GO INNATE IMMUNE RESPONSE,0.001986,0.19506,0.1691,1,1
2,GO RRNA METABOLIC PROCESS,0.00027832,0.1949,0.20374,1,1
2,GO REGULATION OF GENE SILENCING,4.8612e-06,0.19462,0.20349,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.009256,0.19456,0.14542,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,8.4205e-05,0.19414,0.21816,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.023205,0.19381,0.1956,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0011199,0.19372,0.13216,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0010206,0.19365,0.17161,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.0022992,0.19339,0.21419,1,1
2,GO TRANSLATIONAL TERMINATION,0.0027346,0.19306,0.19887,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0087944,0.19283,0.17801,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.016339,0.19272,0.16795,1,1
2,GO INTERACTION WITH SYMBIONT,0.00026903,0.19257,0.20834,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0062634,0.1925,0.15555,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.9904e-06,0.19239,0.18629,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.050569,0.19232,0.11235,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.013465,0.19219,0.13922,1,1
2,GO AXIS ELONGATION,0.0097392,0.19211,0.2848,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.001228,0.19208,0.19615,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.011047,0.19184,0.20818,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0062634,0.19174,0.17703,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0060989,0.19174,0.2469,1,1
2,GO T CELL CYTOKINE PRODUCTION,0.0024367,0.19156,0.20594,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0050528,0.19154,0.16458,1,1
2,GO RESPONSE TO ANTIBIOTIC,2.8418e-05,0.19137,0.23197,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00020448,0.19126,0.21776,1,1
2,GO AMYLOID BETA CLEARANCE,0.019739,0.19123,0.13591,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050569,0.19099,0.12503,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.0017641,0.19091,0.16072,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00079435,0.19076,0.16418,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.02268,0.19061,0.21531,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0028141,0.19059,0.16051,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00040247,0.19058,0.16171,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00022676,0.19043,0.19647,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.00055855,0.19033,0.15573,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.3127e-06,0.19023,0.1871,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.021165,0.19022,0.26321,1,1
2,GO TRNA METABOLIC PROCESS,0.00016023,0.19017,0.18126,1,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.0051916,0.18995,0.16379,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.018398,0.1897,0.17229,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00034072,0.18938,0.18439,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0038387,0.18892,0.16421,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00090094,0.18885,0.1903,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0042883,0.18878,0.17805,1,1
2,GO NCRNA METABOLIC PROCESS,0.00032948,0.18855,0.17732,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0023671,0.18838,0.16374,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0015653,0.18805,0.19001,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0037331,0.18792,0.17383,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0028957,0.18782,0.16711,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00087311,0.18768,0.16801,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0069616,0.18723,0.14593,1,1
2,GO COPPER ION HOMEOSTASIS,0.013139,0.18705,0.16522,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,4.0073e-05,0.18692,0.19612,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0030654,0.1868,0.14439,1,1
2,GO LUNG MORPHOGENESIS,0.036948,0.18659,0.24343,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00026003,0.18629,0.21795,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.03245,0.18627,0.1601,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.02268,0.18611,0.12704,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00010462,0.18602,0.20369,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.18586,0.15521,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.015574,0.18579,0.16367,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00012512,0.18563,0.20959,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.007729,0.18552,0.22702,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,4.8379e-05,0.18533,0.23102,1,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.03245,0.18516,0.17653,1,1
2,GO RENAL TUBULE DEVELOPMENT,0.011047,0.18513,0.16739,1,1
2,GO HAIR CELL DIFFERENTIATION,0.017549,0.18506,0.15097,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.010506,0.18495,0.12317,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,3.8583e-05,0.18464,0.21591,1,1
2,GO REGULATION OF CELL ACTIVATION,0.0010859,0.18456,0.14835,1,1
2,GO TRANSLATIONAL INITIATION,0.045624,0.18407,0.13832,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.019739,0.18404,0.14282,1,1
2,GO TRNA TRANSPORT,2.0833e-05,0.18397,0.22942,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0053338,0.18396,0.19912,1,1
2,GO HIPPO SIGNALING,0.0018173,0.18384,0.32016,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00098941,0.18306,0.1447,1,1
2,GO B CELL MEDIATED IMMUNITY,0.0087944,0.1829,0.14051,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0085714,0.18284,0.1169,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00035231,0.18279,0.17709,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017549,0.18274,0.15102,1,1
2,GO MITOTIC CYTOKINETIC PROCESS,0.02268,0.18272,0.13994,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0007696,0.18267,0.19543,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.00081984,0.18251,0.16062,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.015574,0.18228,0.15129,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.022165,0.18227,0.12265,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0023671,0.18222,0.14845,1,1
2,GO TRNA MODIFICATION,0.00090094,0.18139,0.15525,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0064317,0.18127,0.16999,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.045624,0.18121,0.1291,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.013139,0.18094,0.14169,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.00014935,0.18092,0.17464,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0027346,0.18087,0.17964,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.009256,0.18057,0.19352,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00014935,0.18052,0.20123,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,0.046579,0.18045,0.14899,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028141,0.18025,0.16434,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.022165,0.18014,0.17917,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.00055855,0.18012,0.21663,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0024367,0.17973,0.17892,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.043763,0.1796,0.11918,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.019739,0.17949,0.14288,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00036427,0.17903,0.21535,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00025131,0.17881,0.18496,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00011241,0.17868,0.18554,1,1
2,GO CYTOKINETIC PROCESS,0.0071468,0.17864,0.15921,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0045306,0.17854,0.1458,1,1
2,GO FATTY ACID TRANSPORT,9.389e-05,0.17825,0.19755,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0057817,0.17817,0.17704,1,1
2,GO RESPONSE TO CYTOKINE,0.0041716,0.17803,0.1391,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0010206,0.17797,0.25,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.00027832,0.17781,0.15193,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.7346e-05,0.1777,0.18996,1,1
2,GO RNA MODIFICATION,0.00040247,0.17762,0.15024,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.054842,0.17757,0.093414,1,1
2,GO T CELL ACTIVATION,0.0013872,0.17736,0.15861,1,1
2,GO SYMBIOTIC PROCESS,6.7596e-05,0.17731,0.17533,1,1
2,GO EMBRYO IMPLANTATION,0.050569,0.17722,0.13585,1,1
2,GO LIPID MODIFICATION,0.0014299,0.17696,0.14774,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001662,0.17693,0.18314,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0019282,0.17658,0.1454,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,9.0551e-05,0.17655,0.16811,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.03245,0.17633,0.15215,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00049035,0.17614,0.20246,1,1
2,GO TONGUE DEVELOPMENT,0.025994,0.176,0.22322,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.023741,0.17591,0.1246,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0030654,0.17587,0.15364,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0047853,0.17583,0.16438,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0030654,0.17578,0.20225,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.03245,0.17563,0.13733,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0054795,0.17553,0.14544,1,1
2,GO TRANSLATIONAL ELONGATION,0.02068,0.17542,0.14399,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.045624,0.17541,0.1787,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.011047,0.17538,0.14702,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.16111,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0083534,0.17514,0.13257,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.019739,0.17509,0.17737,1,1
2,GO ERBB SIGNALING PATHWAY,0.0010206,0.17493,0.15465,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0030654,0.1743,0.1551,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.011047,0.17429,0.13322,1,1
2,GO RNA POLYADENYLATION,0.00063551,0.17428,0.14933,1,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.020205,0.17427,0.17278,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00092958,0.17409,0.1513,1,1
2,GO HISTONE DEUBIQUITINATION,0.00052342,0.17402,0.15329,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0073363,0.17385,0.12521,1,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.05161,0.17372,0.12184,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,6.2786e-05,0.1737,0.20019,1,1
2,GO SPLEEN DEVELOPMENT,0.017137,0.17344,0.15127,1,1
2,GO VIRAL LIFE CYCLE,0.00079435,0.17329,0.18862,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.046579,0.17327,0.11651,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17325,0.20163,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0066042,0.17321,0.23783,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0062634,0.1732,0.15691,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.019283,0.17318,0.12077,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.019739,0.17289,0.20208,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.00047456,0.17257,0.20396,1,1
2,GO ANIMAL ORGAN REGENERATION,0.03939,0.17246,0.10909,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0024367,0.17229,0.15263,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0079323,0.17227,0.15365,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.022165,0.17223,0.1857,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.054842,0.17214,0.11679,1,1
2,GO B CELL DIFFERENTIATION,0.0012662,0.1721,0.1543,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.0042883,0.17195,0.19675,1,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.013798,0.17195,0.22173,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0040578,0.17174,0.13136,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0073363,0.17144,0.19473,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0051916,0.17113,0.15462,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.010245,0.17097,0.15359,1,1
2,GO TRNA PROCESSING,0.00050664,0.17067,0.16296,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0010859,0.17018,0.16709,1,1
2,GO MYOBLAST DIFFERENTIATION,0.019283,0.17004,0.17795,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.03245,0.16996,0.11762,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00065623,0.16995,0.19388,1,1
2,GO METANEPHROS DEVELOPMENT,0.017137,0.16974,0.16431,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0022992,0.16972,0.16695,1,1
2,GO REGULATION OF PROTEIN MATURATION,0.03939,0.16966,0.15048,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00353,0.16937,0.12769,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0024367,0.16922,0.22885,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0012662,0.16906,0.18904,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0015189,0.16902,0.15855,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.00034072,0.16901,0.16887,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00059588,0.16894,0.29366,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.013139,0.16886,0.23377,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.041093,0.16862,0.16206,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00050664,0.1686,0.17277,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.012508,0.16844,0.13182,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.010773,0.16839,0.13461,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00017186,0.16832,0.16593,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.015574,0.16811,0.14101,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0016129,0.16808,0.19014,1,1
2,GO RESPONSE TO SALT,0.00353,0.16808,0.20725,1,1
2,GO REGULATION OF PHAGOCYTOSIS,0.010773,0.16808,0.13078,1,1
2,GO VIRAL RELEASE FROM HOST CELL,0.0015189,0.16801,0.18842,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.011326,0.16774,0.13903,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0042883,0.16737,0.22011,1,1
2,GO IRON ION HOMEOSTASIS,0.0047853,0.16724,0.1627,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.014841,0.16685,0.15409,1,1
2,GO IMPORT INTO NUCLEUS,0.012508,0.16674,0.12874,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.010245,0.16661,0.16121,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.001662,0.16659,0.15018,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0022992,0.16654,0.17107,1,1
2,GO CELL KILLING,0.0030654,0.16644,0.16663,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.02843,0.16641,0.13771,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.047551,0.16589,0.22103,1,1
2,GO CYTOKINE PRODUCTION,0.0022992,0.16587,0.1566,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0037331,0.16577,0.16,1,1
2,GO PHOTOPERIODISM,0.0069616,0.16576,0.13363,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.040234,0.16539,0.25299,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0041716,0.16538,0.17239,1,1
2,GO POSITIVE REGULATION OF CELL SIZE,0.0079323,0.16538,0.26635,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.0067808,0.16527,0.13221,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,6.0504e-05,0.1652,0.17858,1,1
2,GO PROTEIN IMPORT,0.001228,0.1648,0.14491,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.0030654,0.16469,0.15468,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.001228,0.16464,0.16989,1,1
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0094949,0.16446,0.18271,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0062634,0.16431,0.16322,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0014738,0.16408,0.16873,1,1
2,GO RRNA TRANSCRIPTION,0.001662,0.16402,0.21177,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.016734,0.16398,0.1212,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00074557,0.16389,0.22936,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0051916,0.16388,0.13998,1,1
2,GO PHAGOCYTOSIS,0.0045306,0.16382,0.15065,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.0079323,0.16371,0.15018,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0059384,0.16363,0.16907,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.024288,0.1636,0.11428,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0013054,0.16319,0.13445,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00042998,0.16318,0.15111,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.01282,0.16306,0.11663,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0015189,0.16303,0.14265,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.035393,0.16299,0.1054,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.041093,0.16298,0.094875,1,1
2,GO CYTOKINE METABOLIC PROCESS,0.0024367,0.16281,0.1635,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.025994,0.16269,0.2116,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.029068,0.1624,0.12845,1,1
2,GO POLYAMINE METABOLIC PROCESS,0.0094949,0.16206,0.16189,1,1
2,GO LYMPHOCYTE ACTIVATION,0.0025083,0.16202,0.13023,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.00044439,0.16199,0.20401,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0022992,0.16194,0.20262,1,1
2,GO TRNA 5 END PROCESSING,0.0013457,0.16194,0.20727,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.036164,0.16192,0.18974,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.023205,0.16189,0.13018,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.001662,0.16187,0.13651,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.031748,0.16183,0.087815,1,1
2,GO RNA CATABOLIC PROCESS,0.00027832,0.16163,0.15185,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00054072,0.16152,0.14389,1,1
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0053338,0.16149,0.19295,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.013798,0.1614,0.12187,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.0099891,0.16111,0.11016,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0029794,0.16065,0.13605,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.033166,0.16064,0.17827,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.03245,0.16054,0.15567,1,1
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.042857,0.16028,0.12737,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.041093,0.16015,0.14217,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.001986,0.16015,0.17369,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.044685,0.16011,0.13661,1,1
2,GO TERPENOID METABOLIC PROCESS,0.03245,0.16011,0.12261,1,1
2,GO P BODY ASSEMBLY,0.00052342,0.1601,0.14872,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.001986,0.16009,0.16039,1,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.038561,0.16006,0.15004,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0023671,0.1598,0.146,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00081984,0.15975,0.1474,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001986,0.15962,0.18271,1,1
2,GO GOLGI RIBBON FORMATION,0.0021062,0.15955,0.19872,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.018836,0.15937,0.16294,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.030383,0.15928,0.13488,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00013917,0.15906,0.18565,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.0071468,0.15898,0.12212,1,1
2,GO UBIQUINONE METABOLIC PROCESS,0.02843,0.1588,0.15779,1,1
2,GO HISTONE PHOSPHORYLATION,0.00029782,0.15873,0.14946,1,1
2,GO TISSUE REGENERATION,0.031059,0.15829,0.14439,1,1
2,GO MAMMARY GLAND DEVELOPMENT,0.02166,0.15813,0.13956,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.010506,0.15797,0.14907,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.055956,0.15794,0.09165,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0085714,0.15793,0.13361,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.0087944,0.15766,0.12523,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.020205,0.15725,0.15004,1,1
2,GO PROTEIN KINASE B SIGNALING,0.015953,0.15722,0.11051,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.0021689,0.15707,0.12169,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.033166,0.15673,0.16502,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0014299,0.15651,0.14866,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.03245,0.15643,0.1097,1,1
2,GO DIGESTION,0.0062634,0.15626,0.13163,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.01282,0.15614,0.12126,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0069616,0.15607,0.13117,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.0047853,0.15558,0.14622,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.0013054,0.15536,0.149,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00036427,0.15532,0.16348,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.014486,0.15451,0.12793,1,1
2,GO RESPONSE TO ACTIVITY,0.0099891,0.15424,0.11843,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0069616,0.15421,0.14414,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.001872,0.15414,0.16769,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.025414,0.15345,0.10906,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00084609,0.15318,0.17793,1,1
2,GO REGULATION OF HEMOPOIESIS,0.0017123,0.15288,0.13745,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00035231,0.15285,0.14871,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0022992,0.15279,0.16871,1,1
2,GO REGULATION OF CELL ADHESION,0.0090226,0.15271,0.13805,1,1
2,GO CHYLOMICRON ASSEMBLY,0.026586,0.15267,0.077236,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0038387,0.15267,0.17561,1,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.052669,0.15256,0.11892,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0032441,0.15244,0.1509,1,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.049546,0.15236,0.096959,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.014486,0.15235,0.15604,1,1
2,GO TRANSCYTOSIS,0.02843,0.15227,0.15234,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0075304,0.15206,0.17528,1,1
2,GO TOXIN TRANSPORT,0.0079323,0.15187,0.15844,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.013139,0.15155,0.16032,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014841,0.15144,0.13068,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0067808,0.15115,0.11335,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.001872,0.15105,0.13347,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.00011241,0.15103,0.14014,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.011047,0.15094,0.13957,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,2.1663e-05,0.15066,0.16142,1,1
2,GO GLUCOSE CATABOLIC PROCESS,0.055956,0.15003,0.15935,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.00087311,0.14995,0.15194,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.01282,0.14971,0.1652,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0010528,0.14967,0.14455,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0021062,0.14964,0.13687,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0042883,0.14943,0.14726,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0021689,0.14938,0.13876,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.025994,0.14926,0.11798,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.010245,0.14916,0.095732,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0028957,0.14896,0.19544,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0011549,0.14883,0.12387,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0024367,0.1487,0.14633,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0026572,0.14853,0.14809,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0081404,0.14849,0.16018,1,1
2,GO PLATELET ACTIVATION,0.017969,0.14845,0.10847,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00054072,0.14839,0.1388,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0038387,0.14829,0.19003,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00022676,0.14828,0.17852,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0022992,0.14824,0.13889,1,1
2,GO GOLGI VESICLE BUDDING,0.0013457,0.1476,0.13131,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.024288,0.14734,0.18708,1,1
2,GO STEROL METABOLIC PROCESS,0.013465,0.14728,0.12129,1,1
2,GO ERK1 AND ERK2 CASCADE,0.01282,0.14694,0.12869,1,1
2,GO VIRION ASSEMBLY,0.021165,0.14681,0.10152,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.033894,0.14679,0.094209,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.4421e-05,0.14657,0.14489,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0017641,0.14623,0.168,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.025994,0.14615,0.12304,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00030804,0.14612,0.14149,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,2.9532e-05,0.146,0.15406,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.0067808,0.14588,0.11925,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.035393,0.14583,0.1003,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.031748,0.14577,0.17538,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00054072,0.1457,0.15254,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00092958,0.14555,0.1381,1,1
2,GO VESICLE TARGETING,0.0027346,0.1451,0.13652,1,1
2,GO GMP METABOLIC PROCESS,0.036164,0.14505,0.14499,1,1
2,GO CELL CHEMOTAXIS,0.017969,0.14491,0.12429,1,1
2,GO INNER EAR MORPHOGENESIS,0.029068,0.14476,0.12327,1,1
2,GO POLYOL METABOLIC PROCESS,0.00087311,0.14471,0.16548,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.022165,0.1447,0.14348,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0013457,0.14463,0.11285,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.034637,0.14463,0.10995,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.0007696,0.14451,0.13514,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.0050528,0.14415,0.13121,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0056288,0.14399,0.1108,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.042857,0.14396,0.15176,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.14395,0.20978,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.054842,0.14392,0.10897,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0041716,0.14388,0.14338,1,1
2,GO IMMATURE B CELL DIFFERENTIATION,0.023741,0.14351,0.18956,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00098941,0.14312,0.154,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.012508,0.14273,0.10702,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.03939,0.14268,0.14454,1,1
2,GO CD40 SIGNALING PATHWAY,0.020205,0.14264,0.14615,1,1
2,GO EXIT FROM MITOSIS,0.0026572,0.14252,0.12075,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.02268,0.14238,0.16093,1,1
2,GO REGULATION OF SPINDLE ASSEMBLY,0.014486,0.14233,0.15209,1,1
2,GO MALE SEX DIFFERENTIATION,0.001872,0.14224,0.16476,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,3.3132e-05,0.14217,0.19739,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.042857,0.14191,0.13632,1,1
2,GO HISTONE H2B UBIQUITINATION,0.013798,0.14186,0.13822,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.052669,0.14184,0.12774,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,5.2139e-05,0.14169,0.17265,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.015953,0.14149,0.13049,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.01282,0.14133,0.16015,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.2524e-05,0.14127,0.13324,1,1
2,GO KERATINOCYTE MIGRATION,0.013139,0.14119,0.16026,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.7118e-05,0.14079,0.15426,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.043763,0.14062,0.12946,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.022165,0.14045,0.14705,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.14017,0.094122,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0014738,0.13998,0.14186,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.0019282,0.13994,0.15827,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00081984,0.13989,0.17331,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.054842,0.13984,0.085853,1,1
2,GO HISTONE MONOUBIQUITINATION,0.031748,0.13944,0.10114,1,1
2,GO ACTIN NUCLEATION,0.00067758,0.13929,0.17911,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.030383,0.13926,0.15113,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0069616,0.13915,0.12918,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0057817,0.13914,0.18873,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.055956,0.13866,0.11968,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.0064317,0.13859,0.12636,1,1
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.042857,0.13849,0.22445,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.013465,0.1384,0.12927,1,1
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.023205,0.13839,0.11433,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0073363,0.13836,0.16754,1,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.026586,0.13835,0.095179,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0041716,0.13793,0.12864,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0085714,0.13782,0.2011,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0020453,0.13778,0.14114,1,1
2,GO INTERLEUKIN 12 PRODUCTION,0.017549,0.13763,0.13812,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0085714,0.13728,0.11616,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.010773,0.13725,0.12264,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010206,0.13715,0.13686,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.014841,0.13707,0.12927,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.044685,0.13672,0.12212,1,1
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.047551,0.13657,0.072919,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.02166,0.13654,0.12687,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0079323,0.1365,0.1359,1,1
2,GO DEFENSE RESPONSE,0.0075304,0.13626,0.11674,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00026903,0.13617,0.14444,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.010245,0.13553,0.18123,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0099891,0.1355,0.12225,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.0006154,0.13545,0.14312,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.010773,0.1353,0.11569,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0062634,0.13512,0.17283,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0006154,0.13502,0.12979,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033894,0.13475,0.089668,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.047551,0.13454,0.12382,1,1
2,GO B CELL ACTIVATION,0.0015189,0.13441,0.1286,1,1
2,GO RUFFLE ORGANIZATION,0.010773,0.13434,0.11869,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.026586,0.13434,0.10025,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.027803,0.13417,0.14261,1,1
2,GO DNA GEOMETRIC CHANGE,2.1663e-05,0.13397,0.16621,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.049546,0.13391,0.10921,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0087944,0.1333,0.14897,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.042857,0.13323,0.13823,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.011326,0.13318,0.11449,1,1
2,GO LIPID METABOLIC PROCESS,0.0014299,0.13283,0.1207,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.13275,0.13341,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.010506,0.13272,0.17081,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0036303,0.13268,0.14574,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.036948,0.13211,0.12918,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0017641,0.13208,0.12141,1,1
2,GO CELL ACTIVATION,0.0054795,0.13196,0.1239,1,1
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.018836,0.13121,0.16463,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00014418,0.13118,0.1271,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0015189,0.13063,0.15281,1,1
2,GO CELLULAR PIGMENTATION,0.031748,0.13024,0.13277,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.016339,0.13007,0.11868,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0015189,0.13005,0.11681,1,1
2,GO MRNA TRANSCRIPTION,0.040234,0.12997,0.11816,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0010206,0.12983,0.13545,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00079435,0.12967,0.13235,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0006154,0.12964,0.12101,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.036948,0.12935,0.10367,1,1
2,GO HISTONE UBIQUITINATION,0.026586,0.12923,0.082941,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.021165,0.12915,0.16777,1,1
2,GO HISTONE H3 DEACETYLATION,0.010245,0.12913,0.12561,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.01282,0.12907,0.10345,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.015203,0.12902,0.13593,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.030383,0.12901,0.12823,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.019739,0.12876,0.13475,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0045306,0.12854,0.11938,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.0053338,0.12848,0.13295,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.12813,0.15174,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0041716,0.12802,0.16291,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.015953,0.12784,0.17694,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0032441,0.12779,0.18548,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.04854,0.12769,0.12032,1,1
2,GO OXIDATIVE DEMETHYLATION,0.02843,0.12765,0.089576,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.0036303,0.12758,0.10873,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0054795,0.12758,0.16716,1,1
2,GO REGULATION OF CELL SHAPE,0.0066042,0.1275,0.15283,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.045624,0.1275,0.12351,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.004408,0.1274,0.11354,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0083534,0.12738,0.11286,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0094949,0.1272,0.17817,1,1
2,GO CELL CELL RECOGNITION,0.018836,0.12718,0.11169,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.014841,0.12693,0.14321,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0046564,0.12692,0.14815,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,0.046579,0.12664,0.097661,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.001872,0.12657,0.12684,1,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.041967,0.12621,0.10457,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.025414,0.12617,0.089846,1,1
2,GO MRNA 3 END PROCESSING,0.00040247,0.12614,0.13639,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.0032441,0.1258,0.1349,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.024846,0.12579,0.13586,1,1
2,GO RNA PROCESSING,6.0504e-05,0.12572,0.14203,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.014138,0.12563,0.11821,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.010245,0.12547,0.12739,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.052669,0.12542,0.09348,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0038387,0.12539,0.091273,1,1
2,GO STEM CELL DIFFERENTIATION,0.0028141,0.12501,0.13406,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.015953,0.12492,0.12201,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.021165,0.12463,0.10483,1,1
2,GO NEPHRON DEVELOPMENT,0.027188,0.12458,0.14006,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.020205,0.12455,0.10261,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.013798,0.12449,0.095218,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.013465,0.12444,0.10184,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0083534,0.12424,0.097072,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.038561,0.124,0.12453,1,1
2,GO BILE ACID METABOLIC PROCESS,0.024288,0.12396,0.13638,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0029794,0.12386,0.13038,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0025083,0.12344,0.12209,1,1
2,GO RENAL SYSTEM PROCESS,0.030383,0.12339,0.10369,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00095906,0.12331,0.14853,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.017137,0.12326,0.21791,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0013054,0.12322,0.16026,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.12308,0.1176,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0027346,0.12301,0.1333,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0017641,0.12295,0.11378,1,1
2,GO LIPID LOCALIZATION,0.038561,0.12285,0.095788,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0018173,0.12279,0.11406,1,1
2,GO PROTEIN SUMOYLATION,8.4205e-05,0.12271,0.1279,1,1
2,GO RESPONSE TO ETHANOL,0.013139,0.12265,0.11975,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.014486,0.12263,0.10606,1,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0069616,0.12258,0.11553,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00026003,0.12257,0.16349,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.00014418,0.12256,0.15438,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010245,0.12248,0.11397,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0066042,0.12222,0.1239,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0075304,0.12222,0.14242,1,1
2,GO TELOMERE ORGANIZATION,0.0007696,0.12211,0.12203,1,1
2,GO RESPONSE TO STEROID HORMONE,0.034637,0.12193,0.11159,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0056288,0.12183,0.19859,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0011199,0.12162,0.10937,1,1
2,GO CELL CELL ADHESION,0.034637,0.12159,0.091482,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0039469,0.12135,0.12336,1,1
2,GO LEUKOCYTE CHEMOTAXIS,0.030383,0.12124,0.10563,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0053338,0.1206,0.10277,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0045306,0.12049,0.10181,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.027188,0.12038,0.17645,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00012964,0.12029,0.1396,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010506,0.12024,0.12087,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.018836,0.1202,0.099386,1,1
2,GO EAR MORPHOGENESIS,0.015203,0.12018,0.13486,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0085714,0.1201,0.11336,1,1
2,GO LIPID CATABOLIC PROCESS,0.019739,0.12006,0.090662,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.015953,0.11976,0.099221,1,1
2,GO ENDOCRINE PROCESS,0.0031536,0.11959,0.16383,1,1
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.023205,0.11958,0.13524,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.016339,0.1194,0.1114,1,1
2,GO BODY FLUID SECRETION,0.0023671,0.11914,0.15461,1,1
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.018836,0.11887,0.09318,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.034637,0.11882,0.094082,1,1
2,GO EPITHELIAL TUBE FORMATION,0.0023671,0.11855,0.15916,1,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.025414,0.11843,0.071009,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.004408,0.11826,0.13239,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0034322,0.11812,0.10832,1,1
2,GO RESPONSE TO ALCOHOL,0.012203,0.11809,0.11121,1,1
2,GO NUCLEAR TRANSPORT,0.0013872,0.11762,0.1187,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025414,0.11746,0.21302,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0030654,0.11728,0.12688,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.03939,0.11727,0.18199,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0069616,0.11667,0.10538,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.02268,0.11658,0.11802,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.017137,0.11644,0.12768,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0085714,0.11621,0.098042,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0056288,0.11587,0.11974,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.0015653,0.11565,0.095857,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.054842,0.11563,0.068166,1,1
2,GO GENE SILENCING,7.6603e-06,0.11563,0.13681,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0021689,0.11562,0.11887,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.0085714,0.11552,0.10497,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0019282,0.11549,0.10724,1,1
2,GO RESPONSE TO UV,0.001228,0.11535,0.13866,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0001547,0.11492,0.13954,1,1
2,GO MRNA CLEAVAGE,0.0014299,0.11434,0.12299,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.11418,0.098194,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0028957,0.11405,0.13883,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.047551,0.11371,0.1078,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.0059384,0.11357,0.10836,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00044439,0.11356,0.10551,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00353,0.1134,0.10467,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.04854,0.11334,0.15244,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.027188,0.1133,0.11002,1,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.011326,0.11296,0.21216,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001228,0.11277,0.13123,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.012508,0.11264,0.18798,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.010245,0.11246,0.12304,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.049546,0.11227,0.096385,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0034322,0.11225,0.10385,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.02068,0.11196,0.084379,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00090094,0.11191,0.11728,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.029068,0.11186,0.085897,1,1
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.011904,0.11181,0.13339,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0060989,0.11169,0.14357,1,1
2,GO TUBE FORMATION,0.0032441,0.11134,0.14733,1,1
2,GO CRISTAE FORMATION,0.043763,0.1113,0.14932,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0053338,0.11128,0.13714,1,1
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.024846,0.11108,0.15877,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0017123,0.11104,0.11219,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.036164,0.11103,0.099056,1,1
2,GO NEURAL TUBE FORMATION,0.017549,0.11103,0.14996,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0099891,0.11076,0.11164,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.054842,0.11037,0.14268,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.009256,0.1101,0.1101,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.042857,0.10998,0.1015,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.020205,0.10997,0.10994,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0045306,0.10989,0.14065,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.053746,0.10963,0.078519,1,1
2,GO BASE EXCISION REPAIR,0.0017641,0.10948,0.12533,1,1
2,GO RNA CAPPING,0.012508,0.10943,0.08959,1,1
2,GO CELLULAR RESPIRATION,0.0069616,0.10918,0.16174,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.05161,0.10809,0.11227,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0027346,0.10774,0.09237,1,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.017969,0.10714,0.13318,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.042857,0.10707,0.079203,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0097392,0.10676,0.098097,1,1
2,GO MITOCHONDRIAL TRANSPORT,0.0030654,0.10672,0.10737,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.00050664,0.10622,0.14548,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.038561,0.10612,0.10364,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.029719,0.10605,0.11745,1,1
2,GO LIPID PHOSPHORYLATION,0.0067808,0.10597,0.10856,1,1
2,GO RESPONSE TO ISCHEMIA,0.047551,0.10592,0.11868,1,1
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.037747,0.10586,0.10854,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0053338,0.10573,0.088047,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0025083,0.10567,0.10112,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.027188,0.10555,0.11587,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00027832,0.10552,0.096532,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0066042,0.10549,0.10086,1,1
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.007729,0.10498,0.095321,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,5.8301e-05,0.10498,0.10638,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.10436,0.10881,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00038934,0.10379,0.096177,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.038561,0.10359,0.098317,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0085714,0.10328,0.084485,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0017123,0.10273,0.10806,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0075304,0.1026,0.11498,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0051916,0.10225,0.10844,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0064317,0.10219,0.10255,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.012203,0.10206,0.089116,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00063551,0.10158,0.13107,1,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.055956,0.10157,0.077527,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.013139,0.1014,0.079748,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.03939,0.10133,0.076749,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0060989,0.10133,0.12978,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.018398,0.1009,0.11184,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0079323,0.10071,0.12949,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0045306,0.1007,0.09882,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0010206,0.1005,0.10835,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.03939,0.10048,0.081631,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02843,0.1002,0.11699,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.013798,0.099889,0.10101,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00024286,0.099248,0.09759,1,1
2,GO MRNA METABOLIC PROCESS,5.0226e-05,0.099237,0.13127,1,1
2,GO PROTEIN MONOUBIQUITINATION,0.021165,0.099211,0.077634,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0025083,0.099083,0.12397,1,1
2,GO MRNA TRANSPORT,0.0025083,0.098822,0.11438,1,1
2,GO POSTREPLICATION REPAIR,0.011047,0.098455,0.085054,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.02843,0.098177,0.078866,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.023741,0.097938,0.092809,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00028792,0.097545,0.11667,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0033369,0.097412,0.13462,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0046564,0.097258,0.12516,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.016734,0.097231,0.12292,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.052669,0.097132,0.079351,1,1
2,GO REGULATION OF CELL DEATH,0.025414,0.097105,0.083289,1,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.055956,0.096919,0.061632,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.096858,0.06368,1,1
2,GO RNA LOCALIZATION,0.00055855,0.096699,0.12365,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0037331,0.096121,0.083705,1,1
2,GO RUFFLE ASSEMBLY,0.054842,0.096081,0.085619,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00081984,0.095996,0.11381,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0025083,0.095835,0.12501,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.09533,0.14395,1,1
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.035393,0.094804,0.083684,1,1
2,GO HISTONE DEACETYLATION,0.0039469,0.094723,0.095636,1,1
2,GO DNA METHYLATION,0.0021062,0.09471,0.10823,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.00092958,0.094627,0.095186,1,1
2,GO ENDOSOME ORGANIZATION,0.033894,0.093945,0.10952,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0033369,0.093801,0.10712,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.0028141,0.09369,0.12623,1,1
2,GO SNRNA PROCESSING,0.011612,0.093359,0.040115,1,1
2,GO RESPONSE TO HEAT,0.014841,0.093356,0.12238,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.092935,0.13944,1,1
2,GO DNA CONFORMATION CHANGE,0.0034322,0.092533,0.091714,1,1
2,GO CHROMATIN REMODELING,0.00057693,0.092448,0.11089,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0099891,0.092377,0.10194,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0047853,0.092202,0.12466,1,1
2,GO CELL AGING,0.0094949,0.092119,0.093273,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0067808,0.0921,0.10134,1,1
2,GO RNA 3 END PROCESSING,0.0030654,0.091576,0.1054,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.014138,0.091224,0.11103,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0007696,0.091177,0.11006,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0087944,0.090846,0.092875,1,1
2,GO REGULATION OF PROTEIN STABILITY,0.0067808,0.090253,0.088782,1,1
2,GO ORGANELLE INHERITANCE,0.054842,0.090197,0.063203,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.036948,0.089617,0.084111,1,1
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.034637,0.089486,0.069304,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.047551,0.089093,0.081,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.029719,0.089026,0.12551,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0085714,0.08902,0.095826,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.00014935,0.088133,0.12202,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.023741,0.087968,0.070738,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.036948,0.08791,0.078041,1,1
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0013872,0.087903,0.082981,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.0066042,0.087286,0.11619,1,1
2,GO APOPTOTIC SIGNALING PATHWAY,0.019739,0.08671,0.091473,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0021689,0.086349,0.08411,1,1
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.030383,0.086166,0.083673,1,1
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0041716,0.086131,0.092557,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.018398,0.085607,0.098805,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0045306,0.085542,0.085438,1,1
2,GO SNRNA METABOLIC PROCESS,0.0028141,0.085496,0.061217,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0039469,0.084422,0.077314,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.030383,0.08426,0.10566,1,1
2,GO MRNA PROCESSING,0.00090094,0.083295,0.10965,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0010206,0.0828,0.095519,1,1
2,GO HISTONE H3 ACETYLATION,0.00098941,0.082508,0.09296,1,1
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0083534,0.082147,0.10142,1,1
2,GO ARTERY MORPHOGENESIS,0.045624,0.082101,0.12536,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0028957,0.081934,0.10897,1,1
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.031059,0.081626,0.059374,1,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.046579,0.081609,0.058324,1,1
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.014841,0.081109,0.085621,1,1
2,GO ERAD PATHWAY,0.018398,0.081021,0.074764,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.0075304,0.080918,0.073666,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014138,0.080462,0.064576,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.03245,0.079849,0.074503,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.033166,0.079151,0.082339,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0046564,0.078644,0.093823,1,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.011047,0.078536,0.080816,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015574,0.078474,0.086071,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0019282,0.078376,0.093717,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.041967,0.07808,0.083339,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.034637,0.077976,0.098315,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.034637,0.077836,0.081767,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.024846,0.077599,0.080629,1,1
2,GO MITOTIC NUCLEAR DIVISION,0.016339,0.07741,0.077965,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.019739,0.077301,0.071534,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.044685,0.076321,0.072237,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.049546,0.076054,0.068742,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.014486,0.075931,0.071861,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.052669,0.075743,0.079593,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY,0.025994,0.075331,0.071377,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0094949,0.075052,0.113,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.014841,0.073885,0.072754,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.014486,0.073541,0.10033,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.02268,0.07269,0.073747,1,1
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.016339,0.072404,0.09783,1,1
2,GO REGULATION OF NUCLEAR DIVISION,0.043763,0.072165,0.067623,1,1
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.010773,0.071944,0.080364,1,1
2,GO RESPONSE TO RADIATION,0.0081404,0.071316,0.065715,1,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.05161,0.071034,0.06528,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.011047,0.070441,0.097044,1,1
2,GO MITOTIC CELL CYCLE,0.015953,0.069715,0.066429,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.033894,0.069367,0.059596,1,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.069301,0.071551,1,1
2,GO REGULATION OF MITOTIC CELL CYCLE,0.011326,0.069181,0.072448,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.02268,0.068676,0.074553,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0071468,0.067742,0.090376,1,1
2,GO APOPTOTIC PROCESS,0.045624,0.067658,0.066561,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.016734,0.067237,0.085578,1,1
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.029068,0.067231,0.053402,1,1
2,GO DNA MODIFICATION,0.0053338,0.066692,0.070712,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.011326,0.066442,0.065536,1,1
2,GO RNA SPLICING,0.0022992,0.066339,0.10726,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.03939,0.066325,0.055375,1,1
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.017969,0.066089,0.088841,1,1
2,GO MACROAUTOPHAGY,0.017137,0.065165,0.075515,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.023205,0.064551,0.089223,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0040578,0.063603,0.094614,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.03245,0.063435,0.074552,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0090226,0.063418,0.067239,1,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.038561,0.063063,0.047798,1,1
2,GO DNA METABOLIC PROCESS,0.0013054,0.062911,0.071136,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0083534,0.061012,0.095274,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.011612,0.059601,0.069967,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.013798,0.058985,0.076267,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0031536,0.058792,0.067964,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0081404,0.058541,0.069333,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.044685,0.057948,0.047075,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.027188,0.057595,0.051873,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.012508,0.056633,0.059545,1,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.021165,0.056371,0.060009,1,1
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.029068,0.056067,0.06714,1,1
2,GO DNA REPAIR,0.0040578,0.055207,0.073507,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.03245,0.053593,0.04543,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.040234,0.05087,0.082004,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0039469,0.050312,0.073846,1,1
2,GO REGULATION OF RNA SPLICING,0.043763,0.049487,0.081919,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.042857,0.048029,0.061711,1,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.02166,0.047228,0.063103,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.020205,0.047121,0.056704,1,1
2,GO CELL CYCLE CHECKPOINT,0.035393,0.046495,0.074418,1,1
2,GO CELL CYCLE PROCESS,0.02068,0.044945,0.057149,1,1
2,GO MITOCHONDRION ORGANIZATION,0.02843,0.044294,0.073419,1,1
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.015203,0.043246,0.075882,1,1
2,GO DNA RECOMBINATION,0.036164,0.043162,0.070728,1,1
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.052669,0.043142,0.081552,1,1
2,GO CHROMOSOME ORGANIZATION,0.012508,0.040902,0.061612,1,1
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.018836,0.040675,0.054048,1,1
2,GO CELL CYCLE,0.036948,0.039103,0.046036,1,1
2,GO COVALENT CHROMATIN MODIFICATION,0.030383,0.036669,0.051737,1,1
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.04854,0.035657,0.048834,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
3,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO MATING,0.033166,0.12237,0.091484,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
3,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,1
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00019079,1.6395,1.2286,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00029782,1.3107,0.97108,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0021062,1.144,0.82209,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.1776e-06,0.98529,1.0912,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.2454e-05,0.94013,0.65639,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.4346e-05,0.89005,0.66802,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00025131,0.88801,0.72849,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,7.889e-07,0.88248,0.81443,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0022992,0.77947,0.47976,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,7.6603e-06,0.77585,0.66157,1,1
4,GO PROGESTERONE METABOLIC PROCESS,3.1888e-05,0.76646,0.87236,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00041602,0.76582,0.5488,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.4044e-06,0.75649,0.69385,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.00072223,0.75633,0.76785,1,1
4,GO TOLERANCE INDUCTION,0.001228,0.75474,0.58494,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0037331,0.74921,0.571,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,8.4205e-05,0.74598,0.6829,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,1.349e-05,0.74407,0.65166,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,9.7346e-05,0.73435,0.66802,1,1
4,GO LIPID DROPLET FORMATION,3.17e-07,0.72388,0.77405,1,1
4,GO HISTAMINE SECRETION,2.7578e-07,0.72337,0.76568,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00047456,0.71125,0.47508,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00010462,0.70248,0.5343,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.5331e-06,0.6893,0.80752,1,1
4,GO HISTAMINE TRANSPORT,2.0829e-07,0.68894,0.73484,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0038387,0.688,0.55211,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.4334e-07,0.68318,0.6227,1,1
4,GO MUCUS SECRETION,0.00021167,0.67366,0.5936,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0067808,0.66632,0.4427,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0007696,0.65651,0.48029,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.00017186,0.65565,0.57282,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,1.7806e-05,0.65554,0.6946,1,1
4,GO RESPONSE TO TYPE I INTERFERON,1.5201e-05,0.65391,0.60966,1,1
4,GO GERMINAL CENTER FORMATION,0.00013433,0.65307,0.5237,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.2962e-05,0.64631,0.66159,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0083534,0.64046,0.45957,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00047456,0.63072,0.59968,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.00032948,0.62683,0.42283,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0010528,0.6241,0.43116,1,1
4,GO RESPONSE TO INTERFERON BETA,0.00025131,0.62376,0.55155,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0015653,0.6148,0.42998,1,1
4,GO MATURE B CELL DIFFERENTIATION,3.7145e-05,0.61019,0.44121,1,1
4,GO RENAL ABSORPTION,5.0226e-05,0.60893,0.56118,1,1
4,GO T CELL EXTRAVASATION,0.00038934,0.60292,0.56408,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.1663e-05,0.60185,0.59654,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00011241,0.59911,0.49596,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,2.2658e-06,0.59804,0.61535,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.0033369,0.59665,0.33966,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0053338,0.59562,0.46225,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.8131e-07,0.5899,0.62779,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,4.4878e-05,0.5861,0.51219,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.6902e-06,0.58576,0.60644,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,5.7413e-06,0.58341,0.58283,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.025414,0.58035,0.2881,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00021909,0.57878,0.57457,1,1
4,GO TOXIN METABOLIC PROCESS,9.0221e-07,0.57472,0.57751,1,1
4,GO DETECTION OF OTHER ORGANISM,2.6307e-05,0.57053,0.56439,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.004408,0.57053,0.60963,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.6414e-07,0.56988,0.59241,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.4121e-05,0.56985,0.52903,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.0264e-07,0.56665,0.51859,1,1
4,GO QUINONE METABOLIC PROCESS,9.0551e-05,0.56322,0.59681,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00036427,0.56304,0.46563,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0017123,0.56093,0.40681,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.349e-05,0.55998,0.58929,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,5.753e-07,0.5582,0.60188,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,6.2367e-06,0.55553,0.52974,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00034072,0.55433,0.3858,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,2.7343e-05,0.5529,0.50911,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.9301e-06,0.55164,0.52287,1,1
4,GO NEGATIVE REGULATION OF CELL KILLING,0.0097392,0.55064,0.39733,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,4.5813e-07,0.54811,0.57419,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.4609e-05,0.54704,0.58994,1,1
4,GO RESPONSE TO COLD,1.2366e-07,0.54652,0.49592,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00016595,0.54275,0.48642,1,1
4,GO KETONE CATABOLIC PROCESS,0.00013917,0.54254,0.4409,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0017123,0.54225,0.41913,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,1.2962e-05,0.54197,0.46735,1,1
4,GO RESPONSE TO EPINEPHRINE,0.00026003,0.54178,0.42578,1,1
4,GO O GLYCAN PROCESSING,7.2754e-05,0.54033,0.43144,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,5.7413e-06,0.53787,0.53877,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.9418e-06,0.53709,0.47915,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.8583e-05,0.53608,0.55573,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00098941,0.53454,0.37286,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0006154,0.53289,0.392,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00023468,0.53059,0.5574,1,1
4,GO SEROTONIN METABOLIC PROCESS,1.4039e-05,0.5302,0.56611,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00057693,0.52941,0.54566,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.7118e-05,0.52794,0.56779,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.014486,0.52551,0.33002,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00038934,0.52315,0.44381,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00016595,0.52109,0.39504,1,1
4,GO EOSINOPHIL MIGRATION,0.00019753,0.52013,0.41872,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.6228e-06,0.51952,0.54478,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,3.8583e-05,0.51559,0.62467,1,1
4,GO INTESTINAL ABSORPTION,5.0683e-06,0.51544,0.56545,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,9.7346e-05,0.51491,0.41058,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00019753,0.51477,0.38523,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.9532e-05,0.51337,0.46534,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00030804,0.5131,0.46527,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0028141,0.51132,0.36548,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,4.4712e-06,0.51091,0.48915,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00026003,0.51062,0.44872,1,1
4,GO REGULATION OF ANOIKIS,3.5759e-05,0.50987,0.51943,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00021167,0.50777,0.44811,1,1
4,GO CELLULAR DEFENSE RESPONSE,2.3654e-06,0.50736,0.4523,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.0184e-05,0.50655,0.48887,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,9.7346e-05,0.50422,0.38861,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00074557,0.50368,0.42269,1,1
4,GO RETINAL METABOLIC PROCESS,0.00023468,0.50162,0.5686,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,3.7791e-06,0.49974,0.50299,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,1.104e-05,0.49798,0.41876,1,1
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.0019282,0.49722,0.43035,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.349e-05,0.49511,0.44734,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0017123,0.49308,0.40012,1,1
4,GO ACTIN FILAMENT SEVERING,0.00020448,0.49226,0.45175,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.9263e-05,0.49225,0.50472,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,1.1964e-05,0.49158,0.5992,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0013872,0.48856,0.37422,1,1
4,GO REGULATION OF BONE REMODELING,9.4334e-07,0.48769,0.48627,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.0013872,0.48767,0.4083,1,1
4,GO PROTEIN DEMANNOSYLATION,2.1702e-06,0.48749,0.47468,1,1
4,GO REGULATION OF TISSUE REMODELING,1.906e-06,0.48624,0.42413,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00027832,0.48564,0.59312,1,1
4,GO RESPONSE TO PAIN,4.2876e-06,0.48465,0.46455,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.014841,0.48376,0.45215,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.0833e-05,0.48323,0.44516,1,1
4,GO RESPONSE TO DIETARY EXCESS,1.2862e-06,0.48098,0.531,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.043763,0.48024,0.2635,1,1
4,GO BONE RESORPTION,6.2985e-07,0.47907,0.46851,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.001986,0.47897,0.36796,1,1
4,GO GALACTOSE METABOLIC PROCESS,8.4205e-05,0.47842,0.5644,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00029782,0.47755,0.4914,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.2505e-07,0.47377,0.44035,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.3763e-07,0.4733,0.46842,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00023468,0.47287,0.48179,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.4039e-05,0.47113,0.51442,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,4.2876e-06,0.4705,0.52576,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.0784e-06,0.47038,0.47614,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00049035,0.47021,0.41942,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00022676,0.46942,0.41931,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,6.0504e-05,0.46621,0.40486,1,1
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.041093,0.46512,0.24104,1,1
4,GO PLASMINOGEN ACTIVATION,0.00049035,0.46443,0.49411,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0047853,0.46365,0.42824,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0011549,0.46226,0.43355,1,1
4,GO ZYMOGEN ACTIVATION,1.7806e-05,0.46214,0.48577,1,1
4,GO REGULATION OF PLATELET ACTIVATION,0.00016023,0.46091,0.37134,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0020453,0.46003,0.46472,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00020448,0.45942,0.37653,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.00021167,0.45856,0.4351,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00029782,0.45776,0.58386,1,1
4,GO RESPONSE TO REDOX STATE,0.00010462,0.4565,0.36022,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.9263e-05,0.45339,0.39923,1,1
4,GO RESPONSE TO ACIDIC PH,0.0012662,0.45304,0.33621,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0013457,0.45264,0.36734,1,1
4,GO VASODILATION,2.8077e-06,0.45088,0.5993,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.020205,0.44998,0.36982,1,1
4,GO STEROID ESTERIFICATION,0.00012074,0.44914,0.54943,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00011241,0.44534,0.4759,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.8936e-07,0.44507,0.49502,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00011241,0.44485,0.59222,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00098941,0.44414,0.37809,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,7.0571e-06,0.44332,0.39451,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00081984,0.44317,0.3723,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.0571e-06,0.44309,0.52089,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0022992,0.44204,0.44082,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,0.00010462,0.4411,0.49932,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.010506,0.44101,0.34837,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,0.44036,0.36146,1,1
4,GO REGULATION OF PLATELET AGGREGATION,0.0028141,0.44001,0.34517,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,2.0033e-05,0.43968,0.43461,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0010528,0.43959,0.36218,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.0011199,0.43944,0.45693,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00025131,0.4388,0.3721,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0015189,0.43848,0.32371,1,1
4,GO REGULATION OF NEURON MATURATION,0.00024286,0.43841,0.35539,1,1
4,GO INSEMINATION,8.7323e-05,0.43836,0.41126,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0059384,0.4382,0.31847,1,1
4,GO LIVER MORPHOGENESIS,7.2754e-05,0.43779,0.40448,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,6.7728e-06,0.43736,0.48482,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0001165,0.43712,0.37338,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,3.0689e-05,0.43705,0.42363,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,3.8583e-05,0.43678,0.4599,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00030804,0.43652,0.40584,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.1964e-05,0.43605,0.4444,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00069957,0.4352,0.38626,1,1
4,GO INTESTINAL LIPID ABSORPTION,1.9263e-05,0.43461,0.59141,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.7118e-05,0.43409,0.64355,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.8077e-06,0.43393,0.34499,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.8521e-05,0.43262,0.41688,1,1
4,GO SUPEROXIDE ANION GENERATION,0.00012512,0.43076,0.44281,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,4.1617e-05,0.43061,0.37173,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.1192e-05,0.43023,0.38334,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.4878e-05,0.42981,0.42314,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00013917,0.42835,0.32935,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0094949,0.42765,0.2724,1,1
4,GO PROTEIN DEGLYCOSYLATION,6.7728e-06,0.4275,0.44457,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0030654,0.42711,0.42717,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0001165,0.42694,0.36929,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00059588,0.42637,0.34202,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0017123,0.42594,0.37661,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.4609e-05,0.42576,0.36783,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0018173,0.42564,0.37341,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.0198e-07,0.42523,0.3534,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.0784e-06,0.42452,0.36336,1,1
4,GO ACUTE PHASE RESPONSE,8.3127e-06,0.42389,0.38251,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,3.0264e-07,0.42369,0.45014,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.6455e-05,0.42364,0.3938,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00063551,0.42101,0.3711,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.5816e-05,0.42012,0.35892,1,1
4,GO B CELL APOPTOTIC PROCESS,5.2533e-07,0.41876,0.47908,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00069957,0.41729,0.38649,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0021689,0.41689,0.35002,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.03245,0.41662,0.23238,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00019079,0.4141,0.37564,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00029782,0.4138,0.34436,1,1
4,GO RESPONSE TO THYROID HORMONE,0.00084609,0.41285,0.28661,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,6.5149e-05,0.41212,0.35351,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0025083,0.41176,0.27253,1,1
4,GO T CELL MEDIATED IMMUNITY,0.00090094,0.41129,0.2862,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,8.1192e-05,0.41117,0.4114,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00098941,0.41069,0.4163,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0014738,0.40997,0.31705,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,6.5149e-05,0.40938,0.39161,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,7.3528e-06,0.40923,0.33909,1,1
4,GO IMMUNOGLOBULIN SECRETION,1.1964e-05,0.40877,0.40831,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.2876e-06,0.40863,0.38223,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0017123,0.40826,0.27711,1,1
4,GO FOAM CELL DIFFERENTIATION,1.2454e-05,0.40809,0.34523,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.019739,0.40734,0.2992,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0040578,0.40728,0.2871,1,1
4,GO LIPOXYGENASE PATHWAY,0.033166,0.40676,0.25849,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00044439,0.40623,0.38683,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00087311,0.40528,0.405,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.906e-06,0.40491,0.40754,1,1
4,GO REGULATION OF COAGULATION,0.00016595,0.40474,0.33444,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.00045924,0.40435,0.40488,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00030804,0.40318,0.34198,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00036427,0.40302,0.36038,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.037747,0.40267,0.36512,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,6.2367e-06,0.40213,0.44317,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.0551e-05,0.40196,0.36711,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.00013433,0.40142,0.35633,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.4994e-06,0.40127,0.39015,1,1
4,GO VACUOLAR ACIDIFICATION,3.0264e-07,0.40117,0.42567,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0013457,0.401,0.3021,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0069616,0.40061,0.30319,1,1
4,GO BONE REMODELING,7.9801e-06,0.40058,0.37083,1,1
4,GO TISSUE REMODELING,1.7118e-05,0.39932,0.32267,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.00067758,0.39859,0.30558,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,3.7791e-06,0.39768,0.40461,1,1
4,GO MUSCLE ATROPHY,0.011612,0.39736,0.2565,1,1
4,GO LIPID DIGESTION,9.389e-05,0.39705,0.52685,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00022676,0.39685,0.36961,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00025131,0.39602,0.33571,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00050664,0.39552,0.40801,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.007729,0.39545,0.28449,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00014935,0.39535,0.35489,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.508e-06,0.39533,0.41935,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0031536,0.39519,0.3436,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00041602,0.39459,0.39783,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0042883,0.39438,0.24825,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,5.0226e-05,0.39393,0.29972,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0014738,0.39378,0.45189,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.39264,0.30581,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,8.628e-07,0.39147,0.39321,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.00065623,0.39135,0.30959,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0017641,0.39027,0.33651,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00019079,0.38921,0.32786,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.9904e-06,0.38905,0.38829,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00019753,0.38855,0.34315,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00014935,0.38851,0.37093,1,1
4,GO RESPONSE TO LITHIUM ION,5.0683e-06,0.38849,0.49377,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0012662,0.38815,0.27498,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00084609,0.38804,0.52236,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.00098941,0.38802,0.28841,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00072223,0.38709,0.25765,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00022676,0.38638,0.37595,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00017186,0.38637,0.43281,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0073363,0.38633,0.37422,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.00021167,0.38613,0.26314,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.5816e-05,0.38574,0.35197,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0036303,0.38548,0.35595,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00031859,0.38508,0.30718,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00032948,0.38504,0.32823,1,1
4,GO RESPONSE TO MINERALOCORTICOID,6.7596e-05,0.38486,0.3132,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0013054,0.38409,0.32457,1,1
4,GO BLOOD VESSEL REMODELING,0.0001165,0.38388,0.33576,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00065623,0.38387,0.28584,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00050664,0.38334,0.33876,1,1
4,GO REGULATION OF MYOBLAST FUSION,3.4421e-05,0.38326,0.38546,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0011199,0.38309,0.3546,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.0024367,0.38236,0.34191,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.6729e-06,0.38176,0.38008,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.4121e-05,0.3805,0.43702,1,1
4,GO INTEGRIN ACTIVATION,5.508e-06,0.38045,0.37797,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,3.4728e-06,0.38006,0.46064,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00014418,0.38006,0.3385,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0018173,0.37983,0.31255,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.0033e-05,0.37888,0.42724,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,4.4712e-06,0.37864,0.33879,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.37847,0.36345,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0032441,0.37811,0.32083,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.00045924,0.37743,0.40393,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0021689,0.37731,0.29356,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.0010206,0.37726,0.32082,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0017641,0.37714,0.37517,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,4.4878e-05,0.37695,0.3508,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.2754e-05,0.37616,0.31371,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00063551,0.3757,0.30571,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,5.0226e-05,0.37551,0.34373,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,5.6174e-05,0.37483,0.31013,1,1
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.044685,0.37425,0.3111,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00012964,0.37394,0.27335,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.0551e-05,0.37386,0.25332,1,1
4,GO LIPID DROPLET ORGANIZATION,2.2658e-06,0.37349,0.35568,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,4.3218e-05,0.37312,0.31782,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,5.2837e-06,0.37223,0.34114,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0083534,0.37208,0.21057,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.00084609,0.372,0.49582,1,1
4,GO PHAGOSOME ACIDIFICATION,4.3763e-07,0.37138,0.39764,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.2754e-05,0.37138,0.31877,1,1
4,GO SNARE COMPLEX ASSEMBLY,6.7596e-05,0.37085,0.315,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00037661,0.37058,0.33336,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00019079,0.37055,0.34167,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00079435,0.37011,0.29085,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014138,0.36842,0.27284,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,5.0226e-05,0.36822,0.29739,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00087311,0.36746,0.27342,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0011549,0.36738,0.35876,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00011241,0.36737,0.33822,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.001662,0.36733,0.50745,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.00024286,0.36648,0.31947,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00057693,0.36633,0.25939,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00081984,0.36632,0.32844,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0006154,0.36623,0.26772,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00012512,0.36595,0.31573,1,1
4,GO ENTRY INTO HOST,0.001228,0.36551,0.23928,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.00074557,0.36476,0.3193,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.00014418,0.36402,0.27597,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.0075304,0.36392,0.28595,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.00059588,0.36387,0.26848,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00036427,0.3635,0.33904,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.013465,0.36299,0.34138,1,1
4,GO LIPID TRANSLOCATION,0.00030804,0.36272,0.26746,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00040247,0.36269,0.3214,1,1
4,GO REGULATION OF ICOSANOID SECRETION,1.4039e-05,0.36244,0.38482,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0042883,0.36228,0.27806,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0037331,0.36217,0.26252,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,2.4346e-05,0.36074,0.45365,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0014299,0.36074,0.42709,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,5.2139e-05,0.3607,0.30926,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0021062,0.36019,0.35998,1,1
4,GO STEROID HORMONE SECRETION,7.8282e-05,0.35939,0.373,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,1.1964e-05,0.35892,0.32137,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.35842,0.38926,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00036427,0.35821,0.33216,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00018427,0.35794,0.2915,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,8.7323e-05,0.35792,0.30339,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00030804,0.3579,0.27733,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00027832,0.35746,0.38589,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00019753,0.35743,0.25874,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00069957,0.35719,0.27781,1,1
4,GO REGULATION OF B CELL ACTIVATION,8.3127e-06,0.35688,0.27408,1,1
4,GO RESPONSE TO GONADOTROPIN,9.389e-05,0.3564,0.30512,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00079435,0.35632,0.29212,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0001165,0.35593,0.33564,1,1
4,GO VASCULAR TRANSPORT,0.0034322,0.35533,0.34077,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,7.8282e-05,0.35533,0.2669,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,3.5759e-05,0.35501,0.32122,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00057693,0.35432,0.35463,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,7.547e-05,0.35408,0.38385,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00010462,0.35321,0.37955,1,1
4,GO NUCLEOTIDE SALVAGE,0.0047853,0.35245,0.29422,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00044439,0.35172,0.28403,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010506,0.35171,0.26391,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00038934,0.3516,0.28798,1,1
4,GO RESPONSE TO INTERLEUKIN 2,0.00024286,0.35096,0.28155,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00028792,0.35066,0.33413,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.628e-07,0.35063,0.38181,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00027832,0.35049,0.26369,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,3.1888e-05,0.3503,0.36584,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0025817,0.35016,0.30608,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00021909,0.35016,0.32217,1,1
4,GO MAGNESIUM ION TRANSPORT,6.2786e-05,0.34988,0.31362,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0099891,0.34984,0.22622,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,1.9263e-05,0.34972,0.31479,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2308e-06,0.34958,0.34783,1,1
4,GO DIGESTION,3.0689e-05,0.34933,0.32164,1,1
4,GO ETHER METABOLIC PROCESS,0.0031536,0.34896,0.22527,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0001547,0.34864,0.26324,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00017796,0.34841,0.23528,1,1
4,GO N GLYCAN PROCESSING,0.00067758,0.34777,0.31382,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0010206,0.34747,0.35209,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.8077e-06,0.34628,0.34855,1,1
4,GO LYSINE METABOLIC PROCESS,0.021165,0.34619,0.24565,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.025414,0.34616,0.36961,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00055855,0.34613,0.40929,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00038934,0.34574,0.30143,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00035231,0.3454,0.27126,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001662,0.34521,0.23171,1,1
4,GO LYTIC VACUOLE ORGANIZATION,5.2533e-07,0.34517,0.35485,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.02268,0.34515,0.19345,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0010206,0.3446,0.33342,1,1
4,GO STEROL HOMEOSTASIS,0.00032948,0.34439,0.31945,1,1
4,GO PROTEIN AUTOPROCESSING,3.0689e-05,0.34438,0.37254,1,1
4,GO ANOIKIS,1.8521e-05,0.34435,0.37908,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,1.349e-05,0.34392,0.30184,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.010245,0.34391,0.20331,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0017123,0.34369,0.20959,1,1
4,GO OPTIC NERVE DEVELOPMENT,4.0073e-05,0.34367,0.47758,1,1
4,GO PARTURITION,0.0062634,0.34299,0.28809,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0001547,0.34296,0.31145,1,1
4,GO NADP METABOLIC PROCESS,0.0039469,0.34278,0.27287,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.349e-05,0.34257,0.29342,1,1
4,GO ALANINE TRANSPORT,0.00050664,0.34242,0.35703,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00016595,0.34234,0.32658,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.6729e-06,0.34233,0.33151,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0020453,0.34168,0.35296,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,7.9801e-06,0.34125,0.30124,1,1
4,GO ZYMOGEN INHIBITION,0.0030654,0.34115,0.24339,1,1
4,GO REGULATION OF FERTILIZATION,0.00010092,0.34114,0.34428,1,1
4,GO ICOSANOID METABOLIC PROCESS,5.4121e-05,0.34061,0.33961,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00063551,0.34022,0.29372,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0019282,0.34016,0.26811,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0025083,0.34002,0.34108,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0019282,0.33986,0.44313,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.7118e-05,0.33943,0.31475,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00013433,0.33936,0.35877,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0030654,0.339,0.39101,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00050664,0.3389,0.22679,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00034072,0.33886,0.33824,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,9.389e-05,0.33857,0.3183,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,1.5816e-05,0.33825,0.3492,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00020448,0.33817,0.31461,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.9904e-06,0.33812,0.27695,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,9.7801e-06,0.33806,0.30278,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0024367,0.3378,0.34004,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.4346e-05,0.33776,0.2682,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.014841,0.33773,0.33325,1,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.024846,0.33732,0.25172,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.00021909,0.33726,0.33117,1,1
4,GO DIET INDUCED THERMOGENESIS,0.004408,0.33721,0.2333,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00057693,0.33629,0.23059,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00035231,0.33577,0.28214,1,1
4,GO REGULATION OF CELL KILLING,4.6597e-05,0.33559,0.31506,1,1
4,GO POLYOL TRANSPORT,0.00031859,0.33533,0.34987,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.0007696,0.33499,0.36856,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0020453,0.33496,0.29546,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0184e-05,0.33473,0.29323,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00084609,0.3347,0.36639,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00074557,0.33447,0.27298,1,1
4,GO PROTEIN PROCESSING,1.2862e-06,0.33412,0.30171,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,6.0504e-05,0.33395,0.30577,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.00030804,0.33393,0.25874,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00063551,0.33334,0.28052,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,9.7801e-06,0.33317,0.33997,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00011241,0.33225,0.34828,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00023468,0.33189,0.25058,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0001165,0.33154,0.34792,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0025083,0.3313,0.21309,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00047456,0.33124,0.34526,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,2.0833e-05,0.33109,0.29504,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00084609,0.33104,0.41268,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,3.0689e-05,0.33091,0.37727,1,1
4,GO INNATE IMMUNE RESPONSE,3.4421e-05,0.3304,0.24732,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.00090094,0.33039,0.23182,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,8.7323e-05,0.33032,0.26339,1,1
4,GO CELL KILLING,7.0571e-06,0.33,0.27345,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.013798,0.32991,0.31278,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0013872,0.32973,0.26863,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00047456,0.3293,0.28408,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0046564,0.32923,0.1833,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.104e-05,0.32867,0.31747,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00074557,0.32867,0.34145,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.014486,0.32854,0.213,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.00010462,0.32848,0.24518,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00012512,0.32844,0.26472,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.32745,0.26454,1,1
4,GO REGULATION OF B CELL PROLIFERATION,2.5774e-06,0.32693,0.35223,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00028792,0.32672,0.32824,1,1
4,GO REGULATION OF WOUND HEALING,0.00036427,0.32558,0.27049,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.016339,0.32541,0.21662,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,9.7346e-05,0.32525,0.30653,1,1
4,GO IMMUNE EFFECTOR PROCESS,4.8379e-05,0.32513,0.2447,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00010462,0.325,0.23206,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00028792,0.3249,0.3062,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00045924,0.32461,0.26065,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.32418,0.23356,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.3916e-06,0.32365,0.29238,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32351,0.2624,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.015203,0.32345,0.30355,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.00037661,0.32341,0.2786,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0025083,0.3234,0.32311,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,8.1192e-05,0.3228,0.26823,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0060989,0.3227,0.39852,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00013433,0.32242,0.25226,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.5308e-05,0.32218,0.23878,1,1
4,GO LIPID LOCALIZATION,2.1702e-06,0.32195,0.28957,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.00030804,0.32192,0.31023,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00010092,0.3216,0.3522,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.0011549,0.32157,0.21998,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0062634,0.32144,0.22642,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.012508,0.32118,0.25497,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.4205e-05,0.32118,0.32218,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.1192e-05,0.32055,0.31183,1,1
4,GO STEROID METABOLIC PROCESS,6.4994e-06,0.32019,0.30785,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0054795,0.32005,0.20727,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,1.9263e-05,0.32001,0.31591,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00052342,0.31981,0.2602,1,1
4,GO PLATELET DEGRANULATION,0.00074557,0.31951,0.25676,1,1
4,GO DRUG METABOLIC PROCESS,4.3218e-05,0.31944,0.35594,1,1
4,GO MAST CELL ACTIVATION,1.6455e-05,0.31927,0.30518,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0081404,0.31918,0.26708,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.6307e-05,0.31915,0.25974,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.0083534,0.31912,0.24084,1,1
4,GO ENDOCRINE PROCESS,7.9801e-06,0.31905,0.30465,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00017796,0.31884,0.30744,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0022992,0.31865,0.2758,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0051916,0.31828,0.22243,1,1
4,GO MAST CELL MEDIATED IMMUNITY,3.1888e-05,0.31812,0.29928,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.029719,0.31785,0.18703,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,2.6902e-06,0.31782,0.30255,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.4121e-05,0.3178,0.3264,1,1
4,GO VIRAL GENOME REPLICATION,0.00098941,0.31749,0.21784,1,1
4,GO RESPONSE TO FATTY ACID,0.00021167,0.31726,0.25247,1,1
4,GO RETINOL METABOLIC PROCESS,0.00010092,0.31713,0.39625,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.5816e-05,0.31709,0.27005,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0046564,0.31684,0.22685,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.017549,0.31679,0.21085,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00013917,0.31646,0.32494,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,8.7323e-05,0.31628,0.27887,1,1
4,GO RESPONSE TO COPPER ION,0.010245,0.31625,0.31915,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,3.7145e-05,0.31584,0.31932,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00072223,0.3158,0.31932,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0028141,0.31579,0.21084,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.019739,0.31565,0.27737,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,5.0226e-05,0.31562,0.37447,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00029782,0.31533,0.33998,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.547e-05,0.31512,0.22685,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0071468,0.31507,0.21307,1,1
4,GO RESPONSE TO INTERLEUKIN 6,7.0571e-06,0.31491,0.36126,1,1
4,GO STEROL METABOLIC PROCESS,0.0001547,0.31479,0.24891,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.6228e-06,0.3142,0.2563,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0015189,0.31395,0.27744,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.7806e-05,0.3137,0.33259,1,1
4,GO B CELL HOMEOSTASIS,5.2139e-05,0.31324,0.2869,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.0021689,0.31314,0.35882,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0022992,0.31311,0.28562,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00020448,0.31307,0.23943,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0094949,0.31306,0.17934,1,1
4,GO RESPONSE TO STARVATION,2.9301e-06,0.31296,0.26502,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00050664,0.31257,0.29767,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0011549,0.31235,0.2291,1,1
4,GO AMINO ACID IMPORT,0.00353,0.31229,0.22444,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,4.0073e-05,0.31213,0.27885,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0031536,0.31206,0.28303,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00024286,0.31186,0.32023,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.011326,0.31178,0.20643,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00079435,0.31141,0.20386,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0040578,0.31137,0.35407,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.8251e-06,0.31042,0.2609,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00029782,0.3103,0.22448,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.049546,0.31012,0.24962,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024846,0.31003,0.17761,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4039e-05,0.30999,0.27895,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00016023,0.30925,0.3477,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00018427,0.30907,0.28642,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.024288,0.3087,0.28164,1,1
4,GO FATTY ACID CATABOLIC PROCESS,6.2367e-06,0.30858,0.29751,1,1
4,GO METHIONINE METABOLIC PROCESS,4.1617e-05,0.30855,0.29805,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0081404,0.30814,0.19147,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00016595,0.30798,0.31054,1,1
4,GO RESPONSE TO INSECTICIDE,0.0012662,0.30798,0.38231,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,1.5816e-05,0.30788,0.3349,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00044439,0.30775,0.32265,1,1
4,GO GLYCOSYLATION,3.7145e-05,0.30755,0.28388,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.349e-05,0.30749,0.25408,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0016129,0.30745,0.34559,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.041093,0.30697,0.22766,1,1
4,GO RESPONSE TO GROWTH HORMONE,3.3132e-05,0.3068,0.35079,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.040234,0.30674,0.21419,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.0011549,0.30661,0.32056,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.1617e-05,0.30658,0.26981,1,1
4,GO HORMONE METABOLIC PROCESS,6.5149e-05,0.30638,0.30472,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.025994,0.3059,0.21017,1,1
4,GO PHOSPHOLIPID TRANSPORT,3.7791e-06,0.30588,0.26104,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00084609,0.30582,0.28466,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.3132e-05,0.30579,0.31886,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0081404,0.30545,0.24104,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0010206,0.30539,0.24159,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0689e-05,0.30526,0.25622,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.00069957,0.30515,0.31201,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.1964e-05,0.3051,0.27667,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00045924,0.30487,0.22066,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0018173,0.30484,0.23541,1,1
4,GO FUCOSYLATION,0.0028141,0.30467,0.29708,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00072223,0.30448,0.27414,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00065623,0.30445,0.2527,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0046564,0.30443,0.30839,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0029794,0.30385,0.23454,1,1
4,GO UBIQUINONE METABOLIC PROCESS,3.5759e-05,0.30333,0.3092,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00057693,0.30301,0.26833,1,1
4,GO TRICARBOXYLIC ACID CYCLE,0.013465,0.3023,0.23599,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0011199,0.30225,0.27485,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0073363,0.30217,0.33601,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0017641,0.30187,0.28997,1,1
4,GO PHOSPHOLIPID EFFLUX,0.00081984,0.30176,0.3556,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,6.8936e-07,0.30129,0.33949,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,0.00017796,0.30124,0.31698,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0013872,0.30083,0.29101,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.6597e-05,0.30069,0.25512,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0024367,0.30053,0.30426,1,1
4,GO B CELL PROLIFERATION,3.4728e-06,0.30034,0.28525,1,1
4,GO ORGANELLE MEMBRANE FUSION,4.4878e-05,0.29998,0.24501,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00016023,0.29986,0.22531,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00059588,0.29982,0.25352,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00035231,0.29977,0.33958,1,1
4,GO T CELL CYTOKINE PRODUCTION,0.0079323,0.29969,0.20753,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0015189,0.29937,0.20664,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.053746,0.29921,0.22805,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.010506,0.2991,0.18842,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.00059588,0.29897,0.2339,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.1192e-05,0.29888,0.30648,1,1
4,GO PROTEIN HYDROXYLATION,0.0021689,0.29878,0.28001,1,1
4,GO RESPIRATORY BURST,0.00016023,0.29868,0.27474,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.00057693,0.29868,0.25122,1,1
4,GO LIPID STORAGE,0.00011241,0.29846,0.27122,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.030383,0.29815,0.20461,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.00016023,0.29811,0.29621,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.023205,0.29804,0.16875,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.024846,0.29781,0.21228,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,2.3654e-06,0.29756,0.27169,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.9263e-05,0.2975,0.2526,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.00017796,0.29707,0.33411,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,4.4878e-05,0.29683,0.23399,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0025817,0.29681,0.36877,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00057693,0.29681,0.20225,1,1
4,GO LYMPHOCYTE MIGRATION,0.00022676,0.29677,0.20838,1,1
4,GO RESPONSE TO VIRUS,0.00019079,0.29659,0.22669,1,1
4,GO REGULATION OF ACROSOME REACTION,0.0081404,0.29638,0.34493,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00019753,0.29619,0.28886,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00011241,0.29608,0.30068,1,1
4,GO INTERLEUKIN 8 PRODUCTION,9.0551e-05,0.29592,0.27828,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00026903,0.2957,0.29937,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,5.9841e-06,0.29563,0.25758,1,1
4,GO BILE ACID METABOLIC PROCESS,3.4421e-05,0.29526,0.35495,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,4.3218e-05,0.29516,0.25158,1,1
4,GO WATER HOMEOSTASIS,0.00047456,0.29514,0.25695,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0001165,0.29483,0.2551,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,5.6174e-05,0.29482,0.22517,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.8418e-05,0.29417,0.34474,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.019283,0.29384,0.28346,1,1
4,GO LUNG CELL DIFFERENTIATION,0.010245,0.29383,0.34557,1,1
4,GO RESPONSE TO PH,0.00050664,0.29371,0.22486,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.015953,0.29352,0.23373,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.012203,0.29334,0.24215,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0001547,0.29297,0.25088,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00081984,0.29271,0.23451,1,1
4,GO DEFENSE RESPONSE,2.1663e-05,0.29261,0.23307,1,1
4,GO KERATINIZATION,0.00052342,0.29252,0.23727,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00047456,0.29232,0.26122,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0010206,0.29231,0.25892,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.00031859,0.29231,0.31107,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0021689,0.29227,0.33194,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.0073e-05,0.29225,0.3206,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00045924,0.29205,0.21732,1,1
4,GO ANDROGEN METABOLIC PROCESS,3.4421e-05,0.29201,0.43097,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0015189,0.29162,0.30549,1,1
4,GO MYOBLAST FUSION,0.00081984,0.29144,0.24839,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00011241,0.29135,0.29461,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,3.4728e-06,0.2912,0.26283,1,1
4,GO INTERLEUKIN 6 PRODUCTION,0.00023468,0.29113,0.21786,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.019283,0.29111,0.15996,1,1
4,GO TRANSFERRIN TRANSPORT,7.889e-07,0.29095,0.34936,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.0022992,0.29089,0.2475,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00020448,0.29029,0.31787,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00065623,0.29026,0.2959,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,8.3127e-06,0.28994,0.30213,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00010092,0.28984,0.30321,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.00065623,0.28963,0.28166,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00036427,0.28954,0.21059,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00042998,0.28952,0.33721,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00044439,0.28946,0.30409,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00084609,0.28933,0.20809,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,7.2754e-05,0.28927,0.2524,1,1
4,GO INTERLEUKIN 12 PRODUCTION,2.1663e-05,0.289,0.29436,1,1
4,GO T CELL MIGRATION,0.0014738,0.28883,0.2079,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,2.7343e-05,0.28871,0.30374,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.0033e-05,0.28863,0.26382,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0012662,0.28853,0.21695,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0019282,0.2885,0.26075,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.7596e-05,0.28845,0.23747,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0023671,0.28842,0.25238,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7596e-05,0.28828,0.24044,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0079323,0.28806,0.31318,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00010092,0.28802,0.29587,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,1.1493e-05,0.28746,0.25385,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.036948,0.28593,0.20889,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00067758,0.28538,0.25977,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00017186,0.2853,0.24753,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0020453,0.28525,0.18403,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00024286,0.28508,0.24329,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00353,0.28498,0.20598,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.001872,0.28454,0.20834,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,5.7413e-06,0.28426,0.33194,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00059588,0.28416,0.23529,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0073363,0.28416,0.21302,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.037747,0.2839,0.15285,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,2.6307e-05,0.28348,0.24177,1,1
4,GO VESICLE TARGETING,0.00092958,0.28289,0.22313,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0079323,0.28266,0.26423,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00030804,0.28242,0.25129,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.010773,0.282,0.26704,1,1
4,GO AMINE METABOLIC PROCESS,5.2533e-07,0.28177,0.30584,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.5759e-05,0.28169,0.27105,1,1
4,GO RESPONSE TO PROTOZOAN,0.00050664,0.2816,0.22483,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.018836,0.28123,0.23631,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.349e-05,0.28112,0.25636,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00052342,0.28096,0.24747,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00057693,0.28085,0.22821,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0069616,0.28075,0.21424,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7145e-05,0.28073,0.21758,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.0073e-05,0.28051,0.28912,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010462,0.28048,0.22747,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00092958,0.28033,0.23902,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00023468,0.28032,0.27912,1,1
4,GO PH REDUCTION,1.4674e-06,0.28021,0.28413,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00019753,0.28,0.29529,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,8.6584e-06,0.27985,0.29847,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.037747,0.27974,0.18503,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.025414,0.27962,0.241,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00040247,0.27943,0.19253,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00044439,0.27902,0.44044,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.041967,0.27902,0.13817,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0046564,0.27892,0.21512,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00067758,0.27886,0.25281,1,1
4,GO RESPONSE TO NUTRIENT,0.0028957,0.27866,0.17843,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.9532e-05,0.27852,0.25086,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00036427,0.27822,0.18793,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.009256,0.27804,0.16441,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,2.3418e-05,0.27784,0.2836,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0083534,0.27772,0.20532,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.0001165,0.27763,0.23148,1,1
4,GO MICROVILLUS ORGANIZATION,0.011047,0.27674,0.26828,1,1
4,GO RESPONSE TO CYTOKINE,8.4205e-05,0.2767,0.20796,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.00054072,0.2764,0.2274,1,1
4,GO RESPONSE TO PROSTAGLANDIN,0.02843,0.27629,0.17234,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,7.013e-05,0.27626,0.20492,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0017123,0.27608,0.18549,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00050664,0.27605,0.21703,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,2.0833e-05,0.27585,0.22775,1,1
4,GO AMINO ACID ACTIVATION,0.0071468,0.27574,0.20581,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00047456,0.27567,0.22129,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0013054,0.27545,0.25346,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,7.013e-05,0.27503,0.25224,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.00069957,0.27502,0.27401,1,1
4,GO DOPAMINE TRANSPORT,0.00063551,0.27494,0.35161,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00011241,0.27464,0.22574,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0057817,0.27462,0.26774,1,1
4,GO CARNITINE METABOLIC PROCESS,0.010245,0.27461,0.22977,1,1
4,GO REGULATION OF LIPID STORAGE,0.00021167,0.27446,0.22474,1,1
4,GO PHAGOSOME MATURATION,4.8379e-05,0.27445,0.28694,1,1
4,GO CYTOKINE PRODUCTION,7.8282e-05,0.27399,0.22041,1,1
4,GO STEROL TRANSPORT,0.00018427,0.27395,0.25564,1,1
4,GO RESPONSE TO BACTERIUM,0.00013433,0.2738,0.20818,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00027832,0.27346,0.25534,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0024367,0.27342,0.29972,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00010845,0.27341,0.23416,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00041602,0.27337,0.22383,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.27309,0.27036,1,1
4,GO INTERLEUKIN 10 PRODUCTION,8.4205e-05,0.27291,0.25008,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.011904,0.27287,0.23073,1,1
4,GO RESPONSE TO KETONE,0.00049035,0.27287,0.18998,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00052342,0.27219,0.39342,1,1
4,GO B CELL ACTIVATION,3.5759e-05,0.27207,0.20681,1,1
4,GO FUCOSE METABOLIC PROCESS,0.024846,0.27183,0.27437,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0094949,0.27164,0.23518,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00021167,0.2716,0.21118,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0038387,0.27146,0.22081,1,1
4,GO LIPID EXPORT FROM CELL,0.00028792,0.2713,0.31981,1,1
4,GO RESPONSE TO FORSKOLIN,0.01282,0.27115,0.26364,1,1
4,GO CHYLOMICRON ASSEMBLY,0.015953,0.271,0.28027,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.5201e-05,0.27076,0.31175,1,1
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.030383,0.27065,0.27436,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.0094949,0.27058,0.21852,1,1
4,GO RESPONSE TO METAL ION,0.00017186,0.2701,0.20519,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00011241,0.26988,0.24114,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.017969,0.26985,0.19132,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00040247,0.26983,0.21654,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.4039e-05,0.26976,0.23969,1,1
4,GO VASCULAR WOUND HEALING,0.0037331,0.26969,0.37732,1,1
4,GO CHEMOKINE PRODUCTION,0.0027346,0.26967,0.18537,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00029782,0.26952,0.20516,1,1
4,GO OXALATE TRANSPORT,0.00067758,0.26949,0.242,1,1
4,GO ETHANOL METABOLIC PROCESS,0.01282,0.26925,0.2265,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0056288,0.26907,0.2488,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0028141,0.26898,0.21893,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010859,0.26882,0.23526,1,1
4,GO PEPTIDE SECRETION,7.3528e-06,0.26868,0.21497,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0031536,0.26861,0.23893,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0090226,0.26859,0.23901,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.104e-05,0.26853,0.25952,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.906e-06,0.26821,0.27791,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0075304,0.26793,0.18687,1,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.023741,0.26786,0.20148,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,7.2754e-05,0.26766,0.22886,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.2962e-05,0.26765,0.26208,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00013433,0.26763,0.21586,1,1
4,GO CORNIFICATION,0.00069957,0.2676,0.2669,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0018173,0.26744,0.27588,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00011241,0.26695,0.21882,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0025083,0.26689,0.17622,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.9532e-05,0.26685,0.25517,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.037747,0.26655,0.18971,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00044439,0.2665,0.20863,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00019079,0.26624,0.25255,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0041716,0.26602,0.21723,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.6623e-06,0.26598,0.25404,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00079435,0.26567,0.22131,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.0053338,0.2656,0.24862,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,0.26535,0.21812,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.015203,0.26505,0.16117,1,1
4,GO GOLGI VESICLE BUDDING,2.3418e-05,0.26471,0.24974,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00026903,0.26458,0.2661,1,1
4,GO PROTEIN MATURATION,3.1904e-06,0.26456,0.24296,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010092,0.26456,0.19801,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00034072,0.26456,0.20376,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0013872,0.26449,0.21946,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,7.3528e-06,0.26448,0.39098,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0059384,0.26432,0.24886,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00090094,0.26409,0.38228,1,1
4,GO LEUKOCYTE MIGRATION,0.00011241,0.26403,0.21631,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.7343e-05,0.2639,0.24176,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00014935,0.26357,0.21407,1,1
4,GO TISSUE HOMEOSTASIS,0.00095906,0.26355,0.18708,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,5.4121e-05,0.26347,0.21237,1,1
4,GO INFLAMMATORY RESPONSE,3.1888e-05,0.2634,0.22966,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.018836,0.26339,0.20364,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.0015189,0.26338,0.2425,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00081984,0.26326,0.29879,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00032948,0.2632,0.2235,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,8.4205e-05,0.26276,0.27223,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.034637,0.26253,0.15802,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00063551,0.26243,0.27955,1,1
4,GO REGULATION OF HORMONE LEVELS,9.0179e-06,0.26243,0.24103,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.054842,0.2623,0.18346,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025817,0.26224,0.24295,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.00019079,0.26209,0.18264,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.036948,0.26206,0.17114,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00087311,0.26162,0.28809,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,0.26146,0.24949,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.02068,0.26134,0.21313,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00036427,0.26133,0.26884,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00084609,0.26117,0.22653,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,4.8379e-05,0.26078,0.2013,1,1
4,GO MUSCLE CELL MIGRATION,0.011047,0.26071,0.18108,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,2.7343e-05,0.26066,0.24568,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.00057693,0.26064,0.18612,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,1.1964e-05,0.26048,0.24697,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00067758,0.26047,0.24167,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00098941,0.26044,0.18683,1,1
4,GO CARBOHYDRATE TRANSPORT,4.4878e-05,0.26034,0.24452,1,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.041967,0.26032,0.18369,1,1
4,GO NEUTROPHIL MIGRATION,8.3127e-06,0.26013,0.2292,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,4.8379e-05,0.26009,0.23939,1,1
4,GO LIPID HOMEOSTASIS,0.00072223,0.25977,0.22569,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00036427,0.25968,0.19226,1,1
4,GO RESPONSE TO CALCIUM ION,0.00042998,0.25965,0.20558,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00044439,0.25919,0.24335,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,9.7346e-05,0.25917,0.24489,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00041602,0.2585,0.17651,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0085714,0.25849,0.28084,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.0006154,0.25843,0.24945,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00054072,0.2581,0.19927,1,1
4,GO RENAL SYSTEM PROCESS,7.013e-05,0.25789,0.23216,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.001662,0.25773,0.22076,1,1
4,GO LEUKOCYTE PROLIFERATION,0.00024286,0.25766,0.20124,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0022992,0.25766,0.19547,1,1
4,GO FLUID TRANSPORT,3.7145e-05,0.25713,0.24153,1,1
4,GO REGULATION OF ANION TRANSPORT,1.1493e-05,0.25712,0.27644,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0010859,0.25706,0.24638,1,1
4,GO REGULATION OF DEFENSE RESPONSE,2.8418e-05,0.257,0.21475,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00012074,0.25693,0.29194,1,1
4,GO AMELOGENESIS,0.010245,0.25685,0.22033,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00024286,0.25673,0.19524,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.0064317,0.25671,0.22086,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.025414,0.25635,0.18986,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.3127e-06,0.25616,0.21423,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00012964,0.25594,0.19724,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00019753,0.2558,0.31585,1,1
4,GO RESPONSE TO CAFFEINE,0.0049174,0.25558,0.22815,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.8612e-06,0.25558,0.27079,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.011326,0.25557,0.2404,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.014138,0.25537,0.24173,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.0059384,0.25502,0.21891,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0011549,0.25494,0.25223,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.0179e-06,0.25479,0.23216,1,1
4,GO EXOCYTOSIS,3.5759e-05,0.2547,0.20415,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013917,0.25464,0.22833,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,9.0551e-05,0.25428,0.24853,1,1
4,GO MYELIN MAINTENANCE,0.043763,0.25392,0.21122,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0013457,0.25353,0.18667,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.024288,0.25345,0.16659,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0040578,0.25325,0.18834,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00079435,0.25314,0.2177,1,1
4,GO COAGULATION,0.00079435,0.25275,0.17552,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.024288,0.2523,0.13907,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0029794,0.25226,0.18869,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,3.5759e-05,0.25184,0.3466,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,2.9301e-06,0.25174,0.23179,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,9.0551e-05,0.25173,0.26289,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.0016129,0.25144,0.29226,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,1.4609e-05,0.25131,0.21974,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00079435,0.2512,0.1898,1,1
4,GO COPII COATED VESICLE BUDDING,6.2786e-05,0.25118,0.23523,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0099891,0.25112,0.23292,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.00014418,0.25101,0.21811,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.7323e-05,0.25096,0.17398,1,1
4,GO MUSCLE HYPERTROPHY,0.0001547,0.25089,0.23031,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0017641,0.25043,0.18301,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00057693,0.25042,0.17691,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.013798,0.25039,0.15607,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.6902e-06,0.24994,0.24962,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.001191,0.24972,0.20475,1,1
4,GO REGULATION OF CELLULAR PH,1.4674e-06,0.24968,0.23818,1,1
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.007729,0.24955,0.21046,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00011241,0.24941,0.25326,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0067808,0.24903,0.16367,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0073363,0.24901,0.22149,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0011549,0.24897,0.391,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.02068,0.24892,0.16426,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00010845,0.24881,0.25111,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019753,0.24878,0.28301,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0016129,0.24805,0.22063,1,1
4,GO LEUKOCYTE CHEMOTAXIS,2.9532e-05,0.24804,0.21881,1,1
4,GO MEMBRANE FUSION,6.2786e-05,0.248,0.21239,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0017123,0.24796,0.20572,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.026586,0.24778,0.11808,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,0.24752,0.20383,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0010859,0.24721,0.23455,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00016023,0.2472,0.26956,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.029719,0.24701,0.16729,1,1
4,GO MONOCYTE CHEMOTAXIS,0.0079323,0.24701,0.17357,1,1
4,GO ORGANELLE FUSION,4.0073e-05,0.24683,0.21146,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.012508,0.24682,0.19856,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0099891,0.24661,0.23949,1,1
4,GO RESPONSE TO LEUCINE,0.0037331,0.24658,0.27673,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.049546,0.24658,0.28648,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.0034322,0.24629,0.23845,1,1
4,GO REPLICATIVE SENESCENCE,0.0030654,0.24611,0.2532,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.00092958,0.24605,0.23918,1,1
4,GO VACUOLE ORGANIZATION,3.6228e-06,0.24597,0.23814,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.042857,0.24586,0.19144,1,1
4,GO SYNCYTIUM FORMATION,0.0017641,0.2457,0.18301,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.4121e-05,0.24569,0.20595,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0017641,0.24565,0.21589,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00079435,0.24563,0.1982,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0014299,0.24559,0.17946,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00057693,0.24553,0.22756,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.004408,0.24546,0.17045,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00087311,0.24531,0.23925,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0067808,0.24522,0.21162,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.009256,0.24484,0.17435,1,1
4,GO RESPONSE TO ALCOHOL,0.00014935,0.24479,0.17928,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,8.4205e-05,0.24476,0.24992,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0025817,0.24465,0.26205,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.010506,0.24462,0.18389,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0025083,0.24436,0.20395,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0021062,0.24427,0.23602,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,6.2786e-05,0.24422,0.19121,1,1
4,GO NECROTIC CELL DEATH,0.00028792,0.24409,0.27539,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.00079435,0.24407,0.18823,1,1
4,GO SECRETION,4.4878e-05,0.24388,0.18187,1,1
4,GO LIPID OXIDATION,0.0001165,0.24357,0.22269,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0001547,0.24351,0.23138,1,1
4,GO XENOBIOTIC TRANSPORT,0.00045924,0.24348,0.32257,1,1
4,GO CAMP BIOSYNTHETIC PROCESS,0.012203,0.24342,0.23,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.012203,0.24327,0.2009,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.00065623,0.24321,0.25198,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00012512,0.24299,0.19354,1,1
4,GO RESPONSE TO PROGESTERONE,0.0067808,0.24299,0.19615,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001165,0.24294,0.20908,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.00019079,0.24255,0.25844,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00052342,0.2425,0.30049,1,1
4,GO GRANULOCYTE MIGRATION,4.3218e-05,0.24249,0.22353,1,1
4,GO COPULATION,0.0079323,0.2422,0.19047,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00026903,0.24216,0.23983,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.001986,0.24212,0.19945,1,1
4,GO MACROPHAGE APOPTOTIC PROCESS,0.036948,0.24204,0.18246,1,1
4,GO GLUCOSE METABOLIC PROCESS,1.2862e-06,0.2419,0.26171,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0039469,0.24168,0.20691,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00013917,0.24164,0.2474,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0046564,0.24144,0.20286,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0013054,0.24141,0.19976,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.1663e-05,0.24128,0.25807,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.0016129,0.24122,0.20549,1,1
4,GO RESPONSE TO ACTIVITY,0.00020448,0.24111,0.23072,1,1
4,GO REGULATION OF VASCULOGENESIS,0.013139,0.24091,0.26744,1,1
4,GO SECRETION BY TISSUE,0.0069616,0.24085,0.18011,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.3127e-06,0.24066,0.27732,1,1
4,GO CELL ACTIVATION,0.00019079,0.24057,0.18463,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0079323,0.24034,0.25147,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.0057817,0.24005,0.19814,1,1
4,GO RESPONSE TO INSULIN,0.00030804,0.23993,0.17283,1,1
4,GO CELL CHEMOTAXIS,5.4121e-05,0.23979,0.21323,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.0018173,0.23972,0.20923,1,1
4,GO INOSITOL METABOLIC PROCESS,0.00019079,0.23955,0.29043,1,1
4,GO PIGMENTATION,0.00013917,0.23952,0.18372,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.019739,0.23951,0.32538,1,1
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0021062,0.23945,0.22475,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00012964,0.23928,0.18252,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.23916,0.18924,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00021167,0.23888,0.18231,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00014418,0.23883,0.22356,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0062634,0.23859,0.25821,1,1
4,GO REGULATION OF HORMONE SECRETION,7.013e-05,0.23842,0.20031,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00023468,0.23839,0.21585,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.00012074,0.23838,0.16341,1,1
4,GO LOCOMOTOR RHYTHM,0.0099891,0.23835,0.19413,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0081404,0.23808,0.20527,1,1
4,GO ALDEHYDE CATABOLIC PROCESS,0.036164,0.23802,0.16312,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00092958,0.23801,0.27438,1,1
4,GO INTERLEUKIN 17 PRODUCTION,0.0062634,0.23789,0.19038,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00021167,0.2378,0.23102,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0018173,0.23778,0.21882,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00025131,0.23773,0.18551,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0013872,0.23759,0.24169,1,1
4,GO MUSCLE ADAPTATION,0.00059588,0.23754,0.19351,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00027832,0.23751,0.23959,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0022992,0.237,0.1911,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,3.7145e-05,0.23695,0.21833,1,1
4,GO ALCOHOL METABOLIC PROCESS,2.7343e-05,0.23674,0.24093,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.023205,0.23673,0.22212,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00095906,0.23657,0.2815,1,1
4,GO REGULATION OF BLOOD PRESSURE,5.7413e-06,0.23643,0.23298,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0069616,0.23635,0.19519,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,4.3218e-05,0.23599,0.23464,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00024286,0.23541,0.17372,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.8282e-05,0.23536,0.18436,1,1
4,GO ER OVERLOAD RESPONSE,0.0046564,0.23509,0.25076,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092958,0.23508,0.19956,1,1
4,GO POSITIVE CHEMOTAXIS,0.0022992,0.2349,0.16997,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0062634,0.23479,0.19656,1,1
4,GO POSITIVE REGULATION OF SECRETION,1.9263e-05,0.23471,0.20973,1,1
4,GO INTERACTION WITH HOST,0.0022332,0.2347,0.17022,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0036303,0.23459,0.17979,1,1
4,GO RESPONSE TO STEROL,0.0012662,0.23429,0.23919,1,1
4,GO ENERGY HOMEOSTASIS,0.0038387,0.23418,0.20757,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.1964e-05,0.23412,0.26115,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.017969,0.234,0.19317,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0022332,0.23372,0.18537,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0024367,0.23371,0.21905,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0011199,0.23365,0.27652,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00069957,0.23363,0.22688,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00013917,0.23359,0.21876,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0029794,0.23354,0.22447,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,2.4346e-05,0.23285,0.22436,1,1
4,GO AEROBIC RESPIRATION,0.00087311,0.2326,0.23877,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0094949,0.23255,0.16557,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,5.6174e-05,0.23254,0.26461,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.23253,0.18548,1,1
4,GO PROTEIN KINASE C SIGNALING,0.027188,0.23245,0.18322,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0011199,0.23244,0.26025,1,1
4,GO REGULATION OF PH,1.5331e-06,0.23234,0.23615,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00040247,0.23227,0.1794,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00024286,0.23196,0.19429,1,1
4,GO CYTOLYSIS,0.027188,0.23194,0.15609,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0064317,0.23188,0.15795,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0045306,0.23181,0.21328,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00010462,0.23176,0.22648,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.00021167,0.23167,0.18134,1,1
4,GO RESPONSE TO ISCHEMIA,0.00055855,0.23166,0.23048,1,1
4,GO VESICLE ORGANIZATION,0.00026903,0.23165,0.17939,1,1
4,GO RESPONSE TO CADMIUM ION,0.025994,0.23163,0.16518,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.5308e-05,0.23162,0.19226,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00087311,0.23159,0.26348,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00023468,0.2314,0.182,1,1
4,GO RESPONSE TO INTERLEUKIN 1,0.00013433,0.23137,0.19064,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.00090094,0.23103,0.17155,1,1
4,GO SODIUM ION HOMEOSTASIS,0.00050664,0.23091,0.19931,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00065623,0.23072,0.18837,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,6.0504e-05,0.23066,0.20015,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.027803,0.23045,0.16508,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.001191,0.23029,0.20054,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00090094,0.23006,0.18898,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00035231,0.22999,0.19909,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.031748,0.22995,0.19255,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00081984,0.22995,0.19988,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.3418e-05,0.22988,0.19956,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.027188,0.22965,0.1542,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,6.5149e-05,0.22959,0.18227,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00017796,0.22927,0.20139,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.023205,0.22915,0.20878,1,1
4,GO REGULATION OF PEPTIDE SECRETION,1.4609e-05,0.22915,0.20645,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00079435,0.22911,0.22156,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.4039e-05,0.22906,0.26604,1,1
4,GO FATTY ACID BETA OXIDATION,0.00029782,0.22904,0.24545,1,1
4,GO MANNOSYLATION,2.1663e-05,0.22889,0.26125,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,7.547e-05,0.22883,0.18883,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00017796,0.22881,0.24797,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.02068,0.22866,0.24608,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0025817,0.22864,0.32785,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0099891,0.22848,0.18633,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0012662,0.22835,0.19407,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0030654,0.22814,0.16574,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.0012662,0.22794,0.23283,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.5759e-05,0.22773,0.19218,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.016734,0.22755,0.12927,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00057693,0.22754,0.16146,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00031859,0.22747,0.21616,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.027188,0.22729,0.15961,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0073363,0.22725,0.20416,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0083534,0.22713,0.15332,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,5.4121e-05,0.22695,0.24479,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.011326,0.2269,0.17194,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0042883,0.22674,0.18658,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00017186,0.22656,0.28844,1,1
4,GO REGULATION OF T CELL MIGRATION,0.00353,0.22642,0.19915,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.0017123,0.22641,0.1684,1,1
4,GO COMPLEMENT ACTIVATION,0.0051916,0.22638,0.18882,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0017123,0.22598,0.18413,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0018173,0.22593,0.30742,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0011549,0.22589,0.15998,1,1
4,GO DIOL METABOLIC PROCESS,0.0042883,0.2255,0.26112,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.007729,0.2254,0.25318,1,1
4,GO B CELL DIFFERENTIATION,2.3418e-05,0.22535,0.21258,1,1
4,GO REGULATION OF HEART RATE,0.0023671,0.22515,0.18958,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,8.7323e-05,0.22512,0.26197,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0032441,0.22503,0.28413,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0010206,0.22466,0.24124,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0094949,0.22459,0.19322,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.00024286,0.22425,0.20957,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.0097392,0.22424,0.19278,1,1
4,GO HORMONE TRANSPORT,3.1888e-05,0.22403,0.21764,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00087311,0.22365,0.16951,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0019282,0.22349,0.17397,1,1
4,GO INSULIN SECRETION,0.00025131,0.2234,0.1916,1,1
4,GO INTERFERON BETA PRODUCTION,0.0087944,0.2234,0.16007,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.0041716,0.22335,0.19006,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.22329,0.13334,1,1
4,GO WOUND HEALING,0.0053338,0.2232,0.14569,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0016129,0.22289,0.13347,1,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0097392,0.22288,0.1487,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.030383,0.22273,0.1606,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0034322,0.22272,0.20974,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0016129,0.22266,0.17824,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00036427,0.22266,0.22187,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0017641,0.22233,0.16132,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00079435,0.22229,0.1638,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00025131,0.22226,0.21646,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.5201e-05,0.22216,0.23457,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0010206,0.22151,0.15424,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.02843,0.22143,0.18172,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0057817,0.22112,0.19261,1,1
4,GO ADAPTIVE THERMOGENESIS,1.0604e-05,0.22078,0.21753,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0030654,0.22049,0.18476,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.001662,0.2204,0.26216,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.001191,0.22021,0.22525,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.0069616,0.22008,0.16751,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.00072223,0.21997,0.19275,1,1
4,GO PANCREAS DEVELOPMENT,0.02843,0.21972,0.14547,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.02843,0.21935,0.22733,1,1
4,GO NEUTROPHIL CHEMOTAXIS,4.0073e-05,0.21918,0.17734,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0045306,0.21913,0.21265,1,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.020205,0.21911,0.20865,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00032948,0.2191,0.15738,1,1
4,GO BONE CELL DEVELOPMENT,0.041093,0.21906,0.15053,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.017549,0.21897,0.25044,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0018173,0.21881,0.17625,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00054072,0.21853,0.16569,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00095906,0.21827,0.29535,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00034072,0.2182,0.23328,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.00047456,0.21813,0.21872,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,1.4039e-05,0.21799,0.26707,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00025131,0.21796,0.22958,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.00092958,0.21777,0.23321,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.0059384,0.21777,0.21182,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00055855,0.21771,0.20113,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0001165,0.21768,0.19695,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.0033369,0.21767,0.17116,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.026586,0.21723,0.13925,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0015653,0.21718,0.1654,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00012964,0.21715,0.17449,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00090094,0.21697,0.23899,1,1
4,GO LIPID METABOLIC PROCESS,8.7323e-05,0.21694,0.19289,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0010528,0.2166,0.20274,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.04854,0.21638,0.13356,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00054072,0.21635,0.28315,1,1
4,GO PEROXISOMAL TRANSPORT,0.00049035,0.21633,0.22118,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0034322,0.21614,0.28676,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0022992,0.216,0.23779,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.012508,0.21599,0.18568,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0020453,0.21584,0.28112,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0007696,0.21573,0.21825,1,1
4,GO HAIR CELL DIFFERENTIATION,0.0071468,0.21562,0.16187,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,7.013e-05,0.21554,0.19355,1,1
4,GO PLATELET AGGREGATION,0.013798,0.21534,0.14703,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,0.21529,0.36391,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.001191,0.21527,0.19258,1,1
4,GO REGULATION OF PROTEOLYSIS,0.00028792,0.21521,0.17022,1,1
4,GO SELECTIVE AUTOPHAGY,0.0001165,0.21513,0.22577,1,1
4,GO CHEMICAL HOMEOSTASIS,8.4205e-05,0.21488,0.16937,1,1
4,GO GOLGI RIBBON FORMATION,0.0021689,0.21485,0.20947,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0017123,0.21481,0.15182,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.00079435,0.21461,0.17853,1,1
4,GO AMYLOID BETA CLEARANCE,0.0026572,0.21441,0.19525,1,1
4,GO ORGANIC ANION TRANSPORT,1.2454e-05,0.21429,0.21406,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.2142,0.1972,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.05161,0.21402,0.1978,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,7.8282e-05,0.21399,0.20014,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0011199,0.21396,0.17334,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0010206,0.21375,0.1527,1,1
4,GO CAMP METABOLIC PROCESS,0.022165,0.21364,0.18346,1,1
4,GO RIG I SIGNALING PATHWAY,0.011047,0.21352,0.13608,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0013054,0.21331,0.1637,1,1
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.021165,0.2132,0.19704,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,7.8282e-05,0.21319,0.17503,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.011904,0.21307,0.15705,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0014299,0.21298,0.17737,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,9.7801e-06,0.21281,0.2311,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0069616,0.21277,0.15971,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0099891,0.21252,0.1396,1,1
4,GO PLATELET ACTIVATION,0.0025083,0.21231,0.16415,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0013457,0.21227,0.19115,1,1
4,GO ACID SECRETION,0.0026572,0.21225,0.18861,1,1
4,GO RESPONSE TO CHEMOKINE,1.7118e-05,0.2119,0.2046,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0017123,0.21183,0.1671,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.0016129,0.21171,0.19677,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,1.349e-05,0.21164,0.23332,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.02843,0.21161,0.13568,1,1
4,GO RESPONSE TO TUMOR CELL,0.030383,0.21157,0.23608,1,1
4,GO PLATELET MORPHOGENESIS,0.0033369,0.21157,0.21804,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0010528,0.21143,0.19599,1,1
4,GO RESPONSE TO IRON ION,0.0034322,0.2114,0.20631,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,2.6307e-05,0.21123,0.21133,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00050664,0.21122,0.22585,1,1
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0054795,0.2111,0.18514,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.052669,0.21104,0.20395,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,8.1192e-05,0.21103,0.19367,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.4346e-05,0.21069,0.24516,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,8.7323e-05,0.21065,0.20469,1,1
4,GO RESPONSE TO DSRNA,0.00028792,0.2106,0.18121,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00040247,0.21059,0.22214,1,1
4,GO VIRION ASSEMBLY,0.0011549,0.21033,0.15062,1,1
4,GO CERAMIDE TRANSPORT,0.041967,0.21031,0.28491,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00059588,0.21027,0.1583,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.001228,0.21013,0.20063,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,3.7145e-05,0.20998,0.22007,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00025131,0.20977,0.24187,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0011199,0.20976,0.17411,1,1
4,GO PROTEOLYSIS,7.547e-05,0.20967,0.15151,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00057693,0.20924,0.1736,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.001986,0.20924,0.2286,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,7.013e-05,0.20922,0.24451,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00098941,0.20897,0.15325,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0017641,0.20895,0.18277,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0039469,0.20865,0.1423,1,1
4,GO EXOCYTIC PROCESS,0.0037331,0.20849,0.19733,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00067758,0.20845,0.24007,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.20823,0.13048,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,3.3132e-05,0.20807,0.24392,1,1
4,GO T CELL ACTIVATION,0.00090094,0.20803,0.1646,1,1
4,GO REGULATION OF TUBE SIZE,8.7323e-05,0.20798,0.22647,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0045306,0.20789,0.18747,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.046579,0.20767,0.12134,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0085714,0.20763,0.19968,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0021062,0.20755,0.16845,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0013054,0.20672,0.18953,1,1
4,GO VIRAL LIFE CYCLE,0.00072223,0.20636,0.16265,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00090094,0.20616,0.20428,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0079323,0.20615,0.15609,1,1
4,GO NUCLEOTIDE TRANSPORT,0.00030804,0.20614,0.20693,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0026572,0.20575,0.16082,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00031859,0.20566,0.16532,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.012203,0.20547,0.18187,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00087311,0.20545,0.1549,1,1
4,GO CHOLESTEROL STORAGE,0.0049174,0.2054,0.2287,1,1
4,GO FIBROBLAST PROLIFERATION,0.029068,0.20518,0.12487,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0067808,0.20515,0.17845,1,1
4,GO PIRNA METABOLIC PROCESS,0.020205,0.20506,0.24608,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0073363,0.205,0.14799,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.00025131,0.2049,0.17195,1,1
4,GO REGULATION OF APPETITE,0.0040578,0.20482,0.14276,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00047456,0.20477,0.18844,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.036948,0.2047,0.22705,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,9.7801e-06,0.20469,0.22864,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0013872,0.20439,0.14723,1,1
4,GO RESPONSE TO TESTOSTERONE,0.0081404,0.20436,0.16147,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,1.1964e-05,0.20427,0.21599,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0020453,0.20421,0.20345,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00045924,0.20401,0.20975,1,1
4,GO ANION TRANSPORT,1.8521e-05,0.20387,0.1955,1,1
4,GO LYMPHOCYTE ACTIVATION,0.00081984,0.20383,0.1467,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,6.0504e-05,0.20375,0.16632,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.010245,0.20331,0.1573,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.00041602,0.20326,0.18665,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0045306,0.20322,0.13844,1,1
4,GO REGULATION OF VESICLE FUSION,0.050569,0.20305,0.19715,1,1
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.045624,0.20298,0.15467,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.031059,0.20296,0.2139,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.014486,0.20295,0.16078,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.00029782,0.20283,0.21319,1,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.025994,0.20273,0.16259,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.015574,0.20233,0.21793,1,1
4,GO CYTOKINE SECRETION,0.00092958,0.20228,0.19796,1,1
4,GO NIK NF KAPPAB SIGNALING,0.00038934,0.20215,0.17045,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00067758,0.20211,0.18383,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00021909,0.20178,0.23021,1,1
4,GO DENDRITIC CELL MIGRATION,0.011612,0.20167,0.15495,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0017123,0.20163,0.1356,1,1
4,GO TRANSCYTOSIS,0.0013054,0.20161,0.23666,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0013872,0.20158,0.18874,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0050528,0.20157,0.15651,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0049174,0.20155,0.17091,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.00037661,0.2015,0.13711,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0020453,0.20148,0.18816,1,1
4,GO INORGANIC ANION TRANSPORT,3.7145e-05,0.20132,0.17173,1,1
4,GO REGULATION OF SECRETION,0.00016023,0.20122,0.16682,1,1
4,GO T CELL HOMEOSTASIS,0.00353,0.2011,0.15368,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.001191,0.20106,0.19223,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0030654,0.20086,0.14781,1,1
4,GO FATTY ACID METABOLIC PROCESS,9.389e-05,0.20076,0.22924,1,1
4,GO REGULATION OF CELL ADHESION,0.0028141,0.20069,0.15283,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00024286,0.20062,0.18219,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.016734,0.20062,0.15028,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.01282,0.20054,0.14796,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00098941,0.20038,0.2291,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00045924,0.20024,0.13738,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0036303,0.20011,0.20607,1,1
4,GO MITOCHONDRIAL GENE EXPRESSION,0.031748,0.20009,0.14034,1,1
4,GO RESPONSE TO LEPTIN,0.025414,0.19969,0.17236,1,1
4,GO AMYLOID BETA FORMATION,0.0050528,0.19963,0.18881,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.0062634,0.1995,0.22489,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0036303,0.19938,0.21399,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,5.2139e-05,0.19929,0.18447,1,1
4,GO SULFUR COMPOUND TRANSPORT,7.547e-05,0.19923,0.22126,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.011047,0.19862,0.13914,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0028141,0.19856,0.18796,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0028141,0.19832,0.19324,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.044685,0.19816,0.13194,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.00032948,0.19791,0.16993,1,1
4,GO PROTEIN ADP RIBOSYLATION,0.024846,0.19787,0.14514,1,1
4,GO T CELL DIFFERENTIATION,0.00040247,0.19787,0.15262,1,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.031748,0.19786,0.28794,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0001547,0.19776,0.21375,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.004408,0.19774,0.17742,1,1
4,GO PROTEIN DESTABILIZATION,0.0016129,0.19767,0.16048,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0047853,0.19757,0.16779,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.00042998,0.19752,0.15875,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0038387,0.19752,0.16852,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0025817,0.19749,0.18252,1,1
4,GO ENDOCYTIC RECYCLING,0.0012662,0.19748,0.15211,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.7323e-05,0.19739,0.16905,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.035393,0.19733,0.17143,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.011047,0.197,0.12024,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0021062,0.1968,0.15153,1,1
4,GO DRINKING BEHAVIOR,0.020205,0.19673,0.17527,1,1
4,GO ZINC ION TRANSPORT,0.0057817,0.19661,0.18154,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.036948,0.19651,0.12153,1,1
4,GO MEMBRANE DEPOLARIZATION,0.017137,0.19639,0.1603,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.053746,0.19631,0.16884,1,1
4,GO GROOMING BEHAVIOR,0.046579,0.19631,0.17228,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.016734,0.19617,0.16094,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.00032948,0.19612,0.21738,1,1
4,GO ACTIN NUCLEATION,0.00081984,0.19608,0.19147,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0017123,0.19599,0.20272,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0012662,0.1959,0.16666,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.04854,0.19589,0.18629,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.024846,0.19584,0.1215,1,1
4,GO CELL MATRIX ADHESION,0.014138,0.19581,0.1271,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00017186,0.19576,0.19417,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00014418,0.19575,0.1863,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00098941,0.19558,0.19581,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017796,0.19549,0.23437,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.013139,0.19543,0.16207,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0041716,0.1954,0.20248,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00034072,0.19535,0.22496,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0041716,0.1953,0.20154,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.1493e-05,0.19529,0.21437,1,1
4,GO METAL ION HOMEOSTASIS,0.00018427,0.19511,0.14694,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,5.6174e-05,0.19481,0.17139,1,1
4,GO PEROXISOME ORGANIZATION,0.00042998,0.19471,0.2091,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.0030654,0.1947,0.16926,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0056288,0.19455,0.17074,1,1
4,GO GLIAL CELL PROLIFERATION,0.042857,0.19437,0.15089,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,3.5759e-05,0.19435,0.18643,1,1
4,GO HUMORAL IMMUNE RESPONSE,9.7801e-06,0.19426,0.22995,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,5.0226e-05,0.19423,0.19716,1,1
4,GO CHLORIDE TRANSPORT,5.6174e-05,0.19408,0.17755,1,1
4,GO RENAL WATER HOMEOSTASIS,0.015953,0.19403,0.11199,1,1
4,GO ION HOMEOSTASIS,0.00016023,0.19384,0.15192,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.027188,0.19375,0.18418,1,1
4,GO CELLULAR EXTRAVASATION,0.02166,0.1936,0.11396,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.020205,0.19353,0.15846,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00084609,0.19332,0.23758,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00034072,0.19327,0.19209,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.00052342,0.19312,0.13702,1,1
4,GO TEMPERATURE HOMEOSTASIS,3.4421e-05,0.19296,0.18908,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0014738,0.1929,0.17733,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.001228,0.19256,0.1371,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0049174,0.19231,0.17531,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.047551,0.19224,0.19727,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0013054,0.19217,0.17451,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,6.2786e-05,0.19204,0.22473,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0025817,0.19202,0.14439,1,1
4,GO ACETYL COA METABOLIC PROCESS,0.012508,0.19201,0.16651,1,1
4,GO PEPTIDE HORMONE SECRETION,0.0001547,0.19181,0.19449,1,1
4,GO SENSORY PERCEPTION OF SMELL,2.8077e-06,0.19148,0.20183,1,1
4,GO WHITE FAT CELL DIFFERENTIATION,0.0026572,0.19146,0.19842,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.00049035,0.19146,0.16806,1,1
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.02166,0.19128,0.1572,1,1
4,GO AMYLOID FIBRIL FORMATION,0.05161,0.19106,0.15339,1,1
4,GO OXIDATION REDUCTION PROCESS,2.6307e-05,0.19069,0.21956,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.0028141,0.19068,0.15715,1,1
4,GO ION TRANSPORT,0.0001547,0.19058,0.15584,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00050664,0.19052,0.13644,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0036303,0.19046,0.15588,1,1
4,GO FATTY ACID TRANSPORT,6.7596e-05,0.19038,0.22446,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.009256,0.19024,0.1385,1,1
4,GO SECRETORY GRANULE ORGANIZATION,0.0069616,0.19024,0.15891,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0034322,0.19021,0.21898,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00016595,0.19016,0.15368,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0006154,0.18987,0.18235,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0027346,0.18983,0.136,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,5.6174e-05,0.18977,0.20637,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.00057693,0.18975,0.13842,1,1
4,GO LYMPH NODE DEVELOPMENT,0.0016129,0.1896,0.23355,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.00038934,0.18956,0.14904,1,1
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.015574,0.18921,0.14952,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0013872,0.18915,0.27467,1,1
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0038387,0.18908,0.25914,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.012203,0.18907,0.11674,1,1
4,GO RESPONSE TO HORMONE,0.00040247,0.1889,0.15581,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.020205,0.18885,0.14268,1,1
4,GO PROTEIN KINASE B SIGNALING,0.0064317,0.18885,0.13346,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0028141,0.18816,0.23003,1,1
4,GO LIPID CATABOLIC PROCESS,1.6455e-05,0.1881,0.23365,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.0036303,0.18795,0.17388,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00042998,0.18785,0.22793,1,1
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.019283,0.18784,0.16534,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.00040247,0.1878,0.15304,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0010206,0.18741,0.14339,1,1
4,GO HOMEOSTATIC PROCESS,8.4205e-05,0.18733,0.1407,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0025083,0.18722,0.15637,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.0028141,0.18713,0.14081,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0016129,0.18699,0.18571,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00059588,0.1869,0.14044,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.016339,0.18645,0.11802,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0027346,0.18636,0.14876,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.0033369,0.18621,0.16351,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,3.7145e-05,0.18617,0.17373,1,1
4,GO IRON ION TRANSPORT,3.7145e-05,0.18597,0.24259,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00016023,0.18543,0.17657,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00047456,0.18538,0.14771,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0054795,0.18515,0.13893,1,1
4,GO REGULATION OF HEMOPOIESIS,0.00052342,0.18515,0.14079,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,3.7145e-05,0.18511,0.19476,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.001986,0.18494,0.25409,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0021689,0.18466,0.18599,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00032948,0.18464,0.16487,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.014841,0.18435,0.15987,1,1
4,GO AGING,0.00010092,0.18431,0.16066,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.001228,0.18423,0.13644,1,1
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.038561,0.18423,0.1172,1,1
4,GO RESPONSE TO LIPID,0.0011549,0.1842,0.1479,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.033894,0.18408,0.12744,1,1
4,GO RESPONSE TO DRUG,0.0017123,0.18402,0.15273,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0067808,0.18392,0.31322,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.0013054,0.18374,0.17921,1,1
4,GO REGULATION OF INSULIN SECRETION,0.00079435,0.18372,0.16717,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.010506,0.18362,0.15708,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017123,0.18351,0.18487,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00010092,0.18325,0.21617,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00016595,0.18306,0.14892,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.031059,0.183,0.18861,1,1
4,GO RESPONSE TO WOUNDING,0.009256,0.18272,0.12649,1,1
4,GO VITAMIN METABOLIC PROCESS,0.0053338,0.18266,0.1966,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.011904,0.18257,0.14087,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0073363,0.18248,0.22088,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0031536,0.18238,0.18189,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.7323e-05,0.18234,0.15435,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.00069957,0.18222,0.18036,1,1
4,GO SPERM CAPACITATION,0.0022332,0.18207,0.21889,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0071468,0.182,0.13946,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0051916,0.18191,0.25441,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0054795,0.18168,0.15611,1,1
4,GO CELLULAR RESPIRATION,0.0011199,0.18136,0.20335,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.033166,0.18121,0.11848,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00045924,0.18111,0.21202,1,1
4,GO VITAMIN TRANSPORT,0.02268,0.18111,0.192,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.0039469,0.18081,0.13892,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.0028141,0.18055,0.14653,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00041602,0.18046,0.13612,1,1
4,GO ANION HOMEOSTASIS,0.052669,0.18042,0.13597,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0053338,0.18028,0.13462,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.022165,0.18026,0.15073,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.011047,0.18025,0.12616,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.015574,0.18019,0.12507,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.00079435,0.18017,0.1216,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00079435,0.17993,0.12832,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.027188,0.17974,0.1913,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0094949,0.17973,0.16419,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.03939,0.17961,0.10027,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.022165,0.17939,0.20146,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0016129,0.17918,0.2709,1,1
4,GO EPIDERMIS DEVELOPMENT,0.0050528,0.17902,0.14586,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0018173,0.17894,0.14895,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00098941,0.17882,0.16323,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0042883,0.17877,0.12302,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.029068,0.17869,0.13829,1,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.034637,0.17855,0.16217,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0011549,0.17825,0.17756,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0050528,0.17812,0.12312,1,1
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.026586,0.17806,0.27612,1,1
4,GO L AMINO ACID TRANSPORT,0.0090226,0.17802,0.17262,1,1
4,GO RESPONSE TO ETHER,0.0051916,0.17797,0.17615,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.049546,0.17782,0.11684,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0049174,0.17777,0.12413,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0022992,0.17777,0.1736,1,1
4,GO MANGANESE ION TRANSPORT,0.0064317,0.17775,0.17138,1,1
4,GO SPLEEN DEVELOPMENT,0.0050528,0.17746,0.17586,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0057817,0.17733,0.13006,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.0069616,0.17698,0.13317,1,1
4,GO EATING BEHAVIOR,0.0022332,0.17685,0.18858,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.02068,0.17675,0.16168,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00029782,0.17661,0.14869,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0011549,0.17653,0.13461,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0021689,0.1763,0.14033,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,7.547e-05,0.17614,0.19286,1,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.018836,0.17611,0.1424,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0053338,0.17609,0.21239,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0033369,0.17586,0.20606,1,1
4,GO REGULATION OF PROTEIN MATURATION,0.043763,0.1755,0.102,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.0025083,0.1753,0.16368,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00035231,0.17522,0.14514,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00019079,0.17478,0.19142,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.00042998,0.17475,0.23572,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.001191,0.17468,0.14553,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00031859,0.17441,0.13784,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0023671,0.17431,0.21669,1,1
4,GO LIPID MODIFICATION,0.00017186,0.1741,0.17826,1,1
4,GO MITOPHAGY,0.0017641,0.17405,0.17791,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.02166,0.17401,0.15902,1,1
4,GO METAL ION TRANSPORT,0.0024367,0.17359,0.11997,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0038387,0.17359,0.26959,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0021689,0.17341,0.23329,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0014738,0.17332,0.18117,1,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.022165,0.17329,0.17375,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,1.349e-05,0.17316,0.18015,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.0019282,0.17312,0.13093,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00098941,0.17289,0.14709,1,1
4,GO ORGANELLE DISASSEMBLY,7.8282e-05,0.17281,0.18259,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00023468,0.17269,0.18193,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00016595,0.17259,0.1906,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.00067758,0.17239,0.18951,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.019739,0.17218,0.16537,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.00023468,0.1717,0.1657,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0020453,0.1717,0.17029,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0020453,0.17158,0.12808,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.017137,0.17147,0.15605,1,1
4,GO GOLGI ORGANIZATION,6.7596e-05,0.17139,0.18346,1,1
4,GO AMINE TRANSPORT,0.0027346,0.17131,0.24194,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.3218e-05,0.17119,0.19525,1,1
4,GO MONOAMINE TRANSPORT,0.0059384,0.17118,0.24986,1,1
4,GO NEUROINFLAMMATORY RESPONSE,0.036948,0.17107,0.1116,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0011549,0.17089,0.1303,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.0045306,0.1708,0.10585,1,1
4,GO DETECTION OF STIMULUS,1.8521e-05,0.17072,0.14829,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,8.1192e-05,0.17065,0.14699,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.01282,0.17064,0.16447,1,1
4,GO BIOMINERALIZATION,0.011612,0.17062,0.12669,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.00092958,0.17033,0.18962,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.01282,0.17024,0.16259,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.042857,0.17022,0.10055,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.029068,0.16972,0.11032,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.007729,0.16942,0.13801,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.022165,0.16925,0.15269,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,9.0551e-05,0.16914,0.22107,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0025817,0.16909,0.1526,1,1
4,GO T CELL LINEAGE COMMITMENT,0.00012512,0.16898,0.20639,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,8.1192e-05,0.1689,0.16895,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0090226,0.16886,0.2079,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0028141,0.16884,0.14689,1,1
4,GO CELLULAR PIGMENTATION,0.0018173,0.16859,0.16629,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.00090094,0.16851,0.15779,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0028141,0.16842,0.12612,1,1
4,GO PHAGOCYTOSIS,0.007729,0.16841,0.128,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0039469,0.16801,0.17677,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.0090226,0.16781,0.15691,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00050664,0.16772,0.19212,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.1675,0.13884,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00037661,0.16743,0.26506,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.016339,0.16735,0.13588,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.011904,0.16725,0.14579,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.012508,0.16722,0.12837,1,1
4,GO T CELL PROLIFERATION,0.0022332,0.16714,0.17127,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00072223,0.16708,0.15259,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.011326,0.16678,0.16935,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0034322,0.16666,0.15998,1,1
4,GO ORGANIC ACID TRANSPORT,4.6597e-05,0.16659,0.21271,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00065623,0.16658,0.14929,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0012662,0.16642,0.12956,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.013798,0.16638,0.14905,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0036303,0.16623,0.18923,1,1
4,GO CARNITINE SHUTTLE,0.0010206,0.16616,0.25103,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0031536,0.16611,0.1793,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.047551,0.16608,0.10854,1,1
4,GO SKIN DEVELOPMENT,0.0064317,0.16599,0.14126,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.010245,0.16597,0.19196,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0018173,0.1657,0.14262,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.02068,0.16558,0.16899,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.02166,0.16554,0.14013,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0069616,0.16554,0.18033,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00052342,0.16537,0.16526,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.001662,0.16521,0.1283,1,1
4,GO MACROPHAGE CHEMOTAXIS,0.017549,0.16477,0.10516,1,1
4,GO PROTEIN MANNOSYLATION,0.0079323,0.16477,0.17178,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0033369,0.16469,0.14552,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.033894,0.16458,0.14387,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.010245,0.16453,0.21014,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00047456,0.16443,0.15139,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.027803,0.16417,0.13726,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0020453,0.16412,0.13729,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.037747,0.16385,0.19257,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0036303,0.16384,0.17307,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00010092,0.16382,0.15503,1,1
4,GO GLUCOSE IMPORT,0.0085714,0.16372,0.15688,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0099891,0.16357,0.1155,1,1
4,GO MAINTENANCE OF LOCATION,0.0023671,0.16349,0.12448,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0023671,0.1634,0.12481,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.029719,0.16325,0.1253,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,4.1617e-05,0.16296,0.22957,1,1
4,GO RESPONSE TO FUNGUS,0.0024367,0.16283,0.14223,1,1
4,GO CATION TRANSPORT,0.0010206,0.16249,0.13113,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0010859,0.16238,0.13249,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0017123,0.16237,0.11728,1,1
4,GO SYMBIOTIC PROCESS,0.0017641,0.16228,0.11807,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0038387,0.16199,0.20145,1,1
4,GO T CELL APOPTOTIC PROCESS,0.024846,0.1619,0.13659,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00038934,0.16187,0.15329,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.00037661,0.16186,0.19366,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0041716,0.16163,0.15828,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0090226,0.16155,0.11546,1,1
4,GO MYOTUBE DIFFERENTIATION,0.00042998,0.16144,0.18682,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0079323,0.16131,0.1276,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.00067758,0.16084,0.13511,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0014738,0.16048,0.12555,1,1
4,GO MEMBRANE ORGANIZATION,0.0028141,0.16037,0.1094,1,1
4,GO RENAL SODIUM EXCRETION,0.0083534,0.15976,0.18059,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00010845,0.15967,0.21058,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0087944,0.15963,0.13838,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.019739,0.15957,0.12924,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013139,0.15953,0.20475,1,1
4,GO REGULATION OF ION TRANSPORT,0.00353,0.15927,0.11931,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0054795,0.1592,0.37815,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0056288,0.15904,0.12081,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.014138,0.15902,0.12143,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00087311,0.15892,0.13082,1,1
4,GO REGULATION OF TRANSPORT,0.0022992,0.15889,0.10664,1,1
4,GO NEGATIVE T CELL SELECTION,0.018836,0.15874,0.098772,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00079435,0.15873,0.18591,1,1
4,GO MACROPHAGE ACTIVATION,0.0006154,0.15822,0.16932,1,1
4,GO ERK1 AND ERK2 CASCADE,0.025414,0.15818,0.11459,1,1
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0049174,0.15813,0.14137,1,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.018836,0.158,0.17873,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0016129,0.15791,0.14064,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00095906,0.15771,0.17826,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.030383,0.15755,0.25937,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.054842,0.15744,0.13663,1,1
4,GO MYELOID CELL HOMEOSTASIS,0.001872,0.15727,0.13632,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00017796,0.15726,0.14335,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0059384,0.15722,0.15558,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00029782,0.15718,0.18128,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.027803,0.15716,0.21868,1,1
4,GO SIGNAL RELEASE,0.0012662,0.15664,0.14234,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.054842,0.15652,0.12255,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.027188,0.15632,0.10291,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0037331,0.15613,0.1483,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.025414,0.15582,0.23881,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.047551,0.15567,0.22326,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023741,0.15544,0.13119,1,1
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.007729,0.15509,0.16252,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.00065623,0.15494,0.13971,1,1
4,GO PROSTAGLANDIN SECRETION,0.012508,0.15466,0.22141,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.007729,0.15448,0.18023,1,1
4,GO REGULATION OF MAPK CASCADE,0.0054795,0.15443,0.12184,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.029068,0.15433,0.090241,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.00079435,0.15428,0.11941,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.041093,0.1542,0.15983,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00067758,0.15416,0.16648,1,1
4,GO FEEDING BEHAVIOR,0.001872,0.15381,0.15774,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0025817,0.15371,0.1651,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0036303,0.1537,0.13558,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00079435,0.15368,0.20356,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.022165,0.15355,0.16174,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.00063551,0.15346,0.12099,1,1
4,GO REGULATION OF MITOPHAGY,0.017969,0.15345,0.13974,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0028957,0.15327,0.10763,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0014299,0.15321,0.13647,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0053338,0.15321,0.12185,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.010773,0.15308,0.11596,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0023671,0.15304,0.13262,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.033894,0.15303,0.16956,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.042857,0.15279,0.144,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0067808,0.15248,0.19132,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0087944,0.15237,0.11412,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0034322,0.15233,0.17546,1,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.027188,0.15221,0.084962,1,1
4,GO COPPER ION TRANSPORT,0.013139,0.15205,0.18299,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0020453,0.15181,0.16496,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,7.547e-05,0.15173,0.14428,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0073363,0.15172,0.14419,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00024286,0.15156,0.16025,1,1
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.015953,0.15155,0.14394,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0028141,0.15155,0.12343,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0097392,0.15152,0.18923,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0019282,0.15146,0.1102,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.0031536,0.15135,0.11077,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0067808,0.15126,0.11152,1,1
4,GO RESPONSE TO PEPTIDE,0.0011549,0.15119,0.12427,1,1
4,GO CALCIUM ION IMPORT,0.0099891,0.15116,0.11193,1,1
4,GO VIRAL BUDDING,0.0037331,0.15107,0.14641,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.043763,0.15096,0.10043,1,1
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.054842,0.15075,0.098,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0056288,0.15068,0.13087,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.15064,0.11717,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.02843,0.15013,0.11733,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0021689,0.1496,0.14857,1,1
4,GO ENDOSOME ORGANIZATION,0.00057693,0.14931,0.17262,1,1
4,GO CHOLESTEROL EFFLUX,0.015574,0.14909,0.17275,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.042857,0.14902,0.11576,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0024367,0.14883,0.13101,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.001228,0.14877,0.10712,1,1
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.03245,0.1487,0.11225,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.010506,0.14857,0.11663,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00016023,0.1483,0.18732,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00079435,0.148,0.20565,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0054795,0.14782,0.1198,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.017549,0.14776,0.093357,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.029719,0.14755,0.13948,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0040578,0.14739,0.1145,1,1
4,GO MUSCLE CELL PROLIFERATION,0.03939,0.14708,0.086008,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00044439,0.14669,0.1277,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.030383,0.14648,0.1481,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00059588,0.14629,0.18279,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0022332,0.1462,0.11078,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.012203,0.1462,0.19273,1,1
4,GO OOCYTE DIFFERENTIATION,0.0037331,0.14594,0.13907,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.030383,0.14587,0.11101,1,1
4,GO POLYOL CATABOLIC PROCESS,0.0026572,0.1458,0.16657,1,1
4,GO NCRNA CATABOLIC PROCESS,0.019283,0.14573,0.12256,1,1
4,GO VESICLE DOCKING,0.044685,0.14564,0.12879,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00084609,0.14555,0.15943,1,1
4,GO EXCRETION,0.0014299,0.14507,0.16968,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0085714,0.14496,0.10927,1,1
4,GO CELLULAR HOMEOSTASIS,0.00038934,0.14495,0.13083,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.016339,0.14443,0.11094,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.021165,0.14441,0.11212,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0049174,0.14428,0.16308,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.02166,0.14417,0.11503,1,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.016339,0.14417,0.13213,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0013457,0.14405,0.14496,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0027346,0.14404,0.10739,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.033894,0.14398,0.23163,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0031536,0.14372,0.14478,1,1
4,GO LYSOSOME LOCALIZATION,0.0006154,0.14364,0.1653,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,6.5149e-05,0.14353,0.17795,1,1
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0069616,0.14328,0.16075,1,1
4,GO CELL MATURATION,0.00040247,0.14327,0.14469,1,1
4,GO RESPONSE TO ETHANOL,0.0039469,0.14321,0.13404,1,1
4,GO BICARBONATE TRANSPORT,0.030383,0.14311,0.14398,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00047456,0.14273,0.16279,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00084609,0.14268,0.17769,1,1
4,GO SODIUM ION TRANSPORT,0.0028957,0.14268,0.14514,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00044439,0.14233,0.15631,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0087944,0.14232,0.14263,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0062634,0.14231,0.10355,1,1
4,GO RESPONSE TO ALKALOID,0.02166,0.1423,0.12168,1,1
4,GO CELL CELL ADHESION,0.0099891,0.14226,0.12491,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0010859,0.14226,0.16226,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.018398,0.14203,0.20049,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.011326,0.14186,0.10263,1,1
4,GO HEART PROCESS,0.041093,0.14179,0.089795,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0067808,0.14179,0.16809,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.00065623,0.14155,0.14363,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0079323,0.14155,0.14673,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0027346,0.14142,0.12799,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.037747,0.14137,0.074608,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00025131,0.1413,0.18702,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00079435,0.14125,0.12545,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.010245,0.14108,0.18585,1,1
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.012508,0.14102,0.17371,1,1
4,GO REGULATION OF TOR SIGNALING,0.00011241,0.141,0.1352,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00049035,0.14093,0.14399,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.0085714,0.14093,0.14609,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0073363,0.14091,0.094392,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0057817,0.14081,0.20391,1,1
4,GO RUFFLE ORGANIZATION,0.037747,0.14073,0.12651,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.014138,0.14066,0.10612,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.021165,0.14066,0.10047,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.011612,0.14061,0.10801,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,0.031059,0.14043,0.11457,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018398,0.1404,0.090281,1,1
4,GO NOTCH SIGNALING PATHWAY,0.001986,0.14035,0.16239,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.01282,0.1403,0.097563,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,5.4121e-05,0.14009,0.17131,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.017137,0.13977,0.13,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02268,0.13947,0.11102,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.013139,0.13895,0.14181,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.041093,0.13892,0.13612,1,1
4,GO CYTOKINETIC PROCESS,0.019739,0.13889,0.11289,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0017641,0.1388,0.11946,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.011612,0.13869,0.10279,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.025994,0.13868,0.16044,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.054842,0.13847,0.13363,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00049035,0.13839,0.13669,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00017186,0.13837,0.21275,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0049174,0.13821,0.10467,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.009256,0.13796,0.12889,1,1
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.024288,0.13794,0.14619,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00069957,0.13781,0.10989,1,1
4,GO RESPONSE TO ESTRADIOL,0.027188,0.13777,0.091097,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.011047,0.13763,0.13613,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.030383,0.13757,0.098875,1,1
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.041967,0.13756,0.1356,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0069616,0.13745,0.10637,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.044685,0.13743,0.11749,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.05161,0.13742,0.092955,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00034072,0.1374,0.12746,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.018398,0.13731,0.21295,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.011612,0.13728,0.14293,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0024367,0.13726,0.14389,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00055855,0.1367,0.1365,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0083534,0.13648,0.13451,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0030654,0.13641,0.10518,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0039469,0.13634,0.11378,1,1
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0071468,0.13618,0.18415,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00045924,0.13617,0.17885,1,1
4,GO TISSUE MIGRATION,0.0090226,0.13569,0.14207,1,1
4,GO ACTION POTENTIAL,0.031748,0.13568,0.13065,1,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.036948,0.13565,0.10549,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0012662,0.13553,0.14432,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.033894,0.13538,0.13484,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0081404,0.13534,0.14627,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0006154,0.13527,0.15034,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.011612,0.13523,0.17673,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0017123,0.1351,0.16687,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.001191,0.13507,0.14577,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.04854,0.13505,0.080709,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.014486,0.1349,0.10455,1,1
4,GO T CELL SELECTION,0.00052342,0.13482,0.14353,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00013917,0.13477,0.15979,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0049174,0.13466,0.10309,1,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.041093,0.13462,0.11636,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.033894,0.1346,0.091334,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00095906,0.13415,0.15963,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.0045306,0.13404,0.17173,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.040234,0.13394,0.10655,1,1
4,GO CATECHOLAMINE SECRETION,0.015953,0.13389,0.2602,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0027346,0.13349,0.14887,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.00054072,0.13315,0.12154,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0051916,0.1328,0.18845,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0071468,0.13279,0.09791,1,1
4,GO POLYOL METABOLIC PROCESS,0.011612,0.13277,0.12466,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0030654,0.13274,0.10409,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.025414,0.13268,0.1014,1,1
4,GO VESICLE LOCALIZATION,0.013139,0.13268,0.10764,1,1
4,GO BIOLOGICAL ADHESION,0.022165,0.13147,0.10555,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0083534,0.13126,0.10751,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00049035,0.13123,0.13087,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.001986,0.13087,0.1187,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.04854,0.13018,0.094082,1,1
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.03939,0.12994,0.095014,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,0.12979,0.13695,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.036164,0.12977,0.10453,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.02268,0.12976,0.2619,1,1
4,GO ORGANELLE INHERITANCE,0.01282,0.12959,0.11241,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0031536,0.12893,0.13228,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.023741,0.12891,0.17989,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.00087311,0.12889,0.12138,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.029068,0.12884,0.10825,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.027188,0.12878,0.13956,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0026572,0.12848,0.10045,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.024846,0.12845,0.12082,1,1
4,GO POSITIVE REGULATION OF BINDING,0.03245,0.12806,0.077368,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.0039469,0.12806,0.11003,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.010506,0.1277,0.15238,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011612,0.12766,0.14104,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.014841,0.12757,0.08792,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00087311,0.12754,0.13236,1,1
4,GO SINGLE FERTILIZATION,0.025994,0.12747,0.083277,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.037747,0.12732,0.077124,1,1
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.031748,0.12728,0.14061,1,1
4,GO DRUG CATABOLIC PROCESS,0.021165,0.127,0.21297,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.0066042,0.12698,0.11044,1,1
4,GO REGULATION OF CELL DEATH,0.0021062,0.12694,0.10961,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.019283,0.12687,0.1608,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0056288,0.12684,0.096769,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0010859,0.12679,0.13261,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0021062,0.12638,0.10542,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.001986,0.1259,0.13096,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0056288,0.12531,0.14525,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.023741,0.12494,0.11751,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0042883,0.12489,0.13432,1,1
4,GO REGULATION OF CHEMOTAXIS,0.0090226,0.12479,0.10357,1,1
4,GO REGULATION OF AUTOPHAGY,0.00024286,0.12429,0.13227,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0021689,0.1242,0.18041,1,1
4,GO VACUOLAR TRANSPORT,0.0018173,0.12414,0.15024,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0033369,0.12407,0.11408,1,1
4,GO TOR SIGNALING,4.4878e-05,0.12378,0.11875,1,1
4,GO THIOESTER METABOLIC PROCESS,0.0026572,0.12366,0.17109,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02068,0.12363,0.095475,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.004408,0.12354,0.12044,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.12354,0.10491,1,1
4,GO IMPORT INTO CELL,0.043763,0.12322,0.10459,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.040234,0.1228,0.076829,1,1
4,GO ORGANIC CATION TRANSPORT,0.011047,0.12273,0.16563,1,1
4,GO CELL CELL RECOGNITION,0.035393,0.12265,0.12505,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0051916,0.12263,0.13985,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.044685,0.12261,0.13849,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.017137,0.12217,0.097801,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0023671,0.12212,0.12173,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.033166,0.12201,0.14434,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.014486,0.1217,0.12846,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.024846,0.12133,0.094681,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.014138,0.12127,0.15307,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.011047,0.12106,0.088295,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.019739,0.12098,0.15611,1,1
4,GO CELL AGING,0.0050528,0.12076,0.10003,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0027346,0.1207,0.20423,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.01282,0.12028,0.13532,1,1
4,GO NEURON MATURATION,0.054842,0.11988,0.14673,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0028141,0.11985,0.1442,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0094949,0.11976,0.10903,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00024286,0.11963,0.17833,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.0037331,0.11936,0.10075,1,1
4,GO ATP METABOLIC PROCESS,0.0015653,0.11883,0.14352,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.014486,0.11775,0.079799,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.052669,0.11729,0.14202,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.0038387,0.11724,0.088148,1,1
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.03245,0.1171,0.073336,1,1
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.11692,0.11144,1,1
4,GO FAT CELL DIFFERENTIATION,0.0062634,0.11682,0.13744,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.02068,0.11678,0.079585,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.018836,0.11639,0.089718,1,1
4,GO MITOCHONDRIAL FUSION,0.047551,0.11637,0.11623,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0028957,0.1163,0.11436,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.011612,0.11581,0.12921,1,1
4,GO GLAND DEVELOPMENT,0.0099891,0.11572,0.10371,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.041093,0.1157,0.082878,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.00092958,0.11562,0.10586,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.0051916,0.11518,0.10143,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.036948,0.11471,0.09615,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.049546,0.11465,0.1117,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.034637,0.11442,0.11285,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0064317,0.11432,0.11272,1,1
4,GO CIRCADIAN RHYTHM,0.0022992,0.11423,0.11151,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.013139,0.11408,0.086606,1,1
4,GO APOPTOTIC PROCESS,0.0017123,0.11407,0.11256,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0094949,0.11337,0.086549,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0097392,0.11221,0.15284,1,1
4,GO FATTY ACYL COA METABOLIC PROCESS,0.030383,0.11218,0.15272,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.013465,0.11207,0.16297,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0099891,0.11155,0.11747,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.013139,0.11138,0.085694,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0056288,0.11117,0.10219,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0038387,0.1111,0.094234,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.015574,0.11093,0.12412,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.013139,0.11058,0.098681,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.026586,0.11032,0.086256,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.014841,0.11012,0.16528,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.047551,0.1099,0.077842,1,1
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.023205,0.10976,0.10674,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0049174,0.10954,0.093796,1,1
4,GO WATER TRANSPORT,0.033894,0.10952,0.086903,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.019283,0.10947,0.09684,1,1
4,GO CYTOSOLIC TRANSPORT,0.00026003,0.10866,0.12763,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0030654,0.10855,0.11184,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.0060989,0.10837,0.1285,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.038561,0.10817,0.085759,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0075304,0.10796,0.13331,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.025414,0.10795,0.083648,1,1
4,GO CELL MOTILITY,0.025994,0.10751,0.090159,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.038561,0.10736,0.10664,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02268,0.10729,0.090239,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0090226,0.10678,0.090179,1,1
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.03245,0.10647,0.10911,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.014486,0.10598,0.086852,1,1
4,GO BODY FLUID SECRETION,0.035393,0.10578,0.086569,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0059384,0.10553,0.10208,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.027803,0.10522,0.094972,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.010245,0.10514,0.11203,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.044685,0.10476,0.061005,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.011904,0.10458,0.1332,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0071468,0.10449,0.10306,1,1
4,GO POSITIVE T CELL SELECTION,0.023205,0.10441,0.09886,1,1
4,GO SOMITOGENESIS,0.019739,0.10429,0.092647,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.050569,0.10402,0.083395,1,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045624,0.10391,0.094471,1,1
4,GO ENDOSOMAL TRANSPORT,0.00020448,0.10357,0.10885,1,1
4,GO MUSCLE SYSTEM PROCESS,0.018836,0.10293,0.093489,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0042883,0.10241,0.11474,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.0075304,0.10221,0.10016,1,1
4,GO CELLULAR SENESCENCE,0.0075304,0.10209,0.10322,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.018398,0.10161,0.15317,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.0057817,0.1015,0.090537,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.044685,0.10134,0.10521,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.015574,0.10131,0.10791,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.014841,0.10115,0.10306,1,1
4,GO MACROAUTOPHAGY,0.00027832,0.10096,0.13842,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.036164,0.10089,0.073167,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0047853,0.1008,0.10581,1,1
4,GO MULTI ORGANISM PROCESS,0.036948,0.10004,0.066406,1,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.04854,0.099358,0.073646,1,1
4,GO PROTEIN STABILIZATION,0.024846,0.099169,0.084727,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.016734,0.099146,0.11407,1,1
4,GO MYELOID CELL DEVELOPMENT,0.024846,0.098561,0.1011,1,1
4,GO NEURON DEATH,0.025414,0.098287,0.067113,1,1
4,GO SENSORY PERCEPTION,0.0066042,0.098146,0.082117,1,1
4,GO SPERM EGG RECOGNITION,0.027803,0.097501,0.10718,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0033369,0.097117,0.11658,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0087944,0.096729,0.14507,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.023741,0.094897,0.06738,1,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.027188,0.094836,0.098921,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0071468,0.094603,0.13392,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0067808,0.094521,0.064777,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.017549,0.094521,0.12263,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0073363,0.094422,0.083362,1,1
4,GO AMINO ACID TRANSPORT,0.015953,0.094372,0.14867,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0097392,0.093413,0.098666,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.026586,0.09294,0.15073,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.026586,0.092504,0.11611,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.049546,0.091426,0.10143,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0028141,0.091356,0.14077,1,1
4,GO REGULATION OF EXOCYTOSIS,0.019739,0.090565,0.12076,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.017137,0.090155,0.089232,1,1
4,GO TRANSLESION SYNTHESIS,0.042857,0.089613,0.086678,1,1
4,GO JNK CASCADE,0.0079323,0.089573,0.11036,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.012203,0.08899,0.093695,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.043763,0.088279,0.05158,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0013054,0.088263,0.11707,1,1
4,GO REGULATION OF OSSIFICATION,0.014138,0.088222,0.11217,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.025414,0.087039,0.073459,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.044685,0.086596,0.06364,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00353,0.08643,0.08358,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0007696,0.085808,0.10877,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.012508,0.08542,0.084689,1,1
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.054842,0.085357,0.037444,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.036948,0.085264,0.067413,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.017137,0.084686,0.079934,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.017137,0.084624,0.078879,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.053746,0.084093,0.12323,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.027188,0.083285,0.080689,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.037747,0.081873,0.075125,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.050569,0.080916,0.056677,1,1
4,GO MUSCLE CONTRACTION,0.044685,0.080896,0.075502,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.02166,0.080894,0.079658,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.02166,0.080525,0.090615,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0047853,0.080434,0.065783,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.023205,0.080106,0.077845,1,1
4,GO REGULATION OF BINDING,0.024846,0.080038,0.079593,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02268,0.079325,0.068056,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.023741,0.079065,0.070818,1,1
4,GO FERTILIZATION,0.052669,0.078343,0.064668,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.023741,0.078293,0.091668,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.022165,0.077415,0.064201,1,1
4,GO INTRACELLULAR TRANSPORT,0.0025817,0.07664,0.077431,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.036164,0.07659,0.14915,1,1
4,GO PROTEIN TETRAMERIZATION,0.033166,0.076134,0.083074,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0090226,0.075727,0.11355,1,1
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.02268,0.074799,0.068369,1,1
4,GO RHYTHMIC PROCESS,0.02068,0.071908,0.07549,1,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.024846,0.07171,0.05084,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.043763,0.071341,0.078608,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.014841,0.066,0.055626,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.023741,0.063856,0.055776,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.035393,0.063334,0.054152,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.05161,0.063116,0.047068,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.027188,0.061828,0.079279,1,1
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.050569,0.056847,0.067938,1,1
4,GO TORC1 SIGNALING,0.02268,0.056692,0.080556,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.010506,0.048722,0.080508,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.0037331,0.043162,0.11027,1,1
4,GO DNA CATABOLIC PROCESS,0.014841,0.041586,0.097555,1,1
5,GO CYTIDINE TO URIDINE EDITING,0.0047853,0.82483,0.52936,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00074557,0.82014,0.56826,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00057693,0.80179,0.50418,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00029782,0.77265,0.67509,1,1
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,5.4977e-07,0.7605,0.76517,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0097392,0.75154,0.74455,1,1
5,GO PROSTATIC BUD FORMATION,0.0038387,0.73154,0.48891,1,1
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.73075,0.65829,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,5.0683e-06,0.71793,0.62147,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00074557,0.71584,0.50699,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00084609,0.70951,0.60566,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0031536,0.69984,0.46054,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00010092,0.67978,0.59847,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0012662,0.67488,0.44085,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.349e-05,0.67393,0.53301,1,1
5,GO ANATOMICAL STRUCTURE REGRESSION,0.00022676,0.66502,0.48306,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,1.9904e-06,0.65156,0.54354,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.0073e-05,0.64544,0.55382,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.1663e-05,0.6448,0.48535,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,8.3127e-06,0.6404,0.60884,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,2.5308e-05,0.63619,0.54663,1,1
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,1.2862e-06,0.63274,0.60611,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,7.5427e-07,0.63049,0.58971,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,1.4609e-05,0.62414,0.60449,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00052342,0.6181,0.64212,1,1
5,GO GLIAL CELL FATE COMMITMENT,0.00010845,0.61446,0.52351,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00054072,0.61139,0.50559,1,1
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,6.7728e-06,0.60835,0.58231,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00022676,0.60818,0.49489,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,7.0571e-06,0.59841,0.57043,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.004408,0.59809,0.44156,1,1
5,GO RENAL ABSORPTION,0.00021167,0.59695,0.46293,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,5.508e-06,0.59517,0.49847,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,2.1702e-06,0.59407,0.56008,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.4346e-05,0.58982,0.45033,1,1
5,GO TOLERANCE INDUCTION,7.8282e-05,0.58641,0.55875,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,1.4039e-05,0.58373,0.45636,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,5.0226e-05,0.58212,0.55134,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00081984,0.57874,0.38437,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,0.00052342,0.57765,0.47147,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00012074,0.57338,0.45089,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,4.8612e-06,0.57096,0.64609,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,7.8282e-05,0.57015,0.56007,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.6597e-05,0.56942,0.5202,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,1.7806e-05,0.56878,0.55073,1,1
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00059588,0.56539,0.5692,1,1
5,GO MICROVILLUS ASSEMBLY,0.00021909,0.5606,0.43302,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00026903,0.5589,0.51948,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,9.0179e-06,0.55402,0.64513,1,1
5,GO REGULATION OF TRANSPOSITION,0.00012964,0.54879,0.41466,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,4.6623e-06,0.54724,0.58016,1,1
5,GO DETECTION OF OTHER ORGANISM,0.00027832,0.54592,0.45755,1,1
5,GO SYNAPSE MATURATION,0.00023468,0.54509,0.53483,1,1
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,2.0033e-05,0.543,0.5084,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,1.349e-05,0.54249,0.50888,1,1
5,GO REGULATION OF PLATELET AGGREGATION,7.0571e-06,0.53961,0.51231,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.3218e-05,0.53755,0.42896,1,1
5,GO KERATINOCYTE DEVELOPMENT,0.0049174,0.53692,0.43316,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00042998,0.5351,0.47937,1,1
5,GO EOSINOPHIL MIGRATION,0.010245,0.53149,0.36335,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00055855,0.53111,0.43005,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,2.2524e-05,0.52938,0.51147,1,1
5,GO EOSINOPHIL CHEMOTAXIS,0.011326,0.52758,0.39189,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00037661,0.524,0.51252,1,1
5,GO TRANSPOSITION,3.7791e-06,0.52267,0.45156,1,1
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,2.7343e-05,0.52005,0.50577,1,1
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.00013433,0.51867,0.55983,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,5.4121e-05,0.51846,0.4934,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,6.0504e-05,0.51812,0.57014,1,1
5,GO TONGUE DEVELOPMENT,2.1663e-05,0.51144,0.48409,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0013457,0.51139,0.38974,1,1
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00047456,0.50882,0.47603,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00040247,0.50492,0.38686,1,1
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,4.6597e-05,0.50447,0.46373,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.5308e-05,0.50326,0.43098,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00036427,0.50107,0.40001,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,6.2985e-07,0.50042,0.43404,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,3.0576e-06,0.4983,0.46293,1,1
5,GO LUNG CELL DIFFERENTIATION,0.00024286,0.49553,0.46502,1,1
5,GO RESPONSE TO TYPE I INTERFERON,0.00072223,0.49498,0.47295,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0038387,0.49416,0.3448,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0001547,0.49362,0.61768,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,2.7343e-05,0.4931,0.52217,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,6.2786e-05,0.49306,0.49521,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00054072,0.49138,0.37529,1,1
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.00010845,0.49109,0.50283,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,2.3418e-05,0.49045,0.47885,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,5.0226e-05,0.4902,0.47578,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,1.349e-05,0.48935,0.4963,1,1
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,1.8251e-06,0.4892,0.45749,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00019753,0.48727,0.41887,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.7145e-05,0.48723,0.3918,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,7.547e-05,0.48691,0.40783,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,1.2454e-05,0.48397,0.57006,1,1
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.029719,0.48274,0.40646,1,1
5,GO DNA DEAMINATION,0.02268,0.4824,0.28461,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.6729e-06,0.48109,0.41696,1,1
5,GO SOMATIC STEM CELL DIVISION,0.0018173,0.47968,0.41643,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00028792,0.47914,0.36403,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00014418,0.47755,0.3748,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00031859,0.47717,0.47149,1,1
5,GO REGULATION OF VASCULOGENESIS,3.8583e-05,0.47686,0.49664,1,1
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.0087944,0.4763,0.37973,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.00019753,0.47421,0.39519,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,5.2139e-05,0.47386,0.43592,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.4346e-05,0.46692,0.39535,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0026572,0.46632,0.52321,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00054072,0.46565,0.42248,1,1
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00012512,0.46463,0.39101,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0011199,0.46382,0.38111,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0041716,0.46004,0.31594,1,1
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,6.2786e-05,0.45974,0.46618,1,1
5,GO RESPONSE TO WATER,0.00010462,0.45845,0.41967,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,2.3418e-05,0.4581,0.39911,1,1
5,GO COCHLEA MORPHOGENESIS,3.7145e-05,0.45766,0.4163,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,6.2786e-05,0.45697,0.42499,1,1
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,9.3916e-06,0.45687,0.40169,1,1
5,GO URETER DEVELOPMENT,0.0013872,0.4555,0.33524,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.5149e-05,0.45482,0.32751,1,1
5,GO SIALYLATION,0.0006154,0.4534,0.36226,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.014138,0.45315,0.29282,1,1
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0015189,0.45294,0.35147,1,1
5,GO CELLULAR RESPONSE TO VITAMIN D,5.2139e-05,0.45192,0.40427,1,1
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011549,0.45149,0.39406,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00030804,0.44973,0.39348,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.5816e-05,0.44806,0.46048,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00040247,0.44794,0.39455,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0010528,0.44729,0.43876,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7801e-06,0.44678,0.39212,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,4.2876e-06,0.44678,0.38179,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00074557,0.44617,0.31127,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00018427,0.44473,0.45978,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,1.5201e-05,0.44419,0.40213,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,2.5308e-05,0.44415,0.42952,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.001228,0.44371,0.32125,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00022676,0.44365,0.48105,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.015953,0.44363,0.34325,1,1
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00063551,0.44346,0.32049,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,8.7323e-05,0.44195,0.37684,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00010845,0.44092,0.37595,1,1
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0071468,0.44012,0.36453,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,9.0179e-06,0.43995,0.35609,1,1
5,GO LUNG EPITHELIUM DEVELOPMENT,6.7596e-05,0.43985,0.35973,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00013433,0.43893,0.35221,1,1
5,GO HEART VALVE FORMATION,0.00021167,0.43851,0.4801,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.6455e-05,0.438,0.38952,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,2.7343e-05,0.43759,0.39949,1,1
5,GO RENAL FILTRATION,0.00027832,0.43709,0.45721,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0014738,0.43661,0.37493,1,1
5,GO REGULATION OF SYNAPSE MATURATION,0.00057693,0.43579,0.4596,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,3.0689e-05,0.43552,0.42558,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00023468,0.43494,0.49304,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0001165,0.43405,0.3839,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.0689e-05,0.43383,0.35408,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,2.7343e-05,0.43358,0.44392,1,1
5,GO GLIAL CELL APOPTOTIC PROCESS,0.0011549,0.43312,0.44395,1,1
5,GO NEPHRIC DUCT MORPHOGENESIS,0.0073363,0.43311,0.3313,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.04854,0.43012,0.19016,1,1
5,GO BRONCHUS DEVELOPMENT,0.0011199,0.42997,0.42288,1,1
5,GO MALE SEX DETERMINATION,8.4205e-05,0.42954,0.39365,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,2.5774e-06,0.4292,0.38931,1,1
5,GO VOCALIZATION BEHAVIOR,0.0017123,0.42877,0.5347,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.0011199,0.42865,0.46753,1,1
5,GO MAST CELL MIGRATION,0.0021689,0.42725,0.48337,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00029782,0.42659,0.41549,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.2139e-05,0.42652,0.42957,1,1
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0011549,0.42644,0.35038,1,1
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,1.5816e-05,0.4245,0.49866,1,1
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0015189,0.42383,0.33063,1,1
5,GO NEGATIVE REGULATION OF ANOIKIS,0.0001547,0.42355,0.50913,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,7.9801e-06,0.42158,0.34324,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.4039e-05,0.42157,0.38996,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.6174e-05,0.42103,0.39634,1,1
5,GO REGULATION OF ODONTOGENESIS,0.0014299,0.42084,0.35159,1,1
5,GO N GLYCAN PROCESSING,0.0014299,0.42044,0.32161,1,1
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00021167,0.42039,0.34635,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00012074,0.4187,0.38944,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0025817,0.41816,0.33978,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,8.6584e-06,0.41812,0.37517,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0034322,0.418,0.41311,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,3.7145e-05,0.41796,0.47725,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.0051916,0.41687,0.26771,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,5.2837e-06,0.41674,0.40437,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00010092,0.41512,0.40271,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0050528,0.41409,0.27224,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0025817,0.41402,0.31537,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00092958,0.41382,0.30685,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00013433,0.41338,0.33353,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,1.3441e-06,0.41288,0.38008,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00081984,0.41165,0.2785,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.001662,0.41139,0.33573,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0028957,0.41134,0.35772,1,1
5,GO RESPONSE TO HYPEROXIA,0.00050664,0.41127,0.32249,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00018427,0.40995,0.37229,1,1
5,GO LIPID DROPLET FORMATION,0.0056288,0.40943,0.40114,1,1
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,4.1617e-05,0.40936,0.42476,1,1
5,GO GLAND MORPHOGENESIS,6.7728e-06,0.409,0.38609,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.0779e-06,0.40865,0.36169,1,1
5,GO NERVE DEVELOPMENT,1.0604e-05,0.40855,0.3536,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,5.6174e-05,0.4084,0.42555,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00013917,0.40785,0.42132,1,1
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0011549,0.40744,0.33573,1,1
5,GO VITAMIN CATABOLIC PROCESS,0.0031536,0.40731,0.33396,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0087944,0.40727,0.43,1,1
5,GO GLIAL CELL PROLIFERATION,2.8418e-05,0.40677,0.31935,1,1
5,GO MYELIN ASSEMBLY,0.00010462,0.40616,0.32668,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.027803,0.40604,0.31113,1,1
5,GO REGULATION OF PLATELET ACTIVATION,0.00012074,0.40419,0.35208,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,6.8936e-07,0.4039,0.43384,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00021167,0.40384,0.35814,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0056288,0.4028,0.25922,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.7806e-05,0.40168,0.31794,1,1
5,GO THALAMUS DEVELOPMENT,0.00024286,0.39983,0.37506,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,0.00042998,0.39876,0.33987,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,7.2754e-05,0.39771,0.3278,1,1
5,GO LEFT RIGHT AXIS SPECIFICATION,0.00098941,0.39753,0.3279,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,0.00021167,0.39724,0.3827,1,1
5,GO LUNG MORPHOGENESIS,0.00017186,0.39688,0.29963,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00035231,0.3968,0.33921,1,1
5,GO PROTEIN KINASE C SIGNALING,0.0021062,0.39665,0.28755,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,6.0504e-05,0.39591,0.36682,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,9.4334e-07,0.395,0.42283,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,3.17e-07,0.39427,0.39154,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.0024367,0.39367,0.33763,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.00036427,0.39359,0.29201,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,1.6455e-05,0.39359,0.42525,1,1
5,GO FORELIMB MORPHOGENESIS,1.2454e-05,0.39286,0.38449,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00030804,0.39273,0.36316,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0037331,0.3921,0.36549,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0014299,0.39157,0.3671,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,2.4692e-06,0.39036,0.42406,1,1
5,GO ESTROUS CYCLE,7.013e-05,0.39026,0.38532,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00013433,0.38984,0.39696,1,1
5,GO VIRAL GENOME REPLICATION,0.0021689,0.38938,0.25365,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.010773,0.38796,0.2571,1,1
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.013465,0.38599,0.2864,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,0.00037661,0.38594,0.31042,1,1
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00072223,0.38593,0.46061,1,1
5,GO RETINAL ROD CELL DIFFERENTIATION,0.00031859,0.38518,0.38788,1,1
5,GO XENOBIOTIC CATABOLIC PROCESS,0.030383,0.38473,0.30674,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.001228,0.38428,0.39779,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00028792,0.38265,0.4149,1,1
5,GO MYOBLAST FUSION,0.00084609,0.38234,0.31333,1,1
5,GO AMMONIUM TRANSPORT,6.5896e-07,0.38227,0.42565,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00044439,0.3812,0.34071,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,4.2876e-06,0.38105,0.31725,1,1
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0051916,0.38076,0.39088,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,4.1617e-05,0.38023,0.31271,1,1
5,GO SEROTONIN METABOLIC PROCESS,0.0007696,0.37964,0.43886,1,1
5,GO MYOBLAST MIGRATION,0.024288,0.37955,0.25,1,1
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,6.5149e-05,0.37937,0.4328,1,1
5,GO ENDOCARDIUM DEVELOPMENT,2.1663e-05,0.37883,0.43591,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.8282e-05,0.37854,0.29271,1,1
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0083534,0.37848,0.26363,1,1
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00023468,0.37803,0.38835,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00040247,0.37799,0.36402,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0087944,0.37785,0.27534,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00026003,0.37697,0.37309,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,4.1112e-06,0.37517,0.32368,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.046579,0.37505,0.19681,1,1
5,GO SKIN MORPHOGENESIS,0.0090226,0.37494,0.28966,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,1.8521e-05,0.3749,0.35633,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.045624,0.37445,0.23175,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.00021167,0.3741,0.33209,1,1
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.015574,0.37391,0.29237,1,1
5,GO PROSTATE GLAND DEVELOPMENT,4.4878e-05,0.37381,0.32675,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.00017186,0.37366,0.35981,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,4.3218e-05,0.37366,0.30329,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0006154,0.37347,0.27113,1,1
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.0053338,0.3734,0.45306,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.5308e-05,0.37336,0.33395,1,1
5,GO SECONDARY PALATE DEVELOPMENT,2.0833e-05,0.37313,0.36706,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.4121e-05,0.37289,0.32841,1,1
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.018398,0.37286,0.29564,1,1
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0037331,0.37247,0.26162,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0027346,0.37233,0.33292,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.0013872,0.37221,0.3073,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,0.00012074,0.37163,0.31203,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.00081984,0.37105,0.38726,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,8.1192e-05,0.37102,0.35297,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0053338,0.3687,0.35985,1,1
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.036164,0.36869,0.22881,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00030804,0.3686,0.32454,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,8.3127e-06,0.36798,0.34564,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.00087311,0.3679,0.30172,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,3.8583e-05,0.36789,0.29828,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,5.508e-06,0.36784,0.3069,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,3.3132e-05,0.3677,0.38276,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00055855,0.36653,0.41866,1,1
5,GO CRANIAL NERVE DEVELOPMENT,9.3916e-06,0.36617,0.34257,1,1
5,GO FUCOSE METABOLIC PROCESS,0.0030654,0.36614,0.24419,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.00010845,0.36541,0.2873,1,1
5,GO ASTROCYTE ACTIVATION,0.00059588,0.36483,0.31585,1,1
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,2.6307e-05,0.36483,0.34181,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.349e-05,0.36278,0.31022,1,1
5,GO REGULATION OF GTP BINDING,0.0037331,0.36272,0.28104,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.9263e-05,0.36246,0.3735,1,1
5,GO RESPONSE TO COLD,0.00026003,0.36201,0.28753,1,1
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.00057693,0.36189,0.33396,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00017186,0.36174,0.28213,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00069957,0.36128,0.26893,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00047456,0.36104,0.31063,1,1
5,GO SHORT TERM MEMORY,0.033894,0.36093,0.22061,1,1
5,GO EPITHELIAL CELL MATURATION,0.00084609,0.36085,0.33354,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00034072,0.36052,0.30835,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,3.6414e-07,0.36035,0.38124,1,1
5,GO MYELIN MAINTENANCE,6.7596e-05,0.36001,0.39505,1,1
5,GO LIVER MORPHOGENESIS,1.9263e-05,0.35981,0.47838,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,9.389e-05,0.35939,0.35187,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,2.4346e-05,0.35861,0.28844,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0024367,0.3583,0.32979,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,7.547e-05,0.35823,0.32361,1,1
5,GO ENERGY HOMEOSTASIS,1.104e-05,0.35819,0.34519,1,1
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.00032948,0.35782,0.31686,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,3.6228e-06,0.35773,0.39986,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0085714,0.35767,0.27211,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.013798,0.35758,0.28351,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0025083,0.357,0.36158,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,2.8077e-06,0.35675,0.37276,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00063551,0.35605,0.31354,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.8583e-05,0.35603,0.30565,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0040578,0.35592,0.25685,1,1
5,GO AXIS ELONGATION,6.2786e-05,0.35576,0.32168,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,2.2524e-05,0.35564,0.38825,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.1964e-05,0.35502,0.39758,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00032948,0.35463,0.43253,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0030654,0.35399,0.22391,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00041602,0.35398,0.3426,1,1
5,GO RETINOIC ACID METABOLIC PROCESS,2.0033e-05,0.35379,0.3869,1,1
5,GO STEROID HORMONE SECRETION,0.0001547,0.35364,0.3232,1,1
5,GO GANGLION DEVELOPMENT,0.0081404,0.35347,0.36738,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.013139,0.35278,0.32475,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.0090226,0.3526,0.28158,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7346e-05,0.3523,0.24397,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.7145e-05,0.35224,0.30202,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00011241,0.35216,0.41723,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.35133,0.29136,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.35096,0.27016,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,5.508e-06,0.35093,0.30867,1,1
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.035393,0.35084,0.32044,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00074557,0.35074,0.2462,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00042998,0.34977,0.32365,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00021167,0.34962,0.27291,1,1
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0013054,0.34962,0.28955,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,0.0013054,0.34931,0.24752,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.0576e-06,0.34928,0.30077,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.001986,0.34922,0.31971,1,1
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.0029794,0.34899,0.31046,1,1
5,GO TRACHEA DEVELOPMENT,0.00029782,0.34776,0.35314,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0013457,0.34775,0.24725,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0085714,0.34762,0.2592,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00019753,0.34749,0.33544,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,1.5816e-05,0.34738,0.28282,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.00014418,0.34684,0.37512,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.4878e-05,0.3467,0.30779,1,1
5,GO MITRAL VALVE DEVELOPMENT,0.0013872,0.3467,0.28602,1,1
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0011199,0.34657,0.28096,1,1
5,GO DENDRITIC CELL MIGRATION,0.020205,0.3464,0.22889,1,1
5,GO EMBRYONIC HEMOPOIESIS,4.1112e-06,0.3462,0.3231,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00021909,0.34588,0.29532,1,1
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0066042,0.34587,0.28057,1,1
5,GO LIPID DROPLET ORGANIZATION,0.00027832,0.34573,0.28802,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.027803,0.34564,0.21498,1,1
5,GO RESPONSE TO POTASSIUM ION,0.00084609,0.3456,0.30062,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00016023,0.3452,0.3007,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.007729,0.34458,0.24338,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.0014299,0.34435,0.31507,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7806e-05,0.34411,0.42992,1,1
5,GO PHAGOCYTOSIS RECOGNITION,0.009256,0.34384,0.20944,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,7.013e-05,0.34342,0.41933,1,1
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.0028141,0.34324,0.25813,1,1
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0016129,0.34291,0.33838,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,7.9801e-06,0.34255,0.29527,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00028792,0.34252,0.30065,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.3287e-06,0.34232,0.32757,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0018173,0.34225,0.24028,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.00017186,0.3419,0.37991,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0015189,0.34186,0.27873,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0017123,0.3416,0.31493,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,5.9841e-06,0.34145,0.40057,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00057693,0.34095,0.28253,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.2754e-05,0.3408,0.3621,1,1
5,GO RESPONSE TO TUMOR CELL,0.013798,0.34075,0.24251,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0013054,0.34068,0.27131,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0031536,0.3404,0.29467,1,1
5,GO MICROVILLUS ORGANIZATION,0.0083534,0.34039,0.25068,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00040247,0.34012,0.26206,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00054072,0.34001,0.25813,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0030654,0.33939,0.3307,1,1
5,GO ENDOTHELIUM DEVELOPMENT,2.4692e-06,0.33937,0.29702,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,5.4977e-07,0.33891,0.30533,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00019753,0.33883,0.33874,1,1
5,GO POSTSYNAPSE ASSEMBLY,0.0066042,0.33865,0.36873,1,1
5,GO SERTOLI CELL DEVELOPMENT,5.6174e-05,0.33852,0.41786,1,1
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00047456,0.33849,0.36015,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.001228,0.33812,0.42245,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00092958,0.338,0.28599,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,0.33792,0.26373,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,5.8301e-05,0.33777,0.33286,1,1
5,GO RESPONSE TO INTERFERON GAMMA,0.0007696,0.33772,0.32518,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,5.7413e-06,0.33761,0.27672,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0056288,0.33759,0.24419,1,1
5,GO RESPONSE TO UV B,0.0022992,0.33738,0.28066,1,1
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0028141,0.33649,0.28763,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0022992,0.33646,0.37444,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,2.1702e-06,0.3363,0.35456,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00063551,0.33612,0.23009,1,1
5,GO CGMP METABOLIC PROCESS,0.0059384,0.33602,0.2655,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,7.013e-05,0.33596,0.35701,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,5.6174e-05,0.33481,0.44,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00021909,0.33464,0.31205,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.1192e-05,0.33452,0.40446,1,1
5,GO ASYMMETRIC CELL DIVISION,0.0060989,0.33444,0.25701,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,4.8612e-06,0.33439,0.39216,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0064317,0.33433,0.24367,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0036303,0.33432,0.2447,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00010462,0.33415,0.30412,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.7343e-05,0.33398,0.26467,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.0049174,0.33385,0.26218,1,1
5,GO NEURAL CREST CELL MIGRATION,0.015953,0.33337,0.25487,1,1
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.0028141,0.33333,0.23279,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,1.9904e-06,0.33312,0.29315,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.0016129,0.33277,0.3661,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,2.2658e-06,0.33272,0.29567,1,1
5,GO FAT CELL DIFFERENTIATION,3.0264e-07,0.33267,0.28463,1,1
5,GO PRO B CELL DIFFERENTIATION,0.0022332,0.33258,0.26971,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.7343e-05,0.33249,0.29196,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0012662,0.3321,0.36575,1,1
5,GO GLIAL CELL DEVELOPMENT,1.1776e-06,0.33196,0.31294,1,1
5,GO NEPHRON MORPHOGENESIS,6.2367e-06,0.3318,0.26927,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.00012512,0.33099,0.35113,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,1.0311e-06,0.33072,0.3021,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,7.8282e-05,0.33059,0.32703,1,1
5,GO REGULATION OF COAGULATION,0.0022992,0.33044,0.24058,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,5.8301e-05,0.33031,0.34139,1,1
5,GO KERATINOCYTE PROLIFERATION,0.0017123,0.33021,0.26192,1,1
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00092958,0.33001,0.26275,1,1
5,GO REGULATION OF ANOIKIS,0.0013457,0.33001,0.34667,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.9263e-05,0.32989,0.25844,1,1
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.001662,0.32981,0.33754,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.02166,0.3298,0.30863,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0001165,0.32962,0.27535,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00018427,0.32947,0.29282,1,1
5,GO ODONTOGENESIS,0.0001547,0.32931,0.2773,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.011904,0.32921,0.19104,1,1
5,GO HEART TRABECULA FORMATION,0.00010462,0.32908,0.341,1,1
5,GO GLIAL CELL MIGRATION,0.00027832,0.3288,0.2452,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,2.0833e-05,0.32867,0.32586,1,1
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0018173,0.32831,0.31322,1,1
5,GO REGULATION OF POSITIVE CHEMOTAXIS,4.6623e-06,0.32708,0.37816,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0030654,0.32705,0.24077,1,1
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.6455e-05,0.32638,0.35996,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0047853,0.32619,0.23991,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00067758,0.32611,0.29455,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.030383,0.32495,0.21314,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,2.9532e-05,0.32493,0.30299,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0054795,0.32491,0.25544,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00027832,0.32481,0.29369,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0031536,0.32475,0.24881,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00040247,0.32458,0.22166,1,1
5,GO PREPULSE INHIBITION,0.012508,0.32439,0.36465,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.6228e-06,0.32433,0.30368,1,1
5,GO RESPONSE TO AXON INJURY,0.00021909,0.32401,0.26102,1,1
5,GO CELLULAR RESPONSE TO SALT STRESS,0.047551,0.32354,0.17867,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0024367,0.32351,0.28239,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00040247,0.32347,0.33197,1,1
5,GO COCHLEA DEVELOPMENT,4.3218e-05,0.32329,0.3188,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.6307e-05,0.32312,0.31531,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,6.2786e-05,0.32309,0.26192,1,1
5,GO PROTEIN OXIDATION,0.030383,0.32266,0.22035,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,9.7346e-05,0.32243,0.34973,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.016339,0.32238,0.29139,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00038934,0.32206,0.26399,1,1
5,GO EPIDERMIS MORPHOGENESIS,8.7323e-05,0.3219,0.3039,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.001662,0.32186,0.22929,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0029794,0.32184,0.26169,1,1
5,GO MAST CELL ACTIVATION,1.7806e-05,0.32179,0.2875,1,1
5,GO VASCULAR WOUND HEALING,0.00010092,0.32151,0.39794,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.025994,0.32111,0.25295,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,5.7413e-06,0.32107,0.39061,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,7.6603e-06,0.32082,0.29046,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0010528,0.32074,0.27214,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.045624,0.32064,0.26487,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,0.0064317,0.31987,0.24345,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015189,0.31974,0.20365,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.0014299,0.31875,0.25386,1,1
5,GO ACTIN CROSSLINK FORMATION,0.00054072,0.31858,0.26675,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0013457,0.31846,0.25274,1,1
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.031748,0.31836,0.31236,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,9.3916e-06,0.31828,0.27048,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0040578,0.31818,0.27803,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00041602,0.31804,0.28608,1,1
5,GO KIDNEY MORPHOGENESIS,3.4728e-06,0.318,0.27633,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.02268,0.31781,0.23909,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0094949,0.31771,0.43847,1,1
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,4.0073e-05,0.31727,0.31744,1,1
5,GO RESPONSE TO ACETYLCHOLINE,0.00026903,0.31722,0.32884,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,9.0221e-07,0.31721,0.2899,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,3.5759e-05,0.31659,0.30059,1,1
5,GO TONGUE MORPHOGENESIS,0.0017641,0.31639,0.46769,1,1
5,GO RECEPTOR CLUSTERING,0.00026003,0.31598,0.24677,1,1
5,GO TISSUE REGENERATION,0.00029782,0.31588,0.26214,1,1
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00081984,0.31586,0.26493,1,1
5,GO ENGULFMENT OF APOPTOTIC CELL,0.00023468,0.3157,0.30771,1,1
5,GO SEQUESTERING OF ACTIN MONOMERS,0.0047853,0.31527,0.32922,1,1
5,GO KETONE CATABOLIC PROCESS,0.011326,0.31474,0.30876,1,1
5,GO ASTROCYTE DIFFERENTIATION,1.4039e-05,0.31471,0.31334,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,6.5149e-05,0.31462,0.26761,1,1
5,GO EPITHELIAL CELL PROLIFERATION,2.1702e-06,0.31447,0.28905,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.9263e-05,0.31437,0.26653,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00065623,0.3143,0.29364,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.001662,0.31424,0.25704,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0051916,0.31414,0.24026,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0015189,0.31413,0.30908,1,1
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0015653,0.31397,0.28379,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,2.5308e-05,0.31383,0.26031,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.014138,0.31305,0.2709,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0045306,0.31281,0.34148,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,5.2533e-07,0.31254,0.29447,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0010528,0.31252,0.30497,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0019282,0.31228,0.27248,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00010462,0.31218,0.26714,1,1
5,GO ENDOTHELIAL CELL PROLIFERATION,1.5201e-05,0.31206,0.28286,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0001547,0.31202,0.2595,1,1
5,GO MAST CELL MEDIATED IMMUNITY,0.00021167,0.31176,0.26967,1,1
5,GO MEMBRANE BIOGENESIS,8.1192e-05,0.31144,0.31273,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00050664,0.31143,0.32543,1,1
5,GO METANEPHROS MORPHOGENESIS,0.00012074,0.31137,0.29044,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,0.00013917,0.31135,0.25676,1,1
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0045306,0.31123,0.46679,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,7.889e-07,0.31107,0.31337,1,1
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0020453,0.31057,0.23375,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0015189,0.31047,0.27537,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.7145e-05,0.31042,0.25568,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,1.8521e-05,0.31032,0.29391,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00017186,0.31027,0.23576,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0038387,0.31009,0.35495,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.049546,0.30978,0.16897,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0022992,0.30952,0.24734,1,1
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00095906,0.30933,0.19848,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,7.6603e-06,0.30915,0.25621,1,1
5,GO CARDIAC ATRIUM DEVELOPMENT,0.0020453,0.30895,0.21529,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.30895,0.27904,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.016734,0.30893,0.24623,1,1
5,GO NOREPINEPHRINE SECRETION,0.0081404,0.30884,0.28776,1,1
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.013465,0.30867,0.34322,1,1
5,GO TOXIN METABOLIC PROCESS,0.050569,0.30836,0.21543,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,6.5149e-05,0.30833,0.28318,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.016734,0.30818,0.18368,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.001986,0.30815,0.35834,1,1
5,GO ATRIAL SEPTUM DEVELOPMENT,0.013139,0.30769,0.24455,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.0226e-05,0.30732,0.2614,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,7.013e-05,0.30653,0.30201,1,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00024286,0.30634,0.33352,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,5.0226e-05,0.30589,0.26601,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.001872,0.30519,0.2081,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.0028141,0.30517,0.43214,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00013433,0.30498,0.27798,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0014299,0.30491,0.21243,1,1
5,GO SPINAL CORD PATTERNING,0.0021062,0.30404,0.34002,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.00052342,0.30363,0.28474,1,1
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0064317,0.30353,0.21601,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,3.0689e-05,0.30352,0.28625,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00055855,0.30336,0.29689,1,1
5,GO HINDLIMB MORPHOGENESIS,0.00026003,0.30332,0.29976,1,1
5,GO SEX DETERMINATION,0.00012964,0.30329,0.33227,1,1
5,GO EPITHELIAL CELL CELL ADHESION,0.004408,0.30321,0.32582,1,1
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0011199,0.30309,0.32335,1,1
5,GO GLIAL CELL DIFFERENTIATION,7.5427e-07,0.30308,0.28535,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.019283,0.30282,0.18293,1,1
5,GO RENAL TUBULE DEVELOPMENT,5.4121e-05,0.30202,0.24403,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,7.2111e-07,0.30191,0.2994,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.038561,0.30184,0.24163,1,1
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0049174,0.30137,0.32531,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00012512,0.30137,0.26745,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,1.3441e-06,0.30134,0.29052,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.0006154,0.30111,0.49362,1,1
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0023671,0.30093,0.2963,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00023468,0.30089,0.26187,1,1
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0023671,0.30072,0.35504,1,1
5,GO REGULATION OF WOUND HEALING,0.00040247,0.30072,0.25928,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0090226,0.30071,0.19291,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0001547,0.30053,0.24331,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00019753,0.30013,0.34168,1,1
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00087311,0.3001,0.26026,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0010528,0.3,0.32138,1,1
5,GO DEFENSE RESPONSE TO VIRUS,0.0030654,0.29986,0.22974,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010092,0.29971,0.30869,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00045924,0.29933,0.22452,1,1
5,GO NEURON PROJECTION REGENERATION,0.00012074,0.29911,0.26441,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00044439,0.29891,0.20969,1,1
5,GO SYNCYTIUM FORMATION,0.00079435,0.2989,0.25629,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0021062,0.29883,0.26566,1,1
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0075304,0.29864,0.29417,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0021689,0.29848,0.22541,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0020453,0.29848,0.23767,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0049174,0.29813,0.2364,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.0023671,0.29799,0.28648,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00029782,0.29788,0.20962,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0046564,0.29775,0.2302,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.00034072,0.29744,0.36042,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018173,0.29733,0.3122,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0056288,0.29719,0.24273,1,1
5,GO LIPID TRANSLOCATION,4.0073e-05,0.29714,0.28065,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0011199,0.29682,0.21626,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010206,0.29653,0.2595,1,1
5,GO LEUKOCYTE CHEMOTAXIS,7.2754e-05,0.29633,0.22226,1,1
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00063551,0.29619,0.24004,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.4121e-05,0.29608,0.33418,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00020448,0.29606,0.2745,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0025083,0.29559,0.22382,1,1
5,GO RESPONSE TO VITAMIN A,0.00065623,0.29555,0.26485,1,1
5,GO LIPID STORAGE,9.7346e-05,0.29536,0.23457,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010092,0.2951,0.24617,1,1
5,GO MACROPHAGE CHEMOTAXIS,7.547e-05,0.29496,0.31663,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010245,0.29443,0.20591,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2139e-05,0.29409,0.22192,1,1
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.00021909,0.29395,0.23237,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.0019282,0.2939,0.3037,1,1
5,GO INNATE IMMUNE RESPONSE,0.0024367,0.29385,0.1809,1,1
5,GO GLIOGENESIS,9.4334e-07,0.2937,0.27139,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0024367,0.29368,0.19026,1,1
5,GO HYPOTONIC RESPONSE,0.015953,0.29344,0.21452,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013054,0.29309,0.20593,1,1
5,GO POSITIVE REGULATION OF OSSIFICATION,2.5308e-05,0.29213,0.31298,1,1
5,GO MUSCLE CELL MIGRATION,3.5759e-05,0.29205,0.31419,1,1
5,GO RESPONSE TO BMP,1.1493e-05,0.29205,0.25566,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.010245,0.29198,0.17052,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,7.3528e-06,0.29151,0.24843,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,0.00054072,0.29145,0.2522,1,1
5,GO APPENDAGE MORPHOGENESIS,0.00013917,0.29131,0.23298,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0017123,0.29087,0.27008,1,1
5,GO MACROPHAGE DIFFERENTIATION,0.00030804,0.29034,0.2075,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,4.4878e-05,0.29022,0.24275,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0023671,0.29015,0.21763,1,1
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0037331,0.29011,0.3022,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,0.0028141,0.29011,0.22626,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0079323,0.29009,0.3236,1,1
5,GO BRAIN MORPHOGENESIS,0.00021167,0.28998,0.24189,1,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0041716,0.28995,0.29367,1,1
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.00052342,0.28992,0.25151,1,1
5,GO MACROPHAGE MIGRATION,2.0033e-05,0.28975,0.30078,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.2754e-05,0.28966,0.25708,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,7.9801e-06,0.28961,0.28443,1,1
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0010859,0.28921,0.3539,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0010859,0.28921,0.41605,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0027346,0.28919,0.2146,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.5816e-05,0.28911,0.27228,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0007696,0.28866,0.2196,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00023468,0.28854,0.23301,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0027346,0.28849,0.21261,1,1
5,GO BODY MORPHOGENESIS,0.0001547,0.28847,0.24612,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,2.4692e-06,0.28807,0.28821,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.0604e-05,0.28791,0.28903,1,1
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00030804,0.28756,0.28418,1,1
5,GO RENAL VESICLE DEVELOPMENT,0.010773,0.28746,0.21197,1,1
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0026572,0.28741,0.26377,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,3.4728e-06,0.28718,0.27767,1,1
5,GO PLASMA MEMBRANE FUSION,0.0030654,0.28709,0.30257,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00055855,0.28684,0.23293,1,1
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0083534,0.28668,0.25342,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.021165,0.28622,0.17591,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,4.4712e-06,0.28603,0.25132,1,1
5,GO MESENCHYME DEVELOPMENT,8.1192e-05,0.28589,0.21539,1,1
5,GO MEMBRANE DEPOLARIZATION,0.0064317,0.28575,0.20817,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.4039e-05,0.28535,0.27861,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,1.2454e-05,0.28534,0.27032,1,1
5,GO FATTY ACID HOMEOSTASIS,0.0054795,0.28467,0.31127,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00098941,0.28455,0.19652,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,2.0033e-05,0.28453,0.23961,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,8.1192e-05,0.2845,0.2278,1,1
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0030654,0.2843,0.23539,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.2786e-05,0.2842,0.26492,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,4.8379e-05,0.28416,0.28587,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,2.6307e-05,0.28391,0.25267,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.28387,0.29075,1,1
5,GO PLACENTA DEVELOPMENT,6.4994e-06,0.28378,0.26222,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00041602,0.28344,0.27595,1,1
5,GO REGULATION OF CELL KILLING,0.0031536,0.28291,0.17878,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,5.7413e-06,0.28287,0.22455,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00020448,0.28281,0.25389,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.2454e-05,0.28242,0.26889,1,1
5,GO REGULATION OF CELL ADHESION,2.4346e-05,0.28193,0.23479,1,1
5,GO CAMP BIOSYNTHETIC PROCESS,0.0054795,0.28182,0.25477,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.00028792,0.28179,0.27819,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0087944,0.28171,0.2359,1,1
5,GO MESONEPHROS DEVELOPMENT,6.4994e-06,0.2817,0.29362,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.00029782,0.28165,0.22973,1,1
5,GO STEM CELL DIVISION,4.0073e-05,0.28158,0.2566,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.01282,0.28153,0.16905,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,5.0683e-06,0.28115,0.26197,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00011241,0.28092,0.22829,1,1
5,GO ANOIKIS,0.00012964,0.28083,0.3127,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,2.9532e-05,0.28075,0.2808,1,1
5,GO METANEPHROS DEVELOPMENT,6.5149e-05,0.28072,0.24068,1,1
5,GO LACTATE METABOLIC PROCESS,0.0031536,0.28061,0.23974,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.0022992,0.28019,0.37347,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0014299,0.28008,0.18042,1,1
5,GO MYOTUBE DIFFERENTIATION,0.0001547,0.28002,0.22764,1,1
5,GO HIPPO SIGNALING,0.011326,0.27999,0.18055,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,1.6455e-05,0.27995,0.26284,1,1
5,GO CELL CELL ADHESION,2.6902e-06,0.27989,0.23643,1,1
5,GO INNERVATION,0.017549,0.27986,0.26915,1,1
5,GO INTERLEUKIN 4 PRODUCTION,5.2139e-05,0.27976,0.26295,1,1
5,GO CELL MATRIX ADHESION,3.3132e-05,0.27968,0.24583,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0017641,0.27966,0.22069,1,1
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00017186,0.27914,0.24793,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0040578,0.27913,0.21275,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.1493e-05,0.27905,0.23714,1,1
5,GO REGULATION OF CELL CELL ADHESION,5.9841e-06,0.27879,0.25404,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0083534,0.27879,0.22107,1,1
5,GO CHEMOKINE PRODUCTION,6.2786e-05,0.27875,0.288,1,1
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.015203,0.27867,0.30253,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00036427,0.27823,0.22608,1,1
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00035231,0.27817,0.28836,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0012662,0.27815,0.25591,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0033369,0.27799,0.20953,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0021062,0.27799,0.25705,1,1
5,GO REGULATION OF GLIOGENESIS,2.8077e-06,0.27793,0.26587,1,1
5,GO SPHINGOID METABOLIC PROCESS,0.0017123,0.27776,0.24519,1,1
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.00079435,0.27775,0.21283,1,1
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.0040578,0.2777,0.20508,1,1
5,GO RESPONSE TO VITAMIN D,0.0041716,0.27767,0.24366,1,1
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0028957,0.27758,0.26634,1,1
5,GO MOLTING CYCLE,4.4712e-06,0.27757,0.23613,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0022992,0.27697,0.18021,1,1
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0060989,0.27692,0.24035,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,8.6584e-06,0.27657,0.24193,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.00034072,0.27656,0.30009,1,1
5,GO RESPONSE TO VITAMIN,0.00038934,0.27589,0.23561,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,5.508e-06,0.27574,0.2719,1,1
5,GO HAIR CELL DIFFERENTIATION,6.2786e-05,0.27556,0.35734,1,1
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0097392,0.27552,0.23998,1,1
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00022676,0.27549,0.27776,1,1
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0026572,0.27521,0.20057,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,2.1663e-05,0.27513,0.31451,1,1
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.013798,0.27499,0.24264,1,1
5,GO RESPONSE TO ACIDIC PH,0.0024367,0.27438,0.22608,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.4039e-05,0.27421,0.23436,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,4.3218e-05,0.27354,0.26045,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00049035,0.27342,0.23302,1,1
5,GO ONE CARBON COMPOUND TRANSPORT,0.00059588,0.27337,0.30106,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00019079,0.27306,0.24773,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.00098941,0.27302,0.24356,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.019283,0.27301,0.19785,1,1
5,GO TUBE MORPHOGENESIS,6.2367e-06,0.27298,0.2305,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.4421e-05,0.27282,0.29873,1,1
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0022992,0.27249,0.22537,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,3.7791e-06,0.27239,0.29139,1,1
5,GO BONE MINERALIZATION,0.00019753,0.27238,0.23341,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.00042998,0.27232,0.24711,1,1
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.0010206,0.27219,0.29399,1,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0028141,0.27208,0.20298,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.0015653,0.27198,0.2674,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0017641,0.27188,0.25447,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0017123,0.27141,0.3397,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00038934,0.2714,0.27794,1,1
5,GO DIENCEPHALON DEVELOPMENT,1.1964e-05,0.2714,0.29864,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,1.5201e-05,0.27125,0.25407,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.0033e-05,0.27115,0.22128,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00065623,0.2708,0.20402,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.0024367,0.27057,0.17435,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0030654,0.27051,0.17408,1,1
5,GO NEURAL CREST CELL DIFFERENTIATION,0.00055855,0.27006,0.24768,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.017137,0.27005,0.15646,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0024367,0.26994,0.324,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0023671,0.26993,0.167,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,4.4878e-05,0.26993,0.24631,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0032441,0.26989,0.34932,1,1
5,GO OSTEOBLAST PROLIFERATION,0.0016129,0.26983,0.27328,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,1.4609e-05,0.26962,0.26506,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.7578e-07,0.2696,0.31859,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.1904e-06,0.26952,0.22028,1,1
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.011047,0.26952,0.16935,1,1
5,GO VITAMIN D METABOLIC PROCESS,0.0047853,0.26942,0.23366,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,3.1888e-05,0.26938,0.23955,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0027346,0.26858,0.26015,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0017641,0.26827,0.23572,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0027346,0.26802,0.24631,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0087944,0.26789,0.26449,1,1
5,GO MONOCYTE CHEMOTAXIS,0.013798,0.26768,0.18839,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.7801e-06,0.26768,0.2442,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,4.3218e-05,0.26748,0.24843,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00010845,0.26747,0.23927,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,6.7596e-05,0.2674,0.26129,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0038387,0.26732,0.21595,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00055855,0.26724,0.23221,1,1
5,GO BONE MATURATION,0.00084609,0.26713,0.26709,1,1
5,GO LEYDIG CELL DIFFERENTIATION,0.011904,0.26683,0.2859,1,1
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.014138,0.26682,0.20133,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0022992,0.26656,0.18646,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00037661,0.26655,0.2198,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0041716,0.26638,0.18143,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00059588,0.26599,0.22777,1,1
5,GO RESPIRATORY BURST,0.015953,0.26595,0.196,1,1
5,GO PLATELET AGGREGATION,0.0017123,0.26572,0.21627,1,1
5,GO SKELETAL MUSCLE ADAPTATION,5.2139e-05,0.26534,0.30937,1,1
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.014138,0.26515,0.24657,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0015189,0.2651,0.21282,1,1
5,GO MULTICELLULAR ORGANISM AGING,0.0021689,0.26479,0.18638,1,1
5,GO HISTAMINE SECRETION,0.05161,0.26474,0.28754,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0011199,0.26472,0.23148,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00032948,0.26471,0.20969,1,1
5,GO RESPONSE TO WOUNDING,0.0001165,0.26398,0.21712,1,1
5,GO CELL SUBSTRATE ADHESION,9.0551e-05,0.26393,0.23939,1,1
5,GO STEROL HOMEOSTASIS,9.389e-05,0.26336,0.22277,1,1
5,GO POTASSIUM ION HOMEOSTASIS,6.4994e-06,0.26328,0.3279,1,1
5,GO NEPHRON TUBULE FORMATION,0.0036303,0.26301,0.30697,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00035231,0.26298,0.28745,1,1
5,GO RENAL SYSTEM PROCESS,4.4712e-06,0.26291,0.24807,1,1
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,3.1888e-05,0.26284,0.2779,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.0689e-05,0.26276,0.2307,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.012508,0.26268,0.15859,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.7118e-05,0.26262,0.21556,1,1
5,GO REGULATION OF HAIR CYCLE,9.7346e-05,0.26238,0.24703,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00011241,0.26237,0.22251,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.016734,0.26234,0.25465,1,1
5,GO CEREBELLAR CORTEX FORMATION,0.0014738,0.26229,0.27509,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.00036427,0.26223,0.2048,1,1
5,GO REGULATION OF TUBULIN DEACETYLATION,0.004408,0.26211,0.26201,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.00074557,0.26205,0.26949,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0001547,0.26197,0.26408,1,1
5,GO LEUKOCYTE MIGRATION,5.2139e-05,0.26169,0.21891,1,1
5,GO BIOLOGICAL ADHESION,1.2454e-05,0.26164,0.22256,1,1
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00045924,0.26158,0.40557,1,1
5,GO NEURON PROJECTION ARBORIZATION,0.0016129,0.26123,0.27425,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00353,0.26107,0.15368,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0045306,0.26086,0.21774,1,1
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.019283,0.26083,0.17552,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.26072,0.21315,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0073363,0.2607,0.23603,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.001228,0.26058,0.19458,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,9.7801e-06,0.26025,0.22929,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0032441,0.26023,0.17501,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.00067758,0.26017,0.2535,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.025994,0.26017,0.22056,1,1
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00090094,0.25992,0.25458,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.00074557,0.25987,0.24885,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.3132e-05,0.25986,0.19965,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,1.349e-05,0.25983,0.2907,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0053338,0.25978,0.20936,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.0006154,0.25971,0.21555,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00027832,0.2595,0.31829,1,1
5,GO DEVELOPMENTAL INDUCTION,0.00016595,0.25929,0.2648,1,1
5,GO SODIUM ION HOMEOSTASIS,0.00016595,0.25919,0.24062,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00017186,0.25917,0.33446,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,5.0226e-05,0.25887,0.20653,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,5.8301e-05,0.25882,0.22042,1,1
5,GO REGULATION OF STEM CELL PROLIFERATION,0.0034322,0.25879,0.19282,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,1.8521e-05,0.25873,0.30065,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.0001547,0.25871,0.28001,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.00021167,0.2583,0.21405,1,1
5,GO ECTODERM DEVELOPMENT,0.00019079,0.25828,0.22398,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,8.1192e-05,0.25813,0.19743,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001662,0.25802,0.18989,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0001165,0.25796,0.24542,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00052342,0.2579,0.24138,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.00036427,0.25789,0.24688,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0087944,0.25777,0.22919,1,1
5,GO ENSHEATHMENT OF NEURONS,1.9904e-06,0.25777,0.24437,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,4.1617e-05,0.25772,0.23101,1,1
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.012508,0.25754,0.2347,1,1
5,GO T CELL PROLIFERATION,3.7145e-05,0.25733,0.2272,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.6597e-05,0.25731,0.29755,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,6.5149e-05,0.25724,0.20816,1,1
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.9841e-06,0.25719,0.23625,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00018427,0.2571,0.22875,1,1
5,GO WATER HOMEOSTASIS,0.00063551,0.25706,0.24588,1,1
5,GO CELL CHEMOTAXIS,6.2786e-05,0.25706,0.23444,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00047456,0.25702,0.20025,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00034072,0.25697,0.28413,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0069616,0.25676,0.21874,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,0.014486,0.25672,0.15985,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,6.2367e-06,0.25669,0.23148,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00012074,0.25659,0.19518,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,5.0683e-06,0.25657,0.22582,1,1
5,GO PLATELET ACTIVATION,0.00050664,0.25653,0.18907,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.2962e-05,0.25645,0.39045,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0028141,0.25638,0.33769,1,1
5,GO INTERFERON ALPHA PRODUCTION,0.025414,0.25638,0.21443,1,1
5,GO RESPONSE TO VIRUS,0.0039469,0.25636,0.18701,1,1
5,GO INTERLEUKIN 6 PRODUCTION,2.1663e-05,0.25629,0.21819,1,1
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0012662,0.25619,0.26238,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.001228,0.25617,0.20836,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,1.5816e-05,0.25588,0.23027,1,1
5,GO INNER EAR MORPHOGENESIS,7.0571e-06,0.2558,0.28565,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,7.9801e-06,0.2558,0.37376,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0013872,0.25548,0.23547,1,1
5,GO ALPHA BETA T CELL ACTIVATION,0.00012964,0.25534,0.21644,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.0010859,0.25527,0.28322,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.010245,0.25527,0.24556,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0037331,0.2552,0.20961,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.4039e-05,0.25459,0.32512,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0042883,0.25458,0.24265,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.0011199,0.25457,0.20571,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0014738,0.25451,0.19713,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,2.6902e-06,0.25442,0.21692,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,7.013e-05,0.25439,0.2535,1,1
5,GO APPENDAGE DEVELOPMENT,6.0504e-05,0.25426,0.21456,1,1
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00054072,0.25424,0.23326,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.034637,0.254,0.19978,1,1
5,GO FIBROBLAST PROLIFERATION,0.00037661,0.25364,0.27629,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,3.1904e-06,0.25352,0.25821,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00010845,0.25349,0.32953,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,7.9801e-06,0.25348,0.23431,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0001165,0.25347,0.27447,1,1
5,GO POSITIVE CHEMOTAXIS,0.00034072,0.25328,0.24411,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00010845,0.25326,0.22976,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.00030804,0.25314,0.28321,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,7.547e-05,0.25312,0.29472,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.0032441,0.25303,0.16713,1,1
5,GO NEGATIVE CHEMOTAXIS,0.02068,0.253,0.26444,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00011241,0.25294,0.20446,1,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00092958,0.25288,0.28726,1,1
5,GO LYMPHOCYTE MIGRATION,0.00010845,0.25253,0.20876,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0007696,0.25252,0.32773,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.7323e-05,0.2525,0.28118,1,1
5,GO ASTROCYTE DEVELOPMENT,0.00044439,0.25241,0.29724,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001191,0.2524,0.20768,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0045306,0.25196,0.15577,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.0689e-05,0.25193,0.2312,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.04854,0.25169,0.16438,1,1
5,GO INTERFERON BETA PRODUCTION,0.012508,0.25129,0.17857,1,1
5,GO REGULATION OF CHEMOTAXIS,4.4878e-05,0.2512,0.2356,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00059588,0.25089,0.19279,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0007696,0.25079,0.20539,1,1
5,GO OUTER DYNEIN ARM ASSEMBLY,0.00038934,0.25079,0.31895,1,1
5,GO RESPONSE TO NICOTINE,0.00016595,0.25071,0.25041,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,6.2786e-05,0.25053,0.25225,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00019079,0.25044,0.22212,1,1
5,GO BIOMINERALIZATION,0.0001547,0.2503,0.21633,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0020453,0.25006,0.32353,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0025083,0.24985,0.22751,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,0.00041602,0.24985,0.18302,1,1
5,GO CARDIAC CELL DEVELOPMENT,3.8583e-05,0.24973,0.21313,1,1
5,GO IMMUNE EFFECTOR PROCESS,0.0025817,0.24969,0.17698,1,1
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,6.7596e-05,0.2496,0.26416,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.0001165,0.2495,0.22566,1,1
5,GO GONADOTROPIN SECRETION,0.0030654,0.24943,0.26731,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.4609e-05,0.24936,0.2518,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.018398,0.24925,0.26693,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.8418e-05,0.24924,0.19747,1,1
5,GO DENDRITIC CELL CHEMOTAXIS,0.045624,0.24923,0.19315,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0042883,0.24913,0.27049,1,1
5,GO TISSUE REMODELING,0.0021689,0.24892,0.20592,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.036164,0.24879,0.17248,1,1
5,GO LIPOXYGENASE PATHWAY,0.017969,0.24879,0.28926,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,5.0226e-05,0.24876,0.29262,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0021062,0.24871,0.21122,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.00044439,0.24868,0.26949,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00090094,0.24858,0.22569,1,1
5,GO DRUG CATABOLIC PROCESS,0.0012662,0.24856,0.19339,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.014138,0.24852,0.18725,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0022992,0.24845,0.21958,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0042883,0.24841,0.25552,1,1
5,GO ANION HOMEOSTASIS,0.0017123,0.24835,0.18496,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,7.013e-05,0.24834,0.23308,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,0.017969,0.24808,0.21722,1,1
5,GO MONONUCLEAR CELL MIGRATION,0.0060989,0.24806,0.18495,1,1
5,GO EAR DEVELOPMENT,4.6623e-06,0.24798,0.27596,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0031536,0.2478,0.38018,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,8.3127e-06,0.24777,0.24705,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00063551,0.24773,0.23637,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0060989,0.24762,0.25545,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00019079,0.24759,0.21756,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,5.9841e-06,0.24758,0.26368,1,1
5,GO TUBE DEVELOPMENT,3.7791e-06,0.24749,0.22246,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0024367,0.24732,0.2742,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00028792,0.24727,0.23665,1,1
5,GO VASCULATURE DEVELOPMENT,6.2786e-05,0.24712,0.20431,1,1
5,GO AORTA MORPHOGENESIS,0.0099891,0.24708,0.16991,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,9.7346e-05,0.24701,0.23803,1,1
5,GO MUSCLE CELL DIFFERENTIATION,2.0784e-06,0.24701,0.2245,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.019283,0.24694,0.20589,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017137,0.24685,0.18003,1,1
5,GO NEURAL TUBE PATTERNING,0.00041602,0.24683,0.21352,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,9.0551e-05,0.24663,0.2384,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.1617e-05,0.24662,0.197,1,1
5,GO DRINKING BEHAVIOR,0.021165,0.24652,0.33696,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.00042998,0.24623,0.2149,1,1
5,GO ACTIN FILAMENT BASED TRANSPORT,0.0030654,0.24585,0.29212,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.013139,0.24585,0.19686,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.00055855,0.24583,0.22434,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.2139e-05,0.24567,0.19607,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00016595,0.24562,0.21066,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.4346e-05,0.24554,0.20663,1,1
5,GO REGULATION OF B CELL ACTIVATION,0.0087944,0.24546,0.17523,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.7343e-05,0.24542,0.21439,1,1
5,GO WOUND HEALING,0.00030804,0.2452,0.20272,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.2452,0.21935,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.033166,0.24503,0.27033,1,1
5,GO DNA DEMETHYLATION,0.0064317,0.245,0.17683,1,1
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.036948,0.24477,0.25723,1,1
5,GO RESPONSE TO PROGESTERONE,0.0015653,0.24469,0.23918,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0011549,0.24406,0.19978,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00029782,0.24405,0.20572,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,1.4039e-05,0.24399,0.2615,1,1
5,GO RESPONSE TO STEROL,0.00090094,0.24387,0.20339,1,1
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0007696,0.24364,0.21859,1,1
5,GO ACTIVATED T CELL PROLIFERATION,1.104e-05,0.2435,0.257,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.011326,0.24347,0.23253,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.040234,0.24345,0.12399,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.010506,0.24342,0.21655,1,1
5,GO HINDBRAIN MORPHOGENESIS,9.7346e-05,0.24324,0.223,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,5.4121e-05,0.24301,0.21982,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,5.8301e-05,0.24297,0.22622,1,1
5,GO SEGMENT SPECIFICATION,0.011612,0.24292,0.28153,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0011549,0.24257,0.19597,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.1493e-05,0.24254,0.39,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0045306,0.24252,0.29881,1,1
5,GO T CELL MIGRATION,0.00055855,0.2425,0.19875,1,1
5,GO INTERLEUKIN 10 PRODUCTION,0.00012512,0.2425,0.25617,1,1
5,GO CARDIAC CONDUCTION,0.00036427,0.24239,0.25421,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.001228,0.24222,0.20659,1,1
5,GO REGULATION OF OSSIFICATION,5.2139e-05,0.24214,0.25138,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00024286,0.24192,0.25893,1,1
5,GO EPIDERMIS DEVELOPMENT,2.7343e-05,0.24191,0.28366,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.03245,0.24154,0.19697,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0085714,0.24151,0.36872,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,2.6902e-06,0.24146,0.26768,1,1
5,GO GLAND DEVELOPMENT,1.1776e-06,0.24145,0.22336,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00019753,0.24132,0.22258,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00019079,0.24118,0.18913,1,1
5,GO ORGANIC CATION TRANSPORT,0.00016595,0.24086,0.24376,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.007729,0.24077,0.36096,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.055956,0.24059,0.13567,1,1
5,GO PROTEIN KINASE B SIGNALING,4.4878e-05,0.24056,0.19693,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0014299,0.24028,0.23906,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0012662,0.24015,0.21443,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0047853,0.24011,0.13459,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0015653,0.24008,0.22234,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0036303,0.24001,0.18251,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00032948,0.23992,0.19194,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,5.7413e-06,0.23967,0.21271,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0015653,0.23953,0.2172,1,1
5,GO SMOOTH MUSCLE CONTRACTION,0.00020448,0.2394,0.19849,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00021167,0.2394,0.22446,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.023205,0.23935,0.15739,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016023,0.23934,0.19021,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,5.508e-06,0.23926,0.20404,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,4.6623e-06,0.23907,0.21328,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,9.7801e-06,0.23897,0.22471,1,1
5,GO HEART VALVE DEVELOPMENT,0.0036303,0.23882,0.18882,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00024286,0.23865,0.25921,1,1
5,GO GRANULOCYTE MIGRATION,0.0027346,0.23848,0.1713,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.00087311,0.23848,0.19365,1,1
5,GO PLASMINOGEN ACTIVATION,0.053746,0.23803,0.1988,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0031536,0.23789,0.21696,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0021062,0.23776,0.19058,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,1.4674e-06,0.23766,0.21769,1,1
5,GO LIPID LOCALIZATION,0.00050664,0.2376,0.15507,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,6.2786e-05,0.23758,0.22319,1,1
5,GO REGENERATION,0.00024286,0.23744,0.18965,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,5.2139e-05,0.23742,0.18609,1,1
5,GO TUBE FORMATION,1.4609e-05,0.23718,0.20347,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,1.5201e-05,0.23715,0.21424,1,1
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0007696,0.23711,0.19645,1,1
5,GO SODIUM ION TRANSPORT,3.5759e-05,0.23703,0.20887,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00031859,0.23698,0.20595,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00026903,0.23684,0.19814,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,2.1702e-06,0.23645,0.21249,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00027832,0.23644,0.19825,1,1
5,GO RESPONSE TO FOOD,0.00018427,0.2356,0.18895,1,1
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.017137,0.23549,0.20539,1,1
5,GO RESPONSE TO RETINOIC ACID,0.00014935,0.23543,0.22095,1,1
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00032948,0.23515,0.20277,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,9.7346e-05,0.23506,0.25881,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00084609,0.23494,0.24105,1,1
5,GO COLLATERAL SPROUTING,0.0015189,0.23493,0.23322,1,1
5,GO SPERM CAPACITATION,2.2524e-05,0.23485,0.24049,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.010773,0.23453,0.25526,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,5.4121e-05,0.2345,0.24014,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,3.1888e-05,0.23438,0.2154,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.9532e-05,0.23436,0.20859,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0069616,0.23426,0.15037,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,4.8379e-05,0.23415,0.23961,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0017123,0.23357,0.15368,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,4.4878e-05,0.23325,0.23389,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00026003,0.23321,0.25233,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.001986,0.23304,0.19773,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.004408,0.23297,0.21521,1,1
5,GO CELL MOTILITY,1.1493e-05,0.23295,0.20276,1,1
5,GO MUSCLE CELL DEVELOPMENT,1.4039e-05,0.23291,0.22325,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0041716,0.23289,0.15894,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0022992,0.23287,0.27575,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.00059588,0.2328,0.20218,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,4.1112e-06,0.23277,0.20537,1,1
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0057817,0.23275,0.22338,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0062634,0.23272,0.22096,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0071468,0.23252,0.40785,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.03939,0.23237,0.29816,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.2139e-05,0.23236,0.20361,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,2.6902e-06,0.23233,0.19761,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00018427,0.23206,0.21233,1,1
5,GO FLUID TRANSPORT,0.0094949,0.23186,0.17015,1,1
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.022165,0.23185,0.16709,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0010206,0.23182,0.18857,1,1
5,GO NEURAL TUBE FORMATION,0.00017796,0.23181,0.17649,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,9.0179e-06,0.23174,0.24103,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,3.7791e-06,0.23166,0.20551,1,1
5,GO REGULATION OF T CELL ACTIVATION,1.4609e-05,0.2315,0.23058,1,1
5,GO INTERACTION WITH HOST,0.0079323,0.23142,0.14202,1,1
5,GO REGULATION OF CELL ACTIVATION,5.6174e-05,0.23136,0.19566,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,9.7346e-05,0.23127,0.19533,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00055855,0.23113,0.19561,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.0015189,0.23105,0.19708,1,1
5,GO FUCOSYLATION,0.0015189,0.23104,0.2057,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00065623,0.23088,0.20535,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,4.0073e-05,0.23088,0.21679,1,1
5,GO CAMP METABOLIC PROCESS,0.025994,0.23086,0.14331,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,8.6584e-06,0.23079,0.28633,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,7.013e-05,0.23074,0.34971,1,1
5,GO EAR MORPHOGENESIS,1.349e-05,0.23072,0.24732,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0079323,0.23069,0.14123,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00044439,0.23063,0.23362,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0047853,0.23046,0.23601,1,1
5,GO ENDOCRINE HORMONE SECRETION,5.9841e-06,0.23028,0.28466,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00034072,0.23021,0.20105,1,1
5,GO FOAM CELL DIFFERENTIATION,0.00050664,0.23018,0.31082,1,1
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0064317,0.23015,0.24022,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,5.508e-06,0.22988,0.25757,1,1
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.014841,0.22983,0.18812,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00021909,0.2298,0.21064,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.0032441,0.22978,0.18059,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00023468,0.22968,0.20677,1,1
5,GO TISSUE MORPHOGENESIS,7.0571e-06,0.22962,0.198,1,1
5,GO RESPONSE TO PROTOZOAN,0.036948,0.22962,0.19591,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.00074557,0.22953,0.1793,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.00026903,0.22938,0.19544,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00074557,0.22924,0.19854,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0011199,0.22919,0.19801,1,1
5,GO T CELL ACTIVATION,3.1888e-05,0.22899,0.21427,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,1.1964e-05,0.22888,0.19387,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00067758,0.22887,0.19708,1,1
5,GO APICAL JUNCTION ASSEMBLY,0.00021167,0.22884,0.27446,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,9.7346e-05,0.22863,0.21735,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00012074,0.22843,0.23339,1,1
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00017796,0.2284,0.18035,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,1.7806e-05,0.22818,0.19391,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0029794,0.22815,0.20613,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.015574,0.22809,0.15595,1,1
5,GO OSSIFICATION,4.6597e-05,0.22808,0.23672,1,1
5,GO SPERM AXONEME ASSEMBLY,0.00087311,0.22797,0.27612,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00013917,0.22794,0.22162,1,1
5,GO MAMMARY GLAND DEVELOPMENT,3.0689e-05,0.22792,0.20518,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,9.7346e-05,0.2274,0.22243,1,1
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0032441,0.22735,0.199,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,2.6902e-06,0.22727,0.21919,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00055855,0.22715,0.19236,1,1
5,GO SKIN DEVELOPMENT,5.6174e-05,0.22712,0.28211,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.009256,0.22708,0.17856,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.0054795,0.2269,0.17651,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0006154,0.2267,0.19331,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0019282,0.22667,0.18351,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,1.8521e-05,0.22651,0.19344,1,1
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0085714,0.2262,0.14913,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0021689,0.2261,0.20984,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,4.0073e-05,0.22594,0.20474,1,1
5,GO MYOBLAST DIFFERENTIATION,0.00020448,0.22593,0.23058,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,0.00041602,0.2259,0.19233,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.0016129,0.22583,0.15232,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0038387,0.22573,0.18239,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0046564,0.22572,0.20722,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,2.1663e-05,0.22563,0.19224,1,1
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0073363,0.22547,0.1834,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.00092958,0.2254,0.18466,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.0037331,0.22528,0.15754,1,1
5,GO BONE MORPHOGENESIS,0.0037331,0.22524,0.18858,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.7145e-05,0.22521,0.19772,1,1
5,GO NOTCH SIGNALING PATHWAY,5.4121e-05,0.22498,0.20141,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.0014299,0.22498,0.19402,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0045306,0.22491,0.29757,1,1
5,GO MUSCLE HYPERTROPHY,0.00084609,0.22488,0.17555,1,1
5,GO STARTLE RESPONSE,0.011326,0.22486,0.22762,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.018836,0.2248,0.17806,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.02068,0.22463,0.17418,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00010092,0.22445,0.19874,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0013457,0.22423,0.18319,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,9.3916e-06,0.22418,0.20005,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.6174e-05,0.22398,0.21633,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0069616,0.22371,0.21103,1,1
5,GO ENDOTHELIAL CELL MIGRATION,0.0022992,0.22362,0.18444,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.016339,0.22355,0.16721,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.011047,0.22355,0.17057,1,1
5,GO ENDOCRINE PROCESS,0.00024286,0.22348,0.21471,1,1
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.021165,0.22338,0.19502,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0038387,0.22337,0.1624,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00067758,0.22308,0.21238,1,1
5,GO RESPONSE TO CADMIUM ION,0.02843,0.22293,0.14754,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0020453,0.22292,0.25337,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.00054072,0.22283,0.18169,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,7.3528e-06,0.22277,0.19784,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.001662,0.22252,0.29184,1,1
5,GO CELL AGGREGATION,0.0030654,0.22249,0.20959,1,1
5,GO CORPUS CALLOSUM DEVELOPMENT,0.0071468,0.22235,0.24151,1,1
5,GO NEPHRON DEVELOPMENT,0.0001165,0.22223,0.20369,1,1
5,GO REGULATION OF APPETITE,0.00012964,0.2221,0.25387,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00038934,0.22205,0.18075,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00026003,0.22198,0.21624,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0069616,0.22188,0.20758,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00019079,0.22185,0.23436,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.014486,0.22172,0.17144,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00026003,0.22169,0.24963,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.00035231,0.22155,0.1925,1,1
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.0067808,0.22144,0.18207,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0094949,0.22143,0.20962,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,7.8282e-05,0.22137,0.21433,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.0053338,0.22134,0.23291,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0022992,0.22125,0.25881,1,1
5,GO CERAMIDE METABOLIC PROCESS,0.0019282,0.22115,0.16707,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0040578,0.22114,0.16119,1,1
5,GO ANIMAL ORGAN MATURATION,0.00084609,0.22086,0.24555,1,1
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.019739,0.22036,0.19717,1,1
5,GO FIBROBLAST MIGRATION,0.00067758,0.22025,0.19167,1,1
5,GO CELL ACTIVATION,0.00034072,0.22018,0.17293,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0046564,0.22016,0.26672,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,2.2524e-05,0.22014,0.19645,1,1
5,GO DEFENSE RESPONSE,0.00069957,0.22007,0.17263,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00041602,0.21986,0.17111,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0014299,0.21973,0.19965,1,1
5,GO B CELL DIFFERENTIATION,9.7346e-05,0.21961,0.17645,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0034322,0.21938,0.22908,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0049174,0.21931,0.21363,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00049035,0.21919,0.16846,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,4.8379e-05,0.21911,0.21301,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0083534,0.2191,0.17479,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0021062,0.21908,0.19794,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.0001547,0.21902,0.17314,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0011549,0.21894,0.17064,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,2.9532e-05,0.21876,0.18012,1,1
5,GO REGULATION OF CELL SHAPE,5.4121e-05,0.21871,0.20765,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00050664,0.21866,0.18765,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00072223,0.21866,0.22291,1,1
5,GO ROOF OF MOUTH DEVELOPMENT,0.00065623,0.21864,0.20028,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013139,0.2185,0.16614,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0022332,0.21811,0.21586,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.0015189,0.21808,0.22713,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0085714,0.21798,0.19078,1,1
5,GO NEURON MATURATION,0.00074557,0.21797,0.23494,1,1
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0013054,0.2178,0.20262,1,1
5,GO STEROL TRANSPORT,0.0029794,0.21778,0.15338,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.0053338,0.21773,0.15772,1,1
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0090226,0.21767,0.34076,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00036427,0.21765,0.20352,1,1
5,GO POSTSYNAPSE ORGANIZATION,0.00040247,0.21748,0.24055,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,1.0184e-05,0.21746,0.2056,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.014841,0.21728,0.23299,1,1
5,GO EMBRYONIC MORPHOGENESIS,4.2876e-06,0.21725,0.19825,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0021062,0.21719,0.20954,1,1
5,GO RESPONSE TO MUSCLE ACTIVITY,0.017137,0.21705,0.19456,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.21702,0.30679,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.001191,0.21701,0.2241,1,1
5,GO DIOL METABOLIC PROCESS,0.020205,0.21695,0.16611,1,1
5,GO RESPONSE TO NUTRIENT,0.00037661,0.21689,0.18546,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00013917,0.21683,0.25795,1,1
5,GO HISTAMINE TRANSPORT,0.02843,0.21677,0.25772,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.00019079,0.21671,0.18762,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.0014299,0.21666,0.17778,1,1
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.0020453,0.21662,0.31247,1,1
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.010506,0.21662,0.20316,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,1.0604e-05,0.21659,0.2106,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00087311,0.21656,0.23904,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.045624,0.21636,0.23234,1,1
5,GO SCHWANN CELL DIFFERENTIATION,0.00020448,0.21623,0.19182,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00021167,0.21616,0.19885,1,1
5,GO AXONEME ASSEMBLY,0.00010462,0.21602,0.27037,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0056288,0.21576,0.16107,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010845,0.21573,0.16524,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0019282,0.21571,0.17927,1,1
5,GO REGULATION OF ICOSANOID SECRETION,0.0016129,0.21552,0.19774,1,1
5,GO MUSCLE FIBER DEVELOPMENT,6.0504e-05,0.21537,0.23701,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,1.8521e-05,0.21535,0.17154,1,1
5,GO PEPTIDE SECRETION,1.4039e-05,0.21534,0.17513,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.00055855,0.21532,0.19711,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00023468,0.21528,0.16177,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,7.9801e-06,0.21525,0.28758,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.037747,0.21521,0.17397,1,1
5,GO TERPENOID METABOLIC PROCESS,0.00013433,0.21502,0.20458,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00090094,0.21501,0.15025,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.00050664,0.21497,0.17065,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,7.889e-07,0.21494,0.21575,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0022992,0.21488,0.19232,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0021062,0.21484,0.16568,1,1
5,GO MEMBRANE REPOLARIZATION,0.0057817,0.21407,0.21582,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.027803,0.21395,0.11859,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00049035,0.21386,0.17665,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.027803,0.21377,0.21404,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00018427,0.21359,0.25041,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.00028792,0.21351,0.20398,1,1
5,GO NOSE DEVELOPMENT,0.0045306,0.21343,0.43211,1,1
5,GO TAXIS,2.1702e-06,0.21341,0.21794,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.00019753,0.21337,0.18953,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,7.2754e-05,0.21324,0.21462,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.012203,0.21316,0.15483,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.013465,0.21307,0.17882,1,1
5,GO CELL KILLING,0.0016129,0.21306,0.1609,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00032948,0.21301,0.21203,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.014486,0.21296,0.19281,1,1
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.013465,0.2129,0.20393,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.00057693,0.21284,0.15598,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.012203,0.21283,0.19532,1,1
5,GO LIPID MODIFICATION,0.00031859,0.2127,0.14306,1,1
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0081404,0.2126,0.22685,1,1
5,GO REGULATION OF CHROMATIN BINDING,0.00092958,0.21251,0.20016,1,1
5,GO PROTEIN PALMITOYLATION,7.547e-05,0.21247,0.23951,1,1
5,GO SEQUESTERING OF TRIGLYCERIDE,0.016734,0.21241,0.212,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.019739,0.21236,0.16672,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,4.6597e-05,0.21236,0.20083,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.00087311,0.21191,0.21359,1,1
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.017549,0.21177,0.21037,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0059384,0.21125,0.19049,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.0013054,0.21121,0.16848,1,1
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.040234,0.21094,0.19623,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0010206,0.21083,0.2298,1,1
5,GO TRABECULA FORMATION,0.0099891,0.21079,0.17643,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,5.6174e-05,0.21074,0.18688,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0007696,0.21072,0.18721,1,1
5,GO STEM CELL PROLIFERATION,1.1964e-05,0.21063,0.21671,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.00031859,0.21063,0.24341,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00038934,0.21063,0.17775,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0051916,0.21054,0.18459,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0038387,0.21051,0.21994,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00026003,0.2105,0.18389,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.1493e-05,0.21045,0.18124,1,1
5,GO EPITHELIAL TUBE FORMATION,2.0833e-05,0.21042,0.19978,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.0015653,0.21038,0.21939,1,1
5,GO PANCREAS DEVELOPMENT,0.00069957,0.21034,0.24716,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0029794,0.21018,0.18118,1,1
5,GO P38MAPK CASCADE,0.0011549,0.21013,0.198,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00023468,0.21002,0.17386,1,1
5,GO EPITHELIUM DEVELOPMENT,4.4712e-06,0.20996,0.20973,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.00067758,0.20985,0.17191,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,4.8379e-05,0.20974,0.23019,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00021909,0.20963,0.19743,1,1
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0066042,0.20959,0.16083,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0010859,0.20952,0.21321,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,2.4346e-05,0.20952,0.17797,1,1
5,GO MALE SEX DIFFERENTIATION,7.9801e-06,0.20948,0.20418,1,1
5,GO LEUKOCYTE PROLIFERATION,9.7346e-05,0.20941,0.21476,1,1
5,GO TISSUE MIGRATION,0.00079435,0.20941,0.18703,1,1
5,GO RESPONSE TO ZINC ION,0.0081404,0.20939,0.19133,1,1
5,GO REGULATION OF SYSTEM PROCESS,1.2962e-05,0.20937,0.20085,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0024367,0.20934,0.37287,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,1.1964e-05,0.20933,0.18154,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.00010845,0.2093,0.20304,1,1
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.018398,0.20929,0.24062,1,1
5,GO REGULATION OF CILIUM MOVEMENT,6.5149e-05,0.20926,0.20825,1,1
5,GO PHOSPHOLIPID TRANSPORT,5.6174e-05,0.20909,0.19249,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.013e-05,0.20887,0.21715,1,1
5,GO GROWTH HORMONE SECRETION,0.00090094,0.20881,0.33485,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.013e-05,0.20873,0.19039,1,1
5,GO THYMIC T CELL SELECTION,1.8521e-05,0.20868,0.22048,1,1
5,GO CELL JUNCTION ORGANIZATION,3.5759e-05,0.20832,0.2005,1,1
5,GO REGULATION OF TUBE SIZE,0.00027832,0.20831,0.16807,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0037331,0.20828,0.18022,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0010528,0.20799,0.21334,1,1
5,GO LYMPH VESSEL DEVELOPMENT,0.02166,0.20793,0.15264,1,1
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021062,0.20793,0.18241,1,1
5,GO ORGAN INDUCTION,0.0011549,0.20776,0.23518,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00050664,0.20775,0.24381,1,1
5,GO FOREBRAIN MORPHOGENESIS,0.027188,0.20769,0.17351,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.017969,0.20767,0.19041,1,1
5,GO RESPONSE TO DRUG,0.00020448,0.20761,0.16907,1,1
5,GO EYE MORPHOGENESIS,6.0504e-05,0.20759,0.18741,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,0.20759,0.1666,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.050569,0.20747,0.11832,1,1
5,GO PROTEIN DEMANNOSYLATION,0.02268,0.20746,0.15085,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00081984,0.20741,0.24623,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0049174,0.20721,0.21121,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0027346,0.20715,0.19153,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.4121e-05,0.2071,0.20641,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.00095906,0.20698,0.20167,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.0010528,0.20689,0.16784,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0019282,0.20658,0.18286,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.0001165,0.20655,0.18089,1,1
5,GO INSEMINATION,0.0090226,0.20652,0.21529,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,8.4205e-05,0.20639,0.19775,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.020205,0.20636,0.16157,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.045624,0.20629,0.15981,1,1
5,GO BONE REMODELING,0.0034322,0.20624,0.22404,1,1
5,GO T CELL DIFFERENTIATION,6.0504e-05,0.20616,0.17583,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,2.1702e-06,0.20606,0.18506,1,1
5,GO EMBRYONIC EYE MORPHOGENESIS,0.0037331,0.20597,0.1872,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0069616,0.20576,0.14982,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00030804,0.2057,0.17653,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.001191,0.20561,0.22563,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0066042,0.20559,0.23962,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0064317,0.20557,0.18915,1,1
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0094949,0.20526,0.16038,1,1
5,GO REGULATION OF CALCIUM ION IMPORT,0.0066042,0.20484,0.15483,1,1
5,GO REGULATION OF PEPTIDE SECRETION,1.1964e-05,0.20472,0.17338,1,1
5,GO CELL JUNCTION ASSEMBLY,6.2786e-05,0.20464,0.19499,1,1
5,GO FEMALE SEX DIFFERENTIATION,4.1617e-05,0.2046,0.19626,1,1
5,GO B CELL ACTIVATION,0.0011549,0.20455,0.16595,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00081984,0.20419,0.20817,1,1
5,GO MOTILE CILIUM ASSEMBLY,0.027188,0.20407,0.18977,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.017137,0.20404,0.1289,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,1.5201e-05,0.20402,0.17298,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.02166,0.20363,0.15484,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0028141,0.20357,0.26419,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014418,0.20341,0.18132,1,1
5,GO EXTRACELLULAR TRANSPORT,0.018398,0.20341,0.15488,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.00019079,0.20341,0.28785,1,1
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.017137,0.20336,0.19384,1,1
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.010506,0.20326,0.13475,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00027832,0.20288,0.19731,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0019282,0.20288,0.18035,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.00014418,0.20287,0.16118,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.026586,0.20283,0.17762,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00023468,0.20264,0.19093,1,1
5,GO REGULATION OF BLOOD CIRCULATION,4.6597e-05,0.20252,0.22478,1,1
5,GO THYMUS DEVELOPMENT,0.0013872,0.20247,0.18974,1,1
5,GO RESPONSE TO PROSTAGLANDIN,0.007729,0.20245,0.14875,1,1
5,GO LOCOMOTORY BEHAVIOR,0.0022992,0.20235,0.19096,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00069957,0.20219,0.16406,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00063551,0.20217,0.16538,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0024367,0.20214,0.16809,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.023205,0.2021,0.13819,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.02068,0.20204,0.15773,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0045306,0.20202,0.16978,1,1
5,GO RESPONSE TO BACTERIUM,0.0010859,0.20188,0.15837,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00012512,0.20188,0.18997,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,4.4878e-05,0.20186,0.17524,1,1
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0017641,0.20168,0.22459,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0024367,0.20159,0.15383,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.0184e-05,0.20145,0.21726,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.00036427,0.2014,0.1737,1,1
5,GO INTERLEUKIN 12 PRODUCTION,0.0015653,0.2014,0.19585,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,3.7145e-05,0.2014,0.21995,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00072223,0.20134,0.17549,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0027346,0.2013,0.15061,1,1
5,GO REGULATION OF LIPID STORAGE,3.5759e-05,0.20127,0.21897,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.017549,0.20117,0.11791,1,1
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.036164,0.20076,0.21692,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,2.8418e-05,0.20075,0.23005,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,1.1964e-05,0.20073,0.18756,1,1
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0034322,0.20061,0.17918,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.0689e-05,0.20051,0.18245,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00353,0.2005,0.16962,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.00054072,0.20046,0.19457,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00021167,0.20044,0.26412,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0039469,0.20042,0.1602,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.0057817,0.20038,0.20837,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00022676,0.20037,0.25045,1,1
5,GO CHONDROCYTE DEVELOPMENT,0.00079435,0.20035,0.28394,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0059384,0.2003,0.16864,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00026903,0.20024,0.16384,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.8583e-05,0.19996,0.18431,1,1
5,GO RESPONSE TO KETONE,0.00067758,0.19991,0.15266,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00092958,0.19991,0.22647,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0047853,0.19986,0.18239,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.00067758,0.19973,0.1993,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.010506,0.19971,0.16044,1,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.001191,0.19959,0.16948,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0029794,0.19953,0.15996,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0015653,0.19953,0.19663,1,1
5,GO O GLYCAN PROCESSING,0.014486,0.1994,0.23857,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.011904,0.1993,0.18539,1,1
5,GO LYMPHOCYTE ACTIVATION,5.8301e-05,0.19917,0.18157,1,1
5,GO COAGULATION,0.001872,0.19914,0.1563,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028957,0.1991,0.1794,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00012964,0.19908,0.19776,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00023468,0.19907,0.17924,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00018427,0.19904,0.17785,1,1
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0094949,0.1989,0.15381,1,1
5,GO RESPONSE TO CYTOKINE,0.0013054,0.1989,0.15874,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0010859,0.19886,0.20645,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,5.0226e-05,0.19882,0.17736,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0012662,0.1988,0.20151,1,1
5,GO RESPONSE TO AMPHETAMINE,0.03939,0.19879,0.1667,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,0.021165,0.19876,0.23595,1,1
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.019283,0.19867,0.19406,1,1
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0071468,0.19863,0.1986,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.0010528,0.19855,0.20926,1,1
5,GO POSITIVE REGULATION OF SIGNALING,4.2876e-06,0.19853,0.16645,1,1
5,GO DEVELOPMENTAL MATURATION,2.3418e-05,0.19849,0.18568,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,9.0551e-05,0.19842,0.16574,1,1
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0017641,0.19818,0.27085,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.020205,0.19764,0.13632,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,1.0184e-05,0.19764,0.18615,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.011612,0.19745,0.19199,1,1
5,GO CHLORIDE TRANSPORT,0.00016023,0.19736,0.17874,1,1
5,GO REGULATION OF PROTEIN MATURATION,0.0085714,0.19728,0.14314,1,1
5,GO OSTEOBLAST DIFFERENTIATION,0.00067758,0.19721,0.20363,1,1
5,GO HEART MORPHOGENESIS,0.00011241,0.1971,0.19623,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0021689,0.19709,0.20414,1,1
5,GO LIPID HOMEOSTASIS,6.5149e-05,0.19709,0.16929,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.01282,0.19698,0.1418,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.007729,0.19692,0.16572,1,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0030654,0.1968,0.18539,1,1
5,GO SECRETION,8.4205e-05,0.19676,0.14872,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00012964,0.19673,0.21234,1,1
5,GO REPLACEMENT OSSIFICATION,0.0039469,0.19671,0.2344,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,7.8282e-05,0.19671,0.16769,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.015574,0.19658,0.32099,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00026003,0.19657,0.1871,1,1
5,GO CHOLESTEROL STORAGE,0.00095906,0.19652,0.21225,1,1
5,GO AMYLOID BETA FORMATION,0.010245,0.19646,0.22757,1,1
5,GO EXOCYTOSIS,0.0011549,0.19643,0.14309,1,1
5,GO LEUKOCYTE DIFFERENTIATION,4.0073e-05,0.19642,0.17146,1,1
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0014738,0.19641,0.22389,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.00050664,0.19624,0.16663,1,1
5,GO RESPONSE TO FATTY ACID,0.0010206,0.1962,0.16805,1,1
5,GO SYNAPSE ORGANIZATION,0.00090094,0.19615,0.20198,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00044439,0.1961,0.23779,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00018427,0.19603,0.16927,1,1
5,GO CELL GROWTH,9.0179e-06,0.19593,0.18554,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,9.0179e-06,0.19565,0.1787,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0030654,0.19551,0.18124,1,1
5,GO DEVELOPMENTAL GROWTH,4.4878e-05,0.19548,0.17485,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,6.7596e-05,0.19538,0.18907,1,1
5,GO HEART DEVELOPMENT,5.2139e-05,0.19528,0.16769,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0083534,0.19528,0.15688,1,1
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00018427,0.19522,0.2602,1,1
5,GO TISSUE HOMEOSTASIS,8.7323e-05,0.19509,0.1636,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.00087311,0.19502,0.17787,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,1.4039e-05,0.19502,0.21179,1,1
5,GO TUBULIN DEACETYLATION,0.0045306,0.19499,0.20765,1,1
5,GO NEURAL TUBE DEVELOPMENT,8.1192e-05,0.19499,0.18371,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.013139,0.19487,0.27202,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.050569,0.19484,0.10699,1,1
5,GO REGULATION OF TISSUE REMODELING,0.0027346,0.19467,0.20542,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.00037661,0.19454,0.19873,1,1
5,GO MUSCLE ATROPHY,0.016339,0.19446,0.17645,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00023468,0.19444,0.17875,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,7.9801e-06,0.19432,0.18864,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00052342,0.19419,0.17937,1,1
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.041093,0.19364,0.22335,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00028792,0.19362,0.1619,1,1
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0029794,0.19359,0.16991,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00025131,0.19358,0.17914,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,3.5759e-05,0.19356,0.16763,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.00045924,0.19334,0.25307,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.001662,0.19324,0.21149,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00029782,0.19315,0.18369,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.024288,0.19314,0.15812,1,1
5,GO MUSCLE ADAPTATION,0.00036427,0.19306,0.17866,1,1
5,GO SYNAPSE ASSEMBLY,0.0037331,0.193,0.20454,1,1
5,GO INFLAMMATORY RESPONSE,0.00017796,0.19298,0.1881,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,8.1192e-05,0.19293,0.18746,1,1
5,GO SCHWANN CELL DEVELOPMENT,0.00072223,0.19292,0.17757,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,7.2754e-05,0.19286,0.19098,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00036427,0.19235,0.16305,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.0025817,0.19232,0.13496,1,1
5,GO SENSORY ORGAN DEVELOPMENT,3.6228e-06,0.19217,0.20961,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.001662,0.19211,0.1592,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.00017796,0.192,0.17122,1,1
5,GO STRESS FIBER ASSEMBLY,0.00040247,0.19199,0.18937,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00069957,0.19198,0.22464,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0094949,0.19193,0.14531,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.0054795,0.19187,0.19518,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,9.7801e-06,0.19161,0.20356,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02166,0.19142,0.21516,1,1
5,GO REGULATION OF LIPID TRANSPORT,8.4205e-05,0.1913,0.17517,1,1
5,GO RESPONSE TO GROWTH FACTOR,4.8379e-05,0.19103,0.17961,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00022676,0.19102,0.16913,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00037661,0.1909,0.2752,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0022332,0.19087,0.14079,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0010859,0.1906,0.13511,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.015953,0.19043,0.12891,1,1
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0015653,0.19031,0.2175,1,1
5,GO GROWTH,3.1904e-06,0.19029,0.17506,1,1
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0010859,0.19026,0.20337,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0053338,0.19021,0.20674,1,1
5,GO PROTEIN POLYGLUTAMYLATION,0.0016129,0.19014,0.20579,1,1
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.023205,0.19012,0.14525,1,1
5,GO CARDIAC CHAMBER DEVELOPMENT,0.0071468,0.19006,0.14137,1,1
5,GO HORMONE TRANSPORT,3.8583e-05,0.18997,0.19401,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00037661,0.18988,0.15724,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.011904,0.18986,0.11828,1,1
5,GO LIPID EXPORT FROM CELL,0.0047853,0.18985,0.13899,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.001986,0.18968,0.2197,1,1
5,GO POSITIVE REGULATION OF SECRETION,5.2139e-05,0.18967,0.16833,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.00037661,0.18963,0.18102,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,6.7728e-06,0.18962,0.20613,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0006154,0.18956,0.16341,1,1
5,GO CYTOKINE PRODUCTION,0.00095906,0.18951,0.17515,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.9532e-05,0.1895,0.18311,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.8379e-05,0.18948,0.15152,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.036948,0.18945,0.14271,1,1
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.013798,0.18938,0.16652,1,1
5,GO REGULATION OF DEFENSE RESPONSE,0.0025083,0.18936,0.13148,1,1
5,GO PROTEIN PROCESSING,0.0034322,0.18936,0.14196,1,1
5,GO POSITIVE T CELL SELECTION,0.00041602,0.18925,0.16203,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00017186,0.18923,0.15982,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,5.8301e-05,0.18922,0.17136,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,1.8521e-05,0.18914,0.1745,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0060989,0.18908,0.18394,1,1
5,GO REGULATION OF HORMONE SECRETION,4.8379e-05,0.18905,0.18547,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.9263e-05,0.18903,0.176,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00059588,0.18893,0.16471,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0038387,0.18883,0.17313,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,3.4421e-05,0.18857,0.19178,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00019079,0.18838,0.20551,1,1
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.042857,0.18824,0.1101,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0024367,0.18821,0.18682,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,2.7343e-05,0.18791,0.18138,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.00014418,0.18788,0.29832,1,1
5,GO HEART PROCESS,4.4878e-05,0.18783,0.22561,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.0083534,0.18781,0.15332,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,3.3132e-05,0.18751,0.16921,1,1
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0022992,0.18745,0.12328,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0028141,0.18744,0.20718,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,2.4346e-05,0.18743,0.23886,1,1
5,GO REGULATION OF AXONOGENESIS,0.0060989,0.18696,0.20232,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,2.2524e-05,0.18688,0.20207,1,1
5,GO REGULATION OF PHOSPHORYLATION,2.8418e-05,0.18687,0.15636,1,1
5,GO POST ANAL TAIL MORPHOGENESIS,0.025414,0.18677,0.16102,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,2.6307e-05,0.18675,0.16629,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00063551,0.18666,0.23303,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00069957,0.18661,0.28895,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.033166,0.18647,0.12047,1,1
5,GO T CELL APOPTOTIC PROCESS,0.013465,0.18643,0.14838,1,1
5,GO SPINAL CORD DEVELOPMENT,0.0046564,0.18641,0.19384,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.00032948,0.1863,0.1841,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00079435,0.18625,0.15648,1,1
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0024367,0.18621,0.21037,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.027803,0.18613,0.16663,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.0029794,0.18587,0.15709,1,1
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0087944,0.18584,0.21675,1,1
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00057693,0.18579,0.18442,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.014841,0.18564,0.15906,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.0016129,0.18545,0.18914,1,1
5,GO ARTERY MORPHOGENESIS,0.007729,0.18543,0.12153,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.00010462,0.1854,0.15613,1,1
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.031059,0.18532,0.20279,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,7.547e-05,0.18526,0.1807,1,1
5,GO ALANINE TRANSPORT,0.04854,0.1852,0.11555,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,2.7343e-05,0.18518,0.16213,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0029794,0.18511,0.15486,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.013e-05,0.1851,0.15643,1,1
5,GO MAINTENANCE OF CELL NUMBER,0.00090094,0.18494,0.12725,1,1
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.0079323,0.1848,0.20545,1,1
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0067808,0.18468,0.21883,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.7806e-05,0.18467,0.15242,1,1
5,GO CELL MATURATION,9.3916e-06,0.18464,0.18074,1,1
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0029794,0.18462,0.18177,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0038387,0.18454,0.15165,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00090094,0.18442,0.12888,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00027832,0.18433,0.2151,1,1
5,GO SULFATION,0.0066042,0.18426,0.15236,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.5816e-05,0.1842,0.16677,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,2.7343e-05,0.1842,0.17719,1,1
5,GO TRANSLESION SYNTHESIS,0.0019282,0.18412,0.14891,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00017796,0.1839,0.15154,1,1
5,GO INTEGRIN ACTIVATION,0.041967,0.18389,0.15189,1,1
5,GO HUMORAL IMMUNE RESPONSE,3.1888e-05,0.18377,0.24261,1,1
5,GO NEGATIVE REGULATION OF GROWTH,1.1493e-05,0.18368,0.19181,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0042883,0.18363,0.18913,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.00095906,0.18355,0.18787,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.00013433,0.18344,0.17461,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00027832,0.18341,0.14114,1,1
5,GO ACTION POTENTIAL,0.0085714,0.18337,0.17839,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.023741,0.18335,0.11803,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.00084609,0.18329,0.16718,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.00057693,0.18328,0.17151,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.015574,0.18323,0.19029,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00010462,0.18322,0.23503,1,1
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.011612,0.18322,0.1757,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.023205,0.18319,0.17048,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00065623,0.183,0.14676,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00098941,0.18297,0.2278,1,1
5,GO CHONDROCYTE PROLIFERATION,0.02068,0.18295,0.17329,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00042998,0.18272,0.15673,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0041716,0.18271,0.28045,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0015653,0.1827,0.15989,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.024288,0.18267,0.15913,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.00044439,0.18254,0.18672,1,1
5,GO RESPONSE TO DOPAMINE,0.00098941,0.18251,0.18508,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.8282e-05,0.18249,0.15393,1,1
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.024846,0.18222,0.14725,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,0.00019753,0.18207,0.19268,1,1
5,GO NEURAL RETINA DEVELOPMENT,0.045624,0.18204,0.13451,1,1
5,GO RESPONSE TO ESTRADIOL,9.7346e-05,0.18203,0.17204,1,1
5,GO NEGATIVE T CELL SELECTION,0.010245,0.18198,0.21593,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0079323,0.18194,0.18006,1,1
5,GO REGULATION OF PROTEOLYSIS,0.0012662,0.18193,0.14795,1,1
5,GO ACUTE PHASE RESPONSE,0.0013054,0.18187,0.15137,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0032441,0.18175,0.18699,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0042883,0.18169,0.27446,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,0.03939,0.18164,0.17788,1,1
5,GO SPROUTING ANGIOGENESIS,0.0021689,0.18161,0.15706,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.014841,0.18157,0.15609,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.0022992,0.18151,0.18813,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.9532e-05,0.18144,0.16493,1,1
5,GO CYTOKINE SECRETION,0.001191,0.18136,0.18242,1,1
5,GO REGULATION OF MAPK CASCADE,2.1663e-05,0.18136,0.20757,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00037661,0.18126,0.1373,1,1
5,GO NEUTROPHIL MIGRATION,0.0033369,0.18102,0.12229,1,1
5,GO REGIONALIZATION,0.00010462,0.18087,0.17911,1,1
5,GO RESPONSE TO STEROID HORMONE,9.7346e-05,0.18085,0.17613,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.01282,0.18079,0.15674,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.00098941,0.18074,0.18993,1,1
5,GO RESPONSE TO IRON ION,0.015574,0.18074,0.17554,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0087944,0.18055,0.1202,1,1
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.043763,0.18049,0.12862,1,1
5,GO CELL MORPHOGENESIS,0.00017186,0.18032,0.17475,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,3.1888e-05,0.18025,0.15946,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00013917,0.18019,0.16311,1,1
5,GO CELLULAR EXTRAVASATION,0.0023671,0.18013,0.14696,1,1
5,GO LIPID METABOLIC PROCESS,0.00092958,0.18009,0.13055,1,1
5,GO NEURON APOPTOTIC PROCESS,1.0604e-05,0.18008,0.15886,1,1
5,GO RESPONSE TO FUNGUS,0.00030804,0.17997,0.23555,1,1
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0083534,0.1799,0.23791,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.00019079,0.17967,0.15695,1,1
5,GO ANIMAL ORGAN FORMATION,0.0033369,0.17966,0.16682,1,1
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.043763,0.1795,0.11701,1,1
5,GO RESPONSE TO LIPID,0.00016595,0.17948,0.15969,1,1
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00010845,0.17943,0.21535,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.05161,0.1794,0.10346,1,1
5,GO MONOAMINE TRANSPORT,0.010245,0.17931,0.25001,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.02843,0.17923,0.15393,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0006154,0.17909,0.18925,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.011904,0.17906,0.13229,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00072223,0.17899,0.24215,1,1
5,GO CELL CELL SIGNALING BY WNT,2.2524e-05,0.17879,0.15846,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.00067758,0.17867,0.16026,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,2.9532e-05,0.17837,0.21021,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,3.7145e-05,0.17829,0.15232,1,1
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.02068,0.17824,0.18425,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00036427,0.17808,0.17303,1,1
5,GO PROTEIN DEMETHYLATION,0.017969,0.17803,0.13897,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00010845,0.17784,0.19353,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.02068,0.17765,0.14421,1,1
5,GO REGULATION OF HEMOPOIESIS,0.00016595,0.17757,0.15564,1,1
5,GO NEUROBLAST PROLIFERATION,2.8418e-05,0.17756,0.25869,1,1
5,GO GLYCOSYLATION,0.0059384,0.17752,0.15785,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0067808,0.17747,0.15689,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00010462,0.17745,0.19125,1,1
5,GO PEPTIDE HORMONE SECRETION,0.00022676,0.17733,0.18852,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.5331e-06,0.17726,0.16996,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,6.5149e-05,0.17716,0.18873,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.036948,0.17701,0.14686,1,1
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.013465,0.17686,0.21262,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.9263e-05,0.17686,0.1548,1,1
5,GO INORGANIC ANION TRANSPORT,0.00030804,0.17679,0.15309,1,1
5,GO ERBB SIGNALING PATHWAY,0.001228,0.17671,0.17004,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.0184e-05,0.17666,0.15721,1,1
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0010859,0.17663,0.18079,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.00030804,0.1765,0.19861,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00092958,0.17643,0.15713,1,1
5,GO CELL CELL SIGNALING,1.4609e-05,0.17634,0.16857,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.5201e-05,0.17626,0.2059,1,1
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.043763,0.17625,0.14828,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,2.4346e-05,0.17618,0.16461,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,5.4121e-05,0.17618,0.14792,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00014935,0.17615,0.1638,1,1
5,GO HINDBRAIN DEVELOPMENT,3.4421e-05,0.17603,0.22758,1,1
5,GO STEROL METABOLIC PROCESS,0.016734,0.17595,0.12846,1,1
5,GO RELAXATION OF MUSCLE,0.050569,0.17588,0.15892,1,1
5,GO DIET INDUCED THERMOGENESIS,0.01282,0.17586,0.16566,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.00023468,0.17581,0.1423,1,1
5,GO REGULATION OF HORMONE LEVELS,1.7806e-05,0.17564,0.17387,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.031748,0.17556,0.16833,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.007729,0.17547,0.18383,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0033369,0.1754,0.17281,1,1
5,GO REGULATION OF ANION TRANSPORT,0.0059384,0.17536,0.12417,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,9.0551e-05,0.17534,0.16213,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,3.0689e-05,0.17531,0.17236,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00045924,0.17528,0.17737,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0033369,0.17516,0.14466,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,1.1964e-05,0.17514,0.15809,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0094949,0.17511,0.13028,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.019739,0.17506,0.12179,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,9.0551e-05,0.17494,0.14231,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.0010206,0.17493,0.12507,1,1
5,GO SECRETION BY TISSUE,0.025994,0.17478,0.15638,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.4346e-05,0.17473,0.17641,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0057817,0.17467,0.25401,1,1
5,GO REPRODUCTION,1.8251e-06,0.17466,0.1561,1,1
5,GO INTERMEMBRANE LIPID TRANSFER,0.011047,0.17462,0.10747,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,7.9801e-06,0.17457,0.16896,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.014841,0.17441,0.17566,1,1
5,GO DORSAL VENTRAL PATTERN FORMATION,0.00081984,0.1744,0.20157,1,1
5,GO REGULATION OF ION TRANSPORT,0.00031859,0.17437,0.15685,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.17406,0.18123,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,2.4346e-05,0.17401,0.16824,1,1
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.04854,0.17395,0.16242,1,1
5,GO REGULATION OF HEART RATE,0.010245,0.17382,0.16828,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.022165,0.17367,0.17247,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.00014418,0.17363,0.17487,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00029782,0.17361,0.1641,1,1
5,GO SARCOMERE ORGANIZATION,0.00027832,0.17352,0.20632,1,1
5,GO CHEMICAL HOMEOSTASIS,1.9263e-05,0.17343,0.15487,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00038934,0.17337,0.15383,1,1
5,GO BEHAVIOR,0.00045924,0.17327,0.16419,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,5.2139e-05,0.17327,0.15637,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0033369,0.17324,0.17059,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0021689,0.17322,0.16328,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00031859,0.173,0.19635,1,1
5,GO FOREGUT MORPHOGENESIS,0.015574,0.17293,0.20493,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.017969,0.17288,0.15798,1,1
5,GO CIRCULATORY SYSTEM PROCESS,3.4421e-05,0.17266,0.18285,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.5308e-05,0.17259,0.1477,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0094949,0.17246,0.13396,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.036948,0.17239,0.15418,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.010773,0.17234,0.16789,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,1.7474e-06,0.17231,0.17497,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00092958,0.17213,0.11711,1,1
5,GO REGULATION OF SECRETION,3.7145e-05,0.17211,0.16167,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014418,0.17211,0.20788,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,1.0184e-05,0.17208,0.15334,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,2.6307e-05,0.17206,0.14505,1,1
5,GO EXCRETION,0.00020448,0.17204,0.17694,1,1
5,GO CHOLESTEROL EFFLUX,0.00054072,0.17201,0.16026,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00063551,0.17193,0.15815,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.010773,0.1719,0.13474,1,1
5,GO ION HOMEOSTASIS,0.0001547,0.1717,0.13661,1,1
5,GO EATING BEHAVIOR,0.00084609,0.17166,0.19791,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,1.349e-05,0.17151,0.17206,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,3.0689e-05,0.1715,0.17898,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00026003,0.17125,0.17595,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00028792,0.17094,0.16884,1,1
5,GO EMBRYO DEVELOPMENT,1.4039e-05,0.17087,0.14941,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.049546,0.17085,0.12636,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00030804,0.1708,0.18387,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0017123,0.17077,0.19615,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.023205,0.17064,0.18646,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.013465,0.17063,0.17551,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0087944,0.17058,0.14307,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00065623,0.17041,0.11545,1,1
5,GO FACE DEVELOPMENT,0.0060989,0.17035,0.16271,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,9.7346e-05,0.17032,0.15693,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.00035231,0.17026,0.14488,1,1
5,GO WATER TRANSPORT,0.0085714,0.17024,0.17324,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00067758,0.17023,0.19082,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,0.0019282,0.17015,0.1423,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.001191,0.16992,0.18586,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0075304,0.1697,0.14062,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00041602,0.16968,0.18315,1,1
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0013054,0.16948,0.15908,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.010506,0.16948,0.13453,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00040247,0.16946,0.20566,1,1
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.052669,0.16924,0.10491,1,1
5,GO IMPORT INTO CELL,0.0010206,0.16918,0.16453,1,1
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0079323,0.16904,0.13688,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.018398,0.169,0.26822,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,1.6455e-05,0.16897,0.1477,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.013e-05,0.16881,0.14588,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,6.0504e-05,0.16877,0.14866,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.0033e-05,0.16863,0.15935,1,1
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.035393,0.16854,0.17127,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0066042,0.16849,0.1433,1,1
5,GO JNK CASCADE,1.349e-05,0.16844,0.16941,1,1
5,GO NEGATIVE REGULATION OF BINDING,3.3132e-05,0.16841,0.15864,1,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.0097392,0.16813,0.19085,1,1
5,GO CALCIUM MEDIATED SIGNALING,3.3132e-05,0.16794,0.16638,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0022332,0.16791,0.1976,1,1
5,GO REGULATION OF GROWTH,1.9904e-06,0.16781,0.17739,1,1
5,GO VACUOLAR TRANSPORT,0.0075304,0.16764,0.10428,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.0012662,0.16749,0.13006,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.054842,0.16749,0.14473,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.022165,0.1674,0.14635,1,1
5,GO MESODERM DEVELOPMENT,0.00010462,0.16735,0.16739,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.014138,0.16712,0.16393,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,4.0073e-05,0.167,0.20969,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00010092,0.16686,0.18111,1,1
5,GO CARDIOCYTE DIFFERENTIATION,0.0024367,0.16679,0.1429,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.031748,0.16676,0.12738,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00072223,0.16669,0.14521,1,1
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.011326,0.16664,0.28917,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00014418,0.16646,0.15124,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0006154,0.16639,0.14985,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.011904,0.16632,0.14346,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.047551,0.16632,0.15653,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,1.4039e-05,0.16607,0.16169,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.0031536,0.16605,0.15312,1,1
5,GO CARTILAGE DEVELOPMENT,0.00063551,0.16579,0.16645,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,1.5816e-05,0.16575,0.1544,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0036303,0.16575,0.13935,1,1
5,GO METENCEPHALON DEVELOPMENT,0.0017641,0.16562,0.21066,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,1.104e-05,0.16535,0.2178,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00072223,0.16533,0.1569,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021909,0.16521,0.204,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,8.1192e-05,0.16521,0.13794,1,1
5,GO REGULATION OF CELL DEVELOPMENT,8.7323e-05,0.16517,0.18043,1,1
5,GO HOMEOSTATIC PROCESS,9.0551e-05,0.16516,0.12293,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.00012074,0.16513,0.17451,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0022992,0.16505,0.1734,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.0028957,0.1648,0.1428,1,1
5,GO CELL VOLUME HOMEOSTASIS,8.7323e-05,0.1647,0.16053,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.045624,0.16446,0.14407,1,1
5,GO RESPONSE TO COPPER ION,0.055956,0.16435,0.19055,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0064317,0.16434,0.21452,1,1
5,GO RESPONSE TO CALCIUM ION,0.0041716,0.16408,0.14723,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0024367,0.16397,0.11903,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.00063551,0.16392,0.17938,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,4.1617e-05,0.16375,0.15051,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.00021167,0.16374,0.12538,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,4.4878e-05,0.16348,0.15419,1,1
5,GO RECEPTOR METABOLIC PROCESS,9.0551e-05,0.16335,0.1601,1,1
5,GO FOREBRAIN CELL MIGRATION,0.029068,0.1632,0.14796,1,1
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.022165,0.16314,0.13096,1,1
5,GO INTERFERON GAMMA PRODUCTION,0.0073363,0.16301,0.12347,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,0.00050664,0.16273,0.13261,1,1
5,GO T CELL SELECTION,0.0006154,0.16268,0.14656,1,1
5,GO MICROTUBULE SEVERING,0.011047,0.16266,0.16473,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00035231,0.16266,0.1706,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.001872,0.16238,0.13166,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.034637,0.16227,0.13981,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0085714,0.16226,0.090097,1,1
5,GO METAL ION TRANSPORT,0.00019753,0.16224,0.14459,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.016734,0.16222,0.14365,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00092958,0.16213,0.21429,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0062634,0.16201,0.17385,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00052342,0.16175,0.15438,1,1
5,GO RESPONSE TO METAL ION,0.00034072,0.16169,0.15255,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.001872,0.16154,0.15673,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,6.2786e-05,0.16152,0.14965,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00095906,0.16147,0.13305,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.8379e-05,0.16115,0.14843,1,1
5,GO RETINA HOMEOSTASIS,0.00022676,0.16079,0.14443,1,1
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.024288,0.16061,0.1681,1,1
5,GO BONE DEVELOPMENT,0.00353,0.16058,0.13649,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.038561,0.16054,0.18456,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.01282,0.16047,0.13508,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.0056288,0.16031,0.10982,1,1
5,GO EMBRYONIC ORGAN MORPHOGENESIS,1.4039e-05,0.15998,0.1958,1,1
5,GO DETECTION OF STIMULUS,4.0073e-05,0.15991,0.13992,1,1
5,GO REGULATION OF TRANSPORT,5.6174e-05,0.15975,0.13581,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00013917,0.15972,0.15066,1,1
5,GO POTASSIUM ION TRANSPORT,0.00067758,0.15963,0.20082,1,1
5,GO RESPONSE TO HORMONE,0.00027832,0.15957,0.13342,1,1
5,GO FEEDING BEHAVIOR,0.00353,0.15942,0.13923,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0014299,0.15929,0.17261,1,1
5,GO RESPONSE TO STARVATION,6.2786e-05,0.15918,0.16301,1,1
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.040234,0.15916,0.17463,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.0689e-05,0.15914,0.17144,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.050569,0.15912,0.16278,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,6.2786e-05,0.15902,0.16168,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,6.7596e-05,0.15902,0.17255,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.2876e-06,0.15893,0.16283,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0019282,0.15892,0.25075,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00069957,0.15887,0.13977,1,1
5,GO REGULATION OF INSULIN SECRETION,0.00087311,0.15883,0.16531,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0054795,0.15877,0.12045,1,1
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0081404,0.15876,0.14305,1,1
5,GO AMINE CATABOLIC PROCESS,0.013465,0.15864,0.18093,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.053746,0.15863,0.085198,1,1
5,GO POSITIVE REGULATION OF GROWTH,5.2837e-06,0.1586,0.16611,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.00036427,0.15852,0.17873,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,5.8301e-05,0.15847,0.15921,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.018836,0.15843,0.14567,1,1
5,GO LIPID OXIDATION,0.0021689,0.15839,0.16606,1,1
5,GO METAL ION HOMEOSTASIS,0.00012512,0.15832,0.14345,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,3.7145e-05,0.1582,0.17914,1,1
5,GO STEROID METABOLIC PROCESS,0.0030654,0.15816,0.1429,1,1
5,GO LYSOSOME LOCALIZATION,0.0031536,0.15809,0.12061,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.0011199,0.15805,0.13774,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,2.5308e-05,0.15789,0.14929,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0087944,0.15747,0.1153,1,1
5,GO B CELL APOPTOTIC PROCESS,0.031748,0.15742,0.2161,1,1
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,7.547e-05,0.1574,0.16079,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00095906,0.15715,0.18272,1,1
5,GO SLEEP,0.00353,0.15709,0.13987,1,1
5,GO AUTOPHAGIC CELL DEATH,0.001872,0.15699,0.21804,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,4.6597e-05,0.15672,0.16794,1,1
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0010528,0.15671,0.17314,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00090094,0.1566,0.15542,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.054842,0.15648,0.087396,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.0027346,0.15615,0.14917,1,1
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.0015653,0.15615,0.19955,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,2.3418e-05,0.15604,0.13513,1,1
5,GO GLUCOSE IMPORT,0.0015653,0.15603,0.13637,1,1
5,GO CELLULAR RESPONSE TO STARVATION,3.4421e-05,0.15595,0.17175,1,1
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.0019282,0.15593,0.15491,1,1
5,GO NERVOUS SYSTEM PROCESS,0.00019079,0.15592,0.14756,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00063551,0.15588,0.11506,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.038561,0.15576,0.11174,1,1
5,GO FEAR RESPONSE,0.052669,0.15555,0.095152,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.036948,0.15553,0.11584,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.011904,0.15549,0.11181,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.016734,0.15535,0.132,1,1
5,GO RESPONSE TO AMYLOID BETA,0.010773,0.15522,0.15231,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.02166,0.15511,0.12644,1,1
5,GO ERK1 AND ERK2 CASCADE,0.00024286,0.15511,0.22985,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00019079,0.15502,0.13393,1,1
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.030383,0.15493,0.1422,1,1
5,GO RESPONSE TO INSULIN,0.0006154,0.15485,0.12093,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.00019753,0.15483,0.15631,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.0047853,0.15478,0.12273,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00040247,0.15465,0.17065,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,2.4346e-05,0.15465,0.13679,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.15454,0.14073,1,1
5,GO EXPLORATION BEHAVIOR,0.02166,0.1545,0.21154,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0001165,0.15413,0.15167,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00054072,0.15409,0.15625,1,1
5,GO SINGLE FERTILIZATION,0.00037661,0.154,0.13326,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,7.2754e-05,0.15394,0.14651,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.004408,0.15366,0.18512,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.011904,0.1536,0.11418,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.017137,0.15357,0.15235,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.017549,0.15346,0.16347,1,1
5,GO RESPONSE TO GROWTH HORMONE,0.050569,0.15337,0.14419,1,1
5,GO HEAD MORPHOGENESIS,0.0057817,0.15322,0.17788,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.7343e-05,0.15316,0.15878,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.00098941,0.15313,0.2034,1,1
5,GO MUSCLE SYSTEM PROCESS,0.00010092,0.153,0.1572,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,0.014486,0.15278,0.17433,1,1
5,GO HORMONE METABOLIC PROCESS,0.00050664,0.15274,0.13668,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.001191,0.15265,0.16704,1,1
5,GO TEMPERATURE HOMEOSTASIS,8.7323e-05,0.15249,0.16102,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0022332,0.15246,0.15451,1,1
5,GO CILIUM MOVEMENT,0.00012512,0.15244,0.16996,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.00017796,0.15237,0.1144,1,1
5,GO SPERM MOTILITY,5.4121e-05,0.1523,0.16222,1,1
5,GO RECEPTOR INTERNALIZATION,0.0022992,0.15215,0.14796,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0029794,0.15203,0.14114,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.026586,0.15189,0.12822,1,1
5,GO REGULATION OF CELL FATE COMMITMENT,0.0073363,0.15188,0.18539,1,1
5,GO FOREBRAIN DEVELOPMENT,0.00065623,0.1514,0.18935,1,1
5,GO SENSORY PERCEPTION,7.547e-05,0.15126,0.14365,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.023205,0.15118,0.15339,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.0079323,0.15114,0.10369,1,1
5,GO CATION TRANSPORT,0.00050664,0.15111,0.13336,1,1
5,GO LIPID CATABOLIC PROCESS,0.0041716,0.15107,0.1227,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00029782,0.15095,0.15785,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.0010859,0.15086,0.13082,1,1
5,GO MULTI ORGANISM PROCESS,2.2524e-05,0.15069,0.1281,1,1
5,GO SEX DIFFERENTIATION,9.7801e-06,0.15067,0.16886,1,1
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.025994,0.15056,0.17501,1,1
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.035393,0.15054,0.15058,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.016339,0.15049,0.11069,1,1
5,GO ORGAN GROWTH,0.0007696,0.15042,0.13105,1,1
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00057693,0.15035,0.15503,1,1
5,GO NEUROMUSCULAR PROCESS,0.0079323,0.15034,0.1513,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00067758,0.15033,0.13103,1,1
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.023205,0.15011,0.15251,1,1
5,GO PROTEIN MATURATION,0.0075304,0.15003,0.10922,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0020453,0.15003,0.14916,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00035231,0.14999,0.17705,1,1
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0051916,0.14975,0.15765,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.027188,0.14971,0.12383,1,1
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.009256,0.14932,0.11572,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.00028792,0.14924,0.14134,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.015953,0.14923,0.253,1,1
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.02068,0.1488,0.18444,1,1
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0099891,0.14877,0.15169,1,1
5,GO MUSCLE CELL PROLIFERATION,0.0032441,0.14873,0.13185,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.013798,0.14871,0.11877,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.009256,0.14861,0.12021,1,1
5,GO HEAD DEVELOPMENT,0.00012074,0.14851,0.1725,1,1
5,GO NUCLEOTIDE PHOSPHORYLATION,0.0075304,0.14849,0.11818,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0062634,0.14794,0.15478,1,1
5,GO CIRCADIAN RHYTHM,1.7118e-05,0.14784,0.13087,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00069957,0.14778,0.12646,1,1
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0047853,0.14774,0.18469,1,1
5,GO RESPONSE TO PEPTIDE,0.00042998,0.14758,0.12198,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00063551,0.14756,0.14039,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.050569,0.14753,0.10283,1,1
5,GO MAINTENANCE OF LOCATION,0.0020453,0.14737,0.12095,1,1
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00092958,0.14728,0.12362,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0054795,0.14725,0.14793,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0060989,0.1472,0.13685,1,1
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0064317,0.14714,0.15532,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,6.0504e-05,0.14695,0.12017,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00012964,0.14694,0.13213,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.025414,0.14692,0.11407,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,2.6307e-05,0.14647,0.13152,1,1
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,1.7118e-05,0.1464,0.1331,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.00011241,0.14636,0.15509,1,1
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.00016023,0.14626,0.17068,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.0011549,0.14614,0.12219,1,1
5,GO ION TRANSPORT,0.00042998,0.14595,0.13066,1,1
5,GO MIDBRAIN DEVELOPMENT,0.00025131,0.14592,0.14527,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0085714,0.14574,0.13509,1,1
5,GO CELL PROJECTION ORGANIZATION,6.0504e-05,0.14571,0.16308,1,1
5,GO ANION TRANSPORT,0.00098941,0.14569,0.10672,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.00067758,0.14563,0.13316,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.00022676,0.14555,0.12125,1,1
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.026586,0.14552,0.11959,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.00017186,0.14525,0.13677,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0006154,0.14516,0.14859,1,1
5,GO KERATINOCYTE MIGRATION,0.012508,0.14506,0.14862,1,1
5,GO REGULATION OF BINDING,4.3218e-05,0.14501,0.13676,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.031059,0.145,0.10986,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.025994,0.14496,0.14293,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0027346,0.14454,0.12196,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,6.0504e-05,0.14437,0.12538,1,1
5,GO OVULATION CYCLE,0.0033369,0.1443,0.15401,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.030383,0.14416,0.090834,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00025131,0.14415,0.1297,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0053338,0.14396,0.11022,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00021909,0.14368,0.1415,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,5.0226e-05,0.14368,0.16956,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.001986,0.14363,0.12014,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.029068,0.14354,0.15015,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0015189,0.14342,0.12679,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00072223,0.14336,0.12806,1,1
5,GO CORNIFICATION,0.05161,0.14315,0.32643,1,1
5,GO NATURAL KILLER CELL PROLIFERATION,0.016339,0.14303,0.17759,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00010092,0.14301,0.13328,1,1
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.033894,0.14297,0.20895,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00022676,0.14295,0.1659,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00050664,0.14288,0.14321,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.012203,0.14252,0.14729,1,1
5,GO NEURON DEVELOPMENT,0.0015189,0.14243,0.17225,1,1
5,GO REGULATION OF CELL SIZE,0.00081984,0.14228,0.16837,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00014935,0.14222,0.16785,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0013054,0.14175,0.11425,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00084609,0.14172,0.18182,1,1
5,GO RESPONSE TO AMINO ACID STARVATION,0.0031536,0.14167,0.14775,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0051916,0.1416,0.096803,1,1
5,GO REGULATION OF DNA BINDING,9.0551e-05,0.14151,0.14233,1,1
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0027346,0.14148,0.16334,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0010859,0.14145,0.14099,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0050528,0.1414,0.10518,1,1
5,GO NEUROGENESIS,0.00026903,0.14126,0.17314,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.0007696,0.14124,0.12112,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.042857,0.14111,0.13428,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.031059,0.14111,0.12387,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0010528,0.14106,0.11045,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,1.6455e-05,0.14103,0.13049,1,1
5,GO HEART TRABECULA MORPHOGENESIS,0.0024367,0.141,0.18456,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.054842,0.14099,0.15269,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.00074557,0.14099,0.13547,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.7474e-06,0.14092,0.13816,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00098941,0.14056,0.13073,1,1
5,GO APOPTOTIC PROCESS,0.00010845,0.1405,0.12516,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00017796,0.14027,0.12542,1,1
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0025083,0.14019,0.12368,1,1
5,GO LYSOSOMAL TRANSPORT,0.0025083,0.14013,0.12895,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,6.7596e-05,0.1401,0.12968,1,1
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.014841,0.13997,0.13115,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.010773,0.13988,0.12775,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.0032441,0.13985,0.15379,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.00047456,0.13973,0.12355,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0028141,0.13967,0.14831,1,1
5,GO RESPONSE TO ETHANOL,0.00098941,0.13955,0.14299,1,1
5,GO CELL RECOGNITION,0.036948,0.1392,0.11897,1,1
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.00049035,0.13914,0.15878,1,1
5,GO DEMETHYLATION,1.5201e-05,0.13904,0.16001,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00084609,0.13896,0.13196,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.00044439,0.13884,0.11861,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.001872,0.13881,0.11003,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.016339,0.13873,0.083173,1,1
5,GO REGULATION OF GTPASE ACTIVITY,0.00067758,0.13863,0.11763,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.022165,0.13848,0.20588,1,1
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.0017641,0.13832,0.14607,1,1
5,GO ENDOCYTIC RECYCLING,0.00072223,0.13822,0.15066,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0016129,0.13817,0.11886,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00021909,0.1381,0.1237,1,1
5,GO NEURON DEATH,1.0184e-05,0.13808,0.15043,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.0018173,0.13794,0.20808,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.00038934,0.13782,0.12217,1,1
5,GO CHEMOSENSORY BEHAVIOR,0.0083534,0.13775,0.24107,1,1
5,GO CATECHOLAMINE SECRETION,0.047551,0.13774,0.25487,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.0073363,0.13766,0.11156,1,1
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.00353,0.13725,0.14222,1,1
5,GO RESPONSE TO SALT,0.0075304,0.13723,0.12205,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00027832,0.13702,0.19674,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.0013054,0.13669,0.11242,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0020453,0.13661,0.11304,1,1
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00084609,0.13661,0.11332,1,1
5,GO NEURON DIFFERENTIATION,0.001191,0.13641,0.17314,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00045924,0.13641,0.10384,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00095906,0.13634,0.1397,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.038561,0.13628,0.10655,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00012964,0.13625,0.1351,1,1
5,GO OUTFLOW TRACT MORPHOGENESIS,0.033166,0.1362,0.16097,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0039469,0.13617,0.12295,1,1
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.021165,0.13616,0.10594,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0094949,0.13599,0.14652,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.015203,0.13598,0.15812,1,1
5,GO CELL PROJECTION ASSEMBLY,7.2754e-05,0.13597,0.1325,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0053338,0.13589,0.10268,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.0028141,0.13577,0.11856,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.0011549,0.13572,0.17123,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0059384,0.13562,0.14188,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.00041602,0.13558,0.11283,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.0013457,0.13464,0.10518,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0001165,0.13451,0.11857,1,1
5,GO REGULATION OF MYELINATION,0.0050528,0.13448,0.14065,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00054072,0.13415,0.127,1,1
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.024288,0.13415,0.10306,1,1
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0030654,0.13407,0.15934,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.00084609,0.134,0.12439,1,1
5,GO PIGMENTATION,0.0054795,0.13377,0.12071,1,1
5,GO RUFFLE ASSEMBLY,0.024288,0.13353,0.12522,1,1
5,GO AXIS SPECIFICATION,0.001986,0.13331,0.17429,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,3.1904e-06,0.13324,0.13998,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.014841,0.13312,0.094225,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.027803,0.13312,0.10607,1,1
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.020205,0.13301,0.14165,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.00047456,0.13299,0.1223,1,1
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.010773,0.13298,0.1009,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.012203,0.13288,0.11333,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.027188,0.13238,0.085818,1,1
5,GO PATTERN SPECIFICATION PROCESS,0.00065623,0.13222,0.15517,1,1
5,GO REGULATION OF LYASE ACTIVITY,0.033166,0.13198,0.11507,1,1
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0045306,0.13192,0.12337,1,1
5,GO PROTEOLYSIS,0.0019282,0.13189,0.096603,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00029782,0.13183,0.1333,1,1
5,GO TRABECULA MORPHOGENESIS,0.0075304,0.13178,0.12705,1,1
5,GO SMOOTHENED SIGNALING PATHWAY,0.00067758,0.13175,0.15039,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0030654,0.13169,0.10965,1,1
5,GO ADAPTIVE THERMOGENESIS,0.00035231,0.13151,0.14577,1,1
5,GO REGULATION OF CELL DEATH,0.00021909,0.1314,0.12169,1,1
5,GO ENDOCYTOSIS,0.0017641,0.1314,0.11405,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.038561,0.13129,0.12229,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,0.0019282,0.13088,0.11523,1,1
5,GO RESPONSE TO ALCOHOL,0.0039469,0.13083,0.113,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0039469,0.1307,0.11411,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.007729,0.13062,0.092164,1,1
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.011904,0.13051,0.11845,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.0025817,0.13042,0.1222,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.030383,0.13041,0.14158,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.0042883,0.13038,0.15554,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.02268,0.13033,0.12362,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.042857,0.13014,0.19308,1,1
5,GO REGULATION OF CELL DIVISION,0.00040247,0.12999,0.12451,1,1
5,GO MUSCLE CONTRACTION,0.00031859,0.12987,0.15406,1,1
5,GO B CELL PROLIFERATION,0.045624,0.1298,0.14453,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.00090094,0.12977,0.12834,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.024846,0.12974,0.091171,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0041716,0.12973,0.12265,1,1
5,GO MEMBRANE ORGANIZATION,0.0024367,0.12969,0.10305,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.014138,0.12953,0.11844,1,1
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0062634,0.12936,0.15152,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0075304,0.12925,0.11954,1,1
5,GO SYNAPTIC SIGNALING,0.0054795,0.12849,0.16748,1,1
5,GO GERM CELL DEVELOPMENT,0.00010092,0.12849,0.13588,1,1
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.035393,0.1284,0.095322,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0056288,0.12836,0.088684,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0017123,0.12836,0.10663,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.017969,0.12816,0.1179,1,1
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0021689,0.12811,0.15847,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,8.1192e-05,0.12799,0.093861,1,1
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0021689,0.12783,0.15545,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,9.389e-05,0.12764,0.13453,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0045306,0.12758,0.12954,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0030654,0.12758,0.17719,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00055855,0.12754,0.11538,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,8.1192e-05,0.12752,0.12985,1,1
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.035393,0.12739,0.093226,1,1
5,GO POSTREPLICATION REPAIR,0.011326,0.12734,0.10021,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.031059,0.12684,0.095095,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.0039469,0.12661,0.1233,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00067758,0.1266,0.11652,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.001228,0.12657,0.14589,1,1
5,GO REGULATION OF VACUOLE ORGANIZATION,0.0075304,0.1265,0.11779,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.03939,0.12636,0.089041,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.015574,0.12632,0.17433,1,1
5,GO GLUCOSE METABOLIC PROCESS,0.00031859,0.1263,0.12225,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0013872,0.12602,0.14323,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0060989,0.126,0.13263,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00026903,0.1259,0.14359,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.01282,0.12574,0.11013,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00019079,0.12535,0.11718,1,1
5,GO RHYTHMIC PROCESS,6.2786e-05,0.12504,0.11752,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.017137,0.12493,0.17878,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.015203,0.12485,0.13791,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0007696,0.12475,0.13176,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.018836,0.12464,0.096727,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0081404,0.12439,0.096985,1,1
5,GO AMYLOID FIBRIL FORMATION,0.02166,0.12439,0.23001,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,3.8583e-05,0.12412,0.12076,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.00084609,0.12379,0.12223,1,1
5,GO OOGENESIS,0.001872,0.12328,0.11556,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.010773,0.12271,0.109,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.054842,0.12266,0.095079,1,1
5,GO CELLULAR HOMEOSTASIS,0.0012662,0.12261,0.10807,1,1
5,GO REGULATION OF PROTEIN BINDING,0.00035231,0.12256,0.14043,1,1
5,GO ACID SECRETION,0.0069616,0.12226,0.18527,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,1.4044e-06,0.12219,0.12695,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.022165,0.12218,0.13229,1,1
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.010773,0.1221,0.16932,1,1
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0064317,0.12198,0.13058,1,1
5,GO RHYTHMIC BEHAVIOR,0.029719,0.12161,0.086777,1,1
5,GO SIGNAL RELEASE,0.00021909,0.12149,0.15777,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.018836,0.12139,0.11388,1,1
5,GO STEM CELL DIFFERENTIATION,0.0011199,0.12139,0.11443,1,1
5,GO CARBOHYDRATE TRANSPORT,0.00087311,0.12131,0.1301,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.05161,0.12103,0.080967,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0024367,0.12072,0.1527,1,1
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.019283,0.1207,0.13643,1,1
5,GO PHOSPHATE ION TRANSPORT,0.055956,0.1206,0.083681,1,1
5,GO GOLGI ORGANIZATION,0.020205,0.12045,0.074523,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0042883,0.12043,0.11676,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0022992,0.12041,0.11663,1,1
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.03939,0.12033,0.087938,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0017641,0.12002,0.12054,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.11973,0.12459,1,1
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.042857,0.11959,0.065885,1,1
5,GO SOMITE DEVELOPMENT,0.017137,0.11957,0.12227,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.014486,0.11914,0.086744,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00014935,0.11911,0.11394,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.001228,0.11897,0.12049,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.013139,0.11893,0.12047,1,1
5,GO SEXUAL REPRODUCTION,8.1192e-05,0.11867,0.11844,1,1
5,GO HISTONE H2A UBIQUITINATION,0.021165,0.11843,0.099866,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00038934,0.1182,0.12114,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.001191,0.11795,0.12471,1,1
5,GO RESPONSE TO CHEMOKINE,0.009256,0.1177,0.11089,1,1
5,GO ORGANIC ANION TRANSPORT,0.0028957,0.11766,0.096723,1,1
5,GO PROTEIN DESTABILIZATION,0.015574,0.11766,0.099227,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.038561,0.1175,0.075326,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0017641,0.11744,0.12569,1,1
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.0015653,0.11739,0.17959,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.2658e-06,0.11732,0.11372,1,1
5,GO RUFFLE ORGANIZATION,0.047551,0.1173,0.10302,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,3.5759e-05,0.11714,0.12007,1,1
5,GO T CELL LINEAGE COMMITMENT,0.040234,0.11698,0.094652,1,1
5,GO CEREBRAL CORTEX DEVELOPMENT,0.014138,0.11657,0.13499,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013139,0.11627,0.11948,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.013139,0.11597,0.097574,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,1.7118e-05,0.11554,0.10873,1,1
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.0059384,0.11546,0.10315,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0073363,0.11543,0.11232,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0066042,0.1154,0.10416,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0028141,0.11535,0.087781,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0099891,0.11527,0.14185,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.016734,0.11515,0.14146,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.010245,0.11513,0.094534,1,1
5,GO POSITIVE REGULATION OF BINDING,0.0081404,0.11472,0.097023,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0013457,0.1146,0.12898,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0011199,0.11455,0.11488,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.0006154,0.11431,0.09693,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00042998,0.11417,0.10633,1,1
5,GO B CELL HOMEOSTASIS,0.035393,0.11384,0.15079,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0025083,0.11371,0.098324,1,1
5,GO DEFENSE RESPONSE TO FUNGUS,0.02843,0.11356,0.17776,1,1
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.0039469,0.11314,0.16497,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.0017641,0.11312,0.1364,1,1
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.010773,0.11309,0.17776,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0012662,0.11295,0.11307,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.043763,0.11293,0.071287,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.0018173,0.11263,0.093586,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00012074,0.11258,0.11964,1,1
5,GO FERTILIZATION,0.001191,0.11209,0.11006,1,1
5,GO RESPONSE TO ACTIVITY,0.0038387,0.11194,0.11866,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.010245,0.11168,0.084958,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0033369,0.11156,0.11613,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.01282,0.11153,0.11209,1,1
5,GO LIMBIC SYSTEM DEVELOPMENT,0.0062634,0.11151,0.15414,1,1
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0064317,0.11148,0.11706,1,1
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.045624,0.11146,0.1222,1,1
5,GO LENS FIBER CELL DEVELOPMENT,0.049546,0.11107,0.21797,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.011326,0.11091,0.099927,1,1
5,GO BONE RESORPTION,0.025414,0.11088,0.16765,1,1
5,GO CELL FATE COMMITMENT,0.00045924,0.11084,0.17669,1,1
5,GO DEPHOSPHORYLATION,0.00012512,0.11064,0.10949,1,1
5,GO GAMETE GENERATION,0.00012964,0.11053,0.11845,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.0099891,0.11037,0.14505,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.0075304,0.11034,0.11579,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00098941,0.11017,0.13274,1,1
5,GO TELENCEPHALON DEVELOPMENT,0.0094949,0.10935,0.1591,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00054072,0.1093,0.11331,1,1
5,GO CYTOSKELETON ORGANIZATION,0.00019753,0.10916,0.11968,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0020453,0.10904,0.11467,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0037331,0.10904,0.10683,1,1
5,GO REGULATION OF AUTOPHAGY,0.0011199,0.10868,0.096791,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0017123,0.10859,0.11372,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.029719,0.10781,0.077882,1,1
5,GO DNA DEALKYLATION,0.015953,0.10746,0.13211,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.0017641,0.10732,0.092626,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.017969,0.10723,0.089775,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0050528,0.10716,0.10577,1,1
5,GO PROTEIN LOCALIZATION TO CILIUM,0.015574,0.10677,0.12803,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00055855,0.10669,0.097604,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.025994,0.10629,0.13574,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.011904,0.10611,0.099459,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.023205,0.1054,0.093413,1,1
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.016339,0.1052,0.095514,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.015574,0.10514,0.094355,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00090094,0.10483,0.10772,1,1
5,GO HISTONE H3 K9 DEMETHYLATION,0.052669,0.10439,0.17285,1,1
5,GO GLOMERULUS DEVELOPMENT,0.02843,0.10388,0.15148,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0066042,0.10351,0.15439,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.024846,0.10335,0.14434,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.015203,0.10301,0.095477,1,1
5,GO SPECIFICATION OF SYMMETRY,0.00098941,0.10296,0.1226,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.045624,0.10272,0.060476,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.00069957,0.10265,0.099265,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.046579,0.10221,0.084081,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.017549,0.10195,0.085665,1,1
5,GO MYOFIBRIL ASSEMBLY,0.0051916,0.10177,0.13424,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.2367e-06,0.10144,0.10066,1,1
5,GO BICARBONATE TRANSPORT,0.035393,0.10133,0.16358,1,1
5,GO CELL CYCLE ARREST,0.0010528,0.10088,0.099012,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.0047853,0.10083,0.11599,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.043763,0.10081,0.073495,1,1
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.017549,0.10072,0.085869,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0045306,0.1007,0.11864,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02166,0.1006,0.10535,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0064317,0.10038,0.074943,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.0028957,0.10027,0.10522,1,1
5,GO MALE GAMETE GENERATION,0.00026003,0.099246,0.11538,1,1
5,GO REGULATION OF T CELL MIGRATION,0.0057817,0.099242,0.12135,1,1
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00098941,0.09922,0.10544,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0087944,0.099192,0.16115,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,9.7346e-05,0.098771,0.1049,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0022992,0.098345,0.097377,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,8.4205e-05,0.098029,0.10098,1,1
5,GO AGING,0.020205,0.097676,0.086052,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.026586,0.09748,0.14273,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.012203,0.097146,0.086035,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0015653,0.096828,0.099937,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0045306,0.096687,0.11353,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.00090094,0.095754,0.075254,1,1
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.040234,0.09568,0.1221,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00028792,0.095538,0.1431,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.004408,0.09484,0.084207,1,1
5,GO REGULATION OF TOR SIGNALING,0.0013054,0.094837,0.10067,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0028957,0.094816,0.13417,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.015574,0.09465,0.11945,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,0.094331,0.083555,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.001662,0.094326,0.096694,1,1
5,GO CALCIUM ION IMPORT,0.01282,0.093836,0.14003,1,1
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.027188,0.093596,0.12172,1,1
5,GO CELLULAR RESPONSE TO RADIATION,0.031748,0.093348,0.057404,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0067808,0.091673,0.087245,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0054795,0.091651,0.072651,1,1
5,GO REGULATION OF PH,0.023205,0.091447,0.068791,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.019739,0.090498,0.099155,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0017123,0.089441,0.079964,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0071468,0.089362,0.12104,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.0056288,0.089207,0.090966,1,1
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.023205,0.089113,0.079422,1,1
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0056288,0.088871,0.12403,1,1
5,GO ORGANIC ACID TRANSPORT,0.019283,0.088257,0.066943,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.014138,0.08794,0.091763,1,1
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.011904,0.087691,0.0844,1,1
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.017549,0.087668,0.13638,1,1
5,GO REGULATION OF CYCLASE ACTIVITY,0.034637,0.087212,0.13392,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0050528,0.086812,0.072222,1,1
5,GO MACROMOLECULE DEACYLATION,0.0020453,0.085935,0.088244,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.02068,0.085563,0.1556,1,1
5,GO HIPPOCAMPUS DEVELOPMENT,0.035393,0.085294,0.13531,1,1
5,GO VESICLE ORGANIZATION,0.031748,0.085221,0.073685,1,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.011612,0.084601,0.085086,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.024846,0.08421,0.1592,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.044685,0.083753,0.092407,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0064317,0.083568,0.078927,1,1
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.02166,0.083512,0.10046,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE,0.0007696,0.082993,0.074265,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.015203,0.081522,0.094452,1,1
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.052669,0.081285,0.11135,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.017137,0.08092,0.069066,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.013139,0.079737,0.19389,1,1
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.0083534,0.079329,0.10975,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.027803,0.079261,0.068895,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0057817,0.077498,0.077274,1,1
5,GO HEART GROWTH,0.017549,0.076523,0.10268,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.023205,0.076109,0.099763,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.045624,0.075945,0.14581,1,1
5,GO RESPONSE TO LIGHT STIMULUS,0.015953,0.075622,0.057164,1,1
5,GO PEPTIDYL THREONINE MODIFICATION,0.040234,0.074804,0.068302,1,1
5,GO MICROTUBULE BASED MOVEMENT,0.018398,0.073812,0.081188,1,1
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.019739,0.071923,0.075693,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0025817,0.071713,0.073711,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.024288,0.070075,0.078499,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.036948,0.069286,0.065638,1,1
5,GO DNA CATABOLIC PROCESS,0.040234,0.069039,0.067377,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.013139,0.067488,0.069906,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.020205,0.067344,0.075167,1,1
5,GO SPERMATID DIFFERENTIATION,0.0018173,0.067195,0.11161,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0037331,0.064353,0.08886,1,1
5,GO REGULATION OF EXOCYTOSIS,0.033166,0.063527,0.1273,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0015189,0.061494,0.064379,1,1
5,GO TOR SIGNALING,0.0087944,0.060726,0.065304,1,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.050569,0.059121,0.07459,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.021165,0.056726,0.054126,1,1
5,GO REGULATION OF CELL CYCLE,0.0025083,0.05389,0.055456,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.017137,0.053726,0.059142,1,1
5,GO CELL CYCLE,0.037747,0.043089,0.038775,1,1
6,GO FOREBRAIN NEURON FATE COMMITMENT,3.3132e-05,0.73192,0.85109,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00098941,0.51584,0.43184,1,1
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00087311,0.45703,0.44827,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00037661,0.45535,0.49967,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.011904,0.45069,0.37421,1,1
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.014841,0.43031,0.31298,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,3.5759e-05,0.39074,0.448,1,1
6,GO NEURON FATE COMMITMENT,2.0033e-05,0.38593,0.42326,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00036427,0.37051,0.36109,1,1
6,GO SPINAL CORD PATTERNING,0.00084609,0.35532,0.35146,1,1
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0020453,0.35448,0.33071,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00049035,0.33125,0.35724,1,1
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.018836,0.31501,0.24453,1,1
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.4878e-05,0.29094,0.37931,1,1
6,GO NOSE DEVELOPMENT,0.00353,0.28387,0.44223,1,1
6,GO GDP METABOLIC PROCESS,0.05161,0.28053,0.18573,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.022165,0.27874,0.22835,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.009256,0.2714,0.35031,1,1
6,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00018427,0.26317,0.23519,1,1
6,GO GENETIC IMPRINTING,0.0001547,0.25871,0.25477,1,1
6,GO MRNA SPLICE SITE SELECTION,9.0179e-06,0.25779,0.29662,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00353,0.25472,0.21321,1,1
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0099891,0.25445,0.20113,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.25061,0.21502,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.024288,0.24932,0.24109,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0075304,0.24014,0.3144,1,1
6,GO VIRAL LATENCY,0.0042883,0.23801,0.19469,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0022332,0.23757,0.2029,1,1
6,GO KINETOCHORE ORGANIZATION,0.0062634,0.23327,0.18494,1,1
6,GO MEGAKARYOCYTE DEVELOPMENT,0.023205,0.22117,0.21043,1,1
6,GO KINETOCHORE ASSEMBLY,0.011612,0.22035,0.16201,1,1
6,GO CELL MIGRATION IN HINDBRAIN,0.040234,0.22009,0.17935,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,0.0046564,0.21515,0.15872,1,1
6,GO SINGLE STRAND BREAK REPAIR,0.0034322,0.21509,0.17425,1,1
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0097392,0.21392,0.19931,1,1
6,GO HISTONE H4 K16 ACETYLATION,7.9801e-06,0.21251,0.23235,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0007696,0.20918,0.22266,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,0.001872,0.20273,0.18606,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.004408,0.20111,0.16519,1,1
6,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0097392,0.197,0.16307,1,1
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.027803,0.19044,0.17106,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00035231,0.18908,0.17086,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00027832,0.18532,0.18874,1,1
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0031536,0.18185,0.15044,1,1
6,GO HISTONE H4 K5 ACETYLATION,0.00011241,0.17844,0.22651,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.026586,0.17694,0.12292,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0060989,0.17428,0.15715,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00087311,0.17415,0.16394,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00013433,0.17326,0.17998,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0010528,0.17228,0.16334,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00072223,0.17221,0.16973,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,0.0010206,0.16842,0.18492,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.034637,0.1682,0.1365,1,1
6,GO CEREBELLAR CORTEX MORPHOGENESIS,0.027803,0.16694,0.13963,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0017641,0.16668,0.18627,1,1
6,GO TELENCEPHALON REGIONALIZATION,0.045624,0.16516,0.26758,1,1
6,GO SPINAL CORD DEVELOPMENT,0.0085714,0.16356,0.13818,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.037747,0.15956,0.16048,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,0.0056288,0.15933,0.14128,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.055956,0.158,0.11887,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0094949,0.15284,0.11647,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.020205,0.1525,0.14234,1,1
6,GO MITOTIC SISTER CHROMATID COHESION,0.0042883,0.15103,0.16939,1,1
6,GO ESCRT COMPLEX DISASSEMBLY,0.04854,0.15078,0.12932,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,0.00034072,0.14936,0.19726,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0007696,0.14674,0.1531,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0032441,0.14432,0.12346,1,1
6,GO HISTONE H2A ACETYLATION,0.00026903,0.14419,0.18664,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0012662,0.14322,0.15234,1,1
6,GO RETROGRADE AXONAL TRANSPORT,0.013139,0.14261,0.16907,1,1
6,GO DORSAL VENTRAL PATTERN FORMATION,0.0067808,0.14087,0.14206,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.049546,0.14012,0.1059,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0036303,0.13993,0.13846,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,0.0069616,0.13756,0.13577,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0066042,0.13695,0.15578,1,1
6,GO NUCLEOSOME ASSEMBLY,0.0037331,0.13487,0.13886,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.037747,0.13456,0.13376,1,1
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0051916,0.13346,0.15907,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00016023,0.13182,0.14422,1,1
6,GO HISTONE EXCHANGE,0.013465,0.13085,0.10882,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.010506,0.12863,0.17398,1,1
6,GO HISTONE H3 K9 ACETYLATION,0.055956,0.12512,0.077122,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.054842,0.12123,0.087401,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0066042,0.12098,0.10935,1,1
6,GO HISTONE H4 ACETYLATION,0.00013433,0.11952,0.12798,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.0024367,0.11811,0.12892,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.031059,0.11504,0.07915,1,1
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.053746,0.11466,0.093333,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0038387,0.11379,0.1201,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,7.547e-05,0.11264,0.13793,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0075304,0.11063,0.13901,1,1
6,GO HISTONE H3 K4 METHYLATION,0.00095906,0.10834,0.15222,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.015953,0.10752,0.099032,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0013872,0.10656,0.10721,1,1
6,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0056288,0.10605,0.099486,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.014841,0.10452,0.091512,1,1
6,GO NUCLEOSOME ORGANIZATION,0.0026572,0.10243,0.10649,1,1
6,GO REPLICATION FORK PROCESSING,0.019283,0.10103,0.093241,1,1
6,GO HISTONE H2A UBIQUITINATION,0.026586,0.099834,0.10552,1,1
6,GO REGULATION OF MRNA PROCESSING,0.023205,0.099215,0.07496,1,1
6,GO HISTONE H3 K9 METHYLATION,0.034637,0.097482,0.10901,1,1
6,GO HISTONE MONOUBIQUITINATION,0.0066042,0.093619,0.09856,1,1
6,GO PEPTIDYL LYSINE METHYLATION,0.0069616,0.093503,0.092374,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,0.0001165,0.093328,0.09633,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.02068,0.09331,0.087296,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.018836,0.092093,0.086271,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.02166,0.09197,0.074868,1,1
6,GO SISTER CHROMATID COHESION,0.0079323,0.091481,0.11709,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.0050528,0.085769,0.11654,1,1
6,GO PROTEIN ACETYLATION,0.0022992,0.085217,0.067771,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,0.010506,0.082791,0.093656,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.034637,0.081689,0.098053,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.025994,0.081414,0.081536,1,1
6,GO RECOMBINATIONAL REPAIR,0.0094949,0.078542,0.073622,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0073363,0.07494,0.093764,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.02166,0.072404,0.068573,1,1
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.021165,0.069938,0.096137,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.041093,0.069155,0.072929,1,1
6,GO REGULATION OF DNA REPAIR,0.019739,0.066759,0.062184,1,1
6,GO CHROMATIN REMODELING,0.033166,0.0633,0.067563,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.047551,0.057433,0.097255,1,1
6,GO REGULATION OF RNA SPLICING,0.037747,0.056808,0.051269,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,0.037747,0.054375,0.041699,1,1
6,GO CHROMATIN ORGANIZATION,0.036164,0.044399,0.046437,1,1
